(S1 (S (NP (NP (NN Generation)) (PP (IN of) (NP (NP (JJ CD1+RelB+) (JJ dendritic) (NNS cells)) (CC and) (NP (ADJP (JJ tartrate-resistant) (NN acid) (JJ phosphatase-positive)) (JJ osteoclast-like) (JJ multinucleated) (JJ giant) (NNS cells)))) (PP (IN from) (NP (JJ human) (NNS monocytes))) (. .))))
(S1 (S (S (NP (PRP We)) (ADVP (RB previously)) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (NP (JJ granulocyte-macrophage) (JJ colony-stimulating) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN GM-CSF)) (-RRB- -RRB-))) (CC and) (NP (NP (NN macrophage) (JJ colony-stimulating) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN M-CSF)) (-RRB- -RRB-)))) (VP (VBP stimulate) (NP (NP (DT the) (NN differentiation)) (PP (IN of) (NP (JJ human) (NNS monocytes))) (PP (IN into) (NP (NP (CD two) (ADJP (RB phenotypically) (JJ distinct)) (NNS types)) (PP (IN of) (NP (NNS macrophages)))))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (ADVP (FW in) (FW vivo)) (, ,) (NP (CONJP (RB not) (RB only)) (NP (NN CSF)) (CONJP (CC but) (RB also)) (NP (JJ many) (JJ other) (NNS cytokines))) (VP (VBP are) (VP (VBN produced) (PP (IN under) (NP (JJ various) (NNS conditions))))) (. .))))
(S1 (S (S (NP (DT Those) (NNS cytokines)) (VP (MD may) (VP (VB modulate) (NP (NP (DT the) (NN differentiation)) (PP (IN of) (NP (NNS monocytes))) (PP (IN by) (NP (NNS CSFs)))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP (PRP we)) (VP (VBD showed) (SBAR (SBAR (IN that) (S (NP (JJ CD14+) (JJ adherent) (JJ human) (NNS monocytes)) (VP (MD can) (VP (VB differentiate) (PP (IN into) (NP (JJ CD1+relB+) (NP (NP (JJ dendritic) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN DC)) (-RRB- -RRB-))))) (PP (IN by) (NP (NP (DT the) (NN combination)) (PP (IN of) (NP (NP (NN GM-CSF)) (CC plus) (NP (NP (NN interleukin-4)) (PRN (-LRB- -LRB-) (NP (NN IL-4)) (-RRB- -RRB-))))))))))) (CC and) (SBAR (IN that) (S (NP (PRP they)) (VP (VBP differentiate) (PP (IN into) (NP (ADJP (JJ tartrate-resistant) (NN acid) (NN phosphatase) (-LRB- -LRB-) (NN TRAP) (-RRB- -RRB-) (JJ -positive)) (JJ osteoclast-like) (NP (NP (JJ multinucleated) (JJ giant) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN MGC)) (-RRB- -RRB-))))) (PP (IN by) (NP (NP (DT the) (NN combination)) (PP (IN of) (NP (NP (NN M-CSF)) (CC plus) (NP (NN IL-4))))))))))) (. .))))
(S1 (S (S (S (ADVP (RB However)) (, ,) (NP (DT the) (JJ monocyte-derived) (NN DC)) (VP (VBD were) (RB not) (NP (ADJP (RB terminally) (VBN differentiated)) (NNS cells))) (: ;)) (S (NP (PRP they)) (VP (MD could) (VP (ADVP (RB still)) (VB convert) (PP (TO to) (NP (NNS macrophages))) (PP (IN in) (NN response) (TO to) (NP (NN M-CSF))))) (. .)))))
(S1 (S (S (NP (NP (NN Tumor) (NN necrosis) (NN factor-alpha)) (PRN (-LRB- -LRB-) (NP (NN TNF-alpha)) (-RRB- -RRB-))) (VP (VBD stimulated) (NP (NP (DT the) (JJ terminal) (NN differentiation)) (PP (IN of) (NP (DT the) (NN DC)))) (PP (IN by) (S (VP (VP (VBG downregulating) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (DT the) (NN M-CSF) (NN receptor)) (, ,) (NP (NN cfms) (NN mRNA)))))) (, ,) (CC and) (VP (VBG aborting) (NP (DT the) (NN potential) (S (VP (TO to) (VP (VB convert) (PP (TO to) (NP (NNS macrophages)))))))))))) (. .))))
(S1 (S (S (PP (IN In) (NN contrast) (TO to) (NP (NN IL-4))) (, ,) (NP (NP (NN interferon-gamma)) (PRN (-LRB- -LRB-) (NP (NN IFN-gamma)) (-RRB- -RRB-))) (VP (VBD had) (NP (DT no) (JJ demonstrable) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN differentiation)) (PP (IN of) (NP (NNS monocytes)))))) (. .))))
(S1 (S (S (ADVP (RB Rather)) (, ,) (NP (NN IFN-gamma)) (VP (VP (VBD antagonized) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN IL-4))))) (CC and) (VP (VBD suppressed) (NP (NP (DT the) (NP (NP (NN DC)) (CC and) (NP (NN MGC))) (NN formation)) (VP (VBN induced) (PP (IN by) (NP (NP (NP (NP (NN GM-CSF)) (CC +) (NP (NN IL-4))) (CC and) (NP (NP (NN M-CSF)) (CC +) (NP (NN IL-4)))) (, ,) (ADVP (RB respectively)))))))) (. .))))
(S1 (S (S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (NP (DT these) (NNS results)) (VP (VP (VBP provide) (NP (DT a) (JJ new) (NN aspect)) (PP (TO to) (NP (NP (PRP$ our) (NN knowledge)) (PP (IN of) (NP (NN monocyte) (NN differentiation)))))) (CC and) (VP (VBP provide) (NP (NN evidence) (SBAR (IN that) (S (NP (JJ human) (NNS monocytes)) (VP (VP (VBP are) (ADJP (JJ flexible)) (PP (IN in) (NP (PRP$ their) (NN differentiation) (NN potential)))) (CC and) (VP (VBP are) (NP (NP (NNS precursors)) (PP (CONJP (RB not) (RB only)) (PP (IN of) (NP (NNS macrophages))) (CONJP (CC but) (RB also)) (PP (IN of) (NP (NP (NN CD1+relB+DC)) (CC and) (NP (JJ TRAP-positive) (NN MGC))))))))))))) (. .))))
(S1 (S (S (NP (NP (PDT Such) (DT a) (JJ diverse) (NN pathway)) (PP (IN of) (NP (NN monocyte) (NN differentiation)))) (VP (MD may) (VP (VB constitute) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (JJ basic) (NNS mechanisms)) (PP (IN of) (NP (JJ immune) (NN regulation)))))))) (. .))))
(S1 (S (NP (NP (NP (NN Regulation)) (PP (IN of) (NP (NP (NN -LSB-Ca2+-RSB-i) (NN rise)) (VP (VBN activated) (PP (IN by) (NP (NP (JJ doxepin-sensitive) (JJ H1-histamine) (NNS receptors)) (PP (IN in) (NP (NP (NN Jurkat) (NNS cells)) (, ,) (NP (VBN cloned) (JJ human) (NN T) (NNS lymphocytes))))))))) (. .)))))
(S1 (S (S (S (S (VP (TO To) (VP (VB clarify) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (NN histamine) (NN receptor)) (CC and) (NP (PRP$ its) (JJ transmembrane) (NN mechanism)))) (PP (IN in) (NP (JJ human) (NN T) (NNS lymphocytes))))))) (, ,) (S (NP (PRP we)) (VP (VBD investigated) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (NP (NNS agonists)) (CC or) (NP (NNS antagonists))) (PP (IN of) (NP (NP (NP (NN histamine) (NN receptor)) (NNS subtypes)) (CC and) (NP (JJ bacterial) (NNS toxins)))))) (PP (IN on) (NP (NP (NP (NP (NP (JJ intracellular) (NN concentration)) (PP (IN of) (NP (NN Ca2+)))) (NP (NN -LSB-Ca2+-RSB-i) (-RRB- -RRB-))) (, ,) (NP (NN -LSB-3H-RSB-pyrilamine) (NN binding)) (CC and) (NP (NP (NN c-fos) (NN mRNA)) (NN expression))) (PP (IN in) (NP (NP (NN Jurkat) (NNS cells)) (, ,) (NP (VBN cloned) (NP (JJ human) (NN T) (NNS lymphocytes)))))))))) (. .)))))
(S1 (S (S (S (NP (NP (NNS H1-agonists)) (PRN (-LRB- -LRB-) (NP (NP (NN histamine)) (CC and) (NP (NN 2-methylhistamine))) (-RRB- -RRB-))) (VP (VBD caused) (NP (NP (DT a) (JJ transient) (NN rise)) (PP (IN of) (NP (NN -LSB-Ca2+-RSB-)))))) (, ,) (CC and) (S (NP (NP (NNS H1-antagonists)) (PRN (-LRB- -LRB-) (NP (NP (NN pyrilamine)) (CC and) (NP (NN doxepin))) (-RRB- -RRB-))) (VP (VBD inhibited) (NP (DT the) (JJ histamine-induced) (NN -LSB-Ca2+-RSB-i) (NN rise)) (ADVP (ADVP (RBR more) (RB potently)) (SBAR (IN than) (S (NP (NP (DT the) (NN H2-antagonist)) (PRN (-LRB- -LRB-) (NP (NN cimetidine)) (-RRB- -RRB-))) (PP (IN on) (NP (NP (DT the) (NN H3-antagonist)) (PRN (-LRB- -LRB-) (NP (NN impromidine)) (-RRB- -RRB-))))))))) (. .))))
(S1 (S (S (NP (NP (NN Binding) (NNS parameters)) (PP (IN of) (NP (NN -LSB-3H-RSB-pyrilamine) (NN binding)))) (VP (VBD were) (NP (NP (NP (NP (NN Kd)) (ADJP (JJ =) (NP (CD 5.53) (NN nM)))) (CC and) (NP (NP (NN Bmax)) (ADJP (JJ =) (NP (CD 2))))) (, ,) (NP (CD 647) (NNS sites/cell)))) (. .))))
(S1 (S (S (NP (NP (NN Pretreatment)) (PP (IN with) (NP (NP (FW B.pertussis)) (, ,) (NP (FW V.cholera.)) (CC or) (NP (FW C.botulinum)) (NP (NN toxin))))) (VP (VBD did) (RB not) (VP (VB influence) (NP (JJ histamine-induced) (NN -LSB-Ca2+-RSB-i) (NN rise)))) (. .))))
(S1 (S (S (NP (NP (NN Western) (NN Blot) (NN analysis)) (VP (VBG using) (NP (NP (NNS antibodies)) (PP (IN against) (NP (NP (NNS subunits)) (PP (IN of) (NP (JJ GTP-binding) (NNS proteins)))))))) (VP (VBD indicated) (SBAR (IN that) (S (NP (NN Gq/G11)) (ADVP (RB richly)) (VP (VBD existed) (PP (IN in) (NP (NN Jurkat) (NNS cells))))))) (. .))))
(S1 (S (S (NP (NN Histamine)) (VP (VBD induced) (NP (NP (NP (NN mRNA)) (NN expression)) (PP (IN of) (NP (NP (DT an) (NP (JJ immediate) (JJ early) (NN gene))) (NP (NN c-fos)))))) (. .))))
(S1 (S (S (NP (NP (NN Pretreatment)) (PP (IN with) (NP (NP (DT a) (NP (NN protein) (NN kinase) (NN C)) (NN activator)) (, ,) (NP (NN phorbol) (NN 12-myristate) (NN 13-acetate)))) (, ,)) (VP (VP (VBD caused) (NP (NP (ADJP (RB almost) (JJ complete)) (NN inhibition)) (PP (IN of) (NP (JJ histamine-induced) (NN -LSB-Ca2+-RSB-i) (NN rise))))) (, ,) (CC but) (VP (VBD did) (RB not) (VP (VB do) (ADVP (RB so)) (PP (IN by) (NP (NP (NNS activators)) (PP (IN of) (NP (NP (NN cAMP-)) (CC and) (NP (JJ cGMP-dependent)) (NP (NN protein) (NNS kinases))))))))) (. .))))
(S1 (S (NP (NP (NN T) (NN cell) (NN response)) (PP (TO to) (NP (JJ Epstein-Barr) (NN virus) (NNS transactivators))) (PP (IN in) (NP (JJ chronic) (JJ rheumatoid) (NN arthritis))) (. .))))
(S1 (S (S (NP (JJ Rheumatoid) (NN arthritis)) (VP (VBZ is) (NP (NP (DT a) (JJ multistep) (NN disorder)) (VP (VBN associated) (PP (IN with) (NP (NP (JJ autoimmune) (NNS features)) (PP (IN of) (NP (ADJP (RB yet) (JJ unknown)) (NN etiology)))))))) (. .))))
(S1 (S (S (S (NP (NP (NN Implication)) (PP (IN of) (NP (NP (NNS viruses)) (PP (JJ such) (IN as) (NP (NP (JJ Epstein-Barr) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN EBV)) (-RRB- -RRB-)))))) (PP (IN in) (NP (JJ rheumatoid) (NN arthritis) (NN pathogenesis)))) (VP (VBZ has) (VP (VBN been) (VP (VBN suspected) (PP (IN on) (DT the) (NN basis) (IN of) (NP (JJ several) (JJ indirect) (NNS observations))))))) (, ,) (CC but) (S (ADVP (RB thus) (RB far)) (, ,) (NP (NP (DT a) (JJ direct) (NN link)) (PP (IN between) (NP (NP (NN EBV)) (CC and) (NP (JJ rheumatoid) (NN arthritis))))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN provided))))) (. .))))
(S1 (S (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT a) (JJ large) (NN fraction)) (PP (IN of) (NP (NN T) (NNS cells))) (VP (VBG infiltrating) (NP (NP (VBN affected) (NNS joints)) (PP (IN from) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (JJ chronic) (JJ rheumatoid) (NN arthritis)))))))) (VP (VBZ recognizes) (NP (NP (CD two) (NN EBV) (NNS transactivators)) (PRN (-LRB- -LRB-) (NP (NP (NN BZLF1)) (CC and) (NP (NN BMLF1))) (-RRB- -RRB-))) (PP (IN in) (NP (DT a) (ADJP (JJ major) (NN histocompatibility) (JJ complex-restricted)) (NN fashion))))))) (. .))))
(S1 (S (S (NP (NP (NNS Responses)) (PP (TO to) (NP (DT these) (NN EBV) (NNS antigens))) (PP (IN by) (NP (NP (JJ synovial) (NNS lymphocytes)) (PP (IN from) (NP (JJ several) (JJ other) (JJ chronic) (JJ rheumatoid) (NN arthritis) (NNS patients)))))) (VP (VBD were) (ADJP (RB readily) (JJ detectable))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (NP (DT these) (NNS results)) (VP (VBP suggest) (NP (NP (DT a) (JJ direct) (NN contribution)) (PP (IN of) (NP (NN EBV))) (PP (TO to) (NP (JJ chronic) (JJ rheumatoid) (NN arthritis) (NN pathogenesis))))) (. .))))
(S1 (S (S (NP (PRP They)) (ADVP (RB also)) (VP (VBP demonstrate) (PP (IN for) (NP (DT the) (JJ first) (NN time))) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (NP (NN T) (NN cell) (NNS responses)) (PP (IN against) (NP (NN EBV) (VBG transactivating) (NNS factors))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD might) (VP (VB be) (ADJP (JJ central)) (PP (IN in) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (NN virus) (NN reactivation))))))))))) (. .))))
(S1 (S (NP (NP (JJ Differential) (JJ nuclear) (NN localization)) (PP (IN of) (NP (NP (NP (NN p50)) (, ,) (NP (NN p52)) (, ,) (CC and) (NP (NN RelB))) (NNS proteins))) (PP (IN in) (NP (NP (JJ human) (JJ accessory) (NNS cells)) (PP (IN of) (NP (NP (DT the) (JJ immune) (NN response)) (ADVP (FW in) (FW situ)))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN Rel/NF-kappa) (NN B) (NNS proteins)) (, ,) (NP (NP (NN p50)) (, ,) (NP (NN p52)) (, ,) (NP (NN p65)) (, ,) (NP (NN c-Rel)) (, ,) (CC and) (NP (NN RelB))) (, ,)) (VP (VBP constitute) (NP (NP (DT a) (NN family)) (PP (IN of) (NP (NN transcription) (NNS factors))) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (JJ positive) (NN regulation)) (PP (IN of) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NNS genes))))) (PP (IN during) (NP (DT the) (JJ immune) (NN response)))))))) (. .))))
(S1 (S (S (ADVP (RB Recently)) (, ,) (NP (PRP it)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (SBAR (IN that) (S (NP (NN RelB) (JJ knockout) (NNS mice)) (VP (VBP have) (NP (DT no) (NP (NP (JJ dendritic) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN DC)) (-RRB- -RRB-)))))))))) (. .))))
(S1 (S (S (NP (NP (DT An) (NN overexpression)) (PP (IN of) (NP (NN p50)))) (VP (VBZ has) (VP (VBN been) (VP (VBN described) (PP (IN in) (NP (NP (JJ follicular) (JJ dendritic) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN FDC)) (-RRB- -RRB-))))))) (. .))))
(S1 (S (S (NP (DT A) (JJ constitutive) (NN NF-kappa) (NN B) (NN activity)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (JJ mature) (NNS macrophages)))))) (. .))))
(S1 (S (S (NP (DT This)) (VP (VBD led) (PP (TO to) (NP (DT the) (NN hypothesis) (SBAR (IN that) (S (NP (NP (DT some)) (PP (IN of) (NP (DT the) (NN Rel/NF-kappa) (NN B) (NNS proteins)))) (VP (VBD were) (NP (NP (JJ key) (JJ nuclear) (NNS factors)) (PP (IN in) (NP (NP (NNS functions)) (PP (IN of) (NP (NP (JJ accessory) (NNS cells)) (PP (IN of) (NP (DT the) (JJ immune) (NN response)))))))))))))) (. .))))
(S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (PRP we)) (VP (VBD investigated) (ADVP (FW in) (FW situ)) (NP (NP (DT the) (JJ nuclear) (NN localization)) (PP (IN of) (NP (NN Rel/NF-kappa) (NN B) (NNS proteins))) (PP (IN in) (NP (NP (JJ accessory) (NNS cells)) (PP (IN of) (NP (DT the) (JJ immune) (NN system)))))) (PP (IN by) (NP (NP (NN immunohistochemistry)) (CC and) (NP (NP (JJ double) (NN labeling)) (PP (IN by) (NP (NN immunofluorescence)))))) (PP (IN from) (NP (NP (CD five) (JJ normal) (JJ human) (NNS tonsils)) (CC and) (NP (NP (CD five) (NN lymph) (NNS nodes)) (PP (IN with) (NP (JJ follicular) (NN hyperplasia))))))) (. .))))
(S1 (S (S (NP (JJ Nuclear) (NP (NP (NN p65)) (CC and) (NP (NN c-Rel))) (NNS proteins)) (VP (VBD were) (VP (VBN found) (PP (IN in) (NP (NP (DT all) (NN cell) (NNS types)) (PP (VBG including) (NP (NNS lymphocytes))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (JJ germinal) (NNS centers) (NN GC))) (, ,) (NP (NP (NN p50)) (, ,) (NP (NN p52)) (, ,) (CC and) (NP (NN RelB))) (VP (VP (VBD were) (VP (VBN found) (PP (IN in) (NP (NP (DT the) (NNS nuclei)) (PP (IN of) (NP (NN FDC))) (ADVP (RB only)))))) (CC and) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (DT the) (NNS nuclei)) (PP (IN of) (NP (JJ CD68+) (NNS cells)))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN T) (NN cell) (NNS areas))) (, ,) (NP (NP (NN p50)) (, ,) (NP (NN p52)) (, ,) (CC and) (NP (NN RelB))) (VP (VBD were) (VP (VBN found) (PP (IN in) (NP (NP (DT the) (NNS nuclei)) (PP (IN of) (NP (NP (JJ HLA-DR+) (NNS cells)) (PP (IN with) (NP (DT an) (NP (NP (JJ antigen-presenting) (NN cell)) (PRN (-LRB- -LRB-) (NP (NN APC)) (-RRB- -RRB-))) (NN morphology))))))))) (. .))))
(S1 (S (S (S (NP (NP (NN p52)) (CC and) (NP (NN RelB))) (VP (VBD were) (VP (VBN detected) (PP (IN in) (NP (NP (DT the) (NNS nuclei)) (PP (IN in) (NP (NP (ADJP (CC both) (ADJP (JJ CD1a+)) (CC and) (ADJP (JJ CD68+))) (NNS cells)) (PP (IN from) (NP (DT the) (NN T) (NN cell) (NN area)))))))))) (, ,) (IN whereas) (S (NP (NN p50)) (VP (VBD was) (VP (VBN found) (PP (RB only) (IN in) (NP (ADJP (ADJP (JJ CD68-)) (CC and) (ADJP (JJ CD1a-))) (NNS cells)))))) (. .))))
(S1 (S (S (NP (NP (NNS Cells)) (PP (IN with) (NP (JJ nuclear) (NN p50)))) (VP (VBD were) (ADJP (JJ negative)) (PP (IN for) (NP (DT the) (NP (NP (NN CD38)) (, ,) (NP (NN CD20)) (CC and) (NP (NN CD2))) (NNS markers)))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP show) (SBAR (SBAR (IN that) (, ,) (S (ADVP (RB physiologically)) (, ,) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NP (JJ nuclear)) (PP (IN of) (NP (NP (NN p50)) (, ,) (NP (NN p52)) (CC and) (NP (NN RelB))))))) (VP (VBP are) (VP (JJ restricted) (PP (TO to) (NP (NP (NP (JJ accessory) (NNS cells)) (PP (IN of) (NP (DT the) (JJ immune) (NN system))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP include) (NP (NP (NN FDC)) (PP (IN in) (NP (NN GC))))))) (, ,)) (CC and) (NP (NP (NP (NN DC)) (CC and) (NP (NNS macrophages))) (PP (IN in) (NP (DT the) (NN T) (NN cell) (NN zone)))))))))) (, ,) (SBAR (IN that) (S (S (NP (NP (VBN specialized) (NN scavenger) (NNS macrophages)) (PP (IN from) (NP (NN GC)))) (VP (VBP do) (RB not) (VP (VB have) (NP (NP (JJ detectable) (NNS levels)) (PP (IN of) (NP (NP (NN p52)) (CC and) (NP (NN RelB)))))))) (, ,) (IN whereas) (S (NP (NP (NNS macrophages)) (PP (IN from) (NP (DT the) (NN T) (NN cell) (NN area))) (, ,) (VP (VBN known) (S (VP (TO to) (VP (VB present) (NP (DT the) (NN antigen)) (PP (TO to) (NP (NN T) (NNS cells))))))) (, ,)) (VP (VBP do) (VP (VB have) (NP (CC both) (JJ nuclear) (NP (NP (NN p52)) (CC and) (NP (NN RelB))))))))) (, ,) (CC and) (SBAR (IN that) (S (PP (IN in) (NP (DT the) (NN T) (NN cell) (NN zone))) (, ,) (S (S (NP (NP (NN p52)) (CC and) (NP (NN RelB))) (VP (VBP are) (ADJP (JJ located) (PP (IN in) (NP (NP (NNS nuclei)) (PP (IN of) (NP (ADJP (DT both) (ADJP (JJ CD1a+)) (, ,) (ADJP (JJ CD68+)) (CC or) (ADJP (DT both)) (, ,)) (NNS cells) (NN APC)))))))) (, ,) (IN whereas) (S (NP (NN p50)) (VP (VBZ is) (VP (JJ restricted) (PP (TO to) (NP (ADJP (ADJP (NN CD1a-)) (CC and) (ADJP (JJ CD68-))) (NN APC))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ different) (NNS patterns)) (PP (IN of) (NP (NP (NP (NN p50)) (, ,) (NP (NN p52)) (CC and) (NP (NN RelB))) (NN protein) (JJ nuclear) (NN localization)))) (VP (MD may) (VP (VB provide) (NP (NP (NN insight)) (PP (IN into) (NP (NP (PRP$ their) (JJ different) (NNS roles)) (PP (IN during) (NP (NP (DT the) (JJ immune) (NN response)) (ADVP (FW in) (FW vivo))))))))) (. .))))
(S1 (S (NP (NP (NN Signal) (NN transduction)) (PP (IN by) (NP (NP (NN DR3)) (, ,) (NP (NP (DT a) (ADJP (NN death) (JJ domain-containing)) (NN receptor)) (ADJP (JJ related) (PP (TO to) (NP (NP (NN TNFR-1)) (CC and) (NP (NN CD95)))))))) (. .))))
(S1 (S (S (NP (NP (NP (NN Tumor) (NN necrosis) (NN factor) (NN receptor-1)) (PRN (-LRB- -LRB-) (NP (NN TNFR-1)) (-RRB- -RRB-))) (CC and) (NP (NP (NN CD95)) (-LRB- -LRB-) (VP (ADVP (RB also)) (VBN called) (S (NP (NP (NN Fas)) (CC or) (NP (NN APO-1))))) (-RRB- -RRB-))) (VP (VBP are) (NP (NP (NN cytokine) (NNS receptors)) (SBAR (WHNP (WDT that)) (S (VP (VBP engage) (NP (NP (DT the) (NN apoptosis) (NN pathway)) (PP (IN through) (NP (NP (DT a) (NN region)) (PP (IN of) (NP (JJ intracellular) (NN homology))))) (, ,) (VP (VBD designated) (S (NP (DT the) (`` ``) (NN death) (NN domain)))))))))) (. .))))
(S1 (S (S (NP (NP (NP (DT Another) (ADJP (NN death) (NN domain-containing)) (NN member)) (PP (IN of) (NP (DT the) (NN TNFR) (NN family)))) (, ,) (NP (NP (NN death) (NN receptor) (CD 3)) (PRN (-LRB- -LRB-) (NP (NN DR3)) (-RRB- -RRB-))) (, ,)) (VP (VP (VBD was) (VP (VBN identified))) (CC and) (VP (VBD was) (VP (VBN shown) (S (VP (TO to) (VP (VB induce) (NP (NP (CC both) (NP (NNS apoptosis)) (CC and) (NP (NN activation))) (PP (IN of) (NP (JJ nuclear) (NN factor) (NN kappaB)))))))))) (. .))))
(S1 (S (S (NP (NP (NN Expression)) (PP (IN of) (NP (NN DR3)))) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (VP (JJ restricted) (PP (TO to) (NP (NP (NNS tissues)) (VP (VBN enriched) (PP (IN in) (NP (NNS lymphocytes))))))))))) (. .))))
(S1 (S (S (NP (NN DR3) (NN signal) (NN transduction)) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (NP (DT a) (NN complex)) (PP (IN of) (NP (NP (JJ intracellular) (VBG signaling) (NNS molecules)) (PP (VBG including) (NP (NP (NN TRADD)) (, ,) (NP (NN TRAF2)) (, ,) (NP (NN FADD)) (, ,) (CC and) (NP (NN FLICE)))))))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NN DR3)) (ADVP (RB likely)) (VP (VBZ plays) (NP (DT a) (NN role)) (PP (IN in) (S (VP (VBG regulating) (NP (NN lymphocyte) (NN homeostasis)))))) (. .))))
(S1 (S (NP (NP (NP (NP (NN Cloning)) (CC and) (NP (NN expression))) (PP (IN of) (NP (DT the) (ADJP (JJ Epstein-Barr) (JJ virus-encoded)) (NN dUTPase))) (: :)) (S (NP (NP (NNS patients)) (PP (IN with) (NP (ADJP (ADJP (JJ acute)) (, ,) (ADJP (VBN reactivated)) (CC or) (ADJP (JJ chronic))) (NN virus) (NN infection)))) (VP (VBP develop) (NP (NP (NNS antibodies)) (PP (IN against) (NP (DT the) (NN enzyme))))) (. .)))))
(S1 (S (S (NP (NP (DT The) (NN gene)) (VP (VBG encoding) (NP (DT the) (ADJP (NP (JJ Epstein-Barr) (NN virus)) (-LRB- -LRB-) (NN EBV) (-RRB- -RRB-) (JJ -specific)) (NN dUTPase)))) (VP (VBD was) (VP (VBN amplified) (PP (IN from) (NP (NN virus) (NN DNA))) (PP (IN by) (NP (NN PCR))))) (. .))))
(S1 (S (S (NP (DT The) (JJ active) (NN enzyme)) (VP (VBD was) (VP (VBN expressed) (PP (PP (IN in) (NP (FW Escherichia) (FW coli))) (CC and) (PP (IN in) (NP (NN insect) (NNS cells)))) (PP (IN as) (NP (DT a) (JJ non-fusion) (NN protein))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN protein)) (PP (IN from) (NP (FW E.) (FW coli)))) (ADVP (RB specifically)) (VP (VP (VBD converted) (NP (NN dUTP)) (PP (TO to) (NP (NN dUMP)))) (CC and) (VP (VBD did) (RB not) (VP (VB react) (PP (IN with) (NP (JJ other) (NP (NP (NNS dNTPs)) (CC or) (NP (NNS NTPs)))))))) (. .))))
(S1 (S (S (NP (JJ Preliminary) (NNS experiments)) (VP (VBD yielded) (NP (NP (DT a) (NN Km) (NN value)) (PP (IN of) (NP (QP (RB about) (CD 0.8)) (NN microM)))) (PP (IN for) (NP (NN dUTP)))) (. .))))
(S1 (S (S (NP (NP (NNS MAbs)) (PP (IN against) (NP (DT the) (NN dUTPase)))) (VP (VBD reacted) (PP (IN with) (NP (NP (DT a) (NN protein)) (PP (IN of) (NP (QP (RB approximately) (CD 31)) (NN kDa))) (PP (IN in) (NP (NP (ADJP (NP (NN 12-O-tetradecanoyl-phorbol-13-acetate)) (-LRB- -LRB-) (NN TPA) (-RRB- -RRB-) (JJ -stimulated)) (NN B) (NNS cells)) (VP (VBG harbouring) (NP (NP (CC either) (NP (NN type) (CD 1)) (CC or) (NP (NN type) (CD 2))) (NN EBV)))))))) (. .))))
(S1 (S (S (S (NP (DT The) (NN protein)) (VP (VBD was) (VP (VBN found) (PP (IN in) (NP (JJ untreated) (NNS cells))) (PP (IN at) (NP (JJ low) (NNS levels)))))) (, ,) (IN whereas) (S (NP (NP (NN induction)) (PP (IN of) (NP (DT the) (JJ lytic) (NN replication) (NN cycle))) (PP (PP (IN by) (NP (NN TPA) (NN treatment))) (CC or) (PP (IN by) (S (VP (VBG providing) (NP (DT the) (JJ immediate) (JJ early) (NN transactivator) (NN BZLF1)))))) (PP (IN in) (NP (NN trans)))) (VP (VBD resulted) (PP (IN in) (NP (VBN increased) (NN expression))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (DT the) (NN virus) (NN dUTPase)) (VP (VBN isolated) (PP (IN from) (NP (JJ EBV-infected) (NNS cells))))) (VP (VBZ is) (NP (DT a) (NN phosphoprotein)))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN protein)) (VP (VBN expressed) (PP (IN in) (NP (NN insect) (NNS cells))))) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB test) (PP (IN for) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ specific) (NNS antibodies))) (PP (IN in) (NP (NP (NN sera)) (PP (PP (IN from) (NP (ADJP (ADJP (JJ normal)) (, ,) (ADJP (JJ healthy))) (NNS carriers))) (CC and) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ various) (NNS diseases))))))))))))))) (. .))))
(S1 (S (S (SBAR (IN While) (S (NP (NP (DT the) (NN sera)) (PP (IN of) (NP (NP (NP (JJ EBV-negative) (NNS individuals)) (PRN (-LRB- -LRB-) (NP (CD 0/3)) (-RRB- -RRB-))) (CC or) (NP (NP (JJ healthy) (NNS carriers)) (PRN (-LRB- -LRB-) (NP (CD 0/33)) (-RRB- -RRB-)))))) (VP (VBD did) (RB not) (VP (VB contain) (NP (NP (JJ detectable) (NNS levels)) (PP (IN of) (NP (NNS antibodies)))))))) (, ,) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NP (NN mononucleosis)) (PRN (-LRB- -LRB-) (NP (CD 5/18)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ chronic) (NN EBV) (NN infection)) (PRN (-LRB- -LRB-) (NP (CD 2/7)) (-RRB- -RRB-))) (, ,) (NP (NP (NN EBV) (NN reactivation)) (PRN (-LRB- -LRB-) (NP (CD 7/20)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ human) (NN immunodeficiency) (NN virus) (NN infection)) (PRN (-LRB- -LRB-) (NP (CD 5/24)) (-RRB- -RRB-)))))) (VP (VBD showed) (NP (NP (JJ elevated) (NN antibody) (NNS titres)) (PP (IN against) (NP (DT the) (NN enzyme))))) (. .))))
(S1 (S (S (NP (DT This)) (VP (VBD indicated) (SBAR (IN that) (S (NP (DT the) (NN dUTPase)) (VP (VBZ is) (VP (VBN expressed) (PP (IN during) (NP (NN EBV) (NP (NP (NN replication)) (CC and) (NP (NN reactivation)))))))))) (. .))))
(S1 (S (S (NP (DT The) (NN enzyme)) (VP (MD might) (ADVP (RB therefore)) (VP (VB be) (NP (NP (DT a) (JJ potential) (NN target)) (PP (IN for) (NP (NN drug) (NN therapy)))) (PP (IN under) (NP (NP (NNS conditions)) (PP (IN of) (NP (JJ active) (NN DNA) (NN replication))))))) (. .))))
(S1 (S (NP (NP (NN Prostaglandin) (NN E2) (NN induction)) (PP (IN of) (NP (NP (NN binding) (NN activity)) (PP (TO to) (NP (NP (NP (NN CRE)) (CC and) (NP (NN AP-2))) (NNS elements))))) (PP (IN in) (NP (JJ human) (NN T) (NNS lymphocytes))) (. .))))
(S1 (S (S (NP (NP (NNP Prostaglandins)) (PP (IN of) (NP (DT the) (NN E) (NNS series)))) (VP (VBP are) (NP (NP (JJ immunomodulatory) (NNS agents)) (SBAR (WHNP (WDT which)) (S (VP (VBP exert) (NP (ADJP (ADJP (JJ inhibitory)) (CONJP (RB as) (RB well) (IN as)) (ADJP (JJ stimulatory))) (NNS effects)) (PP (IN on) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ immune) (NNS responses)))))))))) (. .))))
(S1 (S (S (SBAR (IN Since) (S (NP (PRP it)) (VP (VBZ is) (VP (VBN known) (SBAR (IN that) (S (NP (NN PGE2)) (VP (VBZ is) (ADJP (JJ able) (S (VP (TO to) (VP (VB increase) (NP (NN cAMP) (NNS levels))))))))))))) (, ,) (NP (PRP we)) (VP (VBD investigated) (SBAR (IN whether) (S (NP (PRP it)) (VP (MD can) (VP (VB affect) (NP (NN gene) (NN expression)) (PP (IN through) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NP (DT the) (NN transcription) (NNS factors)) (SBAR (WHNP (WDT which)) (S (VP (VBP bind) (NP (NP (NN enhancer) (NNS elements)) (PP (IN in) (NP (NP (DT the) (NN promoter) (NNS regions)) (PP (IN of) (NP (JJ cAMP-regulated) (NNS genes)))))))))))))))))) (. .))))
(S1 (S (S (S (VP (VBG Using) (NP (JJ electrophoretic) (NN mobility) (NN shift) (NN assay)))) (, ,) (NP (PRP we)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (DT a) (JJ short) (NN treatment)) (PP (IN of) (NP (JJ human) (NN T) (NNS lymphocytes))) (PP (IN with) (NP (NN PGE2)))) (VP (VBZ induces) (NP (NP (JJ specific) (NN binding) (NN activity)) (PP (TO to) (NP (NP (NP (NN CRE)) (CC and) (NP (NP (NN AP-2)) (, ,) (NP (CC but) (RB not)) (NP (NN AP-1)) (, ,))) (NN DNA) (NNS elements)))))))) (. .))))
(S1 (S (S (SBAR (IN Since) (S (NP (NP (DT the) (JJ okadaic) (NN acid)) (, ,) (NP (DT a) (JJ potent) (NN protein) (NN phosphatase) (NN inhibitor)) (, ,)) (VP (VBZ prolongs) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (DT the) (NN binding) (NN activity))))))) (, ,) (NP (NN phosphorylation) (NNS events)) (VP (VBP are) (ADJP (JJ likely) (S (VP (TO to) (VP (VB occur)))))) (. .))))
(S1 (S (S (NP (DT This) (NN activity)) (VP (VBZ seems) (S (VP (TO to) (VP (VB be) (PP (JJ due) (TO to) (NP (VBN increased) (NN cAMP) (NNS levels))) (SBAR (IN because) (S (NP (NP (NN forskolin)) (CC and) (NP (NN IBMX))) (VP (VBP mimic) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN PGE2))))))))))) (. .))))
(S1 (S (S (ADVP (RBR More) (RB interestingly)) (, ,) (NP (NP (NN transfection) (NNS experiments)) (PP (IN with) (NP (NN CRE-CAT) (NN plasmide)))) (VP (VBP show) (SBAR (IN that) (S (NP (NN PGE2)) (VP (VBZ activates) (NP (NP (DT the) (NN transcription)) (PP (IN of) (NP (DT a) (NN CRE-containing) (NN promoter)))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS data)) (VP (VBP support) (NP (NP (DT the) (JJ positive) (NN role)) (PP (IN for) (NP (NN PGE2))) (PP (IN on) (NP (DT some) (JJ immune) (NNS functions))))) (. .))))
(S1 (S (NP (NP (NN Regulation)) (PP (IN of) (NP (NP (NP (NN cytokine)) (CC and) (NP (NN cytokine) (NN receptor))) (NN expression))) (PP (IN by) (NP (NNS glucocorticoids))) (. .))))
(S1 (S (S (NP (NP (NNS Glucocorticoids)) (PRN (-LRB- -LRB-) (NP (NNS GCS)) (-RRB- -RRB-))) (ADVP (RB profoundly)) (VP (VBP inhibit) (NP (NP (JJ several) (NNS aspects)) (PP (IN of) (NP (NN T) (NN cell) (NN immunity)))) (PP (RB largely) (IN through) (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (NN cytokine) (NN expression)) (PP (IN at) (NP (DT the) (ADJP (ADJP (JJ transcriptional)) (CC and) (ADJP (JJ posttranscriptional))) (NNS levels)))))))) (. .))))
(S1 (S (S (NP (NNS GCS)) (VP (VBD were) (VP (ADVP (RB also)) (VBN reported) (S (VP (TO to) (VP (VB act) (ADVP (RB indirectly)) (PP (IN by) (S (VP (VBG inducing) (NP (NP (VBG transforming) (NN growth) (NN factor-beta) (NN expression)) (, ,) (SBAR (WHNP (WDT which)) (S (PP (IN in) (NP (NN turn))) (VP (VBZ blocks) (NP (NN T) (NN cell) (NN immunity)))))))))))))) (. .))))
(S1 (S (S (PP (IN In) (S (VP (VBG exerting) (NP (PRP$ their) (JJ antiproliferative) (NNS effects))))) (, ,) (NP (NNS GCS)) (VP (VBP diffuse) (PP (IN into) (NP (NP (NN target) (NNS cells)) (SBAR (WHADVP (WRB where)) (S (NP (PRP they)) (VP (VBP bind) (NP (NP (PRP$ their) (JJ cytoplasmic) (NN receptor)) (, ,) (SBAR (WHNP (WDT which)) (S (PP (IN in) (NP (NN turn))) (VP (VBZ translocates) (PP (TO to) (NP (NP (DT the) (NN nucleus)) (SBAR (WHADVP (WRB where)) (S (NP (PRP it)) (VP (VBZ inhibits) (NP (NP (NN transcription)) (PP (IN of) (NP (NN cytokine) (NNS genes)))) (PP (PP (IN through) (NP (NP (JJ direct) (NN binding)) (PP (TO to) (NP (NP (NP (DT the) (NN glucocorticoid) (NN response) (NNS elements)) (PRN (-LRB- -LRB-) (NP (NN GRE)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (ADJP (JJ located) (PP (IN in) (NP (NP (DT the) (NN promoter) (NN region)) (PP (IN of) (NP (NN cytokine) (NNS genes))))))))))))) (CC or) (, ,) (PP (ADVP (RB alternatively)) (, ,) (IN through) (NP (NP (NN antagonism)) (PP (IN of) (NP (NP (DT the) (NN action)) (PP (IN of) (NP (NP (NN transcription) (NNS factors)) (VP (VBN required) (PP (IN for) (NP (JJ optimal) (JJ transcriptional) (NN activation)))))))))))))))))))))))))) (. .))))
(S1 (S (S (PP (IN In) (NN contrast) (TO to) (NP (NP (PRP$ their) (JJ inhibitory) (NNS effects)) (PP (IN on) (NP (NN cytokine) (NN expression))))) (, ,) (NP (NNS GCS)) (VP (VBP up-regulate) (NP (NP (NN cytokine) (NN receptor) (NN expression)) (SBAR (WHNP (WDT that)) (S (VP (VBZ correlates) (PP (IN with) (NP (NP (VBN enhanced) (NN cytokine) (NNS effects)) (PP (IN on) (NP (NN target) (NNS cells)))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT this) (NN review))) (, ,) (NP (PRP we)) (VP (VBP summarize) (NP (NP (DT the) (JJ current) (NN state)) (PP (IN of) (NP (NP (NN knowledge)) (PP (IN of) (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (NP (NN action)) (PP (IN of) (NP (NNS GCS))) (, ,) (PP (VBG including) (NP (NP (DT the) (NN phenomenon)) (PP (IN of) (NP (JJ steroid-induced) (NN rebound))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ ensues) (PP (IN upon) (NP (NNS GCS) (NN withdrawal)))))))))))))) (. .))))
(S1 (S (NP (DT The) (NN Oct-2) (NN transcription) (NN factor) (. .))))
(S1 (S (S (NP (DT The) (NN Oct-2) (NN transcription) (NN factor)) (VP (VP (VBZ is) (NP (NP (DT a) (NN member)) (PP (IN of) (NP (NP (DT the) (NP (NP (NN POU)) (PRN (-LRB- -LRB-) (NP (NN Pit-Oct-Unc)) (-RRB- -RRB-))) (NN family)) (PP (IN of) (NP (NN transcription) (NNS factors))))))) (CC and) (VP (VBZ is) (VP (VBN expressed) (PP (PP (ADVP (RB only)) (PP (PP (IN in) (NP (NN B) (NNS lymphocytes))) (CC and) (PP (IN in) (NP (JJ neuronal) (NNS cells))))) (CC but) (PP (RB not) (IN in) (NP (JJ other) (NN cell) (NNS types))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ primary) (NN RNA) (NN transcript)) (PP (IN of) (NP (DT the) (NN gene)))) (VP (VBZ is) (ADJP (JJ subject) (PP (TO to) (NP (JJ alternative) (NN splicing)))) (S (VP (TO to) (VP (VB yield) (NP (NP (JJ different) (NNS variants)) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VP (CC either) (VP (VBP activate)) (CC or) (VP (VBP repress))) (NP (NN gene) (NN expression))))))))))) (. .))))
(S1 (S (S (S (NP (NP (DT The) (NNS forms)) (VP (VBN produced) (PP (IN in) (NP (NN B) (NNS lymphocytes))))) (VP (VBP have) (NP (DT a) (ADJP (RB predominantly) (JJ activating)) (NN effect)) (PP (IN on) (NP (NN gene) (NN expression))))) (IN whereas) (S (NP (NP (DT those)) (VP (VBN produced) (PP (IN in) (NP (JJ neuronal) (NNS cells))))) (VP (VP (VBP have) (NP (DT a) (ADJP (RB predominantly) (JJ inhibitory)) (NN effect))) (CC and) (VP (MD can) (VP (VB repress) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (CC both) (NP (DT the) (NN herpes) (NN simplex) (NN virus) (JJ immediate-early) (NNS genes)) (CC and) (NP (DT the) (JJ cellular) (NN tyrosine) (NN hydroxylase) (NN gene))))))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (NP (NN Oct-2)) (VP (VBZ plays) (NP (DT an) (JJ important) (NN role)) (PP (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NP (JJ cellular) (NN gene) (NN expression)) (PP (IN in) (NP (CC both) (NP (NN B) (NNS cells)) (CC and) (NP (JJ neuronal) (NNS cells)))))))) (CONJP (RB as) (RB well) (IN as)) (PP (IN in) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (JJ viral) (NN latency))))))) (. .))))
(S1 (S (NP (NP (ADJP (NP (NP (NN Tissue)) (CC and) (NP (JJ cell-type))) (JJ specific)) (NN expression)) (PP (IN of) (NP (NP (DT the) (JJ tuberous) (NN sclerosis) (NN gene)) (, ,) (NP (NN TSC2)) (, ,))) (PP (IN in) (NP (JJ human) (NNS tissues))) (. .))))
(S1 (S (S (NP (NN TSC2)) (VP (VBZ is) (NP (NP (DT a) (NN gene)) (PP (IN on) (NP (NN chromosome) (NN 16p13.3))) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (JJ autosomal) (JJ dominant) (JJ neurocutaneous) (NN disorder)) (, ,) (NP (NP (JJ tuberous) (NN sclerosis) (NN complex)) (PRN (-LRB- -LRB-) (NP (NN TSC)) (-RRB- -RRB-)))))))) (. .))))
(S1 (S (S (PP (IN By) (S (VP (VBG using) (NP (NP (NP (DT a) (JJ partial) (JJ nucleotide) (NN sequence)) (PP (IN from) (NP (DT the) (VBN cloned) (NN TSC2)))) (CC and) (NP (NN polymerase) (NN chain) (NN reaction) (NN methodology)))))) (, ,) (NP (PRP we)) (VP (VBD constructed) (NP (DT a) (JJ digoxigenin-labeled) (JJ complementary) (NN DNA) (NN probe)) (S (VP (TO to) (VP (VB examine) (NP (NP (NN TSC2) (NN gene) (NN expression)) (PP (IN in) (NP (ADJP (ADJP (NP (NN autopsy-))) (CC or) (ADJP (JJ biopsy-derived))) (JJ human) (NNS tissues)))) (PP (IN by) (NP (ADJP (FW in) (FW situ)) (NN hybridization))))))) (. .))))
(S1 (S (S (NP (NN TSC2) (NN messenger) (NN RNA)) (VP (VBD was) (VP (ADVP (RB widely)) (VBN expressed) (PP (IN in) (NP (NP (JJ various) (NN cell) (NNS types)) (PP (IN throughout) (NP (DT the) (NN body))) (, ,) (PP (VBG including) (NP (NP (NN epithelia)) (, ,) (NP (NNS lymphocytes)) (, ,) (CC and) (NP (NP (NP (NNS cells)) (PP (IN with) (NP (JJ endocrine) (NNS functions)))) (, ,) (NP (ADVP (FW e.g.)) (, ,) (NP (NP (JJ adrenal) (NN cortex)) (CC and) (NP (JJ anterior) (NN pituitary))))))))))) (. .))))
(S1 (S (S (NP (PRP It)) (VP (VBD was) (VP (ADVP (ADVP (RB prominently)) (CC and) (ADVP (RB selectively))) (-LRB- -LRB-) (PP (IN within) (NP (DT the) (JJ central) (JJ nervous) (NN system))) (-RRB- -RRB-) (VBN expressed) (PP (PP (IN in) (NP (NP (JJ pyramidal) (NNS cells)) (PP (IN of) (NP (NP (DT the) (JJ cerebral) (NN cortex)) (CC and) (NP (JJ other) (NN motor) (NNS neurons)))))) (, ,) (PP (ADVP (FW e.g.)) (, ,) (IN in) (NP (NP (JJ spinal) (NN cord)) (CC and) (NP (NN brainstem) (NNS nuclei))))))) (. .))))
(S1 (S (S (S (NP (JJ Visceral) (NN TSC2) (NN expression)) (VP (VBD was) (ADJP (JJ comparable)) (PP (IN in) (NP (NP (NN autopsy) (NNS tissues)) (PP (IN from) (NP (NP (NNS patients)) (PP (PP (PP (IN with)) (CC and) (PP (IN without))) (NP (NN TSC)))))))) (: ;)) (S (NP (NN TSC2) (NN messenger) (NN RNA) (NN expression)) (VP (VBD was) (ADJP (RBS most) (JJ prominent)) (PP (PP (IN in) (NP (NP (NP (NP (NNS cells)) (PP (IN with) (NP (DT a) (JJ rapid) (JJ mitotic) (NP (NP (NN rate)) (CC and) (NP (NN turnover)))))) (, ,) (NP (ADVP (FW e.g.)) (, ,) (NP (NP (NN epithelia)) (CC and) (NP (NNS lymphocytes)))) (, ,)) (PP (IN with) (S (NP (JJ central) (JJ nervous) (NN system) (NP (NP (JJ pyramidal) (NNS cells)) (CC and) (NP (JJ other) (NNS neurons)))) (VP (VBG being) (NP (DT an) (JJ obvious) (NN exception))))))) (, ,) (CC and/or) (PP (IN in) (NP (NP (NNS cells)) (PP (IN with) (NP (JJ important) (NN secretory/transport) (NNS functions))))))) (. .)))))
(S1 (S (S (NP (NP (DT This) (JJ widespread) (NN expression)) (PP (IN of) (NP (DT the) (NN TSC2) (NN gene)))) (VP (VBZ supports) (NP (DT the) (NN view) (SBAR (IN that) (S (NP (PRP it)) (VP (VBZ encodes) (NP (NP (NP (DT a) (NN protein)) (ADJP (JJ vital) (PP (TO to) (NP (NN cell) (NP (NP (NN growth)) (CC and) (NP (NN metabolism))))))) (CC or) (NP (NP (CD one)) (SBAR (WHNP (WDT that)) (S (VP (VBZ functions) (PP (IN as) (NP (DT a) (NN tumor/growth) (NN suppressor))))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Cell) (JJ specific) (NN expression)) (PP (IN of) (NP (JJ human) (NP (NP (NP (NN Bruton) (POS 's)) (NN agammaglobulinemia) (NN tyrosine) (NN kinase) (NN gene)) (PRN (-LRB- -LRB-) (NP (NN Btk)) (-RRB- -RRB-)))))) (VP (VBZ is) (VP (VBN regulated) (PP (IN by) (NP (NP (NN Sp1-)) (CC and) (NP (NN Spi-1/PU.1-family) (NNS members)))))) (. .))))
(S1 (S (S (NP (NP (NP (NN Bruton) (POS 's)) (NN agammaglobulinemia) (NN tyrosine) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN Btk)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (JJ cytoplasmic) (NN tyrosine) (NN kinase)) (VP (VBN involved) (PP (IN in) (NP (DT the) (JJ human) (NN disease) (NP (NP (JJ X-linked) (NN agammaglobulinemia)) (PRN (-LRB- -LRB-) (NP (NN XLA)) (-RRB- -RRB-)))))))) (. .))))
(S1 (S (S (NP (DT The) (NN gene)) (VP (VBZ is) (VP (VBN expressed) (PP (IN in) (NP (NP (DT all) (JJ hematopoietic) (NNS cells)) (PP (IN with) (NP (NP (DT the) (NN exception)) (PP (IN of) (NP (NP (NNS T-cells)) (CC and) (NP (NN plasma) (NNS cells)))))))))) (. .))))
(S1 (S (S (PP (IN For) (NP (DT this) (NN expression) (NN pattern))) (NP (NP (DT the) (JJ first) (CD 280) (NN bp)) (ADJP (JJ upstream) (PP (IN of) (NP (DT the) (JJ major) (JJ transcriptional) (NN start) (NN site))))) (VP (VBZ seems) (S (VP (TO to) (VP (VB be) (ADJP (JJ sufficient)))))) (. .))))
(S1 (S (S (NP (NP (ADJP (FW In) (FW vitro)) (NN footprinting) (NN analysis)) (PP (IN within) (NP (NP (DT this) (NN part)) (PP (IN of) (NP (DT the) (NN promoter)))))) (VP (VBD revealed) (NP (NP (CD two) (NN Sp1) (NN binding) (NNS sites)) (CONJP (RB as) (RB well) (IN as)) (NP (DT a) (NN PU-box)))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN transcription) (NN factor) (NN Spi-1/PU.1)) (CONJP (RB as) (RB well) (IN as)) (NP (DT the) (ADJP (RB closely) (JJ related)) (NN factor) (NN Spi-B))) (VP (VBD bound) (PP (TO to) (NP (DT the) (NN PU-box))) (PP (IN in) (NP (NNS B-cells)))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT the) (NN erythroleukemia) (NN cell) (NN line) (NN K562))) (, ,) (PP (IN due) (TO to) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NN Spi-B))))) (, ,) (NP (RB only) (NN PU.1)) (VP (VBD bound) (PP (TO to) (NP (DT the) (NN Btk) (NN promoter)))) (. .))))
(S1 (S (S (NP (NP (NN Mutation)) (PP (IN of) (NP (DT either) (NN site)))) (VP (VBD reduced) (NP (DT the) (NN expression)) (PP (IN in) (NP (JJ transient) (NN transfection) (NNS experiments)))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (NN mutation)) (PP (IN of) (NP (DT the) (NN PU) (NN box)))) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN in) (NP (NP (DT the) (NN T-cell) (NN line) (NN Jurkat)) (, ,) (SBAR (WHADVP (WRB where)) (S (NP (NP (NN none)) (PP (IN of) (NP (DT the) (NN Spi-1) (NN family) (NNS members)))) (VP (VBZ is) (VP (VBN expressed)))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN addition))) (NP (NP (NN Spi-B)) (CONJP (RB as) (RB well) (IN as)) (NP (NN PU.1))) (VP (VBD were) (ADJP (JJ able) (S (VP (TO to) (VP (VB transactivate) (NP (NN Btk) (NN expression))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (JJ fetal) (NN liver)) (PP (IN of) (NP (NP (JJ PU.1-/-) (NNS mice)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP lack) (NP (ADJP (ADJP (JJ lymphoid)) (CC and) (ADJP (JJ myeloid))) (NNS cells))))))))) (, ,) (NP (NP (NN expression)) (PP (IN of) (NP (NN Btk)))) (VP (VBD was) (VP (VP (VBN reduced) (ADVP (ADVP (CD two-)) (TO to) (ADVP (RB threefold)))) (CC but) (VP (RB not) (VBN abolished)))) (. .))))
(S1 (S (S (ADVP (RB Collectively)) (NP (DT this) (NN study)) (VP (VBZ shows) (SBAR (IN that) (S (NP (NP (NN expression)) (PP (IN of) (NP (DT the) (NN Btk) (NN gene)))) (VP (VBZ is) (VP (VBN regulated) (PP (IN by) (NP (NP (DT the) (JJ combined) (NN action)) (PP (IN of) (NP (NP (NN Sp1-)) (CC and) (NP (NN PU.1-family) (NNS members))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Elf-1)) (CC and) (NP (NN Stat5))) (VP (VBP bind) (PP (TO to) (NP (NP (DT a) (JJ critical) (NN element)) (PP (IN in) (NP (NP (DT a) (JJ new) (NN enhancer)) (PP (IN of) (NP (DT the) (JJ human) (NN interleukin-2) (NN receptor) (NN alpha) (NN gene))))))) (PRN (-LRB- -LSB-) (S (NP (VBN published) (NN erratum)) (VP (VBZ appears) (PP (IN in) (NP (NP (NNP Mol) (NNP Cell) (NNP Biol)) (NP (CD 1997) (NNP Apr)) (: ;) (NP (CD 17) (-LRB- -LRB-) (CD 4) (-RRB- -RRB-)) (: :) (NP (CD 2351)))))) (-RRB- -RSB-))))))
(S1 (S (S (NP (DT The) (NP (NP (NN interleukin) (CD 2) (NN receptor) (NN alpha-chain)) (PRN (-LRB- -LRB-) (NP (NN IL-2R) (NN alpha)) (-RRB- -RRB-))) (NN gene)) (VP (VBZ is) (NP (NP (DT a) (JJ key) (NN regulator)) (PP (IN of) (NP (NN lymphocyte) (NN proliferation))))) (. .))))
(S1 (S (S (NP (NN IL-2R) (NN alpha)) (VP (VBZ is) (VP (ADVP (ADVP (RB rapidly)) (CC and) (ADVP (RB potently))) (VBN induced) (PP (IN in) (NP (NN T) (NNS cells))) (PP (IN in) (NN response) (TO to) (NP (JJ mitogenic) (NNS stimuli))))) (. .))))
(S1 (S (S (NP (NP (NN Interleukin) (CD 2)) (PRN (-LRB- -LRB-) (NP (NN IL-2)) (-RRB- -RRB-))) (VP (VBZ stimulates) (NP (NN IL-2R) (NN alpha) (NN transcription)) (, ,) (S (ADVP (RB thereby)) (VP (VBG amplifying) (NP (NP (NN expression)) (PP (IN of) (NP (PRP$ its) (JJ own) (NN high-affinity) (NN receptor))))))) (. .))))
(S1 (S (S (NP (NN IL-2R) (NN alpha) (NN transcription)) (VP (VBZ is) (PP (ADVP (IN at) (JJS least)) (IN in) (NP (NN part))) (VP (VBN controlled) (PP (IN by) (NP (NP (CD two) (JJ positive) (JJ regulatory) (NNS regions)) (, ,) (NP (NP (NN PRRI)) (CC and) (NP (NN PRRII))))))) (. .))))
(S1 (S (S (NP (NN PRRI)) (VP (VBZ is) (NP (NP (DT an) (JJ inducible) (JJ proximal) (NN enhancer)) (, ,) (ADJP (JJ located) (PP (IN between) (NP (NNS nucleotides) (NP (NP (CD -276)) (CC and) (NP (CD -244)))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ contains) (NP (NP (NP (NN NF-kappaB)) (CC and) (NP (NN SRE/CArG))) (NNS motifs))))))) (. .))))
(S1 (S (S (NP (NN PRRII)) (VP (VBZ is) (NP (NP (DT a) (JJ T-cell-specific) (NN enhancer)) (, ,) (ADJP (JJ located) (PP (IN between) (NP (NNS nucleotides) (NP (NP (CD -137)) (CC and) (NP (CD -64)))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ binds) (NP (NP (DT the) (JJ T-cell-specific) (NN Ets) (NN protein) (NN Elf-1)) (CC and) (NP (NN HMG-I-LRB-Y-RRB-) (NNS proteins)))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (NN none)) (PP (IN of) (NP (DT these) (JJ proximal) (NNS regions)))) (VP (VBP account) (PP (IN for) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NN IL-2R) (NN alpha) (NN transcription))) (PP (IN by) (NP (NN IL-2)))))) (. .))))
(S1 (S (S (S (VP (TO To) (VP (VB find) (NP (NP (JJ new) (JJ regulatory) (NNS regions)) (PP (IN of) (NP (DT the) (NN IL-2R) (NN alpha) (NN gene))))))) (, ,) (NP (NP (CD 8.5) (NN kb)) (PP (IN of) (NP (NP (DT the) (JJ 5') (NN end) (JJ noncoding) (NN sequence)) (PP (IN of) (NP (DT the) (NN IL-2R) (NN alpha) (NN gene)))))) (VP (VBP have) (VP (VBN been) (VP (VBN sequenced)))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBD identified) (NP (NP (DT an) (JJ 86-nucleotide) (NN fragment)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADJP (NP (CD 90) (NN %)) (JJ identical) (PP (TO to) (NP (DT the) (ADJP (RB recently) (VBN characterized)) (NP (NP (JJ murine) (JJ IL-2-responsive) (NN element)) (PRN (-LRB- -LRB-) (NP (NN mIL-2rE)) (-RRB- -RRB-))))))))))) (. .))))
(S1 (S (S (NP (NP (DT This) (JJ putative) (JJ human) (NN IL-2rE)) (, ,) (VP (VBN designated) (S (NP (NN PRRIII)))) (, ,)) (VP (VBZ confers) (NP (NN IL-2) (NN responsiveness)) (PP (IN on) (NP (DT a) (JJ heterologous) (NN promoter)))) (. .))))
(S1 (S (S (NP (NN PRRIII)) (VP (VBZ contains) (NP (NP (DT a) (NN Stat) (NN protein) (NN binding) (NN site)) (SBAR (WHNP (WDT that)) (S (VP (VBZ overlaps) (PP (IN with) (NP (NP (DT an) (NN EBS) (NN motif)) (PRN (-LRB- -LRB-) (NP (NN GASd/EBSd)) (-RRB- -RRB-))))))))) (. .))))
(S1 (S (S (NP (DT These)) (VP (VBP are) (ADJP (JJ essential) (PP (IN for) (NP (NP (NN IL-2) (NN inducibility)) (PP (IN of) (NP (NN PRRIII/CAT) (NN reporter) (NNS constructs))))))) (. .))))
(S1 (S (S (NP (NN IL-2)) (VP (VBD induced) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NP (NP (NN Stat5a)) (CC and) (NP (NN b))) (NNS proteins))) (PP (TO to) (NP (DT the) (JJ human) (NN GASd) (NN element))))) (. .))))
(S1 (S (S (S (VP (TO To) (VP (VB confirm) (NP (NP (DT the) (JJ physiological) (NN relevance)) (PP (IN of) (NP (DT these) (NNS findings))))))) (, ,) (NP (PRP we)) (VP (VBD carried) (PRT (RP out)) (NP (NP (ADJP (FW in) (FW vivo)) (NN footprinting) (NNS experiments)) (SBAR (WHNP (WDT which)) (S (VP (VBD showed) (SBAR (IN that) (S (NP (NP (NN stimulation)) (PP (IN of) (NP (NN IL-2R) (NN alpha) (NN expression)))) (VP (VBD correlated) (PP (IN with) (NP (NP (NN occupancy)) (PP (IN of) (NP (DT the) (NN GASd) (NN element))))))))))))) (. .))))
(S1 (S (S (NP (PRP$ Our) (NNS data)) (VP (VP (VBP demonstrate) (NP (NP (DT a) (JJ major) (NN role)) (PP (IN of) (NP (DT the) (NN GASd/EBSd) (NN element))) (PP (IN in) (NP (NN IL-2R) (NN alpha) (NN regulation))))) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (NP (DT the) (JJ T-cell-specific) (NN Elf-1) (NN factor)) (VP (MD can) (VP (VB serve) (PP (IN as) (NP (DT a) (JJ transcriptional) (NN repressor))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Association)) (PP (IN of) (NP (NP (NN TRAF1)) (, ,) (NP (NN TRAF2)) (, ,) (CC and) (NP (NN TRAF3)))) (PP (IN with) (NP (NP (DT an) (JJ Epstein-Barr) (NN virus) (NN LMP1) (NN domain)) (ADJP (JJ important) (PP (IN for) (NP (NN B-lymphocyte) (NN transformation)))))) (: :)) (NP (NP (NN role)) (PP (IN in) (NP (NN NF-kappaB) (NN activation)))) (. .))))
(S1 (S (S (NP (NP (NP (DT The) (JJ Epstein-Barr) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN EBV)) (-RRB- -RRB-))) (VBG transforming) (NN protein) (NN LMP1)) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (NP (DT a) (ADJP (RB constitutively) (VBN activated)) (NP (NP (NN tumor) (NN necrosis) (NN factor) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN TNFR)) (-RRB- -RRB-)))) (PP (IN on) (DT the) (NN basis) (IN of) (NP (NP (DT an) (JJ intrinsic) (NN ability) (S (VP (TO to) (VP (VB aggregate) (PP (IN in) (NP (DT the) (NN plasma) (NN membrane))))))) (CC and) (NP (NP (DT an) (NN association)) (PP (IN of) (NP (PRP$ its) (JJ cytoplasmic) (NP (NP (NN carboxyl) (NN terminus)) (PRN (-LRB- -LRB-) (NP (NN CT)) (-RRB- -RRB-))))) (PP (IN with) (NP (NP (JJ TNFR-associated) (NNS factors)) (PRN (-LRB- -LRB-) (NP (NNS TRAFs)) (-RRB- -RRB-))))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (ADVP (RB now)) (VP (VBP show) (SBAR (SBAR (IN that) (S (PP (IN in) (NP (JJ EBV-transformed) (NN B) (NNS lymphocytes))) (NP (NP (NP (JJS most)) (PP (IN of) (NP (NP (NN TRAF1)) (CC or) (NP (NN TRAF3))))) (CC and) (NP (NP (CD 5) (NN %)) (PP (IN of) (NP (NN TRAF2))))) (VP (VBP are) (VP (VBN associated) (PP (IN with) (NP (NN LMP1))))))) (CC and) (SBAR (IN that) (S (NP (NP (JJS most)) (PP (IN of) (NP (NN LMP1)))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (NN TRAF1)) (CC or) (NP (NN TRAF3)))))))))) (. .))))
(S1 (S (S (NP (NP (NN TRAF1)) (, ,) (NP (NN TRAF2)) (, ,) (CC and) (NP (NN TRAF3))) (VP (VBP bind) (PP (TO to) (NP (NP (DT a) (JJ single) (NN site)) (PP (IN in) (NP (NP (DT the) (NN LMP1) (NN CT)) (VP (VBG corresponding) (PP (TO to) (NP (NP (NP (NN amino) (NNS acids)) (PRN (-LRB- -LRB-) (NP (NNS aa)) (-RRB- -RRB-))) (NP (NP (CD 199)) (TO to) (NP (CD 214)))))))) (, ,) (PP (IN within) (NP (NP (DT a) (NN domain)) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (JJ important) (PP (IN for) (NP (NN B-lymphocyte) (NN growth) (NN transformation)))))))) (PRN (-LRB- -LRB-) (NP (NNS aa) (NP (NP (CD 187)) (TO to) (NP (CD 231)))) (-RRB- -RRB-)))))) (. .))))
(S1 (S (S (NP (NP (JJ Further) (UCP (ADJP (JJ deletional)) (CC and) (NP (NN alanine) (NN mutagenesis))) (NNS analyses)) (CC and) (NP (NP (NN comparison)) (PP (IN with) (NP (NP (NN TRAF) (NN binding) (NNS sequences)) (PP (PP (IN in) (NP (NN CD40))) (, ,) (PP (IN in) (NP (NN CD30))) (, ,) (CC and) (PP (IN in) (NP (NP (DT the) (NN LMP1)) (PP (IN of) (NP (JJ other) (NNS lymphycryptoviruses)))))))))) (VP (VBP provide) (NP (DT the) (JJ first) (NN evidence) (SBAR (IN that) (S (NP (NN PXQXT/S)) (VP (VBZ is) (NP (DT a) (NN core) (NN TRAF) (NN binding) (NN motif))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ negative) (NNS effects)) (PP (IN of) (NP (NP (NN point) (NNS mutations)) (PP (IN in) (NP (DT the) (NN LMP1-LRB-1-231-RRB-) (NN core) (NN TRAF) (NN binding) (NN motif))))) (PP (IN on) (NP (NP (NN TRAF) (NN binding)) (CC and) (NP (NN NF-kappaB) (NN activation))))) (ADVP (RB genetically)) (VP (VBP link) (NP (DT the) (NNS TRAFs)) (PP (TO to) (NP (JJ LMP1-LRB-1-231-RRB--mediated) (NN NF-kappaB) (NN activation)))) (. .))))
(S1 (S (S (S (NP (NP (NN NF-kappaB) (NN activation)) (PP (IN by) (NP (NN LMP1-LRB-1-231-RRB-)))) (VP (VBZ is) (ADJP (JJ likely) (S (VP (TO to) (VP (VB be) (VP (VBN mediated) (PP (IN by) (NP (NN TRAF1/TRAF2) (NNS heteroaggregates))) (SBAR (IN since) (S (NP (NN TRAF1)) (VP (VBZ is) (ADJP (JJ unique)) (PP (IN among) (NP (DT the) (NNS TRAFs))) (PP (IN in) (S (VP (VBG coactivating) (NP (NN NF-kappaB)) (PP (IN with) (NP (NN LMP1-LRB-1-231-RRB-)))))))))))))))) (, ,) (S (NP (DT a) (NN TRAF2) (JJ dominant-negative) (NN mutant)) (VP (MD can) (VP (VB block) (NP (NP (JJ LMP1-LRB-1-231-RRB--mediated) (NN NF-kappaB) (NN activation)) (CONJP (RB as) (RB well) (IN as)) (NP (NN TRAF1) (NN coactivation)))))) (, ,) (CC and) (S (NP (NP (CD 30) (NN %)) (PP (IN of) (NP (NN TRAF2)))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NN TRAF1))) (PP (IN in) (NP (JJ EBV-transformed) (NN B) (NNS cells)))))) (. .))))
(S1 (S (S (NP (NN TRAF3)) (VP (VBZ is) (NP (NP (DT a) (JJ negative) (NN modulator)) (PP (IN of) (NP (JJ LMP1-LRB-1-231-RRB--mediated) (NN NF-kappaB) (NN activation))))) (. .))))
(S1 (S (S (ADVP (RB Surprisingly)) (, ,) (NP (NP (NN TRAF1)) (, ,) (NP (CD -2)) (, ,) (CC or) (NP (CD -3))) (VP (VBZ does) (RB not) (VP (VB interact) (PP (IN with) (NP (NP (DT the) (JJ terminal) (NN LMP1) (NN CT) (NNS aa) (NP (NP (CD 333)) (TO to) (NP (CD 386)))) (SBAR (WHNP (WDT which)) (S (VP (MD can) (ADVP (RB independently)) (VP (VBP mediate) (NP (NN NF-kappaB) (NN activation)))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ constitutive) (NN association)) (PP (IN of) (NP (NNS TRAFs))) (PP (IN with) (NP (NN LMP1))) (PP (IN through) (NP (NP (DT the) (NNS aa) (NP (NP (CD 187)) (TO to) (NP (CD 231))) (NN domain)) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (JJ important)) (PP (IN in) (NP (NP (NN NF-kappaB) (NN activation)) (CC and) (NP (JJ primary) (NN B-lymphocyte) (NN growth) (NN transformation)))))))))) (VP (VBZ implicates) (NP (NP (NN TRAF) (NN aggregation)) (PP (IN in) (NP (NN LMP1) (NN signaling))))) (. .))))
(S1 (S (S (NP (NP (NP (NP (NN CD40)) (, ,) (CONJP (CC but) (RB not)) (UCP (NP (NN lipopolysaccharide)) (CC and) (ADJP (JJ anti-IgM)))) (NN stimulation)) (PP (IN of) (NP (JJ primary) (NN B) (NNS lymphocytes))) (, ,)) (VP (VBZ leads) (PP (TO to) (NP (NP (DT a) (JJ persistent) (JJ nuclear) (NN accumulation)) (PP (IN of) (NP (NN RelB)))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT this) (NN study))) (NP (PRP we)) (VP (VBD analyzed) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN CD40) (NN stimulation))) (PP (IN on) (NP (NP (DT the) (NP (NP (NN activity)) (CC and) (NP (JJ nuclear) (NN appearance)))) (PP (IN of) (NP (NP (NP (NP (NN Rel/nuclear) (NN factor) (NN kappaB)) (PRN (-LRB- -LRB-) (NP (NN NF-kappaB)) (-RRB- -RRB-))) (NNS factors)) (PP (IN in) (NP (JJ primary) (JJ murine) (NN B) (NNS lymphocytes))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (NN triggering)) (PP (IN of) (NP (NN CD40) (NN signaling) (NN pathway) (-LRB- -LRB-) (NNS s) (-RRB- -RRB-))) (PP (IN by) (NP (NP (NN CD40) (NNS ligands)) (VP (VBN expressed) (PP (IN on) (NP (NN L) (NNS cells))))))) (VP (VBD led) (PP (TO to) (NP (NP (JJ strong) (NN activation)) (PP (IN of) (NP (NP (DT an) (JJ NF-kappaB-controlled) (NN beta-globin) (NN reporter) (NN gene)) (PP (IN in) (NP (NP (JJ primary) (NN B) (NNS lymphocytes)) (PP (IN from) (NP (JJ transgenic) (NNS mice))))))))))))) (. .))))
(S1 (S (S (NP (NP (NNS Analyses)) (PP (IN of) (NP (NP (JJ nuclear) (NN translocation)) (PP (IN of) (NP (NP (JJ individual) (NNS members)) (PP (IN of) (NP (NN Rel) (NNS proteins))))) (PP (IN after) (NP (NP (NN CD40) (NN induction)) (PP (IN of) (NP (JJ primary) (NN B) (NNS cells)))))))) (VP (VBD showed) (NP (NP (NP (DT a) (ADJP (ADJP (JJ strong)) (CC and) (ADJP (JJ long-lasting))) (NN accumulation)) (PP (IN of) (NP (NN RelB)))) (CC and) (NP (, ,) (ADJP (RBR less) (JJ pronounced)) (, ,) (PP (IN of) (NP (NN c-Rel)))))) (. .))))
(S1 (S (S (S (NP (NN LPS) (NN stimulation)) (VP (VBD did) (RB not) (VP (VB give) (NP (NN rise)) (PP (TO to) (NP (NP (DT a) (JJ persistent) (JJ nuclear) (NN accumulation)) (PP (IN of) (NP (NP (NN RelB)) (CC and) (NP (NN c-Rel))))))))) (, ,) (IN whereas) (S (NP (JJ nuclear) (NP (NP (NN c-Rel)) (, ,) (CONJP (CC but) (RB not)) (NP (NN RelB)) (, ,))) (VP (VBD accumulated) (PP (IN after) (NP (NN B) (NN cell) (NN receptor) (NN stimulation))))) (. .))))
(S1 (S (S (NP (NN CD40)) (VP (VBD induced) (NP (NP (CONJP (RB not) (RB only)) (NP (JJ nuclear) (NN translocation)) (CONJP (CC but) (RB also)) (NP (ADJP (FW de) (FW novo)) (NN synthesis))) (PP (IN of) (NP (NN RelB) (NP (NP (NN RNA)) (CC and) (NP (NN protein))))))) (. .))))
(S1 (S (S (NP (NP (NN S107) (NN plasmacytoma) (NNS cells)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VP (VBP express) (NP (NN CD40))) (CC but) (VP (VBP are) (ADJP (JJ defective) (PP (IN for) (NP (NP (DT the) (JJ nuclear) (NN appearance)) (PP (IN of) (NP (NN p50/p65-NF-kappaB)))))))))) (, ,)) (VP (VBP do) (RB not) (VP (VB express) (NP (NN RelB)) (PP (IN after) (NP (NN CD40) (NN stimulation))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (NN S107) (NNS cells)) (VP (ADVP (RB stably)) (VBN transfected) (PP (IN with) (NP (NN relB) (NNS genes)))))) (, ,) (NP (NP (NN stimulation)) (PP (IN of) (NP (JJ nuclear) (NN RelB) (NN translocation))) (PP (IN by) (NP (NN CD40)))) (VP (VBD was) (VP (VBN observed))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (NN stimulation)) (PP (IN of) (NP (NN CD40) (NN signaling) (NNS pathways)))) (VP (VBZ exerts) (NP (DT a) (JJ long-lasting) (JJ stimulatory) (NN effect)) (PP (IN on) (NP (NP (CC both) (DT the) (NP (NP (NN transcription)) (CC and) (NP (JJ nuclear) (NN translocation)))) (PP (IN of) (NP (NN RelB))))))))) (. .))))
(S1 (S (S (SBAR (IN Since) (S (NP (NP (NN LPS)) (CC and) (NP (NN anti-IgM))) (VP (VBD were) (ADJP (JJ unable) (S (VP (TO to) (VP (VB activate) (NP (NN RelB))))))))) (, ,) (NP (NN CD40)) (VP (VBZ appears) (S (VP (TO to) (VP (VB trigger) (NP (NP (DT a) (JJ special) (NN program)) (PP (IN of) (NP (NN gene) (NN expression))) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NP (NP (NN proliferation)) (CC and/or) (NP (NN differentiation)))) (PP (IN of) (NP (NN B) (NNS lymphocytes))))))))))) (. .))))
(S1 (S (NP (NP (ADJP (NN Sterol) (JJ dependent)) (NN LDL-receptor) (NN gene) (NN transcription)) (PP (IN in) (NP (NP (NNS lymphocytes)) (PP (IN from) (NP (UCP (ADJP (JJ normal)) (CC and) (NP (NN CML))) (NNS patients))))) (. .))))
(S1 (S (S (NP (NP (NN Sterol) (JJ regulatory) (NN element)) (PRN (-LRB- -LRB-) (NP (NN SRE)) (-RRB- -RRB-))) (VP (VBZ has) (VP (VBN been) (VP (VBN recognized) (S (VP (TO to) (VP (VB regulate) (NP (NP (JJ various) (JJ key) (NNS genes)) (VP (VBG coding) (PP (IN for) (NP (NP (NP (ADJP (RB especially) (JJ low)) (NN density) (NN lipoprotein) (-LRB- -LRB-) (NN LDL) (-RRB- -RRB-) (NN -receptor)) (, ,) (NP (NP (NN 3-hydroxy-3-methylglutaryl) (NN coenzyme) (NN A)) (PRN (-LRB- -LRB-) (NP (NN HMG-CoA)) (-RRB- -RRB-)) (NN reductase)) (CC and) (NP (NN HMG-CoA) (NN synthase))) (VP (VBN known) (S (VP (TO to) (VP (VB play) (NP (DT a) (JJ crucial) (NN role)) (PP (IN in) (NP (DT the) (NN cholesterol) (NN feedback) (NN mechanism))))))))))))))))) (. .))))
(S1 (S (S (NP (DT The) (JJ deranged) (NN cholesterol) (NN feedback) (NN mechanism)) (VP (VBZ has) (VP (VBN been) (VP (ADVP (RB widely)) (VBN recognised) (PP (IN in) (NP (NP (NP (NN initiation)) (CONJP (RB as) (RB well) (IN as)) (NP (NN progression))) (PP (IN of) (NP (NP (JJ various) (NNS types)) (PP (IN of) (NP (NNS cancers))) (PP (VBG including) (NP (NP (JJ chronic) (JJ myeloid) (NN leukaemia)) (PRN (-LRB- -LRB-) (NP (NN CML)) (-RRB- -RRB-))))))))))) (. .))))
(S1 (S (S (ADVP (RB Consequently)) (, ,) (NP (DT the) (JJ present) (NN study)) (VP (VP (VBD was) (VP (VBN addressed) (S (VP (TO to) (VP (VB understand) (NP (DT this) (NN phenomenon))))))) (CC and) (VP (VBD revealed) (NP (NP (NP (DT the) (NN existence)) (PP (IN of) (NP (NP (DT a) (JJ unique) (ADJP (CD 47) (NN kDa)) (NN protein) (NN factor)) (VP (VBG having) (NP (NP (NN affinity)) (PP (IN for) (NP (DT this) (NN SRE) (NN sequence))))))) (PP (IN in) (NP (NP (NNS lymphocytes)) (PP (IN from) (NP (JJ normal) (NNS subjects)))))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (PRP$ its) (NN absence)) (PP (IN in) (NP (NP (NNS lymphocytes)) (PP (IN from) (NP (JJ untreated) (NN CML) (NNS patients))))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (DT this) (NN factor)) (VP (VBD appeared) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NN CML) (NNS patients)) (VP (VBD achieved) (NP (NP (JJ complete) (JJ haematological) (NN remission)) (PRN (-LRB- -LRB-) (NP (NN CHR)) (-RRB- -RRB-))) (PP (IN through) (NP (NN alpha-interferon) (NN therapy))))))) (. .))))
(S1 (S (S (ADVP (RB Further)) (, ,) (NP (DT an) (NN inverse) (NN relationship)) (VP (VBD was) (VP (ADVP (RB also)) (VBN observed) (PP (IN between) (NP (NP (ADJP (NN sterol) (JJ modulated)) (NN LDL-receptor) (NN gene) (NN transcription)) (CC and) (NP (NP (DT the) (NN binding) (NN affinity)) (PP (IN of) (NP (DT this) (ADJP (CD 47) (NN kDa)) (NN factor))) (PP (TO to) (NP (DT the) (NN SRE) (NN sequence)))))))) (. .))))
(S1 (S (S (PP (VBN Based) (PP (IN upon) (NP (DT these) (NNS results)))) (NP (PRP we)) (VP (VBP propose) (SBAR (IN that) (S (NP (NN alpha-interferon)) (PP (IN through) (NP (PRP$ its) (NN receptor))) (VP (VBZ initiates) (NP (NP (ADJP (NP (JJ phosphatidic) (NN acid)) (JJ dependent)) (NN signalling)) (SBAR (WHNP (WDT which)) (S (PP (IN in) (NP (NN turn))) (VP (VBZ regulates) (NP (NP (NP (DT the) (NN affinity)) (PP (IN of) (NP (ADJP (CD 47) (NN kDa)) (NN sterol) (JJ regulatory) (NN element) (NN binding) (NN factor)))) (CONJP (RB as) (RB well) (IN as)) (NP (NN LDL-receptor) (NN gene) (NN transcription)))))) (PP (IN in) (NP (NP (NNS lymphocytes)) (PP (IN from) (NP (NN CML) (NNS patients)))))))))) (. .))))
(S1 (S (NP (NP (NNS Effects)) (PP (IN of) (NP (NP (NN Ara-C)) (PP (IN on) (NP (NP (NP (JJ neutral) (NN sphingomyelinase)) (CC and) (NP (ADJP (ADJP (NN mitogen-)) (CC and) (ADJP (JJ stress-activated))) (NN protein) (NNS kinases))) (PP (IN in) (NP (NN T-lymphocyte) (NN cell) (NNS lines))))))) (. .))))
(S1 (S (S (NP (JJ Neutral) (NP (NP (NN sphingomyelinase)) (PRN (-LRB- -LRB-) (NP (NN SMase)) (-RRB- -RRB-)))) (VP (MD can) (VP (VB be) (VP (VBN activated) (PP (IN by) (NP (JJ extracellular) (NNS signals))) (S (VP (TO to) (VP (VB produce) (NP (NP (NN ceramide)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB affect) (NP (NP (NP (JJ mitogen-activated) (NN protein) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN MAPK)) (-RRB- -RRB-))) (NNS activities))))))))))))) (. .))))
(S1 (S (S (NP (JJ Neutral) (NN SMase) (NN activity)) (VP (VBD was) (VP (VBN assessed) (PP (IN in) (NP (NP (NNS membranes)) (PP (IN from) (NP (NP (NP (NN Jurkat)) (, ,) (NP (DT a) (JJ human) (NN T-cell) (NN line)) (, ,)) (CC and) (NP (NP (NN EL4)) (, ,) (NP (DT a) (JJ murine) (NN T-cell) (NN line))))))))) (. .))))
(S1 (S (S (NP (NN Ara-C)) (VP (VBD activated) (NP (NN SMase)) (PP (IN with) (NP (CD 10) (NNS minutes))) (PP (IN in) (NP (NP (CC both) (NP (NN Jurkat)) (CC and) (NP (NN EL4))) (NNS cells))) (, ,) (SBAR (IN while) (S (NP (NP (NN phorbol) (NN ester)) (PRN (-LRB- -LRB-) (NP (NN PMA)) (-RRB- -RRB-))) (VP (VBD had) (NP (DT no) (NN effect)))))) (. .))))
(S1 (S (S (NP (NP (NN PMA)) (, ,) (CONJP (CC but) (RB not)) (NP (NP (NN Ara-C)) (CC or) (NP (NNS ceramides))) (, ,)) (VP (VBD activated) (NP (NN ERK) (NNS MAPKS)) (, ,) (PP (IN in) (NP (NP (NN Jurkat)) (CC and) (NP (NN EL4))))) (. .))))
(S1 (S (S (NP (NN PMA)) (VP (VBD acted) (ADVP (RB synergistically)) (PP (IN with) (NP (NN ionomycin))) (S (VP (TO to) (VP (VB activate) (NP (NN JNK) (NNS MAPKs)) (PP (IN in) (NP (NP (NN Jurkat)) (CC and) (NP (NN EL4)))) (PP (IN within) (NP (CD 10) (NNS minutes))))))) (. .))))
(S1 (S (S (NP (NN Ara-C)) (VP (VBD activated) (NP (NNS JNKs)) (PP (RB only) (IN after) (NP (NP (JJ prolonged) (NN incubation)) (PRN (-LRB- -LRB-) (NP (QP (CD 90-120)) (NNS minutes)) (-RRB- -RRB-))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NN ceramide)) (VP (VBZ is) (RB not) (NP (NP (DT a) (JJ positive) (NN signal)) (PP (IN for) (NP (NP (NN ERK) (NN activation)) (PP (IN in) (NP (NN T-cell) (NNS lines))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NN Ara-C))) (PP (IN on) (NP (NN JNK) (NN activity)))) (VP (MD may) (VP (VB be) (VP (VBN mediated) (PP (IN through) (NP (JJ secondary) (NN response) (NNS pathways)))))) (. .))))
(S1 (S (NP (-LRB- -LSB-) (JJ Cortisone-resistant) (JJ bronchial) (NN asthma) (-RRB- -RSB-))))
(S1 (S (S (S (NP (EX There)) (VP (VBZ is) (NP (NP (JJ general) (NN agreement)) (PP (IN on) (NP (NP (DT the) (JJ inflammatory) (NN pathogenesis)) (PP (IN of) (NP (JJ bronchial) (NN asthma))))))) (: :)) (S (NP (NP (NP (DT an) (NN accumulation)) (PP (IN of) (NP (VBN activated) (NNS eosinophils)))) (, ,) (NP (NP (VBN degranulated) (NN mast) (NNS cells))) (, ,) (NP (NP (NN T) (NNS lymphocytes))) (CC and) (NP (PP (IN in) (NP (ADJP (RB very) (JJ severe)) (NNS forms))) (, ,) (NP (NNS granulocytes)))) (VP (VBZ has) (ADVP (RB constantly)) (VP (VBN been) (VP (VBN found) (PP (IN in) (NP (DT the) (JJ bronchial) (NN mucosa)))))) (. .)))))
(S1 (S (S (PP (IN In) (NP (JJ allergic) (JJ bronchial) (NN asthma))) (, ,) (NP (NN inflammation)) (VP (VBZ seems) (S (VP (TO to) (VP (VB be) (VP (VBN orchestrated) (PP (ADVP (RB predominantly)) (IN by) (NP (NP (DT a) (NN subset)) (PP (IN of) (NP (NN T) (NNS lymphocytes))) (, ,) (PP (IN with) (NP (NP (DT a) (NN phenotype)) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT the) (NN Th2) (NN subset)) (ADJP (JJ able) (S (VP (TO to) (VP (VB produce) (NP (NP (NN IL-4)) (CC and) (NP (NN IL-5))))))))))))))))))) (. .))))
(S1 (S (S (SBAR (IN Although) (S (NP (NNS corticosteroids)) (VP (VBP are) (NP (NP (DT the) (ADJP (RBS most) (JJ potent)) (JJ therapeutic) (NNS agents)) (VP (VBN used) (PP (IN for) (NP (DT this) (NN disease)))))))) (, ,) (NP (PRP$ their) (JJ anti-inflammatory) (NN effect)) (VP (VBZ differs) (PP (PP (IN from) (NP (NN patient))) (PP (TO to) (NP (NN patient))))) (. .))))
(S1 (S (S (NP (NP (DT Some) (NNS criteria)) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VB define) (NP (JJ steroid-resistant) (JJ bronchial) (NN asthma))))))))))) (VP (VBP are) (VP (VBN listed) (ADVP (RB here)))) (. .))))
(S1 (S (S (NP (DT This) (NN review)) (VP (VBZ analyzes) (NP (NP (JJ various) (JJ molecular) (NNS alterations)) (ADJP (JJ responsible) (PP (IN for) (NP (NP (DT the) (JJ deficient) (NN response)) (PP (TO to) (NP (NN corticosteroid) (NN treatment))) (VP (VBN observed) (PP (IN in) (NP (ADJP (JJ steroid-resistant) (JJ bronchial) (JJ asthmatic)) (NNS subjects))))))))) (. .))))
(S1 (S (S (NP (NP (JJ New) (NN knowledge)) (PP (IN on) (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (NN steroid) (NN resistance)))))) (VP (MD may) (VP (VB have) (NP (NP (JJ important) (NNS implications)) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NP (JJ chronic) (NN asthma)) (CC and) (NP (JJ other) (NNS diseases))))))))) (. .))))
(S1 (S (S (NP (NP (NN Expression)) (PP (IN of) (NP (NN Egr-1)))) (VP (VBZ correlates) (PP (IN with) (NP (NP (NP (DT the) (VBN transformed) (NN phenotype)) (CC and) (NP (NP (DT the) (NN type)) (PP (IN of) (NP (JJ viral) (NN latency))))) (PP (IN in) (NP (ADJP (NP (NN EBV) (NN genome)) (JJ positive)) (JJ lymphoid) (NN cell) (NNS lines)))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT this) (NN paper))) (NP (PRP we)) (VP (VBP have) (VP (VBN investigated) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN Egr-1))) (PP (IN in) (NP (NN B) (NN cell) (NN growth) (NN regulation)))) (PP (IN by) (S (VP (VBG examining) (NP (NP (DT the) (NN gene) (NN expression)) (PP (IN in) (NP (NP (DT a) (NN panel)) (PP (IN of) (NP (NP (NN B) (NN cell) (NNS lines)) (, ,) (PP (VBG including) (NP (ADJP (CC both) (ADJP (NP (NN EBV) (NN genome)) (JJ negative)) (CC and) (ADJP (NN EBV) (VBG carrying))) (NN cell) (NNS lines))))))))))))) (. .))))
(S1 (S (S (NP (NN Egr-1) (NN expression)) (VP (VBZ correlates) (PP (IN with) (NP (NP (NP (DT the) (JJ cellular) (NN phenotype)) (CC and) (NP (NP (DT the) (JJ specific) (NN pattern)) (PP (IN of) (NP (JJ viral) (NN latency))))) (VP (VBN established) (PP (IN within) (NP (DT the) (JJ individual) (NN cell) (NNS lines))))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NP (JJ constitutive) (NN activation)) (PP (IN of) (NP (NN Egr-1) (NN gene)))) (VP (VBZ is) (VP (ADVP (RB invariably)) (VBN associated) (PP (IN with) (NP (NP (JJ unrestricted) (NN expression)) (PP (IN of) (NP (JJ viral) (JJ latent) (NNS genes))) (PP (IN in) (NP (DT all) (NN group) (CD III) (ADJP (NP (NN EBV) (NN genome)) (VBG carrying)) (NN cell) (NNS lines))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NN Egr-1) (NN expression)) (VP (VBZ is) (VP (VBN abrogated) (PP (IN in) (NP (NN group) (NN I) (NN Burkitt) (NN tumor) (NNS cells))) (, ,) (ADVP (JJ irrespective) (PP (IN of) (NP (DT the) (NN EBV) (NN genome) (NN carrying) (NN status)))))) (. .))))
(S1 (S (S (NP (NP (VBN Activated) (JJ viral) (NN gene) (NN expression)) (VP (VBN associated) (PP (IN with) (NP (NP (JJ phenotypic) (NN conversion)) (PP (IN of) (NP (NN group) (NN I) (NN cell) (NNS lines))) (PP (IN in) (TO to) (NP (NN group) (NP (NP (CD II)) (CC or) (NP (CD III))))))))) (VP (VBZ restores) (NP (DT the) (NN Egr-1) (NN gene) (NN expression))) (. .))))
(S1 (S (S (S (NP (NP (JJ Several) (NNS forms)) (PP (IN of) (NP (JJ EGR-1) (NN protein)))) (VP (VBP are) (VP (VBN found) (PP (IN within) (NP (NP (DT the) (JJ different) (NNS groups)) (PP (IN of) (NP (NN cell) (NNS lines)))))))) (, ,) (CC and) (S (NP (NP (DT the) (NN binding) (NN activity)) (PP (TO to) (NP (NN DNA) (NN consensus) (NNS sequences)))) (VP (VBD was) (VP (VBN investigated)))) (. .))))
(S1 (S (S (ADVP (RB Finally)) (, ,) (NP (NP (NN time) (NN course) (NN analysis)) (PP (IN of) (NP (NP (NN Egr-1) (NN expression)) (PP (IN during) (NP (NP (DT the) (JJ early) (NNS steps)) (PP (IN of) (NP (NP (NN EBV) (NN infection)) (ADVP (FW in) (FW vitro))))))))) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NN Egr-1)) (VP (VBZ is) (VP (VBN upregulated) (PP (IN within) (NP (NP (NNS minutes)) (PP (IN from) (NP (NP (DT the) (JJ initial) (NN interaction)) (PP (IN with) (NP (DT the) (NN B) (NN lymphocyte)))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ proximal) (JJ regulatory) (NN element)) (PP (IN of) (NP (DT the) (NN interferon-gamma) (NN promoter)))) (VP (VBZ mediates) (NP (JJ selective) (NN expression)) (PP (IN in) (NP (NN T) (NNS cells)))) (. .))))
(S1 (S (S (S (S (NP (NP (NN Interferon-gamma)) (PRN (-LRB- -LRB-) (NP (NN IFN-gamma)) (-RRB- -RRB-))) (VP (VBZ is) (VP (VBN produced) (PP (IN by) (NP (NP (JJ natural) (NN killer) (NNS cells)) (CC and) (NP (NP (JJ certain) (NNS subsets)) (PP (IN of) (NP (NN T) (NNS cells))))))))) (, ,) (CC but) (S (NP (NP (DT the) (NN basis)) (PP (IN for) (NP (PRP$ its) (JJ selective) (NN expression)))) (VP (VBZ is) (ADJP (JJ unknown))))) (. .))))
(S1 (S (SINV (PP (IN Within) (NP (NP (DT the) (NN region)) (PP (IN between) (NP (NP (NP (NP (CD -108)) (CC and) (NP (CD -40))) (NN base) (NNS pairs)) (PP (IN of) (NP (DT the) (NN IFN-gamma) (NN promoter))))))) (VP (VBP are)) (NP (NP (CD two) (ADJP (ADJP (VBN conserved)) (CC and) (ADJP (JJ essential))) (JJ regulatory) (NNS elements)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP confer) (NP (NP (JJ activation-specific) (NN expression)) (PP (IN in) (NP (NN T) (NNS cells)))))))) (. .))))
(S1 (S (S (NP (DT This) (NN report)) (VP (VBZ describes) (NP (NP (NNS studies)) (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (DT the) (ADJP (RBS most) (JJ proximal))) (PP (IN of) (NP (DT these) (CD two) (JJ regulatory) (NNS elements)))) (VP (VBZ is) (NP (NP (DT an) (JJ important) (NN determinant)) (PP (IN of) (NP (PRP$ its) (JJ restricted) (NN expression)))))))))) (. .))))
(S1 (S (S (NP (DT The) (JJ proximal) (NN element)) (VP (VBZ is) (NP (NP (DT a) (JJ composite) (NN site)) (SBAR (WHNP (WDT that)) (S (VP (VBZ binds) (NP (NP (NNS members)) (PP (IN of) (NP (NP (DT the) (NP (NP (NN CREB/ATF)) (, ,) (NP (NN AP-1)) (, ,) (CC and) (NP (NN octamer))) (NNS families)) (PP (IN of) (NP (NN transcription) (NNS factors))))))))))) (. .))))
(S1 (S (S (NP (NN Jun)) (VP (VP (VBZ is) (ADJP (JJ essential) (PP (IN for) (NP (JJ activation-induced) (NN transcription))))) (CC and) (VP (VBZ binds) (ADVP (RB preferably)) (PP (IN as) (NP (DT a) (NN heterodimer))) (PP (IN with) (NP (NN ATF-2))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NN CREB)) (VP (VBZ appears) (S (VP (TO to) (VP (VB dampen) (NP (NP (NN transcription)) (PP (IN from) (NP (DT this) (NN element)))))))) (. .))))
(S1 (S (S (S (NP (NP (DT The) (NN CpG) (NN dinucleotide)) (PP (IN in) (NP (DT this) (NN element)))) (VP (VBZ is) (VP (ADVP (RB selectively)) (VBN methylated) (PP (IN in) (NP (NP (NN Th2) (NN T) (NNS cells)) (CC and) (NP (NP (JJ other) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP do) (RB not) (VP (VB express) (NP (NN IFN-gamma)))))))))))) (, ,) (CC and) (S (NP (NN methylation)) (ADVP (RB markedly)) (VP (VBZ reduces) (NP (NN transcription) (NN factor) (NN binding)))) (. .))))
(S1 (S (S (PP (IN As) (NP (NP (DT a) (NN target)) (PP (PP (IN for) (NP (NN DNA) (NN methylation))) (CC and) (PP (IN for) (NP (NP (NN binding)) (PP (IN of) (NP (NP (NN transcription) (NNS factors)) (SBAR (WHNP (WDT that)) (S (VP (VP (VP (VBP mediate)) (CC or) (VP (VBP impede))) (NP (NN transcription)))))))))))) (, ,) (NP (DT this) (NN element)) (VP (VBZ appears) (S (VP (TO to) (VP (VB play) (NP (DT a) (JJ central) (NN role)) (PP (IN in) (S (VP (VBG controlling) (NP (NN IFN-gamma) (NN expression))))))))) (. .))))
(S1 (S (S (NP (NP (NN Activation)) (PP (IN of) (NP (JJ nuclear) (NN factor-kappaB))) (PP (IN via) (NP (NN T) (NN cell) (NN receptor)))) (VP (VBZ requires) (NP (DT a) (NP (NP (NN Raf) (NN kinase)) (CC and) (NP (NN Ca2+))) (NN influx))) (. .))))
(S1 (S (NP (NP (JJ Functional) (NN synergy)) (PP (IN between) (NP (NP (NN Raf)) (CC and) (NP (NN calcineurin)))) (. .))))
(S1 (S (S (NP (NP (NNS Signals)) (VP (VBN transduced) (PP (IN via) (NP (DT the) (NN TCR))))) (VP (VBP activate) (NP (NP (DT the) (NN transcription) (NN factor) (NP (NP (JJ nuclear) (NN factor-kappaB)) (PRN (-LRB- -LRB-) (NP (NN NF-kappaB)) (-RRB- -RRB-)))) (, ,) (SBAR (WHNP (WDT which)) (, ,) (S (PP (IN in) (NP (NN turn))) (, ,) (VP (VBZ is) (ADJP (JJ critical) (PP (TO to) (NP (NP (DT the) (JJ transcriptional) (NN induction)) (PP (IN of) (NP (NP (JJ many) (NNS genes)) (ADJP (JJ important) (PP (IN for) (NP (NP (DT the) (NP (NP (NN proliferation)) (CC and) (NP (NN expression)))) (PP (IN of) (NP (DT a) (VBN differentiated) (NN phenotype)))))))))))))))) (. .))))
(S1 (S (S (S (NP (NP (NN Treatment)) (PP (IN of) (NP (NN T) (NNS cells))) (PP (IN with) (NP (DT the) (NN protein) (NN kinase) (NN C) (NN activator) (NN PMA))) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN Ca2+) (NNS ionophores)))))) (VP (VBZ mimics) (NP (DT this) (NN process)))) (, ,) (CC and) (S (NP (DT the) (CD two) (NNS agents)) (VP (VBP are) (VP (ADVP (RB often)) (VBN substituted) (PP (IN for) (NP (NN TCR) (NN stimulation)))) (, ,) (S (VP (VBG bypassing) (NP (DT the) (NN TCR)))))) (. .))))
(S1 (S (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP identify) (NP (NP (JJ intracellular) (VBG signaling) (NNS components)) (VP (VBN involved) (PP (IN in) (NP (NP (NN activation)) (PP (IN of) (NP (NN NF-kappaB))) (PP (VBG following) (NP (NN TCR) (NN stimulation)))))))) (. .))))
(S1 (S (S (S (NP (NN TCR) (NN signaling)) (VP (VBD was) (VP (VBN triggered) (PP (IN by) (S (VP (VBG treating) (NP (NN Jurkat) (NN T) (NNS cells)) (PP (IN with) (NP (UCP (NP (NN PHA)) (CC or) (ADJP (JJ anti-CD3))) (NNS Abs))))))))) (, ,) (CC and) (S (NP (NN NF-kappaB) (NN activation)) (VP (VBD was) (VP (VBN monitored) (PP (PP (IN by) (NP (JJ electrophoretic) (NN mobility) (NN shift) (NNS assays))) (CC and/or) (PP (IN by) (NP (JJ kappaB-dependent) (NN reporter) (NNS assays))))))) (. .))))
(S1 (S (S (PP (JJ Contrary) (TO to) (NP (DT the) (NN idea) (SBAR (IN that) (S (NP (NN protein) (NN kinase) (NN C)) (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (NP (JJ TCR-mediated) (NN activation)) (PP (IN of) (NP (NN NF-kappaB))))))))))) (, ,) (NP (NP (JJ high) (NNS doses)) (PP (IN of) (NP (NN staurosporine)))) (VP (VBD did) (RB not) (VP (VB interfere) (PP (IN with) (NP (NP (NN activation)) (PP (IN of) (NP (NN NF-kappaB))) (PP (IN by) (NP (NN PHA))))) (, ,) (SBAR (IN while) (S (NP (NP (DT the) (JJ same) (NN dose)) (PP (IN of) (NP (NN staurosporine)))) (ADVP (RB completely)) (VP (VBD blocked) (NP (NP (NN activation)) (PP (IN by) (NP (NN PMA))))))))) (. .))))
(S1 (S (S (NP (JJ PHA-induced) (JJ kappaB-dependent) (NN reporter) (NN activity)) (VP (VBD was) (, ,) (ADVP (RB however)) (, ,) (VP (ADVP (RB effectively)) (VBN blocked) (PP (IN by) (NP (NP (DT a) (JJ dominant) (JJ negative) (NN form)) (PP (IN of) (NP (NN Raf-1))))) (, ,) (S (VP (VBG suggesting) (NP (NP (DT a) (JJ critical) (NN role)) (PP (IN for) (NP (DT a) (NN Raf) (NN kinase)))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ TCR-mediated) (NN activation)) (PP (IN of) (NP (NN NF-kappaB)))) (VP (VBD was) (ADVP (RB also)) (ADJP (JJ dependent) (PP (IN on) (NP (DT a) (NN Ca2+) (NN influx)))) (, ,) (SBAR (IN because) (S (NP (NP (NP (DT the) (NN Ca2+) (NN channel) (NN blocker)) (, ,) (NP (NN SK&amp;F) (CD 96365))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (JJ other) (NNS agents)) (SBAR (WHNP (WDT that)) (S (VP (VBD prevented) (NP (DT the) (NN Ca2+) (NN influx)))))) (, ,)) (VP (VBD inhibited) (NP (NN NF-kappaB) (NN activation)))))) (. .))))
(S1 (S (S (NP (NP (NN Cotransfection)) (PP (IN of) (NP (NP (DT a) (ADJP (RB constitutively) (JJ active)) (NN form)) (PP (IN of) (NP (NN calcineurin)))))) (VP (VP (ADVP (RB largely)) (VBD substituted) (PP (IN for) (NP (DT the) (NN Ca2+) (NN requirement)))) (CC and) (VP (VBD reversed) (NP (NP (DT the) (NN blockade)) (PP (IN by) (NP (NN SK&amp;F) (CD 96365)))))) (. .))))
(S1 (S (S (ADJP (JJ Consistent) (PP (IN with) (NP (DT these) (NNS observations)))) (, ,) (NP (NP (NN coexpression)) (PP (IN of) (NP (NP (ADJP (RB constitutively) (JJ active)) (NNS forms)) (PP (IN of) (NP (NP (NN Raf-1)) (CC and) (NP (NN calcineurin))))))) (ADVP (RB synergistically)) (VP (VBD induced) (NP (JJ kappaB-dependent) (NN reporter) (NN activity)) (, ,) (S (VP (VBG suggesting) (NP (NP (DT a) (ADJP (RB physiologically) (JJ relevant)) (JJ functional) (NN interaction)) (PP (IN between) (NP (NP (DT the) (NN kinase)) (CC and) (NP (DT the) (NN phosphatase)))))))) (. .))))
(S1 (S (S (NP (NP (NN Induction)) (PP (IN of) (NP (DT the) (NN CD11b) (NN gene))) (PP (IN during) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (JJ monocytic) (NN cell) (NN line) (NN U937)))))) (VP (VBZ requires) (NP (DT a) (JJ novel) (JJ nuclear) (NN factor) (NN MS-2)) (PRN (-LRB- -LSB-) (S (NP (VBN published) (NN erratum)) (VP (VBZ appears) (PP (IN in) (NP (NP (NNP J) (NNP Immunol)) (NP (CD 1999) (NNP Jul) (CD 15)) (: ;) (NP (CD 163) (-LRB- -LRB-) (CD 2) (-RRB- -RRB-)) (: :) (NP (CD 1091)))))) (-RRB- -RSB-))))))
(S1 (S (S (NP (NP (DT The) (NN differentiation)) (PP (IN of) (NP (JJ myeloid) (NNS precursors))) (PP (IN into) (NP (JJ mature) (JJ myelomonocytic) (NNS cells)))) (VP (VBZ is) (VP (VBN characterized) (PP (IN by) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NP (DT the) (NN gene)) (VP (VBG encoding) (NP (DT the) (NN beta2) (NN integrin) (NN CD11b))))))))) (. .))))
(S1 (S (S (S (NP (DT The) (NN transcription) (NNS factors) (NP (NP (NN Sp1)) (CC and) (NP (NN PU.1)))) (VP (VBP prime) (NP (DT the) (NN CD11b) (NN promoter)))) (, ,) (CC but) (S (NP (NP (DT the) (NN nature)) (PP (IN of) (NP (NP (DT the) (NNS factors)) (ADJP (JJ responsible) (PP (IN for) (NP (PRP$ its) (JJ inducible) (NN expression))))))) (VP (VBP are) (ADJP (JJ unknown)))) (. .))))
(S1 (S (S (PP (IN In) (NN addition) (TO to) (NP (DT the) (NN CD11b) (NN gene))) (, ,) (NP (NP (DT the) (JJ homologous) (NNS genes)) (VP (VBG encoding) (NP (NP (NN CD11a)) (CC and) (NP (NN CD11c))))) (ADVP (RB also)) (VP (VBP exhibit) (NP (JJ inducible) (NN expression)) (PP (IN during) (NP (JJ myeloid) (NN differentiation)))) (. .))))
(S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (PRP we)) (VP (VBD compared) (NP (NP (DT the) (JJ nucleotide) (NNS sequences)) (PP (IN of) (NP (DT the) (NP (NP (NN CD11a)) (, ,) (NP (NN CD11b)) (, ,) (CC and) (NP (NN CD11c))) (NN gene) (NNS promoters)))) (S (VP (TO to) (VP (VB identify) (NP (NP (JJ common) (NNS elements)) (SBAR (WHNP (WDT that)) (S (VP (MD might) (VP (VB contribute) (PP (TO to) (NP (JJ inducible) (NN expression)))))))))))) (. .))))
(S1 (S (S (NP (DT This) (NN analysis)) (VP (VBD identified) (NP (NP (CD one) (JJ such) (NN element)) (VP (VBN repeated) (NP (CD four) (NNS times)) (PP (IN within) (NP (DT the) (NN CD11b) (NN promoter)))))) (. .))))
(S1 (S (S (NP (NP (NN Mutation)) (PP (IN of) (NP (DT these) (NNS elements)))) (VP (VBD indicated) (SBAR (IN that) (S (NP (NP (CD two)) (, ,) (NP (NP (NN MS-2beta)) (CC and) (NP (NN MS-2gamma))) (, ,)) (VP (VBP are) (ADJP (JJ critical) (PP (TO to) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (DT the) (NN CD11b) (NN gene))) (PP (IN during) (NP (NP (NN differentiation)) (PP (IN of) (NP (DT the) (JJ pro-monocytic) (NN cell) (NN line) (NN U937)))))))))))) (. .))))
(S1 (S (S (NP (JJ Electrophoretic) (NN mobility) (NN shift) (NNS assays)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (NN MS-2beta)) (CC and) (NP (NN MS-2gamma))) (VP (VBP interact) (PP (IN with) (NP (NP (JJ nuclear) (NNS factors)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN induced) (PP (IN during) (NP (NN U937) (NN differentiation))))))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS factors)) (VP (VBP are) (VP (VBN detected) (PP (IN at) (NP (NP (DT the) (NN time)) (SBAR (S (NP (DT the) (NN CD11b) (NN promoter)) (VP (VBZ is) (VP (VBN activated))))))))) (. .))))
(S1 (S (S (S (NP (NP (DT The) (JJ molecular) (NN mass)) (PP (IN of) (NP (DT these) (NNS factors)))) (VP (VBZ is) (NP (QP (RB approximately) (CD 28)) (NN kDa)))) (, ,) (CC and) (S (NP (PRP$ their) (NN DNA) (NN binding) (NNS characteristics)) (VP (VBP are) (ADJP (JJ indistinguishable) (PP (IN from) (NP (NP (DT those)) (PP (IN of) (NP (DT the) (JJ novel) (JJ nuclear) (NN factor) (NN MS-2)))))))) (. .))))
(S1 (S (S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (NP (PRP$ our) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN MS-2)) (VP (VBZ mediates) (NP (NP (NN induction)) (PP (IN of) (NP (DT the) (NN CD11b) (NN gene)))) (SBAR (IN as) (S (NP (NP (NNS cells)) (PP (IN of) (NP (DT the) (JJ monocytic) (NN lineage)))) (VP (VBP mature)))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN presence)) (PP (IN of) (NP (NP (JJ multiple) (JJ potential) (VBG binding) (NNS sites)) (PP (IN for) (NP (NN MS-2))))) (PP (IN in) (NP (NP (DT the) (NN promoter) (NNS regions)) (PP (IN of) (NP (NP (DT a) (JJ wide) (NN range)) (PP (IN of) (NP (NP (NNS genes)) (VP (VBN expressed) (PP (IN in) (NP (JJ mature) (JJ myeloid) (NNS cells))))))))))) (VP (VBZ suggests) (SBAR (S (NP (DT this) (NN factor)) (VP (VBZ plays) (NP (DT a) (JJ general) (NN role)) (PP (IN in) (NP (JJ myeloid) (NN differentiation))))))) (. .))))
(S1 (S (S (NP (NP (NN HIV-1) (NN LTR) (NN activity)) (PP (IN in) (NP (JJ human) (JJ CD40-activated) (NN B) (NNS lymphocytes)))) (VP (VBZ is) (ADJP (JJ dependent) (PP (IN on) (NP (NN NF-kappaB))))) (. .))))
(S1 (S (S (NP (JJ CD40-stimulated) (JJ human) (NN B) (NNS lymphocytes)) (VP (VBP are) (ADJP (RB highly) (JJ permissive) (PP (TO to) (NP (NP (DT a) (JJ productive) (NN infection)) (PP (IN by) (NP (DT the) (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 1))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT these) (NNS cells))) (, ,) (NP (NP (JJ nuclear) (NNS factors)) (VP (VBN involved) (PP (IN in) (NP (NP (NN activation)) (PP (IN of) (NP (NP (DT the) (NN HIV-1) (NN LTR)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ contains) (NP (NP (DT the) (JJ transcriptional) (NN control) (NNS elements)) (PP (IN of) (NP (DT the) (NN virus))))))) (, ,))))))) (VP (VBP are) (ADJP (JJ unknown))) (. .))))
(S1 (S (S (NP (NP (JJ Transient) (NN expression) (NNS assays)) (PP (IN with) (NP (NP (NNS plasmids)) (VP (VBG containing) (NP (NP (VBN deleted) (NNS parts)) (PP (IN of) (NP (NP (DT the) (NN LTR) (NN region)) (VP (VBN linked) (PP (TO to) (NP (DT a) (NN reporter) (NN gene))))))))))) (VP (VBD showed) (SBAR (IN that) (S (NP (DT the) (NN NF-kappaB) (NN binding) (NN site)) (VP (VBD was) (ADJP (JJ essential) (PP (IN for) (NP (NP (NN HIV-1) (NN LTR) (NN activity)) (PP (IN in) (NP (JJ CD40-stimulated) (NN B) (NNS lymphocytes)))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NP (JJ electrophoretic) (NN mobility) (NN shift)) (CC and) (NP (NN supershift))) (NNS assays)) (VP (VBD revealed) (SBAR (IN that) (S (NP (NP (JJ important) (NN NF-kappaB) (NN binding) (NN activity)) (VP (VBN composed) (PP (IN of) (NP (ADVP (IN at) (JJS least)) (NP (NP (NN p50)) (, ,) (NP (NN p65)) (, ,) (CC and) (NP (NN c-Rel) (NN NF-kappaB))) (NNS subunits))))) (VP (VBD was) (ADJP (JJ present) (PP (IN in) (NP (NP (NNS nuclei)) (PP (IN of) (NP (JJ CD40-stimulated) (NN B) (NNS cells)))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VP (VBP confirm) (PP (IN at) (NP (DT a) (JJ molecular) (NN level))) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN HIV-1))) (S (VP (TO to) (VP (VB replicate) (PP (IN in) (NP (NN B) (NNS cells)))))))) (CC and) (VP (SBAR (IN that) (S (NP (DT this) (NN activity)) (VP (VBZ is) (VP (ADVP (RB strongly)) (VBN associated) (PP (IN with) (NP (NN NF-kappaB))))))))) (. .))))
(S1 (S (S (NP (NP (NN Mutation)) (PP (IN of) (NP (NNS tyrosines) (CD 492/493))) (PP (IN in) (NP (NP (DT the) (NN kinase) (NN domain)) (PP (IN of) (NP (NN ZAP-70)))))) (VP (VBZ affects) (NP (JJ multiple) (NN T-cell) (NN receptor) (NN signaling) (NNS pathways))) (. .))))
(S1 (S (S (NP (DT The) (JJ protein-tyrosine) (NN kinase) (NN ZAP-70)) (VP (VBZ is) (VP (VBN implicated) (, ,) (PP (RB together) (IN with) (NP (DT the) (NN Src) (NN kinase) (NN p56-LRB-lck-RRB-))) (, ,) (PP (IN in) (S (VP (VBG controlling) (NP (NP (DT the) (JJ early) (NNS steps)) (PP (IN of) (NP (DT the) (NP (NP (NN T-cell) (NN antigen) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN TCR)) (-RRB- -RRB-))) (NN signaling) (NN cascade))))))))) (. .))))
(S1 (S (S (S (VP (TO To) (VP (VB help) (S (VP (VB elucidate) (ADVP (RBR further)) (NP (NP (DT the) (NN mechanism)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (NN ZAP-70)) (VP (VBZ regulates) (NP (DT these) (JJ initial) (NNS events))))))))))) (, ,) (NP (PRP we)) (VP (VBD used) (NP (DT a) (JJ dominant-negative) (NN mutant) (NN approach))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBD overexpressed) (PP (IN in) (NP (DT the) (NN Jurkat) (NN T-cell) (NN line))) (NP (NP (NN ZAP-70)) (VP (VBN mutated) (PP (IN on) (NP (NP (NP (NN Tyr-492)) (CC and) (NP (NN Tyr-493))) (PP (IN in) (NP (NP (DT the) (JJ putative) (JJ regulatory) (NN loop)) (PP (IN of) (NP (PRP$ its) (NN kinase) (NN domain)))))))))) (. .))))
(S1 (S (S (NP (DT This) (NN mutant)) (VP (VBD inhibited) (NP (NP (JJ TCR-induced) (NN activation)) (PP (IN of) (NP (NP (JJ nuclear) (NN factor)) (PP (IN of) (NP (VBN activated) (NN T) (NNS cells)))))) (PP (IN by) (S (VP (VBG interfering) (PP (IN with) (NP (CC both) (NP (JJ intracellular) (NN calcium) (NN increase)) (CC and) (NP (NP (JJ Ras-regulated) (NN activation)) (PP (IN of) (NP (JJ extracellular) (JJ signal-regulated) (NNS kinases)))))))))) (. .))))
(S1 (S (S (ADVP (RB Moreover)) (, ,) (NP (NP (JJ TCR-induced) (NN phosphorylation)) (PP (IN of) (NP (NN pp36-38))) (, ,) (VP (VBN thought) (S (VP (TO to) (VP (VB play) (NP (DT a) (NN role)) (ADVP (RB upstream) (PP (IN of) (NP (DT these) (NNS pathways)))))))) (, ,)) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB be) (VP (VBN reduced))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (NN overexpression)) (PP (IN of) (NP (JJ wild-type) (NN ZAP-70)))) (VP (VBD induced) (NP (NP (JJ constitutive) (NN activation)) (PP (IN of) (NP (NP (JJ nuclear) (NN factor)) (PP (IN of) (NP (VBN activated) (NN T) (NNS cells))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN ZAP-70) (NN mutant)) (VP (VBN studied) (ADVP (RB here)))) (VP (VP (MD could) (VP (VB be) (VP (VBN phosphorylated) (PP (IN on) (NP (NN tyrosine))) (SBAR (WHADVP (WRB when)) (S (VP (VBN associated) (PP (TO to) (NP (DT the) (NN TCR) (NN zeta) (NN chain))))))))) (CC and) (VP (VBD was) (ADJP (JJ able) (S (VP (TO to) (VP (VB bind) (NP (NN p56-LRB-lck-RRB-)))))))) (. .))))
(S1 (S (S (NP (DT This) (NN result)) (VP (VBZ demonstrates) (SBAR (IN that) (S (NP (NP (NN Tyr-492)) (CC and) (NP (NN Tyr-493))) (VP (VBP are) (RB not) (ADJP (JJ responsible) (PP (IN for) (NP (NP (DT the) (ADJP (NN Src) (NN homology) (NN domain) (JJ 2-mediated)) (NN association)) (PP (IN of) (NP (NN p56-LRB-lck-RRB-))) (PP (IN with) (NP (NN ZAP-70)))))))))) (. .))))
(S1 (S (S (NP (PRP$ Our) (NNS data)) (VP (VBP are) (ADJP (RBS most) (JJ consistent) (PP (IN with) (NP (NP (DT a) (NN model)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (NN recruitment)) (PP (TO to) (NP (DT the) (NN TCR)))) (VP (VBZ allows) (NP (NP (NN ZAP-70) (NP (NP (NN autophosphorylation)) (CC and) (NP (NP (NN binding)) (PP (TO to) (NP (NN p56-LRB-lck-RRB-)))))) (, ,) (SBAR (WHNP (WDT which)) (S (PP (IN in) (NP (NN turn))) (VP (VBZ phosphorylates) (NP (NP (NN Tyr-492)) (CC and/or) (NP (NN Tyr-493))) (PP (IN with) (NP (NP (JJ consequent) (NN up-regulation)) (PP (IN of) (NP (DT the) (NN ZAP-70) (NN kinase) (NN activity)))))))))))))))) (. .))))
(S1 (S (S (NP (NN ZAP-70)) (VP (MD will) (ADVP (RB then)) (VP (VB be) (ADJP (JJ able) (S (VP (TO to) (ADVP (RB effectively)) (VP (VP (VB control) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (PRP$ its) (NNS substrates))))) (CC and) (VP (VB lead) (PP (TO to) (NP (NN gene) (NN activation)))))))))) (. .))))
(S1 (S (NP (NP (NN Dexamethasone) (NN suppression) (NN test)) (: :) (NP (NP (NN corticosteroid) (NNS receptors) (NN regulation)) (PP (IN in) (NP (NP (JJ mononuclear) (NNS leukocytes)) (PP (IN of) (NP (ADJP (ADJP (JJ young)) (CC and) (ADJP (JJ aged))) (NNS subjects))))) (. .)))))
(S1 (S (S (NP (NP (DT The) (NN dexamethasone) (NN suppression) (NN test)) (PRN (-LRB- -LRB-) (NP (NN DST)) (-RRB- -RRB-))) (VP (VBZ is) (VP (VBN considered) (S (NP (NP (DT an) (NN indicator)) (PP (IN of) (NP (NP (DT the) (NN function)) (PP (IN of) (NP (DT the) (JJ adrenal) (JJ pituitary) (NN axis))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (DT the) (NN steroid)))) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (NP (PRP$ its) (NN binding)) (PP (TO to) (NP (NN corticosteroid) (NNS receptors))))))) (. .))))
(S1 (S (S (NP (PRP We)) (ADVP (RB previously)) (VP (VBD suggested) (SBAR (IN that) (S (NP (NP (DT the) (NN measurement)) (PP (IN of) (NP (NP (NN corticosteroid) (NNS receptors)) (PP (IN in) (NP (NNS lymphocytes)))))) (VP (VBZ is) (NP (NP (DT an) (NN index)) (PP (IN of) (NP (NP (DT an) (JJ analogous) (NN pattern)) (PP (IN in) (NP (NN brain)))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP (NP (NN corticosteroid) (NP (NP (NN Type) (CD I)) (CC and) (NP (NN Type) (CD II))) (NNS receptors)) (PP (IN in) (NP (JJ mononuclear) (NNS leukocytes)))) (VP (VBD were) (VP (VBN measured) (PP (PP (IN in) (NP (CD 10) (JJ elderly) (NNS subjects))) (CC and) (PP (IN in) (NP (CD 9) (JJ young) (NNS adults)))) (, ,) (PP (PP (PP (IN before)) (CC and) (PP (IN after))) (NP (NP (JJ overnight) (NN DST)) (PRN (-LRB- -LRB-) (NP (CD 1) (NN mg)) (-RRB- -RRB-)))))) (. .))))
(S1 (S (S (NP (NNS Receptors)) (VP (VBD were) (VP (VBN measured) (PP (IN by) (NP (NN radioreceptor) (NN assay))))) (. .))))
(S1 (S (S (PP (IN In) (NP (PDT all) (DT the) (NNS subjects))) (, ,) (NP (NN dexamethasone)) (VP (VBD was) (ADJP (JJ able) (S (VP (TO to) (VP (VB suppress) (NP (NN plasma) (NN cortisol))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN number)) (PP (IN of) (NP (NP (NP (NN Type) (CD I)) (CC and) (NP (NN Type) (CD II))) (NNS receptors))) (PP (IN before) (NP (DT the) (NN test)))) (VP (VBD was) (ADJP (ADJP (JJR lower))) (PP (IN in) (NP (JJ elderly) (NNS subjects))) (PP (IN than) (FRAG (PP (IN in) (NP (NNS adults)))))) (. .))))
(S1 (S (S (S (PP (IN In) (NP (DT the) (NN control) (NN group))) (, ,) (NP (NN dexamethasone)) (VP (VBD produced) (NP (NP (DT a) (JJ significant) (NN depression)) (PP (IN of) (NP (NN Type) (CD I) (NNS receptors))) (-LRB- -LRB-) (PP (IN from) (NP (QP (CD 267) (CC +/-) (CD 72)))) (PP (TO to) (NP (QP (CD 169) (CC +/-) (CD 71)))) (NP (NP (NNS receptors)) (PP (IN per) (NP (NN cell)))) (-RRB- -RRB-) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB be) (VP (VBN interpreted) (PP (IN as) (NP (NP (DT a) (JJ primary) (NN involvement)) (PP (IN of) (NP (NN Type) (CD I) (NNS receptors))) (PP (IN in) (NP (NP (DT the) (NN response)) (PP (TO to) (NP (NN dexamethasone)))))))))))))) (: ;)) (S (NP (NN Type) (CD II) (NNS receptors)) (VP (VBD decreased) (PP (IN in) (NP (PDT half) (DT the) (NNS subjects))) (-LRB- -LRB-) (PP (IN from) (NP (QP (CD 2849) (CC +/-) (CD 703)))) (PP (TO to) (NP (QP (CD 2345) (CC +/-) (CD 569)))) (NP (NP (NNS receptors)) (PP (IN per) (NP (NN cell)))) (-RRB- -RRB-)) (. .)))))
(S1 (S (S (PP (IN In) (NP (JJ elderly) (JJ healthy) (NNS subjects))) (, ,) (NP (NN Type) (CD II) (NNS receptors)) (VP (VBD were) (ADVP (RB also)) (VP (ADVP (RB significantly)) (VBN decreased) (-LRB- -LRB-) (PP (IN from) (NP (QP (CD 1796) (CC +/-) (CD 671)))) (PP (TO to) (NP (QP (CD 720) (CC +/-) (CD 345)))) (-RRB- -RRB-))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP suggest) (SBAR (IN that) (S (PP (IN in) (NP (JJ young) (NNS subjects))) (NP (NN Type) (CD II) (NNS receptors)) (VP (VBP are) (VP (VP (ADVP (RB initially)) (VBN up-regulated) (PP (IN by) (NP (NN dexamethasone)))) (, ,) (CC and) (VP (ADVP (RB then)) (VBN down-regulated))) (, ,) (SBAR (IN while) (S (PP (RB in) (NP (JJ aged) (NNS subjects))) (NP (DT an) (NN up-regulation)) (VP (MD can) (RB not) (VP (VB be) (VP (VBN achieved) (, ,) (SBAR (IN as) (S (VP (VBN suggested) (PP (IN by) (NP (NP (DT the) (JJR higher) (NNS values)) (PP (IN of) (NP (NN plasma) (NN cortisol))) (VP (ADVP (RB usually)) (VBN found) (PP (IN in) (NP (VBG aging) (NNS subjects)))))))))))))))))) (. .))))
(S1 (S (S (NP (NP (NNS Lymphocytes)) (PP (IN from) (NP (NN CML) (NNS patients)))) (VP (VBP lack) (NP (NP (DT a) (ADJP (CD 47) (NN kDa)) (NN factor)) (VP (VBG having) (NP (NP (NN affinity)) (PP (IN for) (NP (DT a) (JJ genomic) (NN sterol) (JJ regulatory) (NN sequence))))))) (. .))))
(S1 (S (S (NP (VBN Deranged) (JJ cellular) (NN cholesterol) (NN homeostasis)) (VP (VBZ has) (VP (VBN been) (ADVP (RB widely)) (VP (VBN recognized) (PP (IN in) (NP (NP (DT the) (NP (NP (NN initiation)) (CONJP (RB as) (RB well) (IN as)) (NP (NN progression)))) (PP (IN of) (NP (NP (JJ various) (NNS types)) (PP (IN of) (NP (NNS cancers))) (PP (VBG including) (NP (NP (JJ chronic) (JJ myeloid) (NN leukaemia)) (PRN (-LRB- -LRB-) (NP (NN CML)) (-RRB- -RRB-))))))))))) (. .))))
(S1 (S (S (SBAR (IN Since) (S (NP (DT the) (JJ human) (JJ genomic) (NP (NP (NN sterol) (JJ regulatory) (NN element)) (PRN (-LRB- -LRB-) (NP (NN SRE)) (-RRB- -RRB-)))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB regulate) (NP (NP (JJ various) (JJ key) (NNS genes)) (VP (VBN involved) (PP (IN in) (NP (DT this) (NN phenomenon))))))))))))) (, ,) (NP (DT the) (JJ present) (NN study)) (VP (VBD revealed) (NP (NP (NP (DT the) (NN existence)) (PP (IN of) (NP (NP (DT a) (JJ unique) (ADJP (CD 47) (NN kDa)) (NN protein) (NN factor)) (VP (VBG having) (NP (NP (NN affinity)) (PP (IN for) (NP (DT this) (JJ SRE) (NN sequence))))))) (PP (IN in) (NP (NP (NNS lymphocytes)) (PP (IN from) (NP (JJ normal) (NNS subjects)))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (PRP$ its) (NN absence)) (PP (IN in) (NP (NP (NNS lymphocytes)) (PP (IN from) (NP (JJ untreated) (NN CML) (NNS patients)))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (DT this) (NN factor)) (VP (VBD appeared) (SBAR (WHADVP (WRB when)) (S (NP (DT these) (NN CML) (NNS patients)) (VP (VBD achieved) (NP (NP (JJ complete) (JJ haematological) (NN remission)) (PRN (-LRB- -LRB-) (NP (NN CHR)) (-RRB- -RRB-))) (PP (IN through) (NP (NN alpha-interferon) (NN therapy))))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (DT an) (JJ inverse) (NN relationship)) (VP (VBD was) (ADVP (RB also)) (VP (VBN observed) (PP (IN between) (NP (NP (NP (DT the) (NN LDL) (NN receptor) (NN gene) (NN expression)) (PP (IN at) (NP (DT the) (JJ transcriptional) (NN level)))) (CC and) (NP (NP (DT the) (NN binding) (NN affinity)) (PP (IN of) (NP (DT this) (ADJP (CD 47) (NN kDa)) (NN protein) (NN factor))) (PP (TO to) (NP (DT the) (NN SRE) (NN sequence)))))))) (. .))))
(S1 (S (S (PP (VBN Based) (PP (IN upon) (NP (DT these) (NNS results)))) (NP (PRP we)) (VP (VBP propose) (SBAR (IN that) (S (NP (DT this) (NN factor)) (VP (MD may) (VP (VB have) (NP (DT a) (NN role)) (PP (IN in) (NP (NP (NN pathophysiology)) (PP (IN of) (NP (JJ chronic) (JJ myeloid) (NN leukaemia)))))))))) (. .))))
(S1 (S (S (S (NP (NP (DT A) (JJ novel) (NP (JJ immunosuppressive) (NN factor))) (PP (IN in) (NP (JJ bovine) (NN colostrum)))) (VP (VBZ blocks) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (NP (NN interleukin) (CD 2) (NN gene) (NN enhancer)))) (PP (IN at) (NP (DT the) (NP (NN NFAT) (NN site)))))) (. .)))))
(S1 (S (S (S (NP (NP (NP (DT A) (NN factor)) (PP (IN in) (NP (JJ bovine) (NN colostrum)))) (PRN (-LRB- -LRB-) (NP (NP (NN colostrum) (JJ inhibitory) (NN factor)) (, ,) (NP (NN CIF))) (-RRB- -RRB-))) (VP (VBZ inhibits) (NP (NP (NP (NP (NN interleukin) (CD 2)) (PRN (-LRB- -LRB-) (NP (NN IL2)) (-RRB- -RRB-))) (NN production)) (PP (IN in) (NP (JJ activated) (NP (NN T) (NN helper) (NNS cells))))) (PP (IN by) (S (VP (VBG blocking) (NP (NP (DT the) (NN accumulation)) (PP (IN of) (NP (NN IL2) (NN mRNA)))))))) (. .)))))
(S1 (S (S (S (VP (TO To) (VP (VB determine) (SBAR (IN whether) (S (NP (NN CIF)) (VP (VBZ blocks) (PP (IN at) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NP (NN IL2)) (NN transcription))))))))))) (, ,) (S (NP (PRP we)) (VP (VBD introduced) (NP (NN reporter) (NNS plasmids)) (PP (IN into) (NP (DT the) (NP (JJ human) (NN T) (NN leukemia) (NN cell) (NN line) (NN Jurkat)))) (PP (IN by) (NP (JJ transient) (NN transfection))))) (. .))))
(S1 (S (S (NP (DT These)) (VP (VBD contained) (NP (DT the) (NP (NN luciferase) (NN gene))) (PP (IN under) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (CC either) (NP (NP (DT the) (NP (JJ human) (NN IL2) (JJ upstream) (NN enhancer)) (NN region)) (PRN (-LRB- -LRB-) (NP (NNS segments) (QP (CD -326) (TO to) (CD +45))) (-RRB- -RRB-))) (CC or) (NP (NP (CD three) (NNS repeats)) (PP (IN of) (NP (DT the) (NP (NN NFAT) (NN element)))) (VP (VBN contained) (PP (IN within) (NP (NP (PRP it)) (PRN (-LRB- -LRB-) (NP (NNS segments) (QP (CD -255) (TO to) (CD -285))) (-RRB- -RRB-))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Expression)) (PP (IN of) (NP (NN luciferase))) (PP (IN in) (NP (DT these) (NNS cells)))) (VP (VBD was) (VP (VBN induced) (PP (IN by) (NP (NP (NN phorbol) (NN myristate) (NN acetate)) (CC plus) (NP (DT a) (NN calcium) (NN ionophore)))))) (. .))))
(S1 (S (S (NP (NN CIF)) (VP (VBD inhibited) (NP (NP (NN induction)) (PP (IN of) (NP (DT either) (NN construct)))) (SBAR (IN as) (SINV (VBD did) (NP (NN cyclosporine)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB block) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (NP (NN NFAT) (NN element))))))))))))))) (. .))))
(S1 (S (S (NP (NN CIF)) (VP (VBD failed) (S (VP (TO to) (VP (VB inhibit) (NP (ADJP (JJ several) (JJ other)) (NP (NN enhancer) (NNS elements))))))) (. .))))
(S1 (S (S (NP (DT The) (NP (JJ NFAT-controlled) (NN luciferase) (NN gene) (NN system))) (VP (VBZ distinguishes) (NP (NN CIF)) (PP (IN from) (NP (NP (JJ other) (NN T) (NN cell) (JJ inhibitory) (NNS activities)) (ADJP (JJ present) (PP (IN in) (NP (NN colostrum)))))) (, ,) (PP (IN in) (NP (JJ particular))) (, ,) (NP (NP (NN TGF) (NN beta) (CD 1)) (CC and) (NP (NN TGF) (NN beta) (CD 2)) (CC and) (NP (DT the) (NNS glucocorticoids)))) (. .))))
(S1 (S (S (NP (ADJP (RB Stably) (VBN transfected)) (NN Jurkat) (NNS cells)) (VP (VBD behaved) (ADVP (RB similarly) (PP (TO to) (NP (DT the) (ADJP (RB transiently) (VBN transfected)) (NNS ones)))) (PP (IN with) (NP (NP (NN respect)) (PP (TO to) (NP (NP (NN inhibition)) (PP (IN by) (NP (NP (NN CIF)) (CC and) (NP (NN cyclosporine))))))))) (. .))))
(S1 (S (S (NP (DT The) (JJ NFAT-luc) (NN assay)) (VP (VBZ is) (NP (NP (DT a) (JJ useful) (NN technique)) (PP (IN for) (NP (NP (DT the) (ADJP (ADJP (JJ rapid)) (, ,) (ADJP (JJ sensitive))) (NN measurement)) (PP (IN of) (NP (NP (NN CIF)) (CC or) (NP (NP (JJ other) (NNS immunosuppressants)) (PP (IN with) (NP (NP (DT a) (JJ similar) (NN mode)) (PP (IN of) (NP (NN action)))))))))))) (. .))))
(S1 (S (S (NP (NP (JJ Synergistic) (NNS interactions)) (PP (IN between) (NP (NP (NP (VBG overlapping) (VBG binding) (NNS sites)) (PP (IN for) (NP (DT the) (NN serum) (NN response) (NN factor)))) (CC and) (NP (NN ELK-1) (NNS proteins))))) (VP (VBP mediate) (NP (NP (CC both) (NP (JJ basal) (NN enhancement)) (CC and) (NP (NN phorbol) (NN ester) (NN responsiveness))) (PP (IN of) (NP (JJ primate) (NN cytomegalovirus) (JJ major) (JJ immediate-early) (NNS promoters)))) (PP (IN in) (NP (NP (NP (NN monocyte)) (CC and) (NP (NN T-lymphocyte))) (NN cell) (NNS types)))) (. .))))
(S1 (S (S (NP (NP (NP (NN Cytomegalovirus)) (PRN (-LRB- -LRB-) (NP (NN CMV)) (-RRB- -RRB-))) (NN infection)) (VP (VP (VBZ is) (ADJP (ADJP (JJ nonpermissive)) (CC or) (ADJP (JJ persistent))) (PP (IN in) (NP (JJ many) (ADJP (ADJP (JJ lymphoid)) (CC and) (ADJP (JJ myeloid))) (NN cell) (NNS types)))) (CC but) (VP (MD can) (VP (VB be) (VP (VBN activated) (PP (IN in) (NP (VBN differentiated) (NNS macrophages))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN shown) (ADVP (RB elsewhere)) (SBAR (IN that) (S (NP (CC both) (DT the) (NP (NP (NP (JJ major) (JJ immediate-early) (NN gene)) (PRN (-LRB- -LRB-) (NP (NN MIE)) (-RRB- -RRB-))) (CC and) (NP (JJ lytic) (NN cycle) (JJ infectious) (NN progeny) (NN virus))) (NN expression)) (VP (MD can) (VP (VB be) (VP (VBN induced) (PP (IN in) (NP (NP (ADJP (ADVP (JJ otherwise)) (JJ nonpermissive)) (JJ monocyte-like) (NN U-937) (NN cell) (NNS cultures)) (VP (VBN infected) (PP (IN with) (NP (CC either) (NP (NP (JJ human) (NN CMV)) (PRN (-LRB- -LRB-) (NP (NN HCMV)) (-RRB- -RRB-))) (CC or) (NP (NP (JJ simian) (NN CMV)) (PRN (-LRB- -LRB-) (NP (NN SCMV)) (-RRB- -RRB-)))))))) (PP (IN by) (NP (NP (NN treatment)) (PP (IN with) (NP (NP (DT the) (NN phorbol) (NN ester) (NN 12-O-tetradecanoylphorbol-13-acetate)) (PRN (-LRB- -LRB-) (NP (NN TPA)) (-RRB- -RRB-))))))))))))) (. .))))
(S1 (S (S (NP (NP (NP (CD Two) (JJ multicopy) (JJ basal) (NN enhancer) (NNS motifs)) (PP (IN within) (NP (DT the) (NN SCMV) (NN MIE) (NN enhancer)))) (, ,) (RB namely) (, ,) (NP (NP (NP (NP (CD 11) (NNS copies)) (PP (IN of) (NP (DT the) (JJ 16-bp) (NP (NP (JJ cyclic) (NN AMP) (NN response) (NN element)) (PRN (-LRB- -LRB-) (NP (NN CRE)) (-RRB- -RRB-)))))) (CC and) (NP (NP (CD 3) (NNS copies)) (PP (IN of) (NP (JJ novel) (JJ 17-bp) (NP (NP (NN serum) (NN response) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN SRF)) (-RRB- -RRB-))) (NN binding) (NNS sites))))) (VP (VBN referred) (PP (TO to)) (PP (IN as) (NP (NP (NP (DT the) (NN SNE)) (PRN (-LRB- -LRB-) (NP (JJ SRF/NFkappaB-like) (NN element)) (-RRB- -RRB-))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (CD four) (JJ classical) (NN NFkappaB) (NNS sites)) (PP (IN within) (NP (DT the) (NN HCMV) (NN version)))) (, ,)))))) (VP (VBP contribute) (PP (TO to) (NP (NP (NN TPA) (NN responsiveness)) (PP (IN in) (NP (JJ transient) (NNS assays))) (PP (IN in) (NP (NP (NP (NN monocyte)) (CC and) (NP (NN T-cell))) (NNS types)))))) (. .))))
(S1 (S (S (NP (DT The) (NN SCMV) (NN SNE) (NNS sites)) (VP (VP (VBP contain) (NP (NP (JJ potential) (VBG overlapping) (NN core) (NN recognition) (NN binding) (NNS motifs)) (PP (IN for) (NP (NP (NP (NN SRF)) (, ,) (NP (NN Rel/NFkappaB)) (, ,) (NP (NN ETS)) (, ,) (CC and) (NP (NN YY1))) (NN class) (NN transcription) (NNS factors))))) (CC but) (VP (VBP fail) (S (VP (TO to) (VP (VB respond) (PP (TO to) (NP (CC either) (NP (NN serum)) (CC or) (NP (NN tumor) (NN necrosis) (NN factor) (NN alpha))))))))) (. .))))
(S1 (S (S (ADVP (RB Therefore)) (, ,) (S (VP (TO to) (VP (VB evaluate) (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (NP (NN TPA) (NN responsiveness)) (PP (PP (IN of) (NP (DT the) (NN SNE) (NNS motifs))) (CC and) (PP (IN of) (NP (NP (DT a) (JJ related) (JJ 16-bp) (NP (NP (NN SEE)) (PRN (-LRB- -LRB-) (NP (NN SRF/ETS) (NN element)) (-RRB- -RRB-))) (NN motif)) (VP (VBN found) (PP (IN in) (NP (DT the) (NP (NP (NN HCMV)) (CC and) (NP (NN chimpanzee) (NN CMV))) (NN MIE) (NNS enhancers))))))))))))) (, ,) (NP (PRP we)) (VP (VBP have) (VP (VBN examined) (NP (NP (DT the) (NP (NP (JJ functional) (NNS responses)) (CC and) (NP (NN protein) (NN binding) (NNS properties)))) (PP (IN of) (NP (NP (JJ multimerized) (ADJP (ADJP (JJ wild-type)) (CC and) (ADJP (JJ mutant))) (NNS elements)) (VP (VBN added) (PP (ADVP (RB upstream)) (TO to) (NP (NP (DT the) (NP (NP (NN SCMV) (NN MIE)) (CC or) (NP (JJ simian) (NN virus))) (CD 40) (JJ minimal) (NN promoter) (NNS regions)) (PP (IN in) (NP (DT the) (NP (NP (NN U-937)) (, ,) (NP (NN K-562)) (, ,) (NP (NN HL-60)) (, ,) (NP (NN THP-1)) (, ,) (CC and) (NP (NN Jurkat))) (NN cell) (NNS lines))))))))))) (. .))))
(S1 (S (S (PP (IN Unlike) (NP (JJ classical) (NN NFkappaB) (NNS sites))) (, ,) (NP (NP (CC neither) (NP (DT the) (NN SNE)) (CC nor) (NP (DT the) (NN SEE))) (NN motif)) (VP (VBD responded) (PP (TO to) (NP (NP (NN phosphatase) (NN inhibition)) (PP (IN by) (NP (JJ okadaic) (NN acid)))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (NN TPA) (NN responsiveness)) (PP (IN of) (NP (DT both) (NN CMV) (NNS elements)))) (VP (VBD proved) (S (VP (TO to) (VP (VB involve) (NP (NP (JJ synergistic) (NNS interactions)) (PP (IN between) (NP (NP (NP (DT the) (NN core) (NN SRF) (NN binding) (NN site)) (PRN (-LRB- -LRB-) (NP (NN CCATATATGG)) (-RRB- -RRB-))) (CC and) (NP (NP (DT the) (JJ adjacent) (VBN inverted) (NN ETS) (NN binding) (NNS motifs)) (PRN (-LRB- -LRB-) (NP (NN TTCC)) (-RRB- -RRB-))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD correlated) (ADVP (RB directly)) (PP (IN with) (NP (NP (NN formation)) (PP (IN of) (NP (NP (DT a) (VBN bound) (JJ tripartite) (NN complex)) (VP (VBG containing) (NP (CC both) (NP (DT the) (JJ cellular) (NN SRF)) (CC and) (NP (NN ELK-1) (NNS proteins)))))))))))))))) (. .))))
(S1 (S (S (S (NP (DT This) (NN protein) (NN complex)) (VP (VBD was) (ADJP (ADJP (RBR more) (JJ abundant))) (PP (IN in) (NP (NP (NP (NN U-937)) (, ,) (NP (NN K-562)) (, ,) (CC and) (NP (NN HeLa))) (NN cell) (NNS extracts))) (PP (IN than) (FRAG (PP (IN in) (NP (NP (NP (NN Raji)) (, ,) (NP (NN HF)) (, ,) (NP (NN BALB/c) (NN 3T3)) (, ,) (CC or) (NP (NN HL-60))) (NNS cells))))))) (, ,) (CC but) (S (NP (DT the) (NN binding) (NN activity)) (VP (VBD was) (VP (VBN altered) (ADVP (RB only) (RB twofold)) (PP (IN after) (NP (NN TPA) (NN treatment)))))) (. .))))
(S1 (S (S (NP (NP (DT A) (JJ 40-fold) (NN stimulation)) (PP (IN of) (NP (JJ chloramphenicol) (NN acetyltransferase) (NN activity))) (VP (VBN mediated) (PP (IN by) (NP (NP (CD four) (JJ tandem) (NNS repeats)) (PP (IN of) (NP (DT the) (NN SNE))))))) (VP (MD could) (VP (VB be) (VP (VP (VP (VBN induced) (PP (IN within) (NP (CD 2) (NN h)))) (-LRB- -LRB-) (CC and) (VP (ADVP (RB up) (TO to) (JJ 250-fold)) (PP (IN within) (NP (CD 6) (NN h)))) (-RRB- -RRB-)) (PP (IN after) (NP (NP (NN addition)) (PP (IN of) (NP (NN TPA))) (PP (IN in) (NP (JJ DNA-transfected) (NN U-937) (NNS cells))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (DT the) (NN stimulation)) (VP (VBD appeared) (ADJP (JJ likely) (S (VP (TO to) (VP (VB be) (NP (NP (DT a) (JJ true) (ADJP (NN protein) (NN kinase) (JJ C-mediated)) (NN signal) (NN transduction) (NN event)) (CONJP (RB rather) (IN than)) (NP (DT a) (NN differentiation) (NN response))))))))))))))) (. .))))
(S1 (S (S (NP (NP (JJ Slight) (NNS differences)) (PP (IN in) (NP (NP (DT the) (NN sequence)) (PP (IN of) (NP (DT the) (NN core) (NN SRF) (NN binding) (NN site))))) (PP (VBN compared) (PP (IN with) (NP (NP (DT that)) (PP (IN of) (NP (DT the) (JJ classical) (NN c-Fos) (NN promoter) (NN serum) (NN response) (NN element)))))) (, ,) (PP (RB together) (IN with) (NP (NP (NNS differences)) (PP (IN in) (NP (DT the) (NN spacing))) (PP (IN between) (NP (DT the) (NP (NP (NN SRF)) (CC and) (NP (NN ETS))) (NNS motifs))))) (, ,)) (VP (VBP appear) (S (VP (TO to) (VP (VB account) (PP (IN for) (NP (NP (DT the) (NN inability)) (PP (IN of) (NP (DT the) (NN SCMV) (NNS SNEs))) (S (VP (TO to) (VP (VB respond) (PP (TO to) (NP (NN serum) (NN induction)))))))))))) (. .))))
(S1 (S (NP (NP (NP (NP (NN Energy) (NNS substrates)) (, ,) (NP (NN hormone) (NNS responses)) (CC and) (NP (NN glucocorticoid) (NN binding))) (PP (IN in) (NP (NNS lymphocytes))) (PP (IN during) (NP (ADJP (ADJP (JJ intense)) (ADJP (JJ physical))) (NN exercise))) (PP (IN in) (NP (NNS humans))) (PP (VBG following) (NP (JJ phosphocreatine) (NN administration))) (. .)))))
(S1 (S (S (S (S (NP (CD Eight) (ADJP (JJ healthy) (JJ untrained) (JJ male)) (NNS volunteers)) (VP (VBD pedalled) (NP (DT a) (NN cycle) (NN ergometer)) (PP (VBG according) (PP (TO to) (NP (CD two) (NN exercise) (NNS protocols)))))) (: :) (S (S (NP (DT the) (JJ first)) (VP (VBD involved) (NP (NP (ADJP (RB step-wise) (VBG increasing)) (NP (JJ physical) (NN exercise)) (PP (TO to) (NP (NP (JJ maximal))))) (PRN (-LRB- -LRB-) (NP (NN MPE)) (-RRB- -RRB-))))) (: ;) (S (NP (DT the) (JJ second)) (VP (VBD involved) (NP (NP (NP (ADJP (ADJP (ADJP (JJ prolonged)) (PRN (-LRB- -LRB-) (NP (CD 35) (NN min)) (-RRB- -RRB-))) (ADJP (JJ submaximal))) (JJ physical) (NN exercise)) (PRN (-LRB- -LRB-) (NP (NN PPE)) (-RRB- -RRB-))) (PP (IN at) (NP (NP (CD 70) (NN %)) (PP (IN of) (NP (DT the) (NN individual) (POS 's) (JJ maximal) (NN oxygen) (NN uptake))))))))) (. .)))))
(S1 (S (S (NP (DT Each) (NN volunteer)) (VP (VBD performed) (NP (DT these) (NN exercise)) (ADVP (RB twice)) (, ,) (S (VP (VBG following) (NP (NP (CC either) (DT an) (JJ intravenous) (NN injection)) (PP (IN of) (NP (NP (NP (JJ phosphocreatine)) (PRN (-LRB- -LRB-) (NP (NN PCr)) (-RRB- -RRB-))) (CC or) (NP (NP (DT a) (NN placebo)) (PP (IN of) (NP (DT an) (JJ isotonic) (NN NaCl) (NN solution)))))))))) (. .))))
(S1 (S (S (NP (NP (JJ Anaerobic) (NN threshold)) (PRN (-LRB- -LRB-) (NP (NN AT)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN determined) (PP (PP (IN from) (NP (NP (DT the) (NN point)) (PP (IN of) (NP (NP (NN departure)) (PP (IN of) (NP (DT the) (JJ ventilatory) (NN response))) (PP (IN from) (NP (NN linearity))))))) (CC and) (PP (IN from) (NP (NP (DT the) (JJ sudden) (NN increase)) (PP (IN in) (NP (JJ venous) (NN blood) (NN lactate) (NNS concentrations))) (PP (IN during) (NP (NN MPE)))))))) (. .))))
(S1 (S (S (PP (IN After) (NP (NP (NN exercise)) (PP (VBG following) (NP (NN placebo) (NN administration))))) (NP (PRP we)) (VP (VBD observed) (NP (NP (NNS increases)) (PP (PP (IN in) (NP (NP (NNS concentrations)) (PP (IN of) (NP (NP (NN blood) (NNS substrates)) (, ,) (NP (NP (NN plasma) (NN adrenocorticotropin)) (PRN (-LRB- -LRB-) (NP (NN ACTH)) (-RRB- -RRB-))) (, ,) (NP (NN growth) (NN hormone)) (CC and) (NP (NN cortisol)))))) (CC and) (PP (IN in) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NN glucocorticoid) (NNS receptors))) (PP (IN in) (NP (NNS lymphocytes))))))) (PP (IN without) (NP (NP (NNS changes)) (PP (IN in) (NP (DT the) (NN dissociation) (NN constant)))))) (. .))))
(S1 (S (S (NP (NP (NP (JJ Intravenous) (NN administration)) (PP (IN of) (NP (NN PCr)))) (PRN (-LRB- -LRB-) (VP (VBG starting) (PP (NP (CD 1) (NN day)) (IN before) (NP (NN exercise)))) (-RRB- -RRB-))) (VP (VBD led) (PP (PP (TO to) (NP (NP (DT an) (NN increase)) (PP (PP (IN in) (NP (NP (DT the) (JJ total) (NN workload)) (PRN (-LRB- -LRB-) (PP (IN on) (NP (NN average))) (PP (IN by) (NP (CD 5.8) (NN %))) (-RRB- -RRB-)))) (CC and) (PP (IN in) (NP (NP (NN AT)) (PRN (-LRB- -LRB-) (PP (IN on) (NP (NN average))) (PP (IN by) (NP (CD 6.8) (NN %))) (-RRB- -RRB-))))) (PP (IN during) (NP (NN MPE))))) (CC and) (PP (TO to) (NP (NP (DT a) (JJR better) (NN tolerance)) (PP (IN of) (NP (NN exercise))) (PP (IN during) (NP (NN PPE))))))) (. .))))
(S1 (S (S (PP (VBG Following) (NP (NN PCr) (NN administration))) (NP (PRP we)) (VP (VBD observed) (NP (NP (NP (JJR lower) (NN blood) (NN lactate) (NNS concentrations)) (CC and) (NP (NP (JJ different) (NNS patterns)) (PP (IN of) (NP (DT some) (NN enzyme) (NNS activities)))) (, ,) (NP (NP (ADJP (RBR less) (JJ pronounced)) (NNS changes)) (PP (PP (IN in) (NP (NP (NP (NN plasma) (NN ACTH))) (CC and) (NP (NN cortisol)) (NP (NNS concentrations)))) (CC and) (PP (IN in) (NP (NP (NN glucocorticoid) (NN binding)) (PP (IN in) (NP (NNS lymphocytes)))))))) (, ,) (CC but) (NP (NP (DT no) (NNS changes)) (PP (IN in) (NP (NN plasma) (NN growth) (NN hormone) (NNS concentrations))) (PP (VBN compared) (PP (TO to) (NP (DT the) (NN placebo))))))) (. .))))
(S1 (S (S (NP (DT The) (NNS results)) (VP (VBD showed) (SBAR (IN that) (S (NP (ADJP (ADJP (JJ intense)) (ADJP (JJ physical))) (NN exercise)) (VP (VBD led) (PP (CONJP (RB not) (RB only)) (PP (TO to) (NP (NP (NNS increases)) (PP (IN in) (NP (NN blood) (NN hormone) (NNS concentrations))))) (CONJP (CC but) (RB also)) (PP (TO to) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN density)) (PP (IN of) (NP (NP (NN glucocorticoid) (NNS receptors)) (PP (IN in) (NP (NNS lymphocytes)))))))))))))) (. .))))
(S1 (S (S (NP (JJ Intravenous) (NN PCr) (NN injection)) (VP (VBD led) (PP (PP (TO to) (NP (NP (JJR smaller) (NNS changes)) (PP (IN in) (NP (NP (NP (NN ACTH))) (CC and) (NP (NN cortisol)) (NP (NNS concentrations)))))) (CONJP (RB as) (RB well) (IN as)) (PP (TO to) (NP (NP (DT a) (JJR lower) (NN activation)) (PP (IN of) (NP (NN glucocorticoid) (NN binding))) (PP (IN in) (NP (NNS lymphocytes))))))) (. .))))
(S1 (S (S (NP (NP (JJ Acetylsalicylic) (NN acid)) (CC and) (NP (NN sodium) (NN salicylate))) (VP (VBP inhibit) (NP (NP (NP (JJ LPS-induced) (NN NF-kappa) (NN B/c-Rel) (JJ nuclear) (NN translocation)) (, ,) (CC and) (NP (NP (NN synthesis)) (PP (IN of) (NP (NP (NP (NN tissue) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN TF)) (-RRB- -RRB-))) (CC and) (NP (NP (NN tumor) (NN necrosis) (NN factor) (NN alfa)) (PRN (-LRB- -LRB-) (NP (NN TNF-alpha)) (-RRB- -RRB-))))))) (PP (IN in) (NP (JJ human) (NNS monocytes))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN investigated) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (JJ acetylsalicylic) (NN acid)) (CC and) (NP (NN sodium) (NN salicylate)))) (PP (IN on) (NP (NP (NP (NP (DT the) (JJ LPS-induced) (NN synthesis)) (PP (IN of) (NP (NP (DT the) (JJ pro-coagulant) (NN protein) (NP (NP (NN tissue) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN TF)) (-RRB- -RRB-)))) (CC and) (NP (DT the) (JJ pro-inflammatory) (NN protein) (NP (NP (NN tumor) (NN necrosis) (NN factor-alpha)) (PRN (-LRB- -LRB-) (NP (NN TNF-alpha)) (-RRB- -RRB-))))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (DT the) (NN prostaglandin) (NN PGE2))) (PP (IN in) (NP (JJ human) (NNS monocytes)))))))) (. .))))
(S1 (S (S (NP (DT Both) (NNS drugs)) (ADVP (RB dose-dependently)) (VP (VP (VBD inhibited) (NP (NP (JJ LPS-induced) (NP (NP (NN TF)) (CC and) (NP (NN TNF-alpha))) (NN synthesis)) (PP (IN at) (NP (NP (NP (DT the) (NN mRNA)) (CC and) (NP (DT the) (NN protein))) (NP (NN level)))))) (, ,) (CC and) (VP (VBD reduced) (NP (NN PGE2) (NN production)))) (. .))))
(S1 (S (S (SBAR (IN As) (S (VP (VBN evidenced) (PP (IN by) (NP (NP (NP (NN electro) (NN mobility) (NN shift) (NN assay)) (PRN (-LRB- -LRB-) (NP (NN EMSA)) (-RRB- -RRB-))) (CC and) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (DT a) (NN NF-kappa) (NN B) (JJ prototypic) (NN probe))))))))) (, ,) (NP (DT these) (NNS drugs)) (ADVP (RB probably)) (VP (VBP exert) (NP (PRP$ their) (JJ inhibitory) (NNS effects)) (PP (IN by) (NP (NP (NN interference)) (PP (IN with) (NP (NP (DT the) (JJ nuclear) (NN translocation)) (PP (IN of) (NP (NN NF-kappa) (NN B/c-Rel) (NNS proteins)))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS data)) (VP (MD may) (VP (VB expand) (NP (NP (DT the) (NN understanding)) (PP (IN of) (NP (NP (DT the) (ADJP (ADJP (JJ anti-thrombotic)) (CC and) (ADJP (JJ anti-inflammatory))) (NNS effects)) (PP (IN of) (NP (DT these) (NNS drugs))) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN activation)) (PP (IN of) (NP (NNS monocytes)))) (VP (VBZ occurs))))))))) (. .))))
(S1 (S (NP (NP (ADJP (NN Octamer) (JJ independent)) (NN activation)) (PP (IN of) (NP (NP (NN transcription)) (PP (IN from) (NP (DT the) (NN kappa) (NN immunoglobulin) (NN germline) (NN promoter))))) (. .))))
(S1 (S (S (NP (NP (JJ Previous) (NNS analyses)) (PP (IN of) (NP (NN immunoglobulin) (JJ V) (NN region) (NNS promoters)))) (VP (VBZ has) (VP (VBN led) (PP (TO to) (NP (NP (DT the) (NN discovery)) (PP (IN of) (NP (NP (DT a) (JJ common) (NN octamer) (NN motif)) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADVP (RB functionally)) (ADJP (JJ important)) (PP (IN in) (NP (NP (DT the) (ADJP (ADJP (JJ tissue-specific)) (CC and) (ADJP (RB developmentally) (VBN regulated))) (JJ transcriptional) (NN activation)) (PP (IN of) (NP (NN immunoglobulin) (NNS genes)))))))))))))) (. .))))
(S1 (S (S (NP (NP (NP (DT The) (NN germline) (NNS promoters)) (PRN (-LRB- -LRB-) (NP (NN Ko)) (-RRB- -RRB-))) (ADJP (JJ located) (ADVP (RB upstream) (PP (IN of) (NP (NP (DT the) (JJ J) (NN region) (NN gene) (NNS segments)) (PP (IN of) (NP (DT the) (NN kappa) (NN locus)))))))) (ADVP (RB also)) (VP (VBP contain) (NP (NP (DT an) (NN octamer) (NN motif)) (-LRB- -LRB-) (VP (VP (VBG containing) (NP (DT a) (JJ single) (NN base) (NN pair) (NN mutation))) (CC and) (VP (VBN referred) (PP (TO to)) (PP (IN as) (NP (DT the) (JJ variant) (NN octamer))))) (-RRB- -RRB-) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (ADVP (RB previously)) (S (VP (TO to) (VP (VB bind) (NP (NP (NP (NN Oct-1)) (CC and) (NP (NN Oct-2))) (NN transcription) (NNS factors)) (ADVP (FW in) (FW vitro)))))))))))) (. .))))
(S1 (S (S (S (VP (TO To) (VP (ADVP (RB further)) (VB elucidate) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (DT this) (JJ variant) (NN octamer) (NN motif))) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NP (NN germline) (NN transcription)) (PP (IN from) (NP (DT the) (JJ unrearranged) (NN kappa) (NN locus))))))))))) (, ,) (NP (PRP we)) (VP (VBP have) (VP (VP (VBN quantitated) (NP (NP (DT the) (JJ relative) (NN binding) (NN affinity)) (PP (IN of) (NP (NP (NN Oct-1)) (CC and) (NP (NN Oct-2)))) (PP (IN for) (NP (DT the) (JJ variant) (NN octamer) (NN motif))))) (CC and) (VP (VBD determined) (NP (NP (DT the) (JJ functional) (NN role)) (PP (IN of) (NP (DT this) (NN octamer) (NN motif))) (PP (IN in) (NP (JJ transcriptional) (NN activation))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP find) (SBAR (IN that) (, ,) (S (SBAR (IN although) (S (NP (DT the) (JJ variant) (NN octamer) (NN motif)) (VP (VBZ binds) (NP (NP (NN Oct-1)) (CC and) (NP (NN Oct-2))) (ADVP (FW in) (FW vitro)) (PP (IN with) (NP (NP (ADJP (JJ 5-fold) (JJR lower)) (NN affinity)) (PP (IN than) (NP (DT the) (NN consensus) (NN octamer) (NN motif)))))))) (, ,) (NP (NP (NN mutation)) (PP (IN of) (NP (DT the) (JJ variant) (NN octamer) (NN motif))) (PP (TO to) (NP (CC either) (DT a) (UCP (NP (NN consensus) (NN octamer)) (CC or) (ADJP (JJ non-octamer))) (NN motif)))) (VP (VBZ has) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (JJ transcriptional) (NN activation)) (PP (IN from) (NP (DT the) (NN germline) (NN promoter))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (ADVP (RB also)) (VP (VBP find) (NP (NP (JJ significant) (NNS differences)) (PP (IN in) (NP (NP (NN activation)) (PP (IN of) (NP (NP (NP (NN germline)) (CC and) (NP (JJ V) (NN region))) (NNS promoters))) (PP (IN by) (NP (NN kappa) (NNS enhancers))))))) (. .))))
(S1 (S (S (NP (PRP$ Our) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (DT the) (NP (NP (NN germline) (NNS promoters)) (CC and) (NP (JJ V) (NN region) (NNS promoters)))) (VP (VP (VBP differ) (PP (IN in) (NP (NP (PRP$ their) (NN dependence)) (PP (IN on) (NP (NN octamer))) (PP (IN for) (NP (NN activation)))))) (CC and) (VP (VBP respond) (ADVP (RB differently)) (PP (TO to) (NP (NN enhancer) (NN activation)))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS findings)) (VP (VBP have) (NP (JJ important) (NNS implications)) (PP (IN in) (NP (NP (NP (NN regulation)) (PP (IN of) (NP (NN germline) (NN transcription)))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (JJ concomitant) (NN activation)) (PP (IN of) (NP (NP (DT the) (JJ V-J) (NN recombination)) (PP (IN of) (NP (DT the) (NN kappa) (JJ light) (NN chain) (NN locus))))))))) (. .))))
(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (DT the) (JJ murine) (JJ cyclin-dependent) (NN kinase) (NN inhibitor) (NN gene) (NN p27Kip1))) (. .))))
(S1 (S (S (NP (DT The) (JJ cyclin-dependent) (NN kinase) (NN inhibitor) (NN p27Kip1)) (VP (VBZ plays) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (S (VP (VBG regulating) (NP (JJ cell-cycle) (NN progression)))))) (. .))))
(S1 (S (S (NP (NN p27Kip1)) (ADVP (RB directly)) (VP (VP (VBZ inhibits) (NP (NP (DT the) (JJ catalytic) (NN activity)) (PP (IN of) (NP (NNS cyclin/cdks) (PRN (-LRB- -LRB-) (NP (JJ cyclin-dependent) (NN kinase)) (-RRB- -RRB-)) (NNS complexes))))) (CC and/or) (VP (VBZ interferes) (ADVP (RB physically)) (PP (IN with) (NP (NP (NN cyclin/cdks) (NN activation)) (PP (IN by) (NP (NN CAK))))))) (. .))))
(S1 (S (S (ADVP (RB Interestingly)) (, ,) (NP (NP (DT the) (NN expression) (NN level)) (PP (IN of) (NP (NN p27Kip1) (NN mRNA)))) (VP (VP (VBD was) (ADJP (JJ maximal)) (PP (IN in) (NP (VBG resting) (NN Go) (NNS T-cells)))) (CC and) (VP (ADVP (RB rapidly)) (VBD declined) (PP (VBG following) (NP (JJ anti-CD3) (NN activation))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP report) (ADVP (RB here)) (NP (NP (NP (DT the) (NN cloning)) (PP (IN of) (NP (NN p27Kip1) (NN gene))) (PP (IN from) (NP (JJ murine) (JJ genomic) (NN DNA)))) (CC and) (NP (NP (DT the) (JJ functional) (NN analysis)) (PP (IN of) (NP (NP (DT the) (NN promoter)) (PP (IN of) (NP (DT the) (NN p27Kip1) (NN gene)))))))) (. .))))
(S1 (S (S (NP (DT The) (NN gene)) (VP (VP (VBZ consists) (PP (IN of) (NP (QP (IN at) (JJS least) (CD three)) (NNS exons)))) (CC and) (VP (NNS spans) (NP (NP (QP (RBR more) (IN than) (CD 5.6)) (NN kb)) (PP (IN of) (NP (NN DNA)))))) (. .))))
(S1 (S (S (NP (NP (NP (NN Primer) (NN extension)) (CC and) (NP (NN nuclease) (NN S1) (NN protection))) (NN analysis)) (VP (VBD revealed) (NP (CD two) (JJ major) (NN transcription) (NN initiation) (NNS sites))) (. .))))
(S1 (S (S (NP (DT The) (NN promoter) (NN region)) (VP (VP (VBD lacked) (NP (DT a) (NN TATA) (NN box))) (CC but) (VP (VBD contained) (NP (NP (JJ potential) (VBG binding) (NNS sites)) (PP (IN for) (NP (NP (DT the) (JJ transcriptional) (NNS factors)) (PP (VBG including) (NP (NP (CD two) (NN Sp1)) (, ,) (NP (NN CRE)) (, ,) (NP (NN Myb)) (CC and) (NP (NN NFkB)))))) (ADJP (JJ located) (PP (IN at) (NP (NP (NNS positions) (NP (NP (CD -153)) (, ,) (NP (CD -178)) (, ,) (NP (CD -286)) (, ,) (NP (CD -875)) (, ,) (CC and) (NP (CD -1011)))) (, ,) (ADVP (RB respectively)))))))) (. .))))
(S1 (S (S (S (VP (TO To) (VP (VB analyze) (NP (NP (DT the) (JJ regulatory) (NNS mechanisms)) (VP (VBG controlling) (NP (NN p27Kip1) (NN gene) (NN expression))))))) (, ,) (NP (PRP we)) (VP (VBD characterized) (NP (NP (DT the) (JJ 5'-flanking) (NN region)) (PP (PP (IN from) (NP (NN nt) (CD -1609))) (PP (TO to) (NP (CD +178)))))) (. .))))
(S1 (S (S (NP (DT The) (QP (CD -326) (TO to) (CD -615)) (NN region)) (VP (VBD contained) (NP (JJ positive) (JJ regulatory) (NNS elements))) (. .))))
(S1 (S (NP (NP (JJ Glucocorticoid-mediated) (NN inhibition)) (PP (IN of) (NP (NP (NN RANTES) (NN expression)) (PP (IN in) (NP (JJ human) (NN T) (NNS lymphocytes))))) (. .))))
(S1 (S (S (NP (DT The) (NN chemokine) (NN RANTES)) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP (NP (JJ allergic) (JJ inflammatory) (NNS diseases)) (PP (VBG including) (NP (NP (NP (NN asthma)) (CC and) (NP (NN rhinitis))) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (ADVP (RB frequently)) (VBN treated) (PP (IN with) (NP (NNS glucocorticoids)))))))))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBD observed) (SBAR (IN that) (S (NP (NN dexamethasone)) (ADVP (RB dramatically)) (VP (VBD inhibited) (NP (NN RANTES) (NN mRNA) (NN expression)) (ADVP (NN dose) (RB dependently)) (PP (IN in) (NP (NP (ADJP (NN anti-CD3) (JJ activated)) (NN Hut-78) (NN T) (NNS cells)) (CC and) (NP (JJ human) (NNS PBMCs)))))))) (. .))))
(S1 (S (S (NP (NP (NN Inhibition)) (PP (IN of) (NP (NNS RANTES) (NN expression)))) (VP (VP (VBD did) (RB not) (VP (VB appear) (S (VP (TO to) (VP (VB be) (ADJP (JJ secondary) (PP (TO to) (NP (NN IL-2) (NN inhibition))))))))) (CC and) (VP (VBD required) (NP (NP (VBG binding)) (PP (TO to) (NP (DT the) (JJ intracellular) (NN glucocorticoid) (NN receptor)))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN down-regulation)) (PP (IN of) (NP (NN RANTES) (NN expression))) (PP (IN by) (NP (NP (NNS glucocorticoids)) (PP (IN in) (NP (NN T) (NNS cells)))))) (VP (MD may) (VP (ADVP (RB directly)) (VB contribute) (PP (PP (TO to) (NP (NP (DT the) (NN efficacy)) (PP (IN of) (NP (DT these) (NNS agents))) (PP (IN in) (S (VP (VBG suppressing) (NP (JJ cellular) (NN infiltration))))))) (CC and) (PP (TO to) (NP (PRP$ their) (JJ anti-inflammatory) (NNS properties)))))) (. .))))
(S1 (S (S (S (NP (NP (DT The) (NN state)) (PP (IN of) (NP (NP (NN maturation)) (PP (IN of) (NP (NNS monocytes))) (PP (IN into) (NP (NNS macrophages)))))) (VP (VBZ determines) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (NN IL-4)) (CC and) (NP (NN IL-13)))) (PP (IN on) (NP (NN HIV) (NN replication))))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (JJ molecular) (NNS mechanisms)) (PP (IN of) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (NN IL-4)) (CC and) (NP (NN IL-13)))) (PP (IN on) (NP (NN HIV) (NN infection))))) (PP (IN in) (NP (JJ human) (NNS monocytes)))) (SBAR (IN as) (S (NP (PRP they)) (VP (VBD matured) (PP (IN into) (NP (JJ monocyte-derived) (NNS macrophages))) (PP (IN over) (NP (CD 7) (NNS days)))))) (VP (VBD were) (VP (VBN investigated)) (S (VP (VBG using) (NP (NP (NP (NN HIV-1)) (PRN (-LRB- -LRB-) (NP (NN BaL)) (-RRB- -RRB-))) (, ,) (CC and) (NP (JJ low) (NN passage) (JJ clinical) (NNS strains))))))) (. .))))
(S1 (S (S (NP (NP (NN IL-4)) (CC and) (NP (NN IL-13))) (VP (VBD up-regulated) (NP (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (CC both) (NP (ADJP (JJ genomic))) (CC and) (NP (VBN spliced)) (NP (NN HIV) (NN mRNA))))) (PP (IN in) (NP (NP (NNS monocytes)) (VP (VBN cultured) (PP (IN on) (NP (NN Teflon))))))) (, ,) (SBAR (IN as) (S (VP (VBN determined) (PP (IN by) (NP (NP (NN Northern) (NN analysis)) (CC and) (NP (NP (NN p24) (NN Ag)) (NN assay)))))))) (. .))))
(S1 (S (S (S (VP (VBG Using) (NP (DT a) (JJ nuclear) (JJ run-on) (NN assay)))) (, ,) (S (NP (NP (NN IL-4)) (NN stimulation)) (VP (VBD was) (VP (VBN shown) (S (VP (TO to) (VP (VB enhance) (NP (NN transcription)) (PP (IN by) (NP (CD two-) (TO to) (RB threefold))))))))) (. .))))
(S1 (S (S (NP (NN IL-4)) (VP (VBD stimulated) (NP (NP (JJ nuclear) (NN factor-kappaB)) (NP (JJ nuclear) (NN translocation)) (CC and) (NP (NN binding))) (PP (IN before) (NP (NP (NN enhancement)) (PP (IN of) (NP (NP (NN HIV) (NN RNA)) (NN expression)))))) (. .))))
(S1 (S (S (ADVP (RB Conversely)) (, ,) (S (S (NP (NP (NN IL-4)) (CC and) (NP (NN IL-13))) (ADVP (ADVP (RB markedly)) (CC and) (ADVP (RB significantly))) (VP (VBD inhibited) (NP (NP (NN HIV) (NN replication)) (PP (IN at) (NP (DT the) (JJ transcriptional) (NN level))) (PP (IN in) (NP (JJ monocyte-derived) (NNS macrophages)))))) (, ,) (CC and) (S (NP (DT this)) (VP (VBD occurred) (SBAR (IN whether) (S (NP (DT these) (NP (NNS cytokines))) (VP (VBD were) (VP (VBN added) (PP (PP (IN before)) (CC or) (PP (IN after)) (NP (NN HIV) (NN infection)))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN reversal)) (PP (IN from) (NP (NN stimulation))) (PP (TO to) (NP (NN inhibition)))) (VP (VBD occurred) (PP (IN after) (NP (NP (QP (CD 3) (TO to) (CD 5)) (NNS days)) (PP (IN of) (NP (NP (NN adherence)) (PP (TO to) (NP (NN plastic)))))))) (. .))))
(S1 (S (S (NP (NN IL-4)) (VP (VBD had) (NP (DT no) (JJ significant) (NN effect)) (PP (IN on) (NP (NN HIV) (JJ reverse) (NN transcription)))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (DT both) (NP (NNS cytokines)))) (PP (IN on) (NP (NP (NP (DT the) (NN monocyte) (NN maturation/differentiation)) (PRN (-LRB- -LRB-) (NP (NP (NN CD11b)) (, ,) (NP (NN CD13)) (, ,) (CC and) (NP (NN CD26))) (-RRB- -RRB-))) (CC and) (NP (NP (JJ other) (NP (NN macrophage) (NNS markers))) (PRN (-LRB- -LRB-) (NP (NP (NN CD14)) (CC and) (NP (NN CD68))) (-RRB- -RRB-)))))) (VP (VBD was) (VP (VBN examined))) (. .))))
(S1 (S (S (NP (NN IL-4)) (VP (VP (VBD enhanced) (NP (NN CD11b))) (, ,) (CC but) (VP (VP (VBD inhibited) (NP (NP (NN CD26)) (NN expression))) (CC and) (VP (VBD delayed) (NP (NP (NN CD13)) (NN loss))))) (. .))))
(S1 (S (S (NP (NN IL-13)) (VP (VBD had) (NP (NP (JJ similar) (NNS effects)) (PP (IN on) (NP (NP (NN CD11b)) (CC and) (NP (NN CD13)))) (, ,) (CC but) (NP (DT no) (NN effect)) (PP (IN on) (NP (NN CD26))))) (. .))))
(S1 (S (S (ADVP (RB Hence)) (, ,) (NP (DT these) (NP (NNS cytokines))) (VP (VP (VBP do) (RB not) (ADVP (RB simply)) (VP (VB enhance) (NP (NN monocyte) (NN differentiation)))) (, ,) (CC but) (VP (VBP have) (NP (NP (ADJP (ADJP (JJ complex)) (CC and) (ADJP (RB slightly) (JJ divergent))) (NNS effects)) (SBAR (WHNP (WDT that)) (S (VP (VBP impact) (PP (IN on) (NP (NN HIV) (NN replication))) (PP (ADVP (RB probably)) (IN through) (NP (NP (NN cell) (NN signaling) (NNS pathways)) (CC and) (NP (NP (JJ nuclear) (NN factor-kappaB)) (NN translocation)))))))))) (. .))))
(S1 (S (S (NP (NP (DT A) (JJ novel) (NN SP-1) (NN site)) (PP (IN in) (NP (DT the) (JJ human) (NN interleukin-1) (NN beta) (NN promoter)))) (VP (VBZ confers) (NP (NP (JJ preferential) (JJ transcriptional) (NN activity)) (PP (IN in) (NP (NNS keratinocytes))))) (. .))))
(S1 (S (S (S (VP (TO To) (VP (VB investigate) (NP (NP (DT the) (NNS mechanisms)) (PP (IN of) (NP (NP (JJ transcriptional) (NN activation)) (PP (IN of) (NP (NP (NN interleukin-1beta)) (PRN (-LRB- -LRB-) (NP (NN IL-1beta)) (-RRB- -RRB-)))) (PP (IN in) (NP (JJ non-monocytic) (NNS cells))))))))) (, ,) (NP (PRP we)) (VP (VP (VBD constructed) (NP (NP (DT a) (NN series)) (PP (IN of) (NP (NP (NN reporter) (NNS plasmids)) (PP (IN with) (NP (NP (DT the) (JJ bacterial) (NN chloramphenicol) (NN acetyltransferase) (NN gene)) (VP (VBN linked) (PP (TO to) (NP (NP (JJ various) (NNS parts)) (PP (IN of) (NP (DT the) (JJ human) (NN IL-1beta) (NN promoter)))))))))))) (CC and) (VP (VBD performed) (NP (JJ transient) (NN transfection) (NNS experiments)))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBD identified) (NP (NP (DT a) (NN promoter) (NN segment)) (SBAR (WHNP (WDT that)) (S (VP (VBZ activates) (NP (NN transcription)) (ADVP (RBS most) (RB efficiently)) (PP (IN in) (NP (NNS keratinocytes)))))))) (. .))))
(S1 (S (S (NP (NP (NP (JJ Electrophoretic) (NN mobility) (NN shift) (NNS assays)) (PRN (-LRB- -LRB-) (NP (NN EMSA)) (-RRB- -RRB-))) (PP (IN with) (NP (NP (DT a) (ADJP (NN 43-mer)) (NN oligonucleotide)) (VP (VBN derived) (PP (IN from) (NP (DT the) (ADJP (RB functionally) (VBN identified)) (JJ cis-acting) (NN element))))))) (VP (VBD revealed) (NP (JJ specific) (NNS complexes))) (. .))))
(S1 (S (S (PP (PP (IN By) (NP (NP (NN competition) (NN analysis)) (PP (IN with) (NP (NN transcription) (NN factor) (NN consensus) (NN sequence) (NNS oligonucleotides))))) (CC and) (PP (IN by) (NP (NN immunosupershift)))) (, ,) (NP (NP (NN transcription) (NN factor) (NN SP-1)) (CC or) (NP (DT a) (ADJP (RB closely) (JJ related)) (NN protein))) (VP (VBD was) (VP (VBN shown) (S (VP (TO to) (VP (VBP bind) (PP (TO to) (NP (DT this) (JJ regulatory) (NN element)))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJS closest) (NN match)) (PP (TO to) (NP (DT the) (VBN known) (NN SP-1) (NN consensus) (NN sequence))) (PP (IN within) (NP (DT the) (JJ respective) (NN region)))) (VP (VBZ is) (NP (DT a) (NN TCCCCTCCCCT) (NN motif))) (. .))))
(S1 (S (S (NP (NP (NN Mutation)) (PP (IN of) (NP (DT this) (NN motif)))) (VP (VP (ADVP (ADVP (RB almost) (RB completely)) (, ,) (CC and) (ADVP (RB specifically)) (, ,)) (VBD abolished) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (CD two) (JJ low-mobility) (NNS complexes))))) (CC and) (VP (VBD led) (PP (TO to) (NP (NP (DT a) (CD 95) (NN %) (NN decrease)) (PP (IN of) (NP (NP (JJ constitutive) (JJ transcriptional) (NN activation)) (PP (IN of) (NP (NP (DT a) (NN reporter) (NN construct) (NN IL-1beta)) (PRN (-LRB- -LRB-) (NP (CD -170/+108)) (-RRB- -RRB-)))))))))) (. .))))
(S1 (S (S (ADVP (RB Likewise)) (, ,) (NP (NP (NN activation)) (PP (IN of) (NP (DT this) (NN reporter) (NN construct))) (PP (IN by) (NP (NN tumor) (NN necrosis) (NN factor-alpha)))) (VP (VBD depended) (PP (IN on) (NP (DT the) (NN SP-1) (NN site)))) (. .))))
(S1 (S (S (NP (DT These) (NNS observations)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT a) (JJ so-far-unrecognized) (NN SP-1) (NN site)) (PP (IN in) (NP (DT the) (JJ human) (NN IL-1beta) (NN promoter)))) (VP (MD may) (VP (VB participate) (PP (IN in) (NP (NP (DT the) (JJ transcriptional) (NN regulation)) (PP (IN of) (NP (DT this) (NN gene))) (PP (IN in) (NP (NNS keratinocytes)))))))))) (. .))))
(S1 (S (NP (NP (NNS Effects)) (PP (IN of) (NP (NNS glucocorticoids))) (PP (IN on) (NP (NN lymphocyte) (NN activation))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (ADJP (ADJP (JJ steroid-sensitive)) (CC and) (ADJP (JJ steroid-resistant))) (NN asthma))))) (. .))))
(S1 (S (S (NP (NN BACKGROUND) (: :)) (S (NP (NNS Glucocorticoids)) (VP (VBP are) (NP (NP (JJ important) (NNS medications)) (VP (VBN used) (S (VP (TO to) (VP (VB control) (NP (NP (DT the) (NN airway) (NN inflammation)) (VP (VBN associated) (PP (IN with) (NP (NN asthma))))))))))) (. .)))))
(S1 (S (S (NP (JJ Synthetic) (NNS glucocorticoids)) (VP (VBP vary) (PP (IN in) (NP (NP (PRP$ their) (NN binding) (NN affinity)) (PP (IN for) (NP (NP (DT the) (NN glucocorticoid) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN GCR)) (-RRB- -RRB-))))))) (. .))))
(S1 (S (S (NP (NNS METHODS) (: :)) (S (NP (PRP We)) (VP (VBD compared) (NP (NP (NP (NN hydrocortisone)) (, ,) (NP (NN beclomethasone) (NN dipropionate)) (, ,) (NP (NN triamcinolone) (NN acetonide)) (, ,) (NP (NN flunisolide)) (, ,) (CC and) (NP (NN budesonide)))) (PP (IN with) (NP (NP (NN regard)) (PP (TO to) (NP (PRP$ their) (NN capacity) (S (VP (TO to) (VP (VB inhibit) (NP (JJ phytohemagglutinin-induced) (JJ peripheral) (NN blood) (JJ mononuclear) (NN cell) (NN proliferation))))))))) (PP (IN from) (NP (NP (NP (CD six) (NNS patients)) (PP (IN with) (NP (JJ steroid-sensitive) (NN asthma)))) (CC and) (NP (NP (CD seven) (NNS patients)) (PP (IN with) (NP (JJ steroid-resistant) (NN asthma))))))) (. .)))))
(S1 (S (S (NP (NP (JJ Peripheral) (NN blood) (JJ mononuclear) (NN cell) (NN GCR) (NN binding) (NNS affinities)) (PP (IN for) (NP (NP (NN dexamethasone)) (CC and) (NP (NN budesonide))))) (VP (VBD were) (VP (ADVP (RB also)) (VBN determined) (PP (IN for) (NP (DT both) (NN patient) (NNS groups))) (PP (IN by) (S (VP (VBG using) (NP (NP (DT a) (NN radioligand) (NN binding) (NN assay)) (CC and) (NP (NN Scatchard) (NN analysis)))))))) (. .))))
(S1 (S (S (NP (NNS RESULTS) (: :)) (S (NP (JJ Dose-dependent) (NN inhibition)) (VP (VBD was) (VP (VBN demonstrated) (PP (IN for) (NP (DT all) (NNS glucocorticoids))) (PP (IN in) (NP (DT both) (NN patient) (NNS groups))) (, ,) (PP (IN with) (S (NP (DT the) (JJ steroid-resistant) (NN group)) (VP (VBG requiring) (NP (QP (RB approximately) (CD 2) (JJ log-fold) (JJR more)) (NNS glucocorticoids)) (PP (IN for) (NP (NP (DT an) (JJ equivalent) (NN degree)) (PP (IN of) (NP (NN inhibition)))))))))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (NN mean) (NNS concentrations)) (ADJP (JJ necessary) (S (VP (TO to) (VP (VB cause) (NP (NP (NP (CD 50) (NN %) (NN inhibition)) (PP (IN of) (NP (NN lymphocyte) (NN proliferation)))) (PRN (-LRB- -LRB-) (NP (NNS IC50s)) (-RRB- -RRB-))) (PP (IN for) (NP (DT the) (JJ steroid-sensitive) (NN group)))))))) (VP (VBD ranged) (PP (PP (IN from) (NP (NP (QP (CD 2) (CC x) (CD 10-LRB--10-RRB-)) (NN mol/L)) (PP (IN for) (NP (NN budesonide))))) (PP (TO to) (NP (NP (QP (CD 7) (CC x) (CD 10-LRB--8-RRB-)) (NN mol/L)) (PP (IN for) (NP (NN hydrocortisone)))))))) (, ,) (IN whereas) (S (NP (NP (DT the) (NN mean) (NNS IC50s)) (PP (IN for) (NP (DT the) (JJ steroid-resistant) (NN group)))) (VP (VBD ranged) (PP (PP (IN from) (NP (NP (QP (RB approximately) (CD 2) (CC x) (CD 10-LRB--8-RRB-)) (NN mol/L)) (PP (IN for) (NP (NN budesonide))))) (PP (TO to) (NP (NP (QP (JJR greater) (IN than) (CD 10-LRB--6-RRB-)) (NN mol/L)) (PP (IN for) (NP (NN hydrocortisone)))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (DT a) (JJ significant) (NN correlation)) (VP (VBD was) (VP (VBN noted) (PP (IN between) (NP (NP (NP (DT the) (NN degree)) (PP (IN of) (NP (NP (NP (NN inhibition)) (PP (IN of) (NP (NN lymphocyte) (NN proliferation)))) (PRN (-LRB- -LRB-) (NP (NN IC50)) (-RRB- -RRB-))))) (CC and) (NP (NP (DT the) (NN binding) (NN affinity)) (PP (IN of) (NP (NN dexamethasone))) (PP (TO to) (NP (DT the) (NN GCR)))))))) (. .))))
(S1 (S (S (NP (NP (NNS Patients)) (PP (IN with) (NP (JJ steroid-resistant) (NN asthma)))) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB have) (NP (DT a) (VBN reduced) (NN GCR) (NN binding) (NN affinity)))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN GCR) (NN binding) (NN affinity)) (PP (IN for) (NP (NN budesonide)))) (VP (VP (VBD was) (ADJP (ADJP (RB significantly) (JJR higher))) (PP (IN in) (NP (DT both) (NNS groups)))) (NP (-LRB- -LRB-) (ADVP (FW i.e.)) (, ,) (NP (JJR lower) (NN dissociation) (NN constant)) (-RRB- -RRB-)) (PP (IN than) (NP (NP (DT that)) (VP (VBN obtained) (PP (IN for) (NP (NN dexamethasone))))))) (. .))))
(S1 (S (S (NP (NN CONCLUSION) (: :)) (S (NP (DT These) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NNS glucocorticoids)) (PP (JJ such) (IN as) (NP (NN budesonide)))) (, ,) (PP (IN by) (NN virtue) (IN of) (NP (PRP$ their) (NP (NP (JJ high) (NN GCR) (NN binding) (NNS affinities)) (CC and) (NP (JJR greater) (NN ability) (S (VP (TO to) (VP (VB suppress) (NP (NN lymphocyte) (NN proliferation))))))))) (, ,) (VP (MD may) (ADVP (RB therefore)) (VP (VB be) (ADJP (JJ beneficial)) (PP (IN in) (NP (NP (DT the) (NN management)) (PP (IN of) (NP (JJ difficult-to-control) (NN asthma)))))))))) (. .)))))
(S1 (S (NP (NP (NN Involvement)) (PP (IN of) (NP (JJ nuclear) (NN factor-kappa) (NN B) (NN activation))) (PP (IN in) (NP (NP (NN IgE) (NN synthesis)) (PP (IN in) (NP (JJ human) (NN B) (NNS cells))))) (. .))))
(S1 (S (S (NP (NP (JJ Nuclear) (NN factor-kappa) (NN B)) (PRN (-LRB- -LRB-) (NP (NN NF-kappa) (NN B)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (NN transcription) (NN factor)) (SBAR (WHNP (WDT that)) (S (VP (VBZ binds) (PP (TO to) (NP (NP (DT the) (NN consensus) (NN DNA) (NN sequence)) (PP (IN in) (NP (NP (DT the) (JJ cis-acting) (NNS elements)) (PP (IN of) (NP (JJ various) (NNS genes)))))))))))) (. .))))
(S1 (S (S (SBAR (IN Although) (S (NP (NN NF-kappa) (NN B)) (VP (VBZ activates) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (JJ many) (NNS genes)) (VP (VBN involved) (PP (IN in) (NP (ADJP (ADJP (JJ immune)) (CC and) (ADJP (JJ inflammatory))) (NNS responses)))))))))) (, ,) (NP (JJ little)) (VP (VBZ is) (VP (VBN known) (PP (IN about) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN NF-kappa) (NN B) (NN activation))) (PP (IN in) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NN IgE) (NN synthesis))) (PP (IN in) (NP (JJ human) (NN B) (NNS cells))))))))) (. .))))
(S1 (S (S (ADVP (RB Therefore)) (NP (PRP we)) (ADVP (RB first)) (VP (VBD examined) (NP (NP (DT the) (NN participation)) (PP (IN of) (NP (NN NF-kappa) (NN B))) (PP (IN in) (NP (NP (NN germline) (NN C) (NN epsilon) (NN transcription)) (PP (IN in) (NP (NP (DT a) (JJ human) (NN Burkitt) (NN lymphoma) (NN B) (NN cell) (NN line)) (, ,) (NP (NN DND39)))))))) (. .))))
(S1 (S (S (NP (NP (NN Stimulation)) (PP (IN of) (NP (NN DND39) (NNS cells))) (PP (IN with) (NP (NP (NN IL-4)) (CC or) (NP (JJ anti-CD40) (NP (NP (JJ monoclonal) (NN antibody)) (PRN (-LRB- -LRB-) (NP (NN mAb)) (-RRB- -RRB-))))))) (VP (VP (VBD activated) (NP (NN phosphatidylinositol) (NN 3-kinase))) (CC and) (VP (ADVP (RB subsequently)) (VBD induced) (NP (NP (JJ nuclear) (NN expression)) (PP (IN of) (NP (NN NF-kappa) (NN B))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN identified) (PP (IN by) (NP (JJ electrophoretic) (NN mobility) (NN shift) (NNS assays)))))))))) (. .))))
(S1 (S (S (NP (NP (NP (NN n-Acetyl-L-cysteine)) (PRN (-LRB- -LRB-) (NP (NN NAC)) (-RRB- -RRB-))) (, ,) (NP (DT a) (JJ potent) (NN antioxidant)) (, ,)) (VP (VBD blocked) (NP (NP (NN NF-kappa) (NN B) (NN activation)) (VP (VBN caused) (PP (PP (IN by) (NP (NN IL-4))) (CC and) (PP (IN by) (NP (JJ anti-CD40) (NN mAb))))))) (. .))))
(S1 (S (S (SBAR (IN Although) (S (NP (NP (NN inhibition)) (PP (IN of) (NP (JJ IL-4-driven) (NN germline) (NN C) (NN epsilon) (NN transcription))) (PP (IN by) (NP (NN NAC)))) (VP (VBD was) (RB not) (ADJP (JJ sufficient))))) (, ,) (NP (DT the) (NN agent)) (ADVP (RB remarkably)) (VP (VBD diminished) (NP (NP (ADJP (JJ anti-CD40) (JJ mAb-mediated)) (NN up-regulation)) (PP (IN of) (NP (NN germline) (NN C) (NN epsilon) (NN transcription))))) (. .))))
(S1 (S (S (ADVP (RB Second)) (, ,) (NP (PRP we)) (VP (VBD studied) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN NAC))) (PP (IN on) (NP (NP (NN IgE) (NN synthesis)) (PP (IN in) (NP (NP (JJ human) (JJ normal) (NN B) (NNS cells)) (VP (VBN costimulated) (PP (IN with) (NP (NP (NN IL-4)) (CC and) (NP (JJ anti-CD40) (NN mAb))))))))))) (. .))))
(S1 (S (S (NP (NN NAC)) (VP (VBD was) (ADJP (JJ effective)) (PP (IN in) (S (VP (VBG inhibiting) (NP (NP (NP (JJ mature) (NN C) (NN epsilon) (NN transcription)) (CC and) (NP (NN IgE) (NN synthesis))) (PP (IN in) (NP (DT the) (ADJP (NN T) (JJ cell-independent)) (NN culture) (NN system)))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NN NAC)) (VP (VBD did) (RB not) (ADVP (RB significantly)) (VP (VB affect) (NP (NP (DT the) (JJ spontaneous) (NN production)) (PP (IN of) (NP (NN IgE))) (PP (IN by) (NP (JJ atopic) (NN B) (NNS cells)))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VP (VBP indicate) (SBAR (IN that) (S (NP (NN NF-kappa) (NN B) (NN activity)) (VP (VBZ is) (ADVP (RB commonly)) (ADJP (JJ inducible)) (PP (IN in) (NP (NN DND39) (NNS cells))) (PP (IN by) (NP (NP (NN IL-4)) (CC and) (NP (JJ anti-CD40) (NN mAb)))))))) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NN NF-kappa) (NN B)) (ADJP (JJ sensitive) (PP (TO to) (NP (NN NAC))))) (VP (MD may) (VP (VB play) (NP (DT a) (NN role)) (PP (IN in) (S (VP (VBG regulating) (NP (NP (NN IgE) (NN synthesis)) (PP (IN in) (NP (NN B) (NNS cells))))))))))))) (. .))))
(S1 (S (NP (-LRB- -LSB-) (NP (JJ Molecular) (NNS mechanisms)) (PP (IN of) (NP (JJ age-related) (NN lymphocyte) (NN dysfunction))) (-RRB- -RSB-))))
(S1 (S (S (NP (NN Aging)) (VP (VBZ is) (ADVP (RB classically)) (VP (VBN accompanied) (PP (IN by) (NP (NP (DT a) (NN dysregulation)) (PP (IN of) (NP (DT the) (JJ immunologic) (NN machinery))))))) (. .))))
(S1 (S (S (PP (IN As) (NP (DT a) (NN consequence))) (, ,) (NP (NP (DT the) (JJ immune) (NN response)) (VP (VBN developed) (PP (IN in) (NP (JJ senescent) (NNS organisms))))) (VP (VP (VBZ is) (ADVP (RB usually)) (ADJP (JJ inappropriate))) (, ,) (VP (ADVP (RB often)) (ADJP (JJ inefficient))) (, ,) (VP (ADVP (RB sometimes)) (ADJP (JJ aberrant))) (, ,) (CC and) (VP (ADVP (RB potentially)) (ADJP (JJ detrimental)))) (. .))))
(S1 (S (S (NP (DT The) (JJ age-associated) (JJ immune) (NN dysfunction)) (VP (VP (MD may) (VP (VB be) (VP (VBN implicated) (PP (TO to) (NP (DT some) (NN degree))) (PP (IN in) (NP (NP (DT the) (JJ extreme) (NN susceptibility)) (PP (IN of) (NP (DT the) (JJ elderly))) (PP (TO to) (NP (NP (NN infection)) (CC and) (NP (NN neoplasia))))))))) (CC and) (VP (MD may) (ADVP (RB even)) (VP (VB participate) (PP (IN in) (NP (NP (JJ various) (NNS aspects)) (PP (IN of) (NP (NN senescence)))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ current) (NN understanding)) (PP (IN of) (NP (NP (DT the) (JJ molecular) (NNS mechanisms)) (VP (VBG underlying) (NP (NN immunosenescence)))))) (VP (VBZ is) (ADVP (RB still)) (ADJP (JJ fragmentary))) (. .))))
(S1 (S (S (NP (DT The) (ADJP (ADVP (RBS most) (RB extensively)) (VBN studied)) (NN phenomenon)) (VP (VBZ is) (NP (NP (DT the) (JJ progressive) (NN decline)) (PP (IN in) (NP (NP (DT the) (JJ proliferative) (NNS capacities)) (PP (IN of) (NP (NN T) (NNS lymphocytes))))) (PP (IN with) (NP (NN aging))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN loss)) (PP (IN of) (NP (NP (JJ proliferative) (NN potential)) (PP (IN in) (NN response) (TO to) (NP (JJ antigenic) (NN challenge)))))) (VP (VBZ is) (NP (NP (DT a) (JJ characteristic) (NN feature)) (PP (IN of) (NP (JJ immune) (NN senescence))))) (. .))))
(S1 (S (S (NP (PRP It)) (VP (VBZ is) (ADVP (RB directly)) (VP (VBN implicated) (PP (IN in) (NP (NP (DT the) (NN emergence)) (PP (IN of) (NP (DT the) (JJ age-related) (JJ immune) (NN deficiency))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN purpose)) (PP (IN of) (NP (DT this) (NN review)))) (VP (VBZ is) (S (VP (TO to) (VP (VB show) (SBAR (WHADVP (WRB how)) (S (NP (NP (DT the) (NN accumulation)) (PP (IN of) (NP (JJ various) (JJ biochemical) (NNS lesions))) (PP (IN with) (NP (VBG advancing) (NN age)))) (VP (VBZ leads) (PP (TO to) (NP (NP (DT the) (NN failure)) (PP (IN of) (NP (NP (DT a) (JJ critical) (NN cell) (NN function)) (, ,) (RB namely) (NP (DT the) (JJ activation-induced) (NN lymphocyte) (NN proliferation))))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ biochemical) (NNS modifications)) (ADJP (JJ responsible) (PP (IN for) (NP (NP (DT the) (NN defect)) (PP (IN in) (NP (NP (NP (NN transduction)) (CC and) (NP (NN execution))) (PP (IN of) (NP (DT the) (JJ proliferative) (NN signal))))))))) (VP (VBP are) (VP (VBN analyzed) (PP (IN as) (NP (NP (DT a) (NN function)) (PP (IN of) (NP (NN age))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ multiple) (NNS alterations)) (VP (VBN observed) (PP (IN on) (NP (DT the) (JJ various) (JJ biochemical) (NNS pathways))))) (VP (MD may) (VP (VB appear) (PP (IN as) (NP (NP (DT a) (NN consequence)) (PP (IN of) (NP (NP (DT a) (JJ unique) (JJ deleterious) (NN mechanism)) (ADJP (ADVP (RBR more) (RB fundamentally)) (JJ related) (PP (TO to) (NP (NP (DT the) (NN process)) (PP (IN of) (NP (NP (NN senescence)) (PP (JJ such) (IN as) (NP (DT the) (NN inability) (S (VP (TO to) (VP (VB cope) (PP (IN with) (NP (JJ oxidative) (NN stress))))))))))))))))))) (. .))))
(S1 (S (S (S (NP (NP (NN Engagement)) (PP (IN of) (NP (NP (DT the) (NN Lewis) (NN X) (NN antigen)) (PRN (-LRB- -LRB-) (NP (NN CD15)) (-RRB- -RRB-))))) (VP (VBZ results) (PP (IN in) (NP (NN monocyte) (NN activation)))) (. .)))))
(S1 (S (S (S (NP (PRP We)) (ADVP (RB previously)) (VP (VBD reported) (SBAR (IN that) (S (NP (NP (NN monocyte) (NN adhesion)) (PP (TO to) (NP (NN tumor) (NN necrosis) (NN factor-alpha) (-LRB- -LRB-) (NN TNF-alpha) (-RRB- -RRB-) (JJ -treated) (JJ endothelial) (NNS cells)))) (VP (VBD increased) (NP (NP (NN expression)) (PP (IN of) (NP (NP (NN tissue) (NN factor)) (CC and) (NP (NN CD36)))) (PP (IN on) (NP (NNS monocytes)))))))) (. .)))))
(S1 (S (S (S (VP (VBG Using) (NP (JJ immunological) (NN cross-linking)) (S (VP (TO to) (VP (VB mimic) (NP (NP (NN receptor) (NN engagement)) (PP (IN by) (NP (JJ natural) (NNS ligands))))))))) (, ,) (S (NP (PRP we)) (ADVP (RB now)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (NP (NN CD15)) (PRN (-LRB- -LRB-) (NP (NN Lewis) (NN X)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NP (NN monocyte) (NN counter-receptor))) (PP (IN for) (NP (JJ endothelial) (NNS selectins))))) (VP (MD may) (VP (VB participate) (PP (IN in) (NP (DT this) (NN response))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VP (VBD used) (NP (NN cytokine) (NN production)) (PP (IN as) (NP (NP (DT a) (NN readout)) (PP (IN for) (NP (NN monocyte) (NN activation)))))) (CC and) (VP (VBD found) (SBAR (IN that) (S (NP (NN CD15) (NN cross-linking)) (VP (VBD induced) (NP (NP (NP (NP (NN TNF-alpha)) (NN release)) (PP (IN from) (NP (JJ peripheral) (NN blood) (NNS monocytes)))) (CC and) (NP (NP (NP (NNS cells))) (PP (IN from) (NP (DT the) (NP (JJ monocytic) (NN cell) (NN line) (NN MM6))))))))))) (. .))))
(S1 (S (S (NP (JJ Quantitative) (NP (NP (JJ reverse) (JJ transcriptase-polymerase) (NN chain) (NN reaction)) (PRN (-LRB- -LRB-) (NP (NN RT-PCR)) (-RRB- -RRB-)))) (VP (VBD showed) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (JJ steady-state) (NP (NN TNF-alpha) (NN mRNA))))) (PP (IN after) (NP (NP (QP (CD 3) (TO to) (CD 4)) (NNS hours)) (PP (IN of) (NP (NN cross-linking)))))) (. .))))
(S1 (S (S (NP (NN CD15) (NN cross-linking)) (ADVP (RB also)) (ADVP (RB concomitantly)) (VP (VBD increased) (NP (NN interleukin-1) (NN beta) (-LRB- -LRB-) (NN IL-1) (NN beta) (-RRB- -RRB-) (NN mRNA)) (, ,) (SBAR (IN while) (S (NP (DT no) (JJ apparent) (NN change)) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NN beta-actin) (NN mRNA)))))) (, ,)))) (S (VP (VBG indicating) (NP (NN specificity))))) (. .))))
(S1 (S (S (S (VP (TO To) (VP (VB examine) (NP (NP (JJ transcriptional) (NN regulation)) (PP (IN of) (NP (NN cytokine) (NNS genes))) (PP (IN by) (NP (NN CD15) (NN engagement))))))) (, ,) (S (NP (NP (DT a) (NN CAT) (NN plasmid) (NN reporter) (NN construct)) (VP (VBG containing) (NP (NN IL-1) (NN beta) (NN promoter/enhancer) (NNS sequences)))) (VP (VBD was) (VP (VBN introduced) (PP (IN into) (NP (NN MM6)))))) (. .))))
(S1 (S (S (NP (NP (JJ Subsequent) (NN cross-linking)) (PP (IN of) (NP (NN CD15)))) (VP (VBD increased) (NP (NP (NN CAT)) (NN activity))) (. .))))
(S1 (S (S (NP (NP (NN CD15) (NN engagement)) (PP (IN by) (NP (JJ monoclonal) (NN antibody)))) (ADVP (RB also)) (VP (VBD attenuated) (NP (NP (NN IL-1) (NN beta)) (NN transcript) (NN degradation)) (, ,) (S (VP (VBG demonstrating) (SBAR (IN that) (S (NP (NP (NN signaling)) (PP (IN via) (NP (NN CD15)))) (ADVP (RB also)) (VP (VBD had) (NP (JJ posttranscriptional) (NNS effects)))))))) (. .))))
(S1 (S (S (NP (NP (JJ Nuclear) (NNS extracts)) (PP (IN of) (NP (JJ anti-CD15) (JJ cross-linked) (NNS cells)))) (VP (VP (VBD demonstrated) (NP (NP (VBN enhanced) (NNS levels)) (PP (IN of) (NP (DT the) (NP (JJ transcriptional) (NN factor) (NN activator) (NN protein-1)))))) (, ,) (VP (ADVP (RB minimally)) (VBD changed) (NP (JJ nuclear) (NN factor-kappa) (NN B))) (, ,) (CC and) (VP (VBD did) (RB not) (VP (VB affect) (NP (NN SV40) (NN promoter) (JJ specific) (NN protein-1))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (NP (NP (NN engagement)) (PP (IN of) (NP (NN CD15))) (PP (IN on) (NP (NNS monocytes)))) (VP (VBZ results) (PP (IN in) (NP (NN monocyte) (NN activation))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (NN addition)) (PP (TO to) (NP (PRP$ its) (JJ well-recognized) (JJ adhesive) (NN role))))) (, ,) (NP (NN CD15)) (VP (MD may) (VP (VB function) (PP (IN as) (NP (NP (DT an) (JJ important) (VBG signaling) (NN molecule)) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG initiating) (NP (NP (JJ proinflammatory) (NNS events)) (PP (IN in) (NP (NP (NNS monocytes)) (SBAR (WHNP (WDT that)) (S (VP (VBP come) (PP (IN into) (NP (NP (NN contact)) (PP (IN with) (NP (VBN activated) (NN endothelium))))))))))))))))))) (. .))))
(S1 (S (NP (NP (NP (NP (NP (NN Activation)) (PP (IN of) (NP (NN signaling) (NNS pathways)))) (CC and) (NP (NP (NN prevention)) (PP (IN of) (NP (NN apoptosis))))) (PP (IN by) (NP (NP (NNS cytokines)) (PP (IN in) (NP (NNS eosinophils))))) (. .)))))
(S1 (S (S (S (NP (NP (NN Inhibition)) (PP (IN of) (NP (NP (NN apoptosis)) (PP (IN in) (NP (NNS eosinophils))))) (PP (IN by) (NP (NP (NNS cytokines)) (PP (JJ such) (IN as) (NP (NP (NN IL-5)) (CC and) (NP (NN GM-CSF))))))) (VP (MD may) (VP (VB play) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP (NP (ADJP (JJ allergic))) (CC and) (NP (ADJP (JJ parasitic))) (NP (NNS disorders)))))))) (. .)))))
(S1 (S (S (ADVP (RB Recently)) (, ,) (NP (EX there)) (VP (VBZ has) (VP (VBN been) (NP (NP (DT some) (NN progress)) (PP (IN in) (NP (NP (DT the) (NN understanding)) (PP (IN of) (NP (NP (DT the) (NN signal) (NN transduction) (NNS pathways)) (VP (VBN activated) (PP (IN by) (NP (NP (DT these) (NP (NNS cytokines))) (PP (IN in) (NP (NNS eosinophils))))))))))))) (. .))))
(S1 (S (S (NP (DT The) (NP (NP (NN IL-3))) (, ,) (NP (NP (NN IL-5))) (CC and) (NP (NN GM-CSF) (NNS receptors))) (VP (VBP share) (NP (NP (DT a) (NP (JJ common) (NN signal) (NN transducer))) (SBAR (WHNP (WDT that)) (S (VP (VBZ possesses) (NP (DT no) (NP (JJ intrinsic) (NN kinase) (NN domain)))))))) (. .))))
(S1 (S (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (NN eosinophil) (NN stimulation)) (PP (IN by) (NP (DT these) (NP (NNS cytokines))))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (NNS increases)) (PP (IN in) (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (JJ several) (JJ cellular) (NNS substrates)))))))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT the) (JJ past) (JJ few) (NNS years))) (, ,) (NP (EX there)) (VP (VBZ has) (VP (VBN been) (NP (NP (DT some) (NN progress)) (PP (IN in) (S (VP (VBG defining) (NP (NP (DT the) (NN tyrosine) (NNS kinases)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN activated) (PP (IN by) (NP (NP (DT the) (NP (NN IL-3/IL-5/GM-CSF) (NN receptor) (NN beta-subunit))) (PP (IN in) (NP (NNS eosinophils)))))))))))))))) (. .))))
(S1 (S (S (NP (DT This) (NN review)) (VP (MD will) (VP (VB concentrate) (PP (PP (IN on) (NP (DT this) (JJ topic))) (CC and) (PP (IN on) (NP (NP (PRP$ its) (NN role)) (PP (IN for) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NN eosinophil) (NN apoptosis)))))))))) (. .))))
(S1 (S (NP (NP (NN Stimulation)) (PP (IN of) (NP (JJ human) (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells))) (PP (IN by) (NP (NP (NN zinc)) (CC and) (NP (JJ related) (NNS cations)))) (. .))))
(S1 (S (S (NP (NN Zinc)) (VP (VBZ is) (NP (NP (DT an) (JJ important) (NN trace) (NN element)) (PP (IN for) (NP (JJ immune) (NN function))))) (. .))))
(S1 (S (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (NN zinc) (NN addition)) (PP (IN in) (NP (DT a) (ADJP (ADJP (NP (NN serum-))) (CC and) (ADJP (JJ lipopolysaccharide-free))) (NN cell) (NN culture) (NN system)))) (VP (VBZ leads) (PP (PP (TO to) (NP (NP (ADJP (RB significantly) (JJ enhanced)) (NNS levels)) (PP (IN of) (NP (NP (NP (NN interleukin) (CD 1) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN IL-1) (NN beta)) (-RRB- -RRB-))) (CC and) (NP (NP (NN tumour) (NN necrosis) (NN factor) (NN alpha)) (PRN (-LRB- -LRB-) (NP (NN TNF-alpha)) (-RRB- -RRB-))))))) (CC and) (PP (TO to) (NP (NP (NN expression)) (PP (IN of) (NP (NP (DT the) (JJ corresponding) (NN mRNA)) (PP (IN in) (NP (JJ human) (NP (NP (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN PBMC)) (-RRB- -RRB-)))))))))))))) (. .))))
(S1 (S (S (NP (NP (ADJP (RB Structurally) (JJ related)) (JJ divalent) (NNS cations)) (PP (IN like) (NP (NP (NN cobalt)) (, ,) (NP (NN nickel)) (, ,) (CC and) (NP (NN mercury))))) (ADVP (RB also)) (VP (ADVP (RB partially)) (VBP increase) (NP (NN monokine) (NN secretion)) (CC but) (PP (TO to) (NP (DT a) (ADJP (ADJP (RB much) (JJR lower)) (CC and) (RB thus) (ADJP (JJ insignificant))) (NN extent)))) (. .))))
(S1 (S (S (NP (PRP They)) (VP (VBP fail) (S (VP (TO to) (VP (VB induce) (NP (NP (NN mRNA)) (PP (IN of) (NP (NN TNF-alpha)))) (PP (IN after) (NP (NP (CD 3) (NN h)) (PP (IN of) (NP (NN culture))))))))) (. .))))
(S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NN monokine) (NN induction)) (VP (VBZ is) (NP (NP (DT a) (JJ zinc-specific) (NN effect)) (VP (VBN influenced) (PP (IN by) (NP (NP (DT the) (JJ physicochemical) (NNS properties)) (PP (IN of) (NP (DT the) (NN ion)))))))) (. .))))
(S1 (S (S (NP (NP (NN Confirmation)) (PP (IN of) (NP (NP (DT the) (JJ unique) (NN significance)) (PP (IN of) (NP (NN zinc))) (PP (IN for) (NP (JJ immune) (NN function)))))) (VP (VBZ provides) (NP (NP (DT a) (JJR better) (NN understanding)) (PP (IN of) (NP (NP (DT the) (NNS mechanisms)) (PP (IN of) (NP (JJ specific) (JJ zinc-mediated) (JJ immune) (NN modulation))))))) (. .))))
(S1 (S (NP (NP (NP (NN Sequence) (NN analysis)) (CC and) (NP (NP (NN expression)) (PP (IN in) (NP (VBN cultured) (NNS lymphocytes))))) (PP (IN of) (NP (NP (DT the) (JJ human) (NN FOSB) (NN gene)) (PRN (-LRB- -LRB-) (NP (NN G0S3)) (-RRB- -RRB-)))) (. .))))
(S1 (S (S (NP (NN G0S3)) (VP (VBZ is) (NP (NP (DT a) (NN member)) (PP (IN of) (NP (NP (DT a) (NN set)) (PP (IN of) (NP (NP (NP (JJ putative) (NN G0/G1) (NN switch) (JJ regulatory) (NNS genes)) (PRN (-LRB- -LRB-) (NP (NN G0S) (NNS genes)) (-RRB- -RRB-))) (VP (VBN selected) (PP (IN by) (S (VP (VBG screening) (NP (NP (NN cDNA) (NNS libraries)) (VP (VBN prepared) (PP (IN from) (NP (NP (JJ human) (NN blood) (JJ mononuclear) (NNS cells)) (VP (VBN cultured) (PP (IN for) (NP (CD 2) (NN hr))) (PP (IN with) (NP (NP (NN lectin)) (CC and) (NP (NN cycloheximide))))))))))))))))))) (. .))))
(S1 (S (S (NP (DT The) (NN sequence)) (VP (VBZ shows) (NP (NP (JJ high) (NN homology)) (PP (IN with) (NP (NP (DT the) (JJ murine) (NN FOSB) (NN gene)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ encodes) (NP (NP (DT a) (NN component)) (PP (IN of) (NP (DT the) (NN AP1) (JJ transcriptional) (NN regulator))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Comparison)) (PP (IN of) (NP (NP (NN cDNA)) (CC and) (NP (JJ genomic) (NNS sequences))))) (VP (VBZ reveals) (NP (NP (DT a) (JJ 4-exon) (NN structure) (JJ characteristic)) (PP (IN of) (NP (NP (DT the) (NN FOS) (NN family)) (PP (IN of) (NP (NNS genes))))))) (. .))))
(S1 (S (S (NP (ADJP (RB Freshly) (VBN isolated)) (NNS cells)) (VP (VBP show) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NP (NP (NN FOSB/G0S3)) (CC and) (NP (NN FOS/G0S7))) (NNS mRNAs))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP decline) (ADVP (RB rapidly)) (PP (IN during) (NP (NP (NN incubation)) (PP (IN in) (NP (NN culture) (NN medium)))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NNS kinetics)) (PP (IN of) (NP (NN expression)))) (VP (VP (VBP suggest) (SBAR (IN that) (S (NP (DT the) (JJ high) (JJ initial) (NNS levels)) (VP (VBP are) (VP (VBN caused) (PP (IN by) (NP (DT the) (NN isolation) (NN procedure)))))))) (, ,) (CC and) (VP (VBP do) (RB not) (VP (VB reflect) (NP (JJ constitutive) (NN expression))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (NNS cells)) (VP (VBN preincubated) (PP (IN for) (NP (DT a) (NN day)))))) (, ,) (NP (NP (NNS levels)) (PP (IN of) (NP (NN FOS) (NN mRNA)))) (VP (VP (VBP reach) (NP (DT a) (NN maximum)) (PP (NP (CD 20) (NN min)) (IN after) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NN lectin)))))) (CC and) (VP (VBP decline) (PP (TO to) (NP (NN control) (NNS levels))) (PP (IN over) (NP (DT the) (JJ next) (CD 3) (NN hr))))) (. .))))
(S1 (S (S (NP (NP (NNS Levels)) (PP (IN of) (NP (NN FOSB) (NN mRNA)))) (VP (VP (VBP reach) (NP (DT a) (JJ maximum)) (PP (NP (CD 40) (NN min)) (IN after) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NN lectin)))))) (CC and) (VP (VBP decline) (PP (TO to) (NP (NN control) (NNS levels))) (PP (IN over) (NP (DT the) (JJ next) (CD 6) (NN hr))))) (. .))))
(S1 (S (S (PP (IN In) (NP (ADJP (RB freshly) (VBN isolated)) (NNS cells))) (, ,) (NP (NP (CC both) (NP (NNS FOS)) (CC and) (NP (NN FOSB))) (NNS mRNAs)) (VP (VBP increase) (ADVP (RB dramatically)) (PP (IN in) (NN response) (TO to) (NP (DT the) (NN protein) (NN synthesis) (NN inhibitor) (NN cycloheximide)))) (. .))))
(S1 (S (S (PP (IN In) (NP (JJ preincubated) (NNS cells))) (, ,) (NP (DT the) (NN cycloheximide) (NN response)) (VP (VBZ is) (VP (VBN decreased) (, ,) (PP (RB especially) (IN in) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NN FOSB))))))) (. .))))
(S1 (S (S (NP (NP (DT These) (NNS differences)) (PP (IN in) (NP (NP (NN expression)) (PP (IN of) (NP (NP (NN FOS)) (CC and) (NP (NN FOSB))))))) (VP (VBP suggest) (NP (JJ different) (NP (NP (NNS roles)) (CC and) (NP (NN regulation))))) (. .))))
(S1 (S (S (NP (NP (NNS Regions)) (PP (IN of) (NP (JJ low) (ADJP (NN base) (JJ order-dependent)) (JJ stem-loop) (NN potential))) (PP (IN in) (NP (NP (DT the) (NN region)) (PP (IN of) (NP (DT the) (NN gene)))))) (VP (VBP are) (VP (VBN defined))) (. .))))
(S1 (S (S (NP (DT These)) (VP (VBP indicate) (SBAR (WHADVP (WRB where)) (S (NP (NN base) (NN order)) (VP (VBZ has) (VP (VBN been) (VP (VBN adapted) (PP (IN for) (NP (NP (NP (NNS purposes)) (PP (JJ other) (IN than) (NP (JJ stem-loop) (NN stability)))) (PRN (-LRB- -LRB-) (UCP (ADVP (FW e.g.)) (, ,) (UCP (S (VP (VBG encoding) (NP (NNS proteins)))) (CC or) (NP (NN gene) (NN regulation)))) (-RRB- -RRB-)))))))))) (. .))))
(S1 (S (S (NP (NP (NNS Regions)) (PP (IN of) (NP (JJ low) (NN potential))) (PP (IN in) (NP (NP (DT a) (JJ 68.5-kb) (JJ genomic) (NN segment)) (VP (VBG containing) (NP (DT the) (NN FOSB) (NN gene)))))) (VP (VBP suggest) (SBAR (IN that) (S (NP (DT the) (NN potential)) (VP (MD may) (VP (VB help) (S (VP (VB locate) (NP (NP (NNS genes)) (PP (IN in) (NP (JJ uncharted) (NN DNA) (NNS sequences))))))))))) (. .))))
(S1 (S (S (S (NP (NP (NN STAT1)) (NN pathway)) (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (NP (NN activation)) (PP (IN of) (NP (JJ caprine) (NP (JJ arthritis-encephalitis) (NN virus) (JJ long) (JJ terminal) (NN repeat)))) (PP (IN in) (NP (NNS monocytes))))))) (. .)))))
(S1 (S (S (S (NP (DT The) (NP (JJ caprine) (JJ arthritis-encephalitis) (NN virus) (-LRB- -LRB-) (NN CAEV) (-RRB- -RRB-) (JJ long) (JJ terminal) (NN repeat)) (PRN (-LRB- -LRB-) (NP (NN LTR)) (-RRB- -RRB-))) (VP (VBZ is) (VP (VBN activated) (PP (IN by) (NP (NP (NP (NN gamma) (NN interferon)) (PRN (-LRB- -LRB-) (NP (NN IFN-gamma)) (-RRB- -RRB-))) (PP (IN in) (NP (JJ promonocytic) (NNS cells))))))) (. .)))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB previously)) (VP (VBN shown) (SBAR (IN that) (S (NP (DT a) (NP (JJ 70-bp) (NN element))) (VP (VBZ is) (ADJP (ADJP (JJ necessary)) (CC and) (ADJP (JJ sufficient)) (PP (IN for) (NP (NP (DT the) (NN response)) (PP (IN of) (NP (DT the) (NP (NN CAEV) (NN LTR)))) (PP (TO to) (NP (DT this) (NP (NN cytokine)))))))))))) (. .))))
(S1 (S (S (PP (IN At) (NP (DT the) (NP (JJ 5') (NN end)))) (, ,) (NP (DT this) (NP (JJ 70-bp) (NN IFN-gamma) (NN response) (NN element))) (VP (VBZ contains) (NP (NP (NN sequence) (NN similarity)) (PP (TO to) (NP (DT the) (NP (NP (NN gamma) (JJ activated) (NN site)) (PRN (-LRB- -LRB-) (NP (NN GAS)) (-RRB- -RRB-))))))) (. .))))
(S1 (S (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (DT the) (JJ putative) (NP (NN GAS) (NN element))) (PP (IN in) (NP (DT the) (NP (NN CAEV) (NN LTR))))) (VP (VBZ binds) (PP (ADVP (RB specifically)) (TO to) (NP (NP (DT a) (NP (JJ cellular) (NN factor))) (VP (VBN induced) (PP (IN by) (NP (NP (NN IFN-gamma)) (PP (IN in) (NP (JJ promonocytic) (NNS cells)))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Substitution) (NNS mutations)) (PP (IN in) (NP (DT this) (NP (NN consensus) (NN sequence))))) (VP (VBP eliminate) (NP (NP (NN binding)) (PP (IN of) (NP (DT the) (NP (JJ inducible) (NN factor)))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NP (NN GAS) (NN element))) (PP (IN from) (NP (DT the) (NP (JJ 70-bp) (NN motif))))) (VP (VBZ is) (ADJP (JJ sufficient)) (S (VP (TO to) (VP (VB confer) (NP (NP (NN responsiveness)) (PP (TO to) (NP (NN IFN-gamma))))) (S (VP (VBG using) (NP (DT a) (ADJP (ADJP (JJ heterologous)) (ADJP (JJ minimal))) (NN promoter))))))) (. .))))
(S1 (S (S (ADVP (JJ Consistent) (PP (IN with) (NP (DT the) (NN binding) (NNS data)))) (, ,) (S (NP (NP (DT the) (JJ same) (NNS mutations)) (PP (IN in) (NP (DT the) (NP (NN GAS) (NN element))))) (VP (VBP eliminate) (NP (NP (NN responsiveness)) (PP (TO to) (NP (NN IFN-gamma)))) (PP (IN in) (NP (NP (DT the) (NN context)) (PP (IN of) (NP (CC both) (NP (DT a) (JJ functional) (NP (NN CAEV) (NN LTR))) (CC and) (NP (DT a) (NP (JJ heterologous) (NN promoter))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ cellular) (NN factor)) (SBAR (WHNP (WDT that)) (S (VP (VBZ binds) (PP (TO to) (NP (DT the) (NP (NN GAS) (NN element)))))))) (VP (VBZ is) (ADJP (JJ present) (PP (IN from) (NP (CD 5) (NN min))) (PP (TO to) (NP (CD 14) (NN h))) (PP (IN after) (NP (NP (NN stimulation)) (PP (IN with) (NP (NN IFN-gamma))))))) (. .))))
(S1 (S (S (NP (NP (NN Binding)) (PP (IN of) (NP (DT the) (JJ nuclear) (NN factor))) (PP (TO to) (NP (DT the) (NP (NN GAS) (NN element)))) (PP (IN in) (NP (DT the) (NP (NN CAEV) (NN LTR))))) (VP (VBZ is) (VP (VBN inhibited) (PP (IN by) (NP (NP (NN antibody)) (VP (VBN directed) (PP (IN against) (NP (NP (NN STAT1)) (PRN (-LRB- -LRB-) (NP (NN p91/84)) (-RRB- -RRB-))))))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (S (S (NP (NP (DT the) (NN GAS) (NN sequence)) (PP (IN in) (NP (DT the) (NP (NN CAEV) (NN LTR))))) (VP (VBZ is) (ADJP (JJ essential) (PP (IN for) (NP (NP (DT the) (NN response)) (PP (TO to) (NP (NN IFN-gamma)))))))) (CC and) (S (NP (NP (DT a) (NP (JJ STAT1-like) (NN factor)))) (VP (VBZ binds) (PP (TO to) (NP (DT this) (NN site)))))) (. .))))
(S1 (S (S (NP (DT The) (NN STAT-1) (NN signaling) (NN pathway)) (VP (VBZ provides) (NP (NP (QP (IN at) (JJS least) (CD one)) (NN mechanism)) (PP (IN for) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (NP (NN CAEV) (NN LTR)))) (PP (IN by) (NP (NP (NN IFN-gamma)) (PP (IN in) (NP (NNS monocytes))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS data)) (VP (VBP are) (NP (NP (DT the) (JJ first) (NN demonstration)) (PP (IN of) (NP (NP (DT a) (NN role)) (PP (IN for) (NP (DT a) (NP (NN STAT) (NN family) (NN member)))) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (DT a) (NP (JJ viral) (NN promoter)))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Signaling)) (PP (IN via) (NP (NP (NN IL-2)) (CC and) (NP (NN IL-4)))) (PP (IN in) (NP (JJ JAK3-deficient) (JJ severe) (JJ combined) (NN immunodeficiency) (NNS lymphocytes))) (: :)) (NP (ADJP (ADJP (JJ JAK3-dependent)) (CC and) (ADJP (JJ independent))) (NNS pathways)) (. .))))
(S1 (S (S (NP (CC Both) (NP (NN IL-2)) (CC and) (NP (NN IL-4))) (VP (VBP bind) (PP (TO to) (NP (NP (NNS receptors)) (VP (VBG containing) (NP (NP (DT the) (JJ common) (NN gamma) (NN chain)) (CC and) (NP (NN JAK3))))))) (. .))))
(S1 (S (S (SBAR (IN Although) (S (NP (NN JAK3)) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (JJ proper) (JJ lymphoid) (NN development))))))) (, ,) (NP (NP (DT the) (JJ precise) (NNS roles)) (PP (IN of) (NP (DT this) (NN kinase))) (PP (IN in) (NP (NP (NP (NP (NN IL-2)) (CC and) (NP (NN IL-4))) (NN signaling)) (PP (IN in) (NP (NNS lymphocytes)))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN defined)))) (. .))))
(S1 (S (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP have) (VP (VBN studied) (NP (NP (NP (NP (NN IL-2)) (CC and) (NP (NN IL-4))) (NN signaling)) (PP (IN in) (NP (NP (NN B) (NN cell) (NNS lines)) (VP (VBG lacking) (NP (NN JAK3)))))))) (. .))))
(S1 (S (S (SBAR (IN Although) (S (NP (NP (JJ IL-2-induced) (NN phosphorylation)) (PP (IN of) (NP (NP (NN IL-2R) (NN beta)) (, ,) (NP (NN JAK1)) (, ,) (CC and) (NP (NN STAT5)))) (ADVP (DT all))) (VP (VBN required) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN JAK3))))))) (, ,) (NP (NP (JJ IL-4-mediated) (NN phosphorylation)) (PP (IN of) (NP (NP (NN JAK1)) (, ,) (NP (NN STAT6)) (, ,) (CC and) (NP (NN insulin) (NN receptor) (NNS substrates) (NP (NP (CD 1)) (CC and) (NP (CD 2))))))) (VP (VBD did) (RB not)) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (JJ IL-4-induced) (NNS effects)) (VP (VBD were) (VP (ADVP (RB clearly)) (VBN improved) (PP (VBG following) (NP (NN JAK3) (NN expression))))) (. .))))
(S1 (S (S (NP (DT These) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN IL-4) (NN signaling)) (VP (VP (VBZ occurs) (PP (IN in) (DT the) (NN absence) (IN of) (IN of) (NP (NN JAK3)))) (, ,) (CC but) (VP (VBZ is) (ADJP (RB comparatively) (JJ inefficient))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS findings)) (VP (VP (MD may) (VP (VB help) (PP (RP in) (S (VP (VBG understanding) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP (NP (DT the) (NN immunodeficiency)) (SBAR (WHNP (WDT that)) (S (VP (VBZ occurs) (PP (IN with) (NP (NP (NNS mutations)) (PP (IN of) (NP (NN JAK3)))))))))))))))) (CC and) (VP (MD may) (VP (VB suggest) (NP (NP (DT a) (NN mechanism)) (PP (IN for) (NP (NP (DT the) (JJ pleiotropic) (NNS effects)) (PP (IN of) (NP (NN IL-4))))))))) (. .))))
(S1 (S (NP (NP (NP (JJ Differentiation-dependent) (NN expression)) (PP (IN of) (NP (DT a) (NP (JJ human) (NN carboxylesterase)))) (PP (IN in) (NP (NP (JJ monocytic) (NNS cells)) (CC and) (NP (NP (NN transcription) (NN factor)) (VP (VBG binding) (PP (TO to) (NP (DT the) (NP (NN promoter)))))))) (. .)))))
(S1 (S (S (S (NP (NNS Carboxylesterases)) (VP (VBP play) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (NP (NN defense)) (CC and) (NP (NN clearance)) (NP (NNS mechanisms))) (PP (IN of) (NP (DT the) (NN monocyte/macrophage) (NN system)))))) (. .)))))
(S1 (S (S (PP (IN During) (NP (NP (DT the) (NN differentiation) (NN process)) (PP (IN of) (NP (NP (NNS cells)) (PP (IN from) (NP (DT the) (NP (JJ monocytic) (NN cell) (NN line) (NN THP-1)))))))) (NP (PRP we)) (VP (VBD observed) (NP (NP (DT a) (ADJP (ADJP (JJ transient)) (ADJP (JJ transcriptional))) (NN upregulation)) (PP (IN of) (NP (DT a) (NP (JJ human) (NN carboxylesterase)))) (VP (VBN analyzed) (PP (IN by) (NP (NP (NN means)) (PP (IN of) (NP (NN Northern) (NNS blots)))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (JJ PMA-treated) (NN THP-1) (NNS cells))) (NP (PRP we)) (VP (MD could) (VP (VB detect) (NP (CD three) (JJ major) (NP (NN transcription) (NN initiation) (NNS sites)))) (SBAR (IN as) (S (VP (VBN revealed) (PP (IN by) (NP (NP (NN Nuclease) (NN Protection) (NN Assay)) (VP (VBN carried) (PRT (IN out)) (PP (IN with) (NP (CD two) (NP (VBG overlapping) (JJ antisense) (NN RNA) (NNS probes))))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB recently)) (VP (VP (VBN cloned) (NP (DT the) (NP (NN carboxylesterase) (JJ upstream) (NN sequence)))) (CC and) (VP (VBN showed) (NP (NP (PRP$ its) (NP (JJ basal) (NN promoter)) (NN activity)) (PP (IN in) (NP (NN CHO) (NNS cells))))))) (. .))))
(S1 (S (S (S (VP (VBG Using) (NP (JJ electrophoretic) (NN mobility) (NN shift) (NN analysis)))) (S (NP (PRP we)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (NP (DT the) (NP (NN promoter) (NN region))) (VP (VBG spanning) (NP (NN base) (NNS pairs) (CD -1) (TO to) (CD -275)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ contains) (NP (NP (ADJP (JJ several) (JJ putative)) (VBG binding) (NNS sites)) (PP (IN for) (NP (NN transcription) (NNS factors))))))) (, ,)) (VP (VBZ is) (VP (VBN bound) (PP (PP (IN by) (NP (NP (JJ nuclear) (NNS factors)) (NP (NP (NN Sp1)) (CC and) (NP (NN IRBP))))) (CC but) (PP (RB not) (IN by) (NP (NNS C/EBPs)))))))))) (. .))))
(S1 (S (S (S (VP (VBN Taken) (ADVP (RB together)))) (S (NP (DT these) (NNS data)) (VP (VBP indicate) (SBAR (SBAR (IN that) (S (NP (NP (NN carboxylesterase) (NN gene) (NN transcription)) (PP (IN in) (NP (NN THP-1) (NNS cells)))) (VP (VBZ starts) (PP (IN at) (NP (JJ multiple) (NN initiation) (NNS sites)))))) (CC and) (SBAR (IN that) (S (NP (NP (NN Sp1)) (CC and) (NP (NN IRBP))) (VP (MD may) (VP (VB be) (NP (NP (JJ critical) (NNS factors)) (PP (IN for) (S (VP (VBG modulating) (NP (NP (DT the) (JJ differentiation-dependent) (NN transcription)) (PP (IN of) (NP (DT this) (NP (JJ human) (NN carboxylesterase) (NN gene)))))))))))))))) (. .))))
(S1 (S (NP (NP (NP (ADJP (ADJP (JJ Glycation-dependent)) (, ,) (ADJP (JJ reactive) (NN oxygen) (JJ species-mediated))) (NN suppression)) (PP (IN of) (NP (DT the) (NN insulin) (NN gene) (NN promoter) (NN activity))) (PP (IN in) (NP (NN HIT) (NNS cells))) (. .)))))
(S1 (S (S (S (NP (NP (ADJP (ADJP (JJ Prolonged)) (ADJP (JJ poor)) (ADJP (JJ glycemic))) (NN control)) (PP (IN in) (NP (JJ non-insulin-dependent) (NN diabetes) (NN mellitus) (NNS patients)))) (ADVP (RB often)) (VP (VBZ leads) (PP (TO to) (NP (NP (NP (DT a) (NN decline)) (PP (IN in) (NP (NP (NN insulin) (NN secretion)) (PP (IN from) (NP (JJ pancreatic) (NN beta) (NNS cells)))))) (, ,) (VP (VBN accompanied) (PP (IN by) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NP (DT the) (NN insulin) (NN content)) (PP (IN of) (NP (DT the) (NNS cells))))))))))) (. .)))))
(S1 (S (S (PP (IN As) (NP (NP (DT a) (NN step)) (PP (IN toward) (S (VP (VBG elucidating) (NP (NP (DT the) (JJ pathophysiological) (NN background)) (PP (IN of) (NP (NP (DT the) (JJ so-called) (NN glucose) (NN toxicity)) (PP (TO to) (NP (JJ pancreatic) (NN beta) (NNS cells))))))))))) (, ,) (NP (PRP we)) (VP (VP (VBD induced) (NP (NN glycation)) (PP (IN in) (NP (NN HIT-T15) (NNS cells))) (S (VP (VBG using) (NP (NP (NP (DT a) (NN sugar)) (PP (IN with) (NP (JJ strong) (NN deoxidizing) (NN activity)))) (, ,) (NP (NN D-ribose)))))) (, ,) (CC and) (VP (VBD examined) (NP (NP (DT the) (NNS effects)) (PP (IN on) (NP (NN insulin) (NN gene) (NN transcription)))))) (. .))))
(S1 (S (S (S (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (NP (NN reporter) (NN gene)) (NNS analyses)))) (VP (VBD revealed) (SBAR (IN that) (S (NP (DT the) (NP (NN insulin) (NN gene) (NN promoter))) (VP (VBZ is) (ADJP (ADJP (RBR more) (JJ sensitive)) (PP (TO to) (NP (NN glycation))) (SBAR (IN than) (S (NP (DT the) (JJ control) (NP (NN beta-actin) (NN gene) (NN promoter))))))))))) (: ;) (S (NP (NP (QP (RB approximately) (CD 50) (CC and) (CD 80)) (NN %)) (PP (IN of) (NP (DT the) (NP (NN insulin) (NN gene) (NN promoter)) (NN activity)))) (VP (VBD was) (VP (VBN lost)) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NNS cells)) (VP (VBD were) (VP (VBN kept) (PP (IN for) (NP (CD 3) (NN d))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (ADJP (QP (CD 40) (CC and) (CD 60)) (NN mM)) (NN D-ribose))))) (, ,) (ADVP (RB respectively)))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (NN agreement)) (PP (IN with) (NP (DT this))))) (, ,) (NP (NP (NN decrease)) (PP (IN in) (NP (DT the) (NP (NN insulin) (NN mRNA)) (CC and) (NP (NN insulin) (NN content))))) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (DT the) (NP (JJ glycation-induced) (NNS cells)))))) (. .))))
(S1 (S (S (ADVP (RB Also)) (, ,) (NP (NP (NN gel) (NN mobility) (NN shift) (NNS analyses)) (VP (VBG using) (NP (JJ specific) (NN antiserum)))) (VP (VBD revealed) (NP (NP (NN decrease)) (PP (IN in) (NP (NP (DT the) (NN DNA-binding) (NN activity)) (PP (IN of) (NP (NP (DT an) (NP (NN insulin) (NN gene) (NN transcription) (NN factor))) (, ,) (NP (NN PDX-1/IPF1/STF-1)))))))) (. .))))
(S1 (S (S (NP (NP (DT These) (NNS effects)) (PP (IN of) (NP (NN D-ribose)))) (VP (VP (VBD seemed) (ADJP (RB almost) (JJ irreversible))) (CC but) (VP (MD could) (VP (VB be) (VP (VBN prevented) (PP (IN by) (NP (NP (NN addition)) (PP (IN of) (NP (NP (ADJP (CD 1) (NN mM)) (NN aminoguanidine)) (CC or) (NP (ADJP (CD 10) (NN mM)) (NN N-acetylcysteine))))))))) (, ,) (S (ADVP (RB thus)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN glycation)) (CC and) (NP (NP (JJ reactive) (NN oxygen) (NNS species)) (, ,) (VP (VBN generated) (PP (IN through) (NP (DT the) (NN glycation) (NN reaction))))) (, ,)) (VP (VBP serve) (PP (IN as) (NP (NP (NNS mediators)) (PP (IN of) (NP (DT the) (NNS phenomena))))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS observations)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NP (NN protein) (NN glycation)) (PP (IN in) (NP (JJ pancreatic) (NN beta) (NNS cells)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ occurs) (ADVP (FW in) (FW vivo)) (PP (IN under) (NP (JJ chronic) (NN hyperglycemia)))))) (, ,)) (VP (VP (VBZ suppresses) (NP (NN insulin) (NN gene) (NN transcription))) (CC and) (ADVP (RB thus)) (VP (MD can) (VP (VB explain) (NP (NP (NN part)) (PP (IN of) (NP (DT the) (NN beta) (NN cell) (NN glucose) (NN toxicity)))))))))) (. .))))
(S1 (S (S (S (NP (DT A) (JJ novel) (NP (NN transcription) (NN factor))) (VP (VBZ regulates) (NP (NP (NN expression)) (PP (IN of) (NP (DT the) (NP (JJ vacuolar) (NN H+-ATPase) (NN B2) (NN subunit))))) (PP (IN through) (NP (NN AP-2) (NNS sites))) (PP (IN during) (NP (JJ monocytic) (NN differentiation)))) (. .)))))
(S1 (S (S (S (PP (IN During) (NP (JJ monocyte-to-macrophage) (NN differentiation))) (, ,) (NP (NP (DT the) (JJ cellular) (NN content)) (PP (IN of) (NP (NP (JJ vacuolar) (NN H+-ATPase)) (PRN (-LRB- -LRB-) (NP (NN V-ATPase)) (-RRB- -RRB-))))) (VP (VBZ increases) (NP (RBR more) (IN than) (RB 4-fold))) (. .)))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN shown) (ADVP (RB previously)) (SBAR (SBAR (IN that) (S (NP (NP (VBN amplified) (NN expression)) (PP (IN of) (NP (NP (DT the) (NP (NN B2) (NN subunit))) (PP (IN of) (NP (DT the) (NP (NN V-ATPase))))))) (VP (VBZ occurs) (PP (ADVP (RB solely)) (IN by) (NP (VBN increased) (NN transcription)))))) (, ,) (CC and) (SBAR (IN that) (S (NP (NP (NP (DT the) (NP (JJ 5'-untranslated) (NN region))) (PP (IN of) (NP (DT the) (NP (NN B2) (NN gene))))) (, ,) (VP (VBG containing) (NP (NP (JJ multiple) (NP (NN consensus) (NN binding) (NNS sites))) (PP (IN for) (NP (NP (DT the) (NP (NN transcription) (NNS factors))) (NP (NP (NN AP-2)) (CC and) (NP (NN Sp1))))))) (, ,)) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (DT this) (NN expression)))))))))) (. .))))
(S1 (S (S (NP (DT The) (JJ present) (NN study)) (VP (VBZ demonstrates) (SBAR (SBAR (IN that) (S (NP (NN AP-2) (NN binding) (NNS sequences)) (VP (VBP are) (ADJP (JJ essential) (PP (IN for) (NP (NP (VBN increased) (NN transcription)) (PP (IN from) (NP (DT the) (NP (NN B2) (NN promoter)))) (PP (IN during) (NP (JJ monocyte-macrophage) (NN differentiation))))))))) (CC and) (SBAR (IN that) (S (NP (NP (NN AP-2)) (, ,) (VP (VBN expressed) (ADVP (RB exogenously)) (PP (IN in) (NP (NP (NN THP-1)) (CC and) (NP (JJ other) (NNS cells))))) (, ,)) (VP (VBZ activates) (NP (NP (NN transcription)) (PP (IN from) (NP (DT the) (NP (NN B2) (NN promoter)))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN mobility) (NN shift) (NNS assays))) (, ,) (NP (NP (DT a) (NP (JJ nuclear) (NN factor))) (PP (IN from) (NP (NP (NN THP-1)) (CC and) (NP (NN U-937) (NNS cells))))) (VP (VBD was) (VP (VBN identified))) (SBAR (WHNP (WDT that)) (S (VP (VP (VBZ binds) (PP (TO to) (NP (NP (JJ several) (NP (NN AP-2) (NN response) (NNS elements))) (PP (IN within) (NP (DT the) (NP (NN B2) (NN promoter))))))) (, ,) (CC but) (VP (VBZ does) (RB not) (VP (VB react) (PP (IN with) (NP (NN AP-2) (NNS antibodies))))) (, ,) (CC and) (VP (VBZ has) (NP (NP (DT a) (NP (NN DNA) (NN sequence)) (NN binding) (NN affinity) (NN profile)) (SBAR (WHNP (WDT that)) (S (VP (VBZ differs) (PP (IN from) (NP (NN AP-2))))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS findings)) (VP (VBP suggest) (SBAR (IN that) (S (NP (DT a) (JJ novel) (NP (JJ AP-2-like) (NN transcription) (NN factor))) (VP (VBZ is) (ADJP (JJ responsible) (PP (IN for) (NP (NP (NN V-ATPase) (NN B) (NN subunit)) (NN amplification))) (PP (IN during) (NP (NN monocyte) (NN differentiation)))))))) (. .))))
(S1 (S (NP (NP (NN Identification)) (PP (IN of) (NP (NP (NN Bcd)) (, ,) (NP (NP (DT a) (JJ novel) (NN proto-oncogene)) (VP (VBN expressed) (PP (IN in) (NP (NNS B-cells))))))) (. .))))
(S1 (S (S (NP (DT A) (JJ novel) (ADJP (ADJP (NN B-cell) (JJ derived)) (PRN (-LRB- -LRB-) (ADJP (NN Bcd)) (-RRB- -RRB-))) (NN oncogene)) (VP (VBZ has) (VP (VBN been) (VP (VBN isolated) (PP (IN from) (NP (NP (DT the) (JJ peripheral) (NN blood) (NNS lymphocytes)) (PP (IN of) (NP (CD one) (NP (NP (NN B-cell) (JJ chronic) (JJ lymphocytic) (NN leukemia)) (PRN (-LRB- -LRB-) (NP (NN B-CLL)) (-RRB- -RRB-))) (NN patient))))) (S (VP (VBG using) (NP (NP (NN DNA) (NN transfer)) (CC and) (NP (DT a) (NN mouse) (NN tumorigenicity) (NN assay)))))))) (. .))))
(S1 (S (S (NP (DT The) (NN Bcd) (NN proto-oncogene)) (VP (VBD was) (VP (VBN activated) (PP (IN by) (NP (NP (DT a) (NN truncation)) (PP (IN in) (NP (DT the) (JJ 5') (NN UTR))))))) (. .))))
(S1 (S (S (NP (PRP It)) (VP (VBZ predicts) (PP (IN for) (NP (CD two) (NP (NP (JJ open) (NN reading) (NNS frames)) (PRN (-LRB- -LRB-) (NP (NNS ORFs)) (-RRB- -RRB-)))))) (. .))))
(S1 (S (S (NP (NN ORF1)) (VP (VBZ consists) (PP (IN of) (NP (NP (CD 240) (NN bp)) (SBAR (WHNP (WDT that)) (S (VP (MD would) (VP (VB encode) (NP (CD 80) (NN amino) (NNS acids)))))))) (, ,) (SBAR (IN while) (S (NP (DT the) (JJ major) (NN ORF2)) (VP (VBZ consists) (PP (IN of) (NP (NP (CD 648) (NN bp)) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG coding) (PP (IN for) (NP (CD 216) (NN amino) (NNS acids))))))))))))) (. .))))
(S1 (S (S (NP (NP (VBN Predicted) (NN peptide) (NN sequence)) (PP (IN of) (NP (NN ORF2)))) (VP (VBD contained) (NP (NP (DT a) (NN zinc) (NN finger) (NN domain)) (SBAR (WHNP (WDT which)) (S (VP (VBD showed) (NP (NP (JJ significant) (NN homology)) (PP (TO to) (NP (NN GC) (NN box) (NN binding) (NNS proteins) (NP (NP (NN BTEB2)) (CC and) (NP (NN SP1))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Transfection)) (PP (IN of) (NP (NP (DT an) (NN expression) (NN vector)) (VP (VBG containing) (NP (NP (NN ORF2)) (CONJP (CC but) (RB not)) (NP (JJ full) (NN length) (NN cDNA))))))) (VP (VBD was) (ADJP (JJ able) (S (VP (TO to) (VP (VP (VB transform) (NP (NN NIH3T3) (NNS cells))) (CC and) (VP (VB induce) (NP (NNS tumors)) (PP (IN in) (NP (JJ nude) (NNS mice))))))))) (. .))))
(S1 (S (S (NP (NP (NN Bcd) (NN mRNA) (NNS transcripts)) (PP (IN of) (NP (ADJP (ADJP (JJR &lt;)) (CC or) (ADJP (JJ =))) (CD 2.6) (NN kb)))) (VP (VBD were) (VP (ADVP (RB selectively)) (VBN expressed) (PP (IN in) (NP (NP (NP (NN PBL)) (CC and) (NP (NN testis))) (PP (IN of) (NP (JJ healthy) (NNS individuals))))))) (. .))))
(S1 (S (S (PP (IN Within) (NP (DT the) (NN PBL))) (, ,) (NP (NN Bcd) (NN gene) (NN expression)) (VP (VBD was) (ADJP (ADJP (JJ restricted) (PP (TO to) (NP (JJ CD19+) (NNS B-cells)))) (CC and) (ADJP (JJ absent) (PP (IN from) (NP (NP (JJ CD14+) (NNS monocytes)) (CC and) (NP (NNS T-cells))))))) (. .))))
(S1 (S (S (NP (NN Bcd) (NNS transcripts)) (VP (VBD were) (VP (VBN detected) (PP (PP (IN in) (NP (NP (DT all) (JJ normal) (NN PBL) (NNS samples)) (VP (VBN tested)))) (CC but) (PP (RB not) (IN in) (NP (JJ several) (JJ malignant) (JJ human) (NN B-cell) (NNS lines))) (CC and) (PP (RB not) (IN in) (NP (NP (CD 50) (NN %)) (PP (IN of) (NP (NP (NNS B-cells)) (PP (IN from) (NP (NN B-CLL) (NNS patients)))))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (NN stimulation)) (PP (IN of) (NP (NP (NNS B-cells)) (PP (IN from) (NP (NN B-CLL) (NNS patients))))) (PP (IN under) (NP (NP (NNS conditions)) (SBAR (WHNP (WDT which)) (S (VP (VBD induced) (NP (NP (NN differentiation)) (PP (IN into) (NP (NN plasma) (NNS cells)))))))))) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (NN induction)) (PP (IN of) (NP (NN Bcd) (NN gene) (NN expression))))))) (. .))))
(S1 (S (S (NP (DT The) (NN Bcd) (NN gene)) (VP (MD may) (ADVP (RB therefore)) (VP (VB play) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NN B-cell) (NP (NP (NN growth)) (CC and) (NP (NN development))))))) (. .))))
(S1 (S (S (S (NP (NP (NN GATA-1)) (NN DNA) (NN binding) (NN activity)) (VP (VBZ is) (VP (VBN down-regulated) (PP (IN in) (NP (JJ late) (NN S) (NN phase))) (PP (IN in) (NP (JJ erythroid) (NNS cells))))) (. .)))))
(S1 (S (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN set) (PRT (RP out)) (S (VP (TO to) (VP (VB test) (NP (NP (NP (DT a) (NN model)) (PP (IN for) (NP (JJ tissue-specific) (NN gene) (NN expression)))) (SBAR (WHNP (WDT that)) (S (VP (VBZ relies) (PP (IN on) (NP (NP (DT the) (JJ early) (NN replication)) (PP (IN of) (NP (VBN expressed) (NNS genes))))) (S (VP (TO to) (VP (VB sequester) (NP (VBG limiting) (VBG activating) (NP (NN transcription) (NNS factors))))))))))))))) (. .)))))
(S1 (S (S (S (VP (VBG Using) (NP (DT an) (NP (JJ erythroid) (NN cell) (NN line))))) (, ,) (S (NP (PRP we)) (VP (VBP have) (VP (VBN tested) (NP (NP (DT the) (NNS changes)) (PP (IN in) (NP (NP (DT the) (NN DNA) (NN binding) (NN activity)) (PP (IN of) (NP (NP (DT the) (NP (JJ lineage-restricted) (NN transcription) (NN factor))) (NP (NN GATA-1)))))) (PP (IN through) (NP (DT the) (NN cell) (NN cycle))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP find) (SBAR (IN that) (S (NP (NP (NN GATA-1)) (NN activity)) (VP (VP (VBZ is) (ADJP (JJ low) (PP (IN in) (NP (NN G1))))) (, ,) (VP (VBZ peaks) (PP (IN in) (NP (NN mid-S) (NN phase)))) (, ,) (CC and) (ADVP (RB then)) (VP (VBZ decreases) (PP (IN in) (NP (NN G2/M)))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (DT the) (NN binding) (NNS activities)) (PP (IN of) (NP (NP (CD two) (JJ ubiquitous) (NP (NN transcription) (NNS factors))) (, ,) (NP (NP (NN Oct1)) (CC and) (NP (NN Sp1))))) (, ,)) (VP (VBP remain) (ADJP (JJ high) (PP (IN in) (NP (NN G2/M))))) (. .))))
(S1 (S (S (NP (NP (NP (NN GATA-1)) (NN protein)) (CC and) (NP (NN mRNA))) (VP (VBP vary) (PP (IN in) (NP (DT a) (JJ similar) (NN manner))) (PP (IN through) (NP (DT the) (NN cell) (NN cycle))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (DT the) (NN gene)))) (CC or) (NP (NP (DT the) (NN stability)) (PP (IN of) (NP (PRP$ its) (NN message))))) (VP (VBZ is) (VP (VBN regulated)))))))) (. .))))
(S1 (S (S (SBAR (IN Although) (S (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NP (NN transcription) (NNS factors)) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (NP (DT the) (NN cell) (NN cycle)) (CC or) (NP (NN DNA) (NN replication)))))))))) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB peak) (PP (IN in) (NP (NN S) (NN phase))))))))))) (, ,) (S (NP (DT this)) (VP (VBZ is) (NP (NP (DT the) (JJ first) (NN example)) (PP (IN of) (NP (NP (DT a) (NP (JJ lineage-restricted) (NN transcription) (NN factor))) (VP (VBG displaying) (NP (NN S) (JJ phase-specific) (NN DNA) (NN binding) (NN activity)))))))) (. .))))
(S1 (S (S (NP (NP (CD One) (NN interpretation)) (PP (IN of) (NP (DT these) (NNS data)))) (VP (VBZ leads) (PP (TO to) (NP (NP (DT a) (NN model)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (DT the) (NN peak)) (PP (IN in) (NP (NP (NN GATA-1)) (NN DNA) (NN binding)))) (VP (VBZ amplifies) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (JJ early) (NN replication))) (PP (IN on) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (JJ erythroid-specific) (NNS genes))))) (PP (IN at) (NP (NP (DT the) (JJ same) (NN time)) (PP (IN as) (NP (NP (VBG preventing) (NN activation)) (PP (IN of) (NP (NP (JJ non-erythroid) (NNS genes)) (VP (VBG containing) (NP (JJ GATA-responsive) (NNS elements)))))))))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (MD may) (ADVP (RB also)) (VP (VB relate) (PP (TO to) (NP (NP (JJ recent) (NNS data)) (VP (VBG implicating) (NP (NP (NN GATA-1)) (NN function)) (PP (IN in) (NP (NP (NN apoptosis)) (CC and) (NP (NN cell) (NN cycle) (NN progression))))))))) (. .))))
(S1 (S (NP (NP (NP (JJ Constitutive) (NP (NN dephosphorylation)) (CC and) (NP (NN activation))) (PP (IN of) (NP (NP (DT a) (NN member)) (PP (IN of) (NP (DT the) (NP (NP (JJ nuclear) (NN factor) (IN of) (VBN activated) (NN T) (NNS cells)) (, ,) (NP (NN NF-AT1))))))) (, ,) (PP (IN in) (NP (NP (JJ Tax-expressing)) (CC and) (NP (NN type) (CD I) (JJ human) (NN T-cell) (NN leukemia) (JJ virus-infected)) (NP (JJ human) (NN T) (NNS cells)))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (NN tax) (NN gene) (NN product)) (PP (IN of) (NP (NP (DT the) (NN type) (CD I) (JJ human) (NN T-cell) (NN leukemia) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN HTLV-I)) (-RRB- -RRB-))))) (VP (VBZ transactivates) (NP (NN interleukin-2) (-LRB- -LRB-) (NN IL-2) (-RRB- -RRB-) (NN gene)) (PP (IN through) (NP (NP (NN activation)) (PP (IN of) (NP (NP (DT an) (NN enhancer)) (VP (VBN termed) (S (NP (NP (NN CD28) (JJ responsive) (NN element)) (PRN (-LRB- -LRB-) (NP (NN CD28RE)) (-RRB- -RRB-)))))))))) (. .)))))
(S1 (S (S (NP (NP (NP (NN Tax)) (NN activation)) (PP (IN of) (NP (DT the) (NP (NN CD28RE))))) (VP (VBZ is) (ADVP (RB partially)) (VP (VBN mediated) (PP (IN by) (NP (NP (DT a) (NN member)) (PP (IN of) (NP (DT the) (NP (NP (JJ nuclear) (NN factor) (IN of) (VBN activated) (NN T) (NNS cells)) (, ,) (NP (NN NF-AT1))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB previously)) (VP (VBN shown) (SBAR (IN that) (S (NP (NN NF-AT1)) (VP (VBZ is) (ADJP (RB constitutively) (JJ active) (PP (IN in) (NP (NP (NN Jurkat) (NN T) (NNS cells)) (VP (ADVP (RB stably)) (VBN transfected) (PP (IN with) (NP (DT the) (NP (NN Tax) (NN cDNA)))))))) (, ,) (SBAR (IN although) (S (NP (NP (DT the) (VBG underlying) (JJ molecular) (NN mechanism)) (CC and) (NP (NP (JJ physiological) (NN relevance)) (PP (IN of) (NP (DT this) (NN finding))))) (VP (VBP remain) (ADJP (JJ unclear)))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT this) (NN report))) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (DT the) (JJ active) (NN form)) (PP (IN of) (NP (NN NF-AT1)))) (VP (VBZ is) (ADVP (RB also)) (ADJP (JJ present) (PP (IN in) (NP (NP (NP (DT the) (NNS nuclei)) (PP (IN of) (NP (JJ HTLV-I-transformed) (NN T) (NNS cells)))) (SBAR (WHNP (WDT that)) (S (VP (VBP express) (NP (DT the) (NP (NN Tax) (NN protein))))))))))))) (. .))))
(S1 (S (S (ADVP (RB Interestingly)) (, ,) (NP (NP (DT the) (JJ constitutive) (NN activation)) (PP (IN of) (NP (NP (NN NF-AT1)) (PP (IN in) (NP (DT these) (NP (NN T) (NNS cells))))))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (PRP$ its) (NN dephosphorylation))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (DT the) (VBN dephosphorylated) (NP (NN NF-AT1))) (VP (MD can) (VP (VB be) (ADVP (RB rapidly)) (VP (VBN rephosphorylated))) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NNS cells)) (VP (VBP are) (VP (VBN incubated) (PP (IN with) (NP (NP (NN cyclosporin) (NN A)) (, ,) (NP (NP (DT an) (NN immunosuppressant)) (VP (VBG inhibiting) (NP (DT the) (NP (NN serine/threonine) (NN phosphatase)) (NP (NN calcineurin)))))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NN activation)) (PP (IN of) (NP (NN NF-AT1))) (PP (IN in) (NP (NP (JJ Tax-expressing)) (CC and) (NP (JJ HTLV-I-transformed)) (NP (NN T) (NNS cells))))) (VP (VBZ results) (PP (IN from) (NP (PRP$ its) (NN dephosphorylation))) (, ,) (SBAR (WHNP (WDT which)) (S (PP (IN in) (NP (NN turn))) (VP (MD may) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (NP (NN deregulation)) (PP (IN of) (NP (NN calcineurin)))))))))))))) (. .))))
(S1 (S (NP (NP (NP (NP (NN Elf-2)) (, ,) (NP (DT a) (NP (NN rhombotin-2) (NN binding) (NN ets) (NN transcription) (NN factor))) (: :)) (NP (NP (NP (NN discovery)) (CC and) (NP (JJ potential) (NN role))) (PP (IN in) (NP (NN T) (NN cell) (NN leukemia)))) (. .)))))
(S1 (S (S (S (NP (NP (NN Rhombotin-2)) (PRN (-LRB- -LRB-) (NP (NN RBTN-2)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (NP (NN proto-oncogene))) (PP (ADVP (RB only)) (IN in) (NP (NP (DT the) (NN context)) (PP (IN of) (NP (NN T) (NNS lymphocytes))))))) (. .)))))
(S1 (S (S (NP (PRP We)) (VP (VBD postulated) (SBAR (IN that) (S (NP (NP (DT the) (JJ oncogenic) (NN effect)) (PP (IN of) (NP (NN RBTN-2))) (PP (IN in) (NP (NN T) (NNS cells)))) (VP (VBZ is) (ADVP (RB likely)) (VP (VBN mediated) (PP (IN by) (NP (NP (NP (VBG binding) (NN protein)) (-LRB- -LRB-) (NNS s) (-RRB- -RRB-)) (PP (IN with) (NP (NN T) (JJ cell-specific) (NN expression)))))))))) (. .))))
(S1 (S (S (PP (IN By) (S (VP (VBG screening) (NP (DT a) (NN T) (NN cell) (NP (NN cDNA) (NN library)))))) (, ,) (NP (PRP we)) (VP (VBD identified) (NP (NP (DT a) (NP (JJ novel) (NN ets) (NN transcription) (NN factor))) (SBAR (WHNP (WDT that)) (S (VP (VBZ binds) (NP (NN RBTN-2))))))) (. .))))
(S1 (S (S (NP (DT This) (NN protein)) (VP (VBD was) (VP (VBN named) (S (NP (NN elf-2)))) (SBAR (IN because) (S (NP (PRP$ its) (NP (JJ DNA-binding) (NN domain))) (VP (VBZ is) (ADJP (RB virtually) (JJ identical) (PP (TO to) (NP (NP (DT that)) (PP (IN of) (NP (NP (NN ets) (NN family) (NN member)) (NP (NN elf-1))))))))))) (. .))))
(S1 (S (S (NP (NN Northern) (NNS analyses)) (VP (VBD showed) (NP (NP (JJ similar) (NNS levels)) (PP (IN of) (NP (NP (CD two) (NP (NN elf-2) (NNS transcripts))) (PRN (-LRB- -LRB-) (NP (NP (CD 3.5) (NN kb)) (CC and) (NP (CD 3.8) (NN kb))) (-RRB- -RRB-))))) (PP (IN in) (NP (NP (DT all) (NNS tissues)) (PP (IN except) (NP (NN thymus)))))) (. .))))
(S1 (S (S (NP (NNS Thymocytes)) (VP (VBD expressed) (NP (NP (NP (ADJP (NP (CD four-) (TO to) (RB 10-fold)) (JJR greater)) (NNS amounts)) (PP (IN of) (NP (DT the) (NP (CD 3.5) (NN kb) (NN transcript))))) (SBAR (IN than) (S (NP (JJ other) (NNS tissues)))))) (. .))))
(S1 (S (S (NP (NP (NN Sequence) (NNS analyses)) (PP (IN of) (NP (NN cDNA) (NNS clones)))) (VP (VBD indicated) (SBAR (IN that) (S (NP (DT these) (NNS transcripts)) (VP (VP (VBP encode) (NP (NP (NNS proteins)) (VP (VBG differing) (PP (ADVP (RB only)) (IN at) (NP (PRP$ their) (NP (NN amino) (NNS termini))))))) (, ,) (CC and) (VP (ADVP (RB likely)) (VBP represent) (NP (ADJP (RB alternatively) (VBN spliced)) (NNS isoforms))))))) (. .))))
(S1 (S (S (NP (NP (DT These) (NNS isoforms)) (PRN (-LRB- -LRB-) (NP (NP (NN elf-2a)) (CC and) (NP (NN elf-2b))) (-RRB- -RRB-))) (VP (VBP contain) (NP (ADJP (JJ identical)) (NP (NN RBTN-2) (NN binding) (NNS regions)) (CC and) (NP (JJ DNA-binding) (NNS domains)))) (. .))))
(S1 (S (S (NP (NN Elf-2b)) (VP (VBZ lacks) (NP (DT a) (NP (JJ putative) (NN transactivation) (NN domain)))) (. .))))
(S1 (S (S (NP (DT The) (NN expression) (NNS patterns)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN RBTN-2)) (ADVP (RB normally)) (VP (VBZ interacts) (ADVP (RB equally)) (PP (IN with) (NP (NP (NN elf-2a)) (CC and) (NP (NN elf-2b)))))))) (. .))))
(S1 (S (S (S (PP (IN In) (NP (NN contrast))) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NN RBTN-2)) (VP (VBZ is) (ADVP (RB inappropriately)) (VP (VBN expressed) (PP (IN in) (NP (NN T) (NNS cells))))))) (, ,) (S (NP (NN RBTN-2)) (VP (MD would) (VP (VB interact) (PP (ADVP (RB predominantly)) (IN with) (NP (NN elf-2b))))))) (: ;) (S (NP (DT this) (NN interaction)) (VP (MD may) (VP (VB lead) (PP (TO to) (NP (NN T) (NN cell) (NN proliferation)))))) (. .))))
(S1 (S (NP (NP (NP (NN Isolation)) (PP (IN of) (NP (DT a) (NP (JJ B-cell-specific) (NN promoter)))) (PP (IN for) (NP (DT the) (NP (JJ human) (NN class) (CD II) (NN transactivator)))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (NP (NN class) (CD II) (NN transactivator))) (PRN (-LRB- -LRB-) (NP (NN CIITA)) (-RRB- -RRB-))) (VP (VBZ is) (ADJP (JJ essential) (PP (IN for) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (JJ major) (NN histocompatibility) (NN complex) (-LRB- -LRB-) (NN MHC) (-RRB- -RRB-) (NN class) (CD II) (NNS antigens))))))) (. .)))))
(S1 (S (S (S (NP (NP (NP (DT The) (JJ tissular) (NNS patterns)) (PP (IN of) (NP (NN CIITA)))) (CC and) (NP (NN MHC) (NN class) (CD II) (NN gene) (NN expression))) (VP (VBP are) (ADVP (RB tightly)) (VP (VBN correlated)))) (: :) (S (NP (NN CIITA) (NN mRNA)) (VP (VP (VBZ is) (ADVP (RB highly)) (VP (VBN expressed) (PP (IN in) (NP (NN B) (NNS cells))))) (, ,) (CC and) (VP (VBZ is) (VP (VBN induced) (PP (IN by) (NP (NP (NP (NN interferon) (NN gamma)) (PRN (-LRB- -LRB-) (NP (NN IFN-gamma)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NN macrophage)) (CC and) (NP (JJ epithelial)) (NP (NN cell) (NNS lines)))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (ADVP (RB first)) (VP (VBD isolated) (NP (NP (NP (CD two) (VBG overlapping) (NP (NNS cosmids))) (VP (VBG encoding) (NP (JJ human) (NN CIITA)))) (SBAR (WHNP (WDT which)) (S (, ,) (SBAR (WHADVP (WRB when)) (S (VP (VBN co-transfected)))) (, ,) (VP (VBP are) (ADJP (JJ able) (S (VP (TO to) (VP (VB restore) (NP (NP (NP (NN MHC) (NN class) (CD II)) (NN expression)) (PP (IN in) (NP (NP (DT a) (NP (NP (JJ B-lymphoblastoid) (NN cell) (NN line)) (PRN (-LRB- -LRB-) (NP (NN B-LCL)) (-RRB- -RRB-)))) (ADJP (JJ defective) (PP (IN for) (NP (NN CIITA)))))))))))))))) (. .))))
(S1 (S (S (ADVP (RB Subsequently)) (, ,) (NP (NP (DT a) (NP (CD 1.8) (NN kilobase) (-LRB- -LRB-) (NN kb) (-RRB- -RRB-) (NN fragment))) (PP (IN of) (NP (DT the) (NP (NN CIITA) (NN promoter))))) (VP (VBD was) (VP (VP (VBN isolated)) (CC and) (VP (VBN sequenced)))) (. .))))
(S1 (S (S (NP (NP (DT A) (NN motif)) (VP (VBG presenting) (NP (NP (DT a) (JJ strong) (NN similarity)) (PP (TO to) (NP (DT an) (NN initiator)))))) (VP (VBD was) (VP (VBN detected))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (JJ putative) (VBG binding) (NNS sites)) (PP (IN for) (NP (NP (NP (NP (NN Sp1))) (, ,) (NP (NP (NN GATA-2))) (, ,) (NP (NP (NN LyF-1))) (, ,) (NP (NP (NN ets-1))) (, ,) (NP (NP (NN AP1))) (, ,) (CC and) (NP (NP (NN MZF1))) (NP (NN transcription) (NNS factors))) (, ,) (CC and) (NP (CD two) (NP (NN GAS) (NNS motifs)))))) (. .))))
(S1 (S (S (SBAR (WHADVP (WRB When)) (S (VP (VBN introduced) (PP (IN in) (NP (NP (NN front)) (PP (IN of) (NP (DT a) (NP (NN luciferase) (NN reporter) (NN gene))))))))) (, ,) (S (NP (DT this) (NN promoter)) (VP (VBZ is) (ADJP (JJ able) (S (VP (TO to) (VP (VB direct) (NP (NP (DT a) (JJ high) (NP (NN luciferase)) (NN activity)) (PP (IN in) (NP (DT a) (NP (JJ human) (NN B-LCL))))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (NN luciferase)) (NN expression)) (VP (VBD was) (RB not) (VP (VBN stimulated) (PP (IN after) (NP (NP (NN IFN-gamma)) (NN treatment)))) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NN construct)) (VP (VBD was) (VP (VBN transfected) (PP (PP (IN in) (NP (NN macrophage))) (CC or) (PP (IN in) (NP (JJ epithelial) (NN cell) (NNS lines))))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (DT an) (NN induction)) (PP (IN of) (NP (DT the) (NP (JJ human) (NN CIITA) (NN gene))))) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (NP (NN mouse) (NN macrophage)) (CC and) (NP (NN fibrosarcoma)) (NP (NN cell) (NNS lines))))) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NNS cells)) (VP (VBD were) (VP (VBN transfected) (PP (IN with) (NP (NP (DT a) (NP (NN cosmid))) (VP (VP (VBG containing) (NP (DT the) (NP (JJ human) (NN CIITA) (NN gene)))) (, ,) (CC but) (VP (VBG lacking) (NP (NP (DT the) (NP (CD 1.8) (NN kb) (NN promoter))) (VP (VBN described) (ADVP (RB above))))))))))))) (. .))))
(S1 (S (S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (S (NP (DT these) (NNS data)) (VP (VBP suggest) (NP (NP (DT the) (NN existence)) (PP (IN of) (NP (NP (DT an) (JJ intragenic) (NN promoter)) (VP (VBG driving) (NP (NP (DT an) (JJ IFN-gamma-inducible) (NN expression)) (PP (IN of) (NP (NN CIITA)))))))))) (. .))))
(S1 (S (NP (NP (NP (JJ Shared) (NP (NN gamma-LRB-c-RRB-) (NN subunit))) (PP (IN within) (NP (DT the) (NP (JJ human) (NN interleukin-7) (NN receptor) (NN complex)))) (. .)))))
(S1 (S (NP (NP (DT A) (JJ molecular) (NN basis)) (PP (IN for) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP (JJ X-linked) (JJ severe) (JJ combined) (NN immunodeficiency))))) (. .))))
(S1 (S (S (S (NP (JJ Genetic) (NN evidence)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NP (NNS mutations)) (PP (IN in) (NP (DT the) (NP (NN gamma-LRB-c-RRB-) (NN receptor) (NN subunit))))) (VP (VBP cause) (NP (NP (JJ X-linked) (JJ severe) (JJ combined) (NN immunodeficiency)) (PRN (-LRB- -LRB-) (NP (NN X-SCID)) (-RRB- -RRB-))))))) (. .)))))
(S1 (S (S (S (NP (DT The) (NP (NN gamma-LRB-c-RRB-) (NN subunit))) (VP (MD can) (VP (VB be) (VP (VBN employed) (PP (IN in) (NP (NP (NN receptor) (NNS complexes)) (PP (IN for) (NP (NP (NN IL-2)) (, ,) (NP (CD -4)) (, ,) (NP (CD -7)) (, ,) (NP (CD -9)) (, ,) (CC and) (NP (CD -15)))))))))) (, ,) (CC and) (S (NP (NP (DT the) (JJ multiple) (NN signaling) (NNS defects)) (SBAR (WHNP (WDT that)) (S (VP (MD would) (VP (VB result) (PP (IN from) (NP (NP (DT a) (JJ defective) (NP (NN gamma-LRB-c-RRB-) (NN chain))) (PP (IN in) (NP (DT these) (NNS receptors)))))))))) (VP (VBP are) (VP (VBN proposed) (S (VP (TO to) (VP (VB cause) (NP (NP (DT the) (JJ severe) (NN phenotype)) (PP (IN of) (NP (NN X-SCID) (NNS patients)))))))))) (. .))))
(S1 (S (S (ADVP (RB Interestingly)) (, ,) (NP (NP (NN gene) (NN disruption)) (PP (IN of) (NP (CC either) (NP (NN IL-7)) (CC or) (NP (DT the) (NP (NN IL-7) (NN receptor) (-LRB- -LRB-) (NN IL-7R) (-RRB- -RRB-) (NN alpha) (NN subunit))))) (PP (IN in) (NP (NNS mice)))) (VP (VBZ leads) (PP (TO to) (NP (NP (JJ immunological) (NNS defects)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (JJ similar) (PP (TO to) (NP (JJ human) (NN X-SCID)))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS observations)) (VP (VBP suggest) (NP (NP (DT the) (JJ functional) (NN importance)) (PP (IN of) (NP (NN gamma-LRB-c-RRB-))) (PP (IN in) (NP (DT the) (NP (NN IL-7R) (NN complex)))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP (NP (NN structure/function) (NNS analyses)) (PP (IN of) (NP (DT the) (NP (NN IL-7R) (NN complex)))) (VP (VBG using) (NP (DT a) (NP (JJ chimeric) (NN receptor)) (NN system)))) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NN gamma-LRB-c-RRB-)) (VP (VBZ is) (ADVP (RB indeed)) (ADJP (JJ critical) (PP (IN for) (NP (NP (NN IL-7R)) (NN function)))))))) (. .))))
(S1 (S (S (ADVP (RB Nonetheless)) (, ,) (NP (NP (RB only) (DT a) (JJ limited) (NN portion)) (PP (IN of) (NP (NP (DT the) (NP (JJ cytoplasmic) (NN domain))) (PP (IN of) (NP (NN gamma-LRB-c-RRB-)))))) (VP (VBZ is) (ADJP (JJ necessary) (PP (IN for) (NP (NP (NN IL-7R)) (NN signal) (NN transduction))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (NP (NN replacement)) (PP (IN of) (NP (DT the) (NP (NN gamma-LRB-c-RRB-)) (NP (JJ cytoplasmic) (NN domain)))) (PP (IN by) (NP (DT a) (NP (RB severely) (VBN truncated) (NN erythropoeitin) (NN receptor))))) (VP (VBZ does) (RB not) (VP (VB affect) (NP (VBN measured) (NP (NN IL-7R)) (NN signaling) (NNS events)))) (. .))))
(S1 (S (S (NP (DT These) (NNS findings)) (VP (VBP support) (NP (NP (DT a) (NN model)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NN gamma-LRB-c-RRB-)) (VP (VBZ serves) (S (ADVP (RB primarily)) (VP (TO to) (VP (VB activate) (NP (NN signal) (NN transduction)) (PP (IN by) (NP (DT the) (NP (NN IL-7R) (NN complex))))))) (, ,) (SBAR (IN while) (S (NP (NN IL-7R) (NN alpha)) (VP (VBZ determines) (NP (JJ specific) (NN signaling) (NNS events)) (PP (IN through) (NP (NP (PRP$ its) (NN association)) (PP (IN with) (NP (JJ cytoplasmic) (NN signaling) (NNS molecules))))))))))))) (. .))))
(S1 (S (S (ADVP (RB Finally)) (, ,) (NP (DT these) (NNS studies)) (VP (VBP are) (ADJP (JJ consistent) (PP (IN with) (NP (DT the) (NN hypothesis) (SBAR (IN that) (S (NP (NP (DT the) (JJ molecular) (NN pathogenesis)) (PP (IN of) (NP (NN X-SCID)))) (VP (VBZ is) (ADJP (JJ due) (PP (ADVP (RB primarily)) (TO to) (NP (NP (JJ gamma-LRB-c-RRB--mediated) (NNS defects)) (PP (IN in) (NP (DT the) (NN IL-7/IL-7R) (NN system))))))))))))) (. .))))
(S1 (S (S (S (S (NP (NP (NN V3) (NN loop)) (PP (IN of) (NP (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 1)))) (VP (VBZ suppresses) (NP (NN interleukin) (JJ 2-induced) (NN T) (NN cell) (NN growth)))) (S (-LRB- -LSB-) (NP (VBN published) (NN erratum)) (VP (VBZ appears) (PP (IN in) (NP (NP (NNP AIDS) (NNP Res) (NNP Hum) (NNPS Retroviruses)) (NP (CD 1997) (NN May) (CD 1)) (: ;) (NP (CD 13) (-LRB- -LRB-) (CD 7) (-RRB- -RRB-)) (: :) (NP (CD 633))))) (-RRB- -RSB-))))))
(S1 (S (S (S (NP (PRP We)) (VP (VBD tested) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (NP (CD three) (JJ linear)) (CC or) (NP (CD two) (NN loop)) (NP (NNS peptides))) (VP (VBN derived) (PP (IN from) (NP (NP (NP (DT the) (NP (NN V3) (NN region))) (PP (IN of) (NP (DT the) (NN HTLV-III) (NN BH10) (NN clone)))) (CC or) (NP (NP (DT the) (NN SF2) (NN strain)) (PP (IN of) (NP (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 1))))))))) (PP (IN on) (NP (JJ IL-2-driven) (NN T) (NN cell) (NN proliferation))))) (. .)))))
(S1 (S (S (NP (NP (NN V3-BH10)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VP (VBZ consists) (PP (IN of) (NP (CD 42) (NN amino) (NNS acids)))) (CC and) (VP (VBZ has) (NP (DT a) (NP (NN loop) (NN structure))))))) (, ,)) (VP (VBD suppressed) (NP (NP (JJ IL-2-driven) (NN proliferation)) (PP (IN of) (NP (NP (NP (DT all) (NP (JJ IL-2-dependent) (NNS cells))) (PRN (-LRB- -LSB-) (NP (NP (NN Kit225)) (, ,) (NP (NN ED-40515-LRB-+-RRB-)) (, ,) (NP (NN KT-3)) (, ,) (NP (JJ 7-day) (NNS PHA-blasts)) (, ,) (CC and) (NP (JJ fresh) (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells))) (-RRB- -RSB-))) (VP (VBN tested))))) (, ,) (SBAR (IN whereas) (S (NP (PRP it)) (VP (VBD did) (RB not) (VP (VB suppress) (NP (NP (DT the) (NN cell) (NN growth)) (PP (IN of) (NP (NP (JJ IL-2-independent) (NN cell) (NNS lines)) (PRN (-LRB- -LRB-) (NP (NP (NN Hut102)) (, ,) (NP (NN Molt-4)) (, ,) (CC and) (NP (NN Jurkat))) (-RRB- -RRB-)))))))))) (. .))))
(S1 (S (S (NP (DT This) (JJ suppressive) (NN effect)) (VP (VBD was) (ADVP (RB also)) (VP (VBN seen) (PP (IN in) (NP (NP (JJ IL-2-driven) (NN cell) (NN growth)) (PP (IN of) (NP (NP (JJ CD8-positive) (NNS lymphocytes)) (VP (VBN purified) (PP (IN from) (NP (JJ 7-day) (NNS PHA-blasts))))))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NN CD4) (NNS molecules)) (VP (VBD were) (RB not) (VP (VBN required) (PP (IN for) (NP (DT the) (NN suppression)))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN treatment)) (PP (IN with) (NP (NP (JJ anti-V3) (NN loop) (JJ monoclonal) (NN antibody)) (PRN (-LRB- -LRB-) (NP (CD 902) (NN antibody)) (-RRB- -RRB-))))) (ADVP (RB completely)) (VP (VBD abolished) (NP (NP (DT the) (JJ suppressive) (NN effect)) (PP (IN of) (NP (NN V3-BH10))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NN V3-BH10)) (VP (VBD generated) (NP (NP (DT the) (NN arrest)) (PP (IN of) (NP (NP (NN Kit225) (NNS cells)) (CC and) (ADVP (RB also)) (NP (VBD purified) (JJ CD8-positive) (NNS lymphocytes)))) (PP (IN in) (NP (NN G1) (NN phase))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN IL-2))))))) (. .))))
(S1 (S (S (NP (CC Neither) (NP (NP (NN chromatin)) (NN condensation)) (CC nor) (NP (NN DNA) (NN fragmentation))) (VP (VBD was) (VP (VBN detected) (PP (IN in) (NP (NP (NN Kit225) (NNS cells)) (VP (VBN cultured) (PP (IN with) (NP (NP (NN V3-BH10)) (CC and) (NP (NN IL-2))))))))) (. .))))
(S1 (S (S (NP (NN V3-BH10)) (VP (CC neither) (VP (VBD blocked) (NP (NP (VBN radiolabeled) (NP (NN IL-2)) (NN binding)) (PP (TO to) (NP (NN IL-2) (NNS receptors))))) (CC nor) (VP (VBD affected) (NP (NP (NP (NN tyrosyl) (NN phosphorylation)) (PP (IN of) (NP (NP (JJ several) (NP (JJ cellular) (NNS proteins))) (PRN (-LRB- -LRB-) (NP (NP (NN p120)) (, ,) (NP (NN p98)) (, ,) (NP (NN p96)) (, ,) (NP (NN p54)) (, ,) (CC and) (NP (NN p38))) (-RRB- -RRB-))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADVP (RB immediately)) (VP (VBN induced) (PP (IN by) (NP (NP (NN IL-2)) (NN stimulation)))))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NN V3-BH10)) (VP (VBD enhanced) (NP (NP (JJ IL-2-induced) (NN mRNA) (NN expression)) (PP (IN of) (NP (NP (NN c-fos)) (CONJP (CC but) (RB not)) (NP (NP (NN c-myc)) (CC or) (NP (NN junB))))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NP (NN V3) (NN loop)) (PP (IN of) (NP (NN gp120))))) (PP (TO to) (NP (DT the) (NN cell) (NN surface) (NN molecule) (-LRB- -LRB-) (NNS s) (-RRB- -RRB-)))) (VP (VBZ appears) (S (VP (TO to) (VP (VB affect) (NP (NP (JJ intracellular) (NP (NN IL-2)) (NN signaling)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ leads) (PP (TO to) (NP (NP (DT the) (NN suppression)) (PP (IN of) (NP (JJ IL-2-induced) (NN T) (NN cell) (NN growth))))))))))))) (. .))))
(S1 (S (S (S (NP (NP (NP (JJ Nuclear) (NN factor-kappaB)) (NN activation)) (PP (IN in) (NP (NP (JJ human) (NNS monocytes)) (VP (VBN stimulated) (PP (IN with) (NP (NN lipopolysaccharide))))))) (VP (VBZ is) (VP (VBN inhibited) (PP (IN by) (NP (NP (NN fibroblast) (JJ conditioned) (NN medium)) (CC and) (NP (JJ exogenous) (NN PGE2)))))) (. .)))))
(S1 (S (S (S (NP (DT The) (NP (NP (JJ nuclear) (NN factor) (NN kappaB)) (PRN (-LRB- -LRB-) (NP (NN NF-kappaB)) (-RRB- -RRB-)))) (VP (VBZ is) (VP (VBN thought) (S (VP (TO to) (VP (VB be) (ADVP (RB crucially)) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN gene) (NN activation)) (PP (IN of) (NP (NP (JJ several) (NP (NNS cytokines))) (, ,) (PP (VBG including) (NP (NP (NN tumor) (NN necrosis) (NN factor) (NN alpha)) (PRN (-LRB- -LRB-) (NP (NN TNF)) (-RRB- -RRB-)))))))))))))) (. .)))))
(S1 (S (S (ADVP (RB Previously)) (, ,) (NP (PRP we)) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (NN fibroblast) (JJ conditioned) (NN medium)) (PRN (-LRB- -LRB-) (NP (NN FCM)) (-RRB- -RRB-))) (VP (VBZ is) (ADJP (JJ able) (S (VP (TO to) (VP (VB inhibit) (NP (NP (CC both) (NP (NP (NN TNF) (NN mRNA)) (NN accumulation)) (CC and) (NP (NN protein) (NN release))) (PP (IN in) (NP (NP (NP (JJ peripheral) (JJ blood-derived) (JJ human) (NNS monocytes)) (PRN (-LRB- -LRB-) (NP (NNS PBM)) (-RRB- -RRB-))) (VP (VBN stimulated) (PP (IN with) (NP (NP (NN lipopolysaccharide)) (PRN (-LRB- -LRB-) (NP (NN LPS)) (-RRB- -RRB-)))))))))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT this) (NN study))) (NP (PRP we)) (VP (VBP have) (VP (VBN investigated) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN FCM))) (PP (IN on) (NP (NP (DT the) (JJ LPS-induced) (NN DNA-binding) (NN activity)) (PP (IN of) (NP (NN NF-kappaB)))))) (, ,) (PP (IN by) (NP (NP (NNS means)) (PP (IN of) (NP (NP (JJ electrophoretic) (NN shift) (NN assay)) (PRN (-LRB- -LRB-) (NP (NN EMSA)) (-RRB- -RRB-)))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP provide) (NP (NN evidence) (SBAR (IN that) (S (NP (NN FCM)) (ADVP (RB strongly)) (VP (VBZ inhibits) (NP (NP (DT the) (JJ LPS-induced) (NP (NN NF-kappaB)) (NN activation)) (PP (IN in) (NP (NNS PBM))))))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (JJ exogenous) (NN PGE2)) (VP (VBZ mimics) (NP (NP (DT the) (NP (NN NF-kappaB)) (JJ inhibitory) (NN effect)) (PP (IN of) (NP (NN FCM)))))))) (. .))))
(S1 (S (S (PP (IN On) (NP (DT the) (JJ other) (NN hand))) (, ,) (NP (NP (NN FCM)) (VP (VBN produced) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN indomethacin))))))) (VP (VBZ does) (RB not) (VP (VB inhibit) (NP (NP (NP (NN NF-kappaB)) (NN activation)) (PP (IN by) (NP (NN LPS)))))) (. .))))
(S1 (S (S (NP (PRP$ Our) (NNS results)) (VP (VBP lend) (NP (JJ further) (NN support)) (PP (TO to) (NP (DT the) (NN hypothesis) (SBAR (IN that) (S (NP (NP (NP (ADJP (JJ inflammatory))) (CC and) (NP (ADJP (JJ immune))) (NP (NNS responses))) (PP (IN of) (NP (NNS monocytes/macrophages)))) (VP (MD may) (VP (VB be) (VP (VBN modulated) (PP (IN at) (NP (DT the) (JJ molecular) (NN level))) (PP (IN by) (NP (NP (NNS signals)) (VP (VBG originating) (PP (IN from) (NP (NP (NN tissue) (JJ structural) (NNS cells)) (PP (JJ such) (IN as) (NP (NNS fibroblasts)))))))))))))))) (. .))))
(S1 (S (NP (NP (NP (JJ Differential) (NN interaction)) (PP (IN of) (NP (JJ nuclear) (NNS factors))) (PP (IN with) (NP (NP (DT the) (NP (NN PRE-I) (NN enhancer) (NN element))) (PP (IN of) (NP (NP (DT the) (NP (JJ human) (NN IL-4) (NN promoter))) (PP (IN in) (NP (JJ different) (NP (NN T) (NN cell) (NNS subsets)))))))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (JJ immunomodulatory) (NP (NN cytokine))) (NP (NN IL-4))) (VP (VBZ affects) (NP (NP (NNS cells)) (PP (IN of) (NP (JJS most) (NP (JJ hemopoietic) (NNS lineages)))))) (. .)))))
(S1 (S (S (NP (NN IL-4)) (VP (VP (VBZ is) (VP (VBN secreted) (PP (IN by) (NP (VBN activated) (NP (NP (NN Th2))) (CC but) (RB not) (NP (NN Th1) (NNS cells)))))) (CC and) (VP (VBZ plays) (NP (DT a) (JJ major) (NN role)) (PP (IN in) (NP (DT the) (JJ immune) (NN response))) (PP (IN by) (S (VP (VBG modulating) (NP (NP (DT the) (NN differentiation)) (PP (IN of) (NP (JJ naive) (NN Th) (NNS cells))) (PP (IN toward) (NP (DT the) (NP (NN Th2) (NN phenotype)))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB previously)) (VP (VBN identified) (NP (NP (NP (DT an) (NP (NN enhancer) (NN element))) (, ,) (NP (NN PRE-I))) (, ,) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADJP (JJ essential) (PP (IN for) (NP (NP (DT the) (NN function)) (PP (IN of) (NP (DT the) (NP (JJ human) (NN IL-4) (NN promoter))))))))))))) (. .))))
(S1 (S (S (S (VP (TO To) (VP (VB investigate) (NP (NP (DT the) (NNS mechanisms)) (ADJP (JJ responsible) (PP (IN for) (NP (NP (JJ tissue-specific) (NN expression)) (PP (IN of) (NP (DT the) (NP (NN IL-4)) (NN gene)))))))))) (, ,) (S (NP (PRP we)) (VP (VP (VBD analyzed) (NP (NP (JJ nuclear) (NNS factors)) (VP (VBG binding) (PP (TO to) (NP (DT the) (NP (NN PRE-I) (NN site))))))) (CC and) (VP (VBD compared) (NP (NP (DT the) (NN binding) (NNS activities)) (PP (IN of) (NP (DT these) (NNS factors)))) (PP (TO to) (NP (NP (DT the) (NP (NN IL-4)) (NN promoter)) (PP (IN of) (NP (NP (NN Th1)) (CC and) (NP (NN Th2)) (NP (NNS cells))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP show) (SBAR (IN that) (S (NP (NN PRE-I)) (VP (VBZ interacts) (PP (IN with) (NP (ADJP (ADJP (ADJP (NN PMA-)) (CC and) (ADJP (JJ PMA/ionomycin-inducible))) (, ,) (ADJP (NN cyclosporin) (JJ A-sensitive))) (NP (JJ nuclear) (NNS factors)))))))) (. .))))
(S1 (S (S (S (VP (VBG Using) (NP (NP (NP (JJ anti-C/EBPbeta)) (PRN (-LRB- -LRB-) (NP (NN NF-IL6)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ anti-C/EBPdelta)) (PRN (-LRB- -LRB-) (NP (NN NF-IL6beta)) (-RRB- -RRB-))) (, ,) (NP (JJ anti-NF-ATc)) (, ,) (NP (JJ anti-NF-ATp)) (, ,) (NP (NP (JJ anti-Fos))) (, ,) (CC and) (NP (JJ anti-Jun) (NNS Abs))))) (S (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (DT the) (ADJP (RB previously) (VBN identified)) (NP (NN PRE-I) (NN binding) (NN factor))) (NP (NN POS-1))) (VP (VBZ is) (VP (VBN composed) (PP (IN of) (NP (NP (JJ different) (NP (NN transcription) (NNS factors))) (PP (IN in) (NP (JJ different) (NN Th) (NN cell) (NNS subsets))))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT the) (NP (NP (JJ IL-4-producing) (JJ Th0-like) (JJ human) (NN Jurkat))) (CC and) (NP (NN mouse) (NN EL-4) (NNS cells)))) (, ,) (NP (NP (NN POS-1)) (PRN (-LRB- -LRB-) (VP (VBN designated) (S (NP (NN POS-1a)))) (-RRB- -RRB-))) (VP (VBZ contains) (NP (NP (NN NF-IL6beta)) (CC and) (NP (NN Jun)))) (. .))))
(S1 (S (S (PP (PP (IN In) (NP (DT the) (NP (NN mouse) (NN Th2) (NN D10) (NNS cells)))) (CC and) (PP (IN in) (NP (DT the) (NP (JJ human) (NN Th2) (NNS clones))))) (, ,) (NP (NP (NN POS-1)) (PRN (-LRB- -LRB-) (VP (VBN designated) (S (NP (NN POS-1b)))) (-RRB- -RRB-))) (VP (VBZ contains) (NP (NP (NN NF-IL6beta)) (, ,) (NP (NN Jun)) (, ,) (CC and) (NP (NN NF-ATc/p)))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NN POS-1)) (VP (VBD was) (RB not) (VP (VBN found) (PP (IN in) (NP (NP (JJ nuclear) (NNS extracts)) (PP (IN of) (NP (JJ human) (NN Th1) (NNS clones))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS findings)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN PRE-I)) (VP (MD may) (VP (VB play) (NP (DT a) (NN role)) (PP (IN in) (NP (NP (DT the) (JJ differential) (NN regulation)) (PP (IN of) (NP (NP (NN IL-4) (NN gene)) (NN expression) (NNS levels)))))))))) (. .))))
(S1 (S (NP (NP (NP (JJ Inhibitory) (NN effect)) (PP (IN of) (NP (NN growth) (NN hormone))) (PP (IN on) (NP (NP (NP (NP (NN TNF-alpha)) (NN secretion)) (CC and) (NP (NP (JJ nuclear) (NN factor-kappaB)) (NN translocation))) (PP (IN in) (NP (JJ lipopolysaccharide-stimulated) (JJ human) (NNS monocytes))))) (. .)))))
(S1 (S (S (S (NP (JJ Several) (NNS studies)) (VP (VBP have) (VP (VBN pointed) (PP (TO to) (NP (NP (DT a) (NN link)) (PP (IN between) (NP (NP (NP (ADJP (JJ immune))) (CC and) (NP (ADJP (JJ endocrine))) (NP (NNS systems))) (, ,) (PP (VBG including) (NP (NP (DT a) (JJ regulatory) (NN function)) (PP (IN of) (NP (NN GH))) (PP (IN on) (NP (NN monocyte) (NN activation))))))))))) (. .)))))
(S1 (S (S (NP (DT The) (JJ present) (NN study)) (VP (VBZ demonstrates) (SBAR (IN that) (S (NP (NP (JJ human) (NP (NN THP-1) (JJ promonocytic) (NNS cells))) (, ,) (VP (VBN engineered) (PP (IN by) (NP (NN gene) (NN transfer))) (S (VP (TO to) (ADVP (RB constitutively)) (VP (VB produce) (NP (NP (JJ human) (NN growth) (NN hormone)) (PRN (-LRB- -LRB-) (NP (NN hGH)) (-RRB- -RRB-))))))) (, ,)) (VP (VBD secreted) (NP (NP (VBN depressed) (NNS amounts)) (PP (IN of) (NP (NN TNF-alpha)))) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NP (NN challenge)) (PP (IN by) (NP (NN LPS))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NN GH)))) (VP (VBZ appears) (S (VP (TO to) (VP (VB occur) (PP (IN in) (NP (DT an) (JJ autocrine) (NN fashion)))))) (, ,) (SBAR (IN since) (S (NP (NP (DT the) (JJ inhibitory) (NN effect)) (PP (IN on) (NP (NP (NP (NN TNF-alpha)) (NN secretion)) (PP (IN by) (NP (JJ constitutive) (NN GH) (NN production)))))) (VP (MD could) (VP (VB be) (VP (VBN abolished) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ anti-hGH) (NN mAb))))))))))) (. .))))
(S1 (S (S (NP (DT The) (ADJP (ADJP (JJ GH-induced)) (ADJP (JJ inhibitory))) (NN effect)) (VP (VBD was) (ADVP (RB also)) (VP (VBN observed)) (S (VP (VBG using) (NP (NP (JJ normal) (JJ human) (NNS monocytes)) (CC and) (NP (JJ monocyte-derived) (NNS macrophages)))))) (. .))))
(S1 (S (S (NP (NP (NN Inhibition)) (PP (IN of) (NP (NP (NP (NN TNF-alpha)) (NN production)) (PP (IN by) (NP (NP (JJ THP-1-hGH-transfected) (NNS cells)) (VP (VBN cultured) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN LPS))))))))))) (VP (VBZ is) (ADJP (JJ dependent) (PP (IN on) (NP (DT a) (JJ selective) (NN pathway)))) (, ,) (SBAR (IN since) (S (NP (NP (DT no) (NN inhibition)) (PP (IN of) (NP (NP (NN TNF-alpha)) (NN production)))) (VP (VBD was) (VP (VBN observed)) (SBAR (WHADVP (WRB when)) (S (NP (NNS cells)) (VP (VBD were) (VP (VBN cultured) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN PMA))))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Inhibition)) (PP (IN of) (NP (NP (NP (NN TNF-alpha)) (NN secretion)) (PP (IN by) (NP (JJ LPS-stimulated) (NN THP-1-hGH) (NNS cells)))))) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NP (JJ nuclear) (NN translocation)) (PP (IN of) (NP (JJ nuclear) (NN factor-kappaB))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN capacity)) (PP (IN of) (NP (NN GH))) (S (VP (TO to) (VP (VB inhibit) (NP (NP (JJ LPS-induced) (NP (NN TNF-alpha)) (NN production)) (PP (IN by) (NP (NNS monocytes)))) (PP (IN without) (S (VP (VBG altering) (NP (NP (JJ other) (NNS pathways)) (VP (VBG leading) (PP (TO to) (NP (NP (NN TNF-alpha)) (NN production)))))))))))) (VP (MD may) (VP (VB be) (PP (IN of) (NP (NP (JJ potential) (NN relevance)) (PP (IN in) (NP (JJ septic) (NN shock)))))) (, ,) (SBAR (IN since) (S (NP (NN GH)) (VP (VBZ is) (ADJP (JJ available) (PP (IN for) (NP (JJ clinical) (NN use)))))))) (. .))))
(S1 (S (NP (NP (NP (NP (JJ Impaired) (NN induction)) (PP (PP (IN of) (NP (NN c-fos/c-jun) (NNS genes))) (CC and) (PP (IN of) (NP (NP (JJ transcriptional) (JJ regulatory) (NNS proteins)) (VP (VBG binding) (NP (JJ distinct) (NP (NN c-fos/c-jun) (NN promoter) (NNS elements)))))))) (PP (IN in) (NP (VBN activated) (JJ human) (NN T) (NNS cells))) (PP (IN during) (NP (NN aging))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (NN activation)) (PP (IN of) (NP (NP (JJ transcriptional) (NN factor)) (NP (NN c-Fos/c-Jun) (NP (NN AP-1)))))) (VP (VP (VBZ is) (ADJP (JJ essential) (PP (IN for) (NP (JJ normal) (NP (NN T) (NN cell)) (NN responsiveness))))) (CC and) (VP (VBZ is) (ADVP (RB often)) (ADJP (JJ impaired) (PP (IN in) (NP (NN T) (NNS cells))) (PP (IN during) (NP (NN aging)))))) (. .)))))
(S1 (S (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP (PRP we)) (VP (VBD investigated) (SBAR (IN whether) (S (NP (NP (NNS aberrancies)) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NN c-fos/c-jun))))) (PP (IN at) (NP (DT the) (NP (NN mRNA)) (CC or) (NP (NN protein)) (NP (NN level))))) (VP (MD might) (VP (VB underlie) (NP (NP (DT the) (JJ age-associated) (NNS impairments)) (PP (IN of) (NP (NN AP-1))) (PP (IN in) (NP (JJ human) (NN T) (NNS cells))))))))) (. .))))
(S1 (S (S (SBAR (IN Whereas) (S (NP (NP (NN T) (NNS cells)) (PP (IN from) (NP (JJ young) (NNS subjects))) (VP (VBN stimulated) (PP (PP (IN with) (NP (NP (NP (JJ cross-linked) (JJ anti-CD3epsilon) (NN mAb)) (NP (NN OKT3))) (CC plus) (NP (NN PMA)))) (CC or) (PP (IN with) (NP (NP (NP (DT the) (NP (NN lectin))) (NP (NN PHA))) (CC plus) (NP (NN PMA))))))) (VP (VBD demonstrated) (NP (NP (JJ considerable) (NNS increases)) (PP (IN in) (NP (NP (NN c-Fos)) (NN protein) (NN expression))))))) (, ,) (S (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (NN c-Fos)) (CONJP (CC but) (RB not)) (NP (NN c-Jun))))) (VP (VBD was) (ADVP (RB markedly)) (VP (VBN reduced) (PP (IN in) (NP (NP (VBN stimulated) (NP (NN T) (NNS cells))) (PP (IN from) (NP (JJ certain) (JJ elderly) (NNS subjects)))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NN RNase)) (NN protection) (NNS assays)) (VP (VBD revealed) (SBAR (IN that) (S (NP (NP (JJ anti-CD3/PMA-stimulated) (NN T) (NNS cells)) (PP (IN from) (NP (NP (DT a) (JJ substantial) (NN proportion)) (PP (IN of) (NP (JJ elderly) (NNS subjects)))))) (VP (VBD exhibited) (NP (NP (JJ decreased) (NNS levels)) (PP (IN of) (NP (NP (NN c-fos)) (CC and/or) (NP (NN c-jun)) (NP (NN mRNA))))) (PP (VBN compared) (PP (TO to) (NP (NP (NN T) (NNS cells)) (PP (IN from) (NP (JJ young) (NNS subjects)))))))))) (. .))))
(S1 (S (S (S (VP (VBG Using) (NP (JJ electrophoretic) (NN mobility) (NN shift) (NNS assays)))) (, ,) (S (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NP (JJ nuclear) (JJ regulatory) (NNS proteins)) (VP (VBG recognizing) (NP (NP (DT the) (NP (NN AP-1) (NN consensus) (NN TRE) (NN motif))) (, ,) (NP (DT the) (NP (JJ proximal) (NN c-jun) (JJ TRE-like) (NN promoter) (NN element))) (, ,) (CC and) (NP (NP (DT the) (NP (NN c-fos) (NN serum) (NN response) (NN element))) (PRN (-LRB- -LRB-) (NP (NN SRE)) (-RRB- -RRB-)))))))) (VP (VBD were) (VP (VBN determined) (PP (IN in) (NP (NP (VBG resting)) (CC and) (NP (VBN stimulated)) (NP (NN T) (NNS cells))))))) (. .))))
(S1 (S (S (SBAR (IN Although) (NP (NP (DT the) (NN stimulation)) (PP (IN of) (NP (NP (NN T) (NNS cells)) (PP (IN from) (NP (JJ young) (NNS subjects)))))) (VP (VBD resulted) (PP (IN in) (NP (NP (VBN coordinated) (NNS increases)) (PP (IN of) (NP (NP (JJ nuclear) (NN protein) (NNS complexes)) (VP (VBG binding) (NP (DT the) (NP (NP (NN AP-1) (NN TRE))) (, ,) (NP (NP (NN c-jun) (NN TRE))) (, ,) (CC and) (NP (NN c-fos) (NN SRE) (NN DNA) (NN sequence) (NNS motifs)))))))))) (, ,) (S (NP (NP (JJ age-related) (NNS reductions)) (PP (IN in) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN AP-1)))))) (VP (VBD were) (VP (VBN accompanied) (PP (IN by) (NP (NP (VBN decreased) (NNS levels)) (PP (IN of) (NP (NP (NN c-jun) (NN TRE)) (CC and) (NP (NN c-fos) (NN SRE)) (NP (NN binding) (NNS complexes))))))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (NP (DT the) (NP (JJ nuclear) (NN protein) (NNS complexes))) (VP (VBG binding) (NP (NP (DT the) (NP (NN SRE) (NN motif))) (VP (VBN induced) (PP (IN in) (NP (NP (VBN activated) (NN T) (NNS cells)) (PP (IN of) (NP (NP (ADJP (JJ young))) (CC and) (NP (ADJP (JJ elderly))) (NP (NNS subjects)))))))))) (VP (VBD contained) (NP (NP (NP (NN serum) (NN response) (NN factor)) (CC and) (NP (NN Elk-1))) (VP (VBG pointing) (PP (IN toward) (NP (NP (JJ age-related) (NNS defects)) (PP (IN in) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NP (JJ transcriptional) (JJ regulatory) (NNS proteins)) (ADJP (JJ distinct) (PP (IN from) (NP (NN c-jun/AP-1))))))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (VBG underlying) (NNS aberrancies)) (PP (IN in) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NP (NN c-fos/c-jun)) (CONJP (RB as) (RB well) (IN as)) (NP (PRP$ their) (NP (JJ nuclear) (JJ regulatory) (NNS proteins)))))))) (VP (MD may) (VP (VB contribute) (PP (TO to) (NP (NP (DT the) (JJ age-related) (NNS impairments)) (PP (IN of) (NP (NP (NP (NN AP-1)) (NN activation)) (PP (IN in) (NP (JJ human) (NN T) (NNS cells)))))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Dissociation)) (PP (IN of) (NP (DT the) (NP (NN Jak) (NN kinase)) (NN pathway))) (PP (IN from) (NP (NP (NP (NN G-CSF) (NN receptor)) (NN signaling)) (PP (IN in) (NP (NNS neutrophils))))) (. .)))))
(S1 (S (S (S (NP (NP (NN Activation)) (PP (IN of) (NP (DT the) (NP (NP (NN granulocyte) (JJ colony-stimulating) (NN factor) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN G-CSFR)) (-RRB- -RRB-)))))) (VP (VBZ induces) (NP (NP (JJ rapid) (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (JJ multiple) (NP (JJ intracellular) (NNS substrates))))) (PP (IN in) (NP (NP (VBG proliferating) (NNS cells)) (CC and) (NP (JJ nonproliferating) (, ,) (RB terminally) (VBN differentiated) (NNS neutrophils))))) (. .)))))
(S1 (S (S (NP (NP (DT The) (NNS kinases)) (SBAR (WHNP (WDT that)) (S (VP (VBP couple) (NP (NN ligand) (VBG binding)) (PP (TO to) (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (JJ cellular) (NNS substrates))) (PP (IN by) (NP (DT the) (NN G-CSFR))))) (PP (IN with) (NP (NP (NN activation)) (PP (IN of) (NP (ADJP (ADJP (JJ specific)) (ADJP (JJ functional))) (NNS programs))))))))) (VP (VBP are) (ADJP (RB largely) (JJ unknown))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBD examined) (NP (NP (JJ early) (NN signaling) (NNS events)) (PP (IN in) (NP (NP (NP (VBG proliferating))) (CC and) (NP (RB terminally) (VBN differentiated) (NNS cells)))) (PP (VBG following) (NP (NP (NN G-CSF)) (NN stimulation)))) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (JJ identical) (NN signaling) (NNS cascades)) (VP (VBP are) (VP (VBN activated))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (JJ murine) (NN Ba/F3) (NNS cells)) (VP (VBN transfected) (PP (IN with) (NP (NP (NP (DT the) (NP (JJ human) (NN G-CSFR))) (CC and) (NP (NN NFS-60) (NNS cells))) (VP (ADVP (RB constitutively)) (VBG expressing) (NP (DT the) (NP (JJ murine) (NN G-CSFR))))))))) (, ,) (NP (NN G-CSF)) (VP (VBD induced) (NP (NP (NP (NN tyrosine) (NN phosphorylation)) (CC and) (NP (NN activation))) (PP (IN of) (NP (NP (NN Jak1)) (, ,) (NP (NN Jak2)) (, ,) (CC and) (NP (NN Tyk2)))))) (. .))))
(S1 (S (S (NP (NP (NN Tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NP (NN Stat3)) (CC and) (, ,) (PP (TO to) (NP (DT a) (JJR lesser) (NN extent))) (, ,) (NP (NN Stat1))))) (VP (VBD was) (ADVP (RB also)) (VP (VBN detected) (PP (VBG following) (NP (NP (NN G-CSF)) (NN stimulation))))) (. .))))
(S1 (S (S (S (VP (VBG Using) (NP (NP (DT a) (NP (RB mitogenically) (JJ incompetent) (JJ human) (NN G-CSFR) (NN mutant))) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (NN Pro639)) (CC and) (NP (NN Pro641))) (VP (VBD were) (VP (VBN substituted) (PP (IN by) (NP (NN alanine)))))))))) (, ,) (S (NP (DT the) (NP (NN box) (CD 1) (NN PDP) (NN motif))) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB be) (VP (VBN required) (PP (IN for) (NP (NP (NP (NN activation)) (PP (IN of) (NP (NN Jak) (NNS kinases)))) (, ,) (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (DT the) (NP (NN G-CSFR))))) (, ,) (CC and) (NP (NP (NN recruitment)) (PP (IN of) (NP (NN Stat) (NNS proteins))))))))))))) (. .))))
(S1 (S (S (ADVP (RB Notably)) (, ,) (NP (NP (DT no) (NN activation)) (PP (IN of) (NP (NP (NN Jak1)) (, ,) (NP (NN Jak2)) (, ,) (NP (NN Tyk2)) (, ,) (NP (NN Stat1)) (, ,) (CC or) (NP (NN Stat3))))) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (NNS neutrophils))) (PP (VBG following) (NP (NP (NN G-CSF)) (NN stimulation))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (JJ detectable) (NN activation)) (PP (IN in) (NP (NNS neutrophils))) (PP (IN of) (NP (NP (DT the) (ADJP (RB recently) (VBN cloned)) (NP (NN Jak3) (NN kinase))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB be) (VP (VBN expressed) (PP (IN at) (NP (JJ high) (NNS levels))))))))) (SBAR (IN as) (S (NP (JJ myeloid) (NNS cells)) (VP (VBP undergo) (NP (ADJP (ADJP (JJ terminal)) (ADJP (JJ neutrophilic))) (NN maturation)))))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VP (VBP indicate) (NP (NP (DT a) (NN lack)) (PP (IN of) (NP (NP (NN involvement)) (PP (IN of) (NP (NN Jak) (NNS kinases))) (PP (IN in) (NP (NP (NN signaling)) (PP (IN by) (NP (DT the) (NP (NN G-CSFR)))) (PP (IN in) (NP (NNS neutrophils))))))))) (, ,) (CC and) (VP (VBP suggest) (NP (NP (NN utilization)) (PP (IN of) (NP (NP (JJ alternative) (NN signal) (NN transduction) (NNS pathways)) (ADJP (JJ distinct) (PP (IN from) (NP (NP (DT those)) (PP (IN in) (NP (VBG proliferating) (NNS cells))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Activation)) (PP (IN of) (NP (DT the) (JJ Jak-Stat) (NN pathway)))) (VP (VP (VBZ correlates) (PP (IN with) (NP (NP (JJ proliferative) (NN signaling)) (PP (IN by) (NP (DT the) (NP (NN G-CSFR))))))) (CC and) (VP (VBZ requires) (NP (NP (DT the) (NP (JJ membrane-proximal) (NN box) (CD 1) (NN PXP) (NN motif))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN conserved) (PP (IN in) (NP (NP (NNS members)) (PP (IN of) (NP (DT the) (NP (NN cytokine) (NN receptor) (NN superfamily))))))))))))) (. .))))
(S1 (S (S (S (NP (NN Adenovirus) (NN E1B) (NN 19K) (NN protein)) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (JJ efficient) (NN DNA) (NN replication)) (PP (IN in) (NP (NN U937) (NNS cells))))))) (. .)))))
(S1 (S (S (S (NP (DT The) (NP (NN adenovirus) (NN E1B) (NN 19K) (NN gene))) (VP (VBZ plays) (NP (DT an) (JJ essential) (NN role)) (PP (PP (IN in) (NP (NP (NN transformation)) (PP (IN of) (NP (JJ primary) (JJ rodent) (NNS cells))) (PP (IN in) (NP (NP (NN cooperation)) (PP (IN with) (NP (NN E1A))))))) (CC and) (PP (IN in) (NP (NP (DT the) (NN inhibition)) (PP (IN of) (NP (NN apoptosis))) (PP (IN during) (NP (JJ lytic) (NN infection))))))) (. .)))))
(S1 (S (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (SBAR (IN that) (S (NP (DT this) (NP (NN E1B) (NN 19K) (NN protein))) (VP (VBZ is) (RB not) (ADJP (JJ necessary) (PP (IN for) (NP (NP (JJ viral) (NN DNA) (NN replication)) (PP (IN in) (NP (NP (JJ human) (NN cell) (NNS lines)) (, ,) (PP (JJ such) (IN as) (NP (NP (NN HeLa)) (CC and) (NP (NN KB))))))))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBD reported) (ADVP (RB here)) (SBAR (IN that) (S (NP (DT the) (NP (NN E1B) (NN 19K)) (JJ mutant) (NNS viruses)) (VP (VBD were) (ADJP (JJ unable) (S (VP (TO to) (VP (VB replicate) (ADVP (RB efficiently)) (PP (IN in) (NP (NP (DT a) (NP (NN monocyte) (NN cell) (NN line))) (, ,) (NP (NN U937)))))))))))) (. .))))
(S1 (S (S (NP (NP (JJ Viral) (NN DNA) (NN synthesis)) (CC and) (NP (JJ late) (NN gene) (NN expression))) (VP (VBD were) (VP (VBN found) (S (VP (TO to) (VP (VB be) (ADJP (JJ defective) (PP (IN in) (NP (NP (NN U937) (NNS cells)) (VP (VBN infected) (PP (IN with) (NP (NP (NN E1B) (NN 19K)) (NNS mutants)))))) (PP (VBN compared) (PP (IN with) (NP (JJ wild-type) (NN virus)))))))))) (. .))))
(S1 (S (S (NP (ADJP (ADJP (RB Early)) (ADJP (JJ viral))) (NN RNA) (NN splicing) (NNS patterns)) (ADVP (RB also)) (VP (VBP differ) (PP (IN between) (NP (NP (ADJP (JJ wild-type))) (CC and) (NP (ADJP (JJ dl337-infected))) (NP (NNS cells))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (NP (DT the) (NN defect)) (PP (IN in) (NP (JJ viral) (NN replication)))) (VP (MD could) (VP (VB be) (VP (VBN complemented) (PP (IN by) (NP (NP (NN dl312) (NN virus)) (ADJP (JJ defective) (PP (IN in) (NP (NP (NN E1A)) (NN expression)))))) (PP (NP (CD 4) (NNS days)) (IN after) (NP (NP (NN infection)) (PP (IN with) (NP (NN E1B) (NNS mutants))))))) (, ,) (S (VP (VBG suggesting) (NP (NP (NN persistence)) (PP (IN of) (NP (NP (DT the) (NP (NN E1B) (JJ mutant) (NN genome))) (PP (IN in) (NP (DT the) (JJ infected) (NNS cells))))) (PP (IN despite) (NP (NP (JJ defective) (NN onset)) (PP (IN of) (NP (NP (DT the) (JJ late) (NN phase)) (PP (IN of) (NP (NN replication))))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP imply) (SBAR (IN that) (S (NP (NN E1B) (NN 19K)) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (ADJP (ADJP (JJ efficient)) (ADJP (JJ viral))) (NN DNA) (NN replication)) (PP (IN in) (NP (NN U937) (NNS cells)))))))))) (. .))))
(S1 (S (S (NP (JJ Inefficient) (NN DNA) (NN replication)) (VP (VBZ is) (ADVP (RB also)) (VP (VBN found) (PP (IN in) (NP (DT another) (NP (NP (NN monocyte) (NN cell) (NN line)) (, ,) (NP (NN THP-1))))))) (. .))))
(S1 (S (NP (NP (NP (NN Interaction)) (PP (IN of) (NP (NP (NN transcription) (NNS factors)) (NP (NP (NN RFX1)) (CC and) (NP (NN MIBP1))))) (PP (IN with) (NP (NP (DT the) (NP (NN gamma) (NN motif))) (PP (IN of) (NP (NP (DT the) (NP (JJ negative) (JJ regulatory) (NN element))) (PP (IN of) (NP (DT the) (NP (NN hepatitis) (NN B) (NN virus) (NN core) (NN promoter)))))))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (NP (NP (JJ negative) (JJ regulatory) (NN element)) (PRN (-LRB- -LRB-) (NP (NN NRE)) (-RRB- -RRB-)))) (PP (IN of) (NP (DT the) (NP (NN hepatitis) (NN B) (NN virus) (-LRB- -LRB-) (NN HBV) (-RRB- -RRB-) (NN core) (NN promoter))))) (VP (VBZ contains) (NP (NP (CD three) (NNS subregions)) (SBAR (WHNP (WDT which)) (S (VP (VBP act) (ADVP (RB synergistically)) (S (VP (TO to) (VP (VB suppress) (NP (NN core) (NN promoter) (NN activity)))))))))) (. .)))))
(S1 (S (S (NP (NP (NP (CD One)) (PP (IN of) (NP (DT these) (NNS subregions)))) (, ,) (NP (NN NRE) (NN gamma)) (, ,)) (VP (VP (VBZ is) (ADJP (JJ active) (PP (IN in) (NP (CC both) (NP (NN HeLa) (JJ cervical) (NN carcinoma) (NNS cells)) (CC and) (NP (NN Huh7) (NN hepatoma) (NNS cells)))))) (CC and) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB be) (VP (VBN bound) (PP (IN by) (NP (NP (DT a) (NN protein) (NN factor)) (ADJP (JJ present) (PP (IN in) (NP (DT both) (NN cell) (NNS types))))))))))))) (. .))))
(S1 (S (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (NP (NN transcription) (NN factor))) (NP (NN RFX1))) (VP (MD can) (VP (VP (VB bind) (PP (TO to) (NP (NN NRE) (NN gamma)))) (CC and) (VP (VB transactivate) (NP (DT the) (NP (NN core) (NN promoter))) (PP (IN through) (NP (DT this) (NN site))))))))) (. .))))
(S1 (S (S (NP (NP (NNS Mutations)) (SBAR (WHNP (WDT which)) (S (VP (VBD abrogated) (NP (NP (DT the) (JJ gene-suppressive) (NN activity)) (PP (IN of) (NP (NN NRE) (NN gamma)))))))) (VP (VBD prevented) (NP (NN RFX1)) (PP (IN from) (NP (NP (NN binding)) (PP (TO to) (NP (NN NRE) (NN gamma)))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NN RFX1)) (VP (MD can) (VP (VB bind) (ADVP (RB simultaneously)) (, ,) (PP (ADVP (RBS most) (JJ likely)) (IN as) (NP (DT a) (NP (NN heterodimer)))) (, ,) (PP (IN with) (NP (NP (NP (DT the) (NP (NN transcription) (NN factor))) (NP (NN MIBP1))) (PP (TO to) (NP (NN NRE) (NN gamma))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NP (DT a) (VBN cloned) (NP (NN MIBP1) (NN gene))) (PP (IN for) (NP (JJ further) (NNS studies))))))) (, ,) (NP (PRP we)) (VP (VBP hypothesize) (SBAR (IN that) (S (NP (NN RFX1)) (VP (VBZ acts) (PP (IN with) (NP (NN MIBP1))) (S (VP (TO to) (ADVP (RB negatively)) (VP (VB regulate) (NP (DT the) (NN core) (NN promoter) (NN activity)) (PP (IN through) (NP (DT the) (NP (NN NRE) (NN gamma) (NN site))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN ability)) (PP (IN of) (NP (NN RFX1))) (S (VP (TO to) (VP (VB transactivate) (NP (DT the) (NP (NN core) (NN promoter))))))) (VP (VBZ raises) (NP (DT the) (NN possibility) (SBAR (IN that) (S (NP (NN RFX1)) (VP (MD may) (VP (VB play) (NP (DT a) (JJ dual) (NN role)) (PP (IN in) (S (VP (VBG regulating) (NP (NN HBV) (NN gene) (NN expression))))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Evaluation)) (PP (IN of) (NP (JJ monoclonal) (JJ anti-D) (NNS reagents))) (VP (VBG using) (NP (NN D) (JJ variant) (NNS cells))) (. .)))))
(S1 (S (S (S (NP (NP (JJ Monoclonal) (JJ anti-D) (NNS antibodies)) (VP (VBN submitted) (PP (TO to) (NP (DT the) (NNP Third) (NNP Monoclonal) (NNP International) (NNP Workshop))))) (VP (VBD were) (VP (VBN evaluated) (PP (IN against) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NN D) (JJ variant) (NNS cells)))))) (S (VP (VBG using) (NP (ADJP (ADJP (JJ standard)) (ADJP (JJ serological))) (NNS techniques))))) (. .)))))
(S1 (S (S (NP (DT The) (NP (JJ monoclonal) (NNS antibodies))) (VP (VBD were) (ADJP (JJ able) (S (VP (TO to) (VP (VB discriminate) (PP (IN between) (NP (NP (NP (DT the) (NNS cells)) (PP (IN of) (NP (NNS Categories) (NP (NN Va)) (, ,) (NP (NN VI)) (CC and) (NP (NN DFR))))) (CONJP (CC but) (RB not)) (NP (NN Category) (CD III) (NNS cells))))))))) (. .))))
(S1 (S (S (NP (NP (NNS Cells)) (PP (IN within) (NP (DT each) (NN category)))) (VP (VBD did) (RB not) (VP (VB give) (NP (DT any) (JJ aberrant) (NNS results)))) (. .))))
(S1 (S (S (NP (DT The) (NP (NN Rh) (: :) (CD 33) (NNS cells))) (VP (VBD behaved) (PP (IN as) (NP (JJ normal) (NN Rh) (-LRB- -LRB-) (NN D) (-RRB- -RRB-) (JJ positive) (NNS cells)))) (. .))))
(S1 (S (NP (NP (JJ Pancreatic) (NP (NP (NN development)) (CC and) (NP (NN maturation)))) (PP (IN of) (NP (DT the) (NN islet) (NN B) (NN cell))) (. .))))
(S1 (S (NP (NP (NNS Studies)) (PP (IN of) (NP (JJ pluripotent) (NN islet) (NNS cultures))) (. .))))
(S1 (S (S (NP (NN Pancreas) (NN organogenesis)) (VP (VBZ is) (NP (NP (DT a) (ADJP (RB highly) (VBN regulated)) (NN process)) (, ,) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (CD two) (NNS anlage)) (VP (VBP evaginate) (PP (IN from) (NP (DT the) (JJ primitive) (NN gut)))))))) (. .))))
(S1 (S (S (S (NP (PRP They)) (ADVP (RB later)) (VP (VBP fuse))) (, ,) (CC and) (, ,) (S (PP (IN under) (NP (NP (DT the) (NN influence)) (PP (IN of) (NP (DT the) (VBG surrounding) (NN mesenchyme))))) (, ,) (NP (DT the) (JJ mature) (NN organ)) (VP (VBZ develops) (, ,) (S (VP (VBG being) (VP (ADVP (RB mainly)) (VBN composed) (PP (IN of) (NP (ADJP (ADJP (JJ ductal)) (, ,) (ADJP (JJ exocrine)) (CC and) (ADJP (JJ endocrine))) (NNS compartments)))))))) (. .))))
(S1 (S (S (NP (JJ Early) (NNS buds)) (VP (VBP are) (VP (VBN characterized) (PP (IN by) (NP (NP (DT a) (VBG branching) (NN morphogenesis)) (PP (IN of) (NP (NP (DT the) (JJ ductal) (NN epithelium)) (SBAR (WHPP (IN from) (WHNP (WDT which))) (S (NP (ADJP (ADJP (JJ endocrine)) (CC and) (ADJP (JJ exocrine))) (NN precursor) (NNS cells)) (VP (VBP bud) (S (VP (TO to) (VP (ADVP (RB eventually)) (VB form) (NP (DT the) (CD two) (JJ other) (NNS compartments)))))))))))))) (. .))))
(S1 (S (S (NP (DT The) (CD three) (NNS compartments)) (VP (VBP are) (VP (VBN thought) (S (VP (TO to) (VP (VB be) (PP (IN of) (NP (JJ common) (JJ endodermal) (NN origin))) (: ;) (PP (IN in) (NN contrast) (TO to) (NP (NP (JJR earlier) (NNS hypotheses)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD suggested) (SBAR (IN that) (S (NP (DT the) (JJ endocrine) (NN compartment)) (VP (VBD was) (PP (IN of) (NP (JJ neuroectodermal) (NN origin)))))))))))))))) (. .))))
(S1 (S (S (NP (PRP It)) (VP (VBZ is) (ADVP (RB thus)) (VP (ADVP (RB generally)) (VBN believed) (SBAR (IN that) (S (NP (DT the) (JJ pancreatic) (NN endocrine-lineage)) (VP (VBZ possesses) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB mature) (PP (IN along) (NP (NP (DT a) (NN differentiation) (NN pathway)) (SBAR (WHNP (WDT that)) (S (VP (VBZ shares) (NP (JJ many) (NNS characteristics)) (PP (IN with) (NP (NP (DT those)) (PP (IN of) (NP (JJ neuronal) (NN differentiation))))))))))))))))))) (. .))))
(S1 (S (S (PP (IN During) (NP (JJ recent) (NNS years))) (, ,) (NP (NP (NNS studies)) (PP (IN of) (NP (NP (JJ insulin-gene) (NN regulation)) (CC and) (, ,) (NP (PP (IN in) (NP (JJ particular))) (, ,) (NP (DT the) (JJ tissue-specific) (JJ transcriptional) (NN control)) (PP (IN of) (NP (JJ insulin-gene) (NN activity))))))) (VP (VBP have) (VP (VBN provided) (NP (NP (NN information)) (PP (IN on) (NP (NN pancreas) (NN development))) (PP (IN in) (NP (JJ general)))))) (. .))))
(S1 (S (S (NP (DT The) (JJ present) (NN review)) (VP (VBZ summarizes) (NP (DT these) (NNS findings)) (, ,) (PP (IN with) (NP (NP (DT a) (JJ special) (NN focus)) (PP (IN on) (NP (NP (PRP$ our) (JJ own) (NNS studies)) (PP (IN on) (NP (NP (JJ pluripotent) (JJ endocrine) (NNS cultures)) (PP (IN of) (NP (NN rat) (NN pancreas)))))))))) (. .))))
(S1 (S (NP (NP (NN Induction)) (PP (IN of) (NP (JJ vascular) (NN cell) (NN adhesion) (NN molecule-1))) (PP (IN by) (NP (JJ low-density) (NN lipoprotein))) (. .))))
(S1 (S (S (NP (NP (JJ Low-density) (NN lipoprotein)) (PRN (-LRB- -LRB-) (NP (NN LDL)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (JJ well-established) (NN risk) (NN factor)) (PP (IN for) (NP (NN atherosclerosis))))) (. .))))
(S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (JJ endothelial) (NNS cells)) (VP (VBP are) (VP (VBN incubated) (PP (IN with) (NP (DT this) (NN lipoprotein))) (PP (IN in) (NP (JJ pathophysiologic) (NNS amounts))))))) (, ,) (NP (DT the) (NNS cells)) (VP (VBP are) (VP (VBN activated))) (. .))))
(S1 (S (SINV (PP (IN Among) (NP (NP (DT the) (VBN documented) (JJ cellular) (NNS responses)) (PP (TO to) (NP (NN LDL))))) (VP (VBZ is)) (NP (NP (VBN increased) (NN recruitment)) (PP (IN of) (NP (NP (NNS monocytes)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBN believed) (S (VP (TO to) (VP (VB play) (NP (DT a) (JJ major) (NN role)) (PP (IN in) (S (VP (VBG promoting) (NP (JJ intimal) (NN plaque) (NN formation))))))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NNS findings)) (VP (VBN presented) (ADVP (RB here)))) (VP (VB link) (NP (NP (DT an) (JJ atheogenic) (NN lipoprotein)) (, ,) (NP (NN LDL)) (, ,)) (PP (IN with) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NP (DT an) (NN adhesion) (NN molecule)) (ADJP (JJ important) (PP (IN in) (NP (NN atherogenesis))))))))))))
(S1 (S (S (NP (JJ Human) (NN LDL)) (VP (VBZ induces) (NP (NP (DT the) (JJ vascular) (NN cell) (NN adhesion) (NN molecule-1)) (PRN (-LRB- -LRB-) (NP (NN VCAM-1)) (-RRB- -RRB-))) (ADVP (RB transcriptionally)) (PP (IN with) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NN mRNA) (NNS levels))))) (PP (IN through) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (NN VCAM) (NN promoter)))))) (. .))))
(S1 (S (S (NP (DT This) (NN effect)) (VP (VBZ is) (VP (VBN blocked) (PP (IN by) (NP (JJ anti-VCAM) (NNS antibodies))))) (. .))))
(S1 (S (S (PP (IN After) (NP (NP (DT a) (JJ 2-day) (NN incubation)) (PP (IN in) (NP (NN LDL))))) (, ,) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NP (NN NF-kappa) (NN B)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN believed) (S (VP (TO to) (VP (VB be) (NP (NP (DT a) (JJ key) (JJ oxidative-stress) (NN sensor)) (PP (IN for) (NP (NN VCAM) (NN regulation))))))))))) (, ,)))) (VP (VBZ remains) (PP (IN at) (NP (JJ basal) (NN level)))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (DT the) (NN binding) (NNS activities)) (PP (IN of) (NP (NP (NN AP-1)) (CC and) (NP (NN GATA))))) (, ,) (PP (IN on) (NP (DT the) (JJ other) (NN hand))) (, ,) (VP (VBP are) (VP (VBN increased) (PP (IN by) (NP (NN LDL))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NP (DT a) (NN component)) (PP (IN of) (NP (NP (JJ LDL-enhanced) (JJ endothelial) (NN recruitment)) (PP (IN of) (NP (NNS monocytes)))))) (VP (VBZ is) (VP (VBN attributed) (PP (TO to) (NP (NP (JJ VCAM-1) (NN expression)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (VP (VBN mediated) (PP (IN through) (NP (NP (NN AP-1)) (CC and) (NP (NN GATA))))))))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS data)) (VP (VBP identify) (NP (NN LDL)) (PP (IN as) (NP (NP (DT a) (NN VCAM-inducer)) (ADJP (ADVP (RB possibly)) (JJ distinct) (PP (IN from) (NP (NP (NNS cytokines)) (CC and) (NP (NN endotoxin)))))))) (. .))))
(S1 (S (NP (NP (NP (NP (NN Cloning)) (CC and) (NP (NN expression))) (PP (IN of) (NP (NP (DT the) (NP (NN glucocorticoid) (NN receptor))) (PP (IN from) (NP (NP (NP (DT the) (NN squirrel) (NN monkey)) (PRN (-LRB- -LRB-) (NP (FW Saimiri) (FW boliviensis) (FW boliviensis)) (-RRB- -RRB-))) (, ,) (NP (DT a) (JJ glucocorticoid-resistant) (NN primate)))))) (. .)))))
(S1 (S (S (S (NP (NP (JJ New) (NN World) (NNS primates)) (PP (JJ such) (IN as) (NP (DT the) (NN squirrel) (NN monkey)))) (VP (VBP have) (VP (VBN elevated) (NP (NP (NN cortisol) (NNS levels)) (CC and) (NP (NN glucocorticoid) (NN resistance))))) (. .)))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (JJ apparent) (NN binding) (NN affinity)) (PP (IN of) (NP (NP (DT the) (NP (NN glucocorticoid) (NN receptor))) (PP (IN in) (NP (NN squirrel) (NN monkey) (NNS lymphocytes)))))) (VP (VBZ is) (ADJP (ADJP (ADJP (RB 5-fold) (JJR lower)) (PP (IN than) (NP (NP (DT that)) (PP (IN in) (NP (JJ human) (NNS lymphocytes)))))) (PRN (-LRB- -LRB-) (NP (NP (NP (JJ apparent) (NN Kd)) (, ,) (NP (NP (QP (CD 20.9) (CC +/-) (CD 1.8))) (CC and) (NP (QP (CD 4.3) (CC +/-) (CD 0.2))) (NP (NN nmol/L))) (, ,) (ADVP (RB respectively))) (: ;) (NP (NP (NN n)) (ADJP (JJ =) (NP (CD 3))))) (-RRB- -RRB-))) (, ,) (ADVP (JJ consistent) (PP (IN with) (NP (NP (JJ previous) (NNS studies)) (PP (IN in) (NP (NP (JJ mononuclear) (NNS leukocytes)) (VP (VBN isolated) (PP (IN from) (NP (DT the) (CD two) (NNS species)))))))))))))) (. .))))
(S1 (S (S (PP (IN As) (NP (NP (DT a) (JJ first) (NN step)) (PP (IN in) (S (VP (VBG understanding) (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (NP (VBN decreased) (NN binding) (NN affinity)) (PP (IN in) (NP (JJ New) (NN World) (NNS primates))))))))))) (, ,) (NP (PRP we)) (VP (VP (VBD used) (NP (JJ reverse) (NN transcription-PCR)) (S (VP (TO to) (VP (VB clone) (NP (DT the) (NP (NN glucocorticoid) (NN receptor))) (PP (IN from) (NP (NN squirrel) (NN monkey) (NN liver))))))) (CC and) (VP (VBP have) (VP (VBN compared) (NP (DT the) (NN sequence)) (PP (TO to) (NP (NP (NN receptor) (NNS sequences)) (VP (VBN obtained) (PP (IN from) (NP (NP (NN owl) (NN monkey) (NN liver)) (, ,) (NP (JJ cotton-top) (NN tamarin) (NN B95-8) (NNS cells)) (, ,) (CC and) (NP (JJ human) (NNS lymphocytes)))))))))) (. .))))
(S1 (S (S (NP (DT The) (NN squirrel) (NN monkey) (NP (NN glucocorticoid) (NN receptor))) (VP (VBZ is) (ADJP (NP (QP (RB approximately) (CD 97)) (NN %)) (JJ identical) (PP (IN in) (NP (NP (NN nucleotide)) (CC and) (NP (NN amino) (NN acid) (NN sequence)))) (PP (TO to) (NP (DT the) (NP (JJ human) (NN receptor)))))) (. .))))
(S1 (S (S (NP (NP (NP (DT The) (NP (JJ ligand-binding) (NN domain))) (PRN (-LRB- -LRB-) (NP (NN amino) (NNS acids) (CD 528-777)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (NN squirrel) (NN monkey) (NP (NN glucocorticoid) (NN receptor))))) (VP (VBZ contains) (NP (NP (NP (CD four) (NN amino) (NN acid) (NNS differences)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN Ser551)) (PP (TO to) (NP (NN Thr)))) (, ,) (NP (NP (NN Ser616)) (PP (TO to) (NP (NN Ala)))) (, ,) (NP (NP (NN Ala618)) (PP (TO to) (NP (NN Ser)))) (, ,) (CC and) (NP (NP (NN Ile761)) (PP (TO to) (NP (NN Leu))))) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (NP (DT all)) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (VBP are) (ADJP (JJ present) (PP (IN in) (NP (NP (NN owl) (NN monkey)) (CC and) (NP (JJ cotton-top) (NN tamarin)) (NP (NNS receptors)))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NP (JJ DNA-binding) (NN domain))) (PRN (-LRB- -LRB-) (NP (NN amino) (NNS acids) (CD 421-486)) (-RRB- -RRB-))) (VP (VBZ is) (ADVP (RB completely)) (VP (VBN conserved) (PP (IN among) (NP (NP (ADJP (JJ human))) (, ,) (NP (NN squirrel) (NN monkey)) (, ,) (NP (NN owl) (NN monkey)) (, ,) (CC and) (NP (JJ cotton-top) (NN tamarin)) (NP (NNS receptors)))))) (. .))))
(S1 (S (S (NP (NP (CD Twenty-two) (NNS differences)) (PP (IN from) (NP (DT the) (JJ human) (NN sequence)))) (VP (VBD were) (VP (VBN found) (PP (IN in) (NP (NP (NP (DT the) (NP (JJ N-terminal) (NN region))) (PRN (-LRB- -LRB-) (NP (NN amino) (NNS acids) (CD 1-421)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (NN squirrel) (NN monkey) (NN receptor))))))) (. .))))
(S1 (S (S (NP (NP (NN None)) (PP (IN of) (NP (DT the) (NNS substitutions))) (PP (IN in) (NP (DT the) (NP (JJ ligand-binding) (NN domain))))) (VP (VBD matched) (NP (NP (NNS mutations)) (VP (VBN known) (S (VP (TO to) (VP (VB influence) (NP (NP (NN binding) (NN affinity)) (PP (IN in) (NP (JJ other) (NNS species)))))))))) (. .))))
(S1 (S (S (S (VP (TO To) (VP (VB determine) (SBAR (IN whether) (S (NP (NP (DT the) (NNS substitutions)) (ADVP (FW per) (FW se))) (VP (VBD were) (ADJP (JJ responsible) (PP (IN for) (NP (VBN decreased) (NN affinity)))))))))) (, ,) (S (NP (NP (NN squirrel) (NN monkey)) (CC and) (NP (JJ human) (NN glucocorticoid) (NNS receptors))) (VP (VBD were) (VP (VBN expressed) (PP (IN in) (NP (DT the) (NN TNT) (JJ Coupled) (NN Reticulocyte) (NN Lysate) (NN System)))))) (. .))))
(S1 (S (S (NP (NP (NNS Expressions)) (PP (IN of) (NP (NP (NP (NP (ADJP (JJ human))) (CC and) (NP (NN squirrel) (NN monkey)) (NP (NN glucocorticoid) (NNS receptors))) (CC and) (NP (DT a) (NP (NN squirrel) (NN monkey) (NN receptor)))) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NN Phe774)) (VP (VBD was) (VP (VBN mutated) (PP (TO to) (NP (NP (NN Leu)) (PRN (-LRB- -LRB-) (NP (NN F774L)) (-RRB- -RRB-))))))))))) (VP (VBD were) (ADJP (JJ similar))) (. .))))
(S1 (S (S (SBAR (WHADVP (WRB When)) (S (VP (VBN expressed) (PP (IN in) (NP (DT the) (NN TNT) (NN System)))))) (, ,) (S (NP (NP (NN squirrel) (NN monkey)) (CC and) (NP (JJ human) (NN glucocorticoid) (NNS receptors))) (VP (VBD had) (NP (NP (NP (ADJP (ADJP (JJ similar)) (, ,) (ADJP (JJ high))) (NN affinity) (NN binding)) (PP (IN for) (NP (NN dexamethasone)))) (PRN (-LRB- -LRB-) (NP (NP (NP (JJ apparent) (NN Kd)) (, ,) (NP (NP (QP (CD 5.9) (CC +/-) (CD 1.2))) (CC and) (NP (QP (CD 4.3) (CC +/-) (CD 0.5))) (NP (NN nmol/L)) (, ,) (ADVP (RB respectively)))) (: ;) (NP (NP (NN n)) (ADJP (JJ =) (NP (CD 3))))) (-RRB- -RRB-))) (, ,) (SBAR (IN whereas) (S (NP (DT the) (NP (NN squirrel) (NN monkey) (NN F774L) (NN receptor))) (VP (VBD had) (NP (NP (JJR lower) (NN affinity) (NN binding)) (PRN (-LRB- -LRB-) (NP (NP (NP (JJ apparent) (NN Kd)) (, ,) (NP (QP (CD 20.4) (CC +/-) (CD 2.0)) (NN nmol/L))) (: ;) (NP (NP (NN n)) (ADJP (JJ =) (NP (CD 3))))) (-RRB- -RRB-)))))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NP (NNS substitutions)) (PP (IN within) (NP (NP (DT the) (NP (JJ ligand-binding) (NN domain))) (PP (IN of) (NP (DT the) (NN squirrel) (NN monkey) (NP (NN glucocorticoid) (NN receptor))))))) (VP (MD can) (RB not) (VP (VB account) (PP (IN for) (NP (NP (DT the) (VBN decreased) (NN binding) (NN affinity)) (PP (IN of) (NP (NP (DT these) (NNS receptors)) (PP (IN in) (NP (NN squirrel) (NN monkey) (NNS cells))))))))) (. .))))
(S1 (S (S (ADVP (RB Rather)) (, ,) (NP (DT the) (NN binding) (NN affinity)) (VP (VBZ is) (ADVP (RB probably)) (VP (VBN influenced) (PP (IN by) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (JJ cytosolic) (NNS factors)) (SBAR (WHNP (WDT that)) (S (VP (VBP affect) (NP (NP (NN glucocorticoid) (NN receptor)) (NN function))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN NF-kappa) (NN B) (NN inhibitor)) (, ,) (NP (NN tepoxalin)) (, ,)) (VP (VBZ suppresses) (NP (NP (NN surface) (NN expression)) (PP (IN of) (NP (DT the) (NN cell) (NN adhesion) (NNS molecules) (NP (NP (NN CD62E)) (, ,) (NP (NN CD11b/CD18)) (CC and) (NP (NN CD106))))))) (. .))))
(S1 (S (S (NP (NP (NN Tepoxalin)) (, ,) (NP (NP (DT a) (JJ dual) (NN enzyme) (NN inhibitor)) (PP (IN of) (NP (NP (NN cyclooxygenase)) (CC and) (NP (NN 5-lipoxygenase)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB inhibit) (NP (NN T-cell) (NN activation)))))))) (. .))))
(S1 (S (S (NP (PRP$ Its) (JJ immunosuppressive) (NN property)) (VP (VBZ is) (ADJP (JJ distinct) (PP (IN from) (NP (NN cyclosporin)))) (SBAR (IN because) (S (NP (NP (RB only) (NN tepoxalin)) (, ,) (CONJP (CC but) (RB not)) (NP (NN cyclosporin)) (, ,)) (VP (VBZ suppresses) (NP (NN NF-kappa) (NN B) (NN activation)))))) (. .))))
(S1 (S (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP report) (SBAR (IN that) (S (NP (NN tepoxalin)) (ADVP (RB selectively)) (VP (VBZ inhibits) (NP (NP (ADJP (NP (JJ intercellular) (NN adhesion) (NN molecule-1) (-LRB- -LRB-) (NN ICAM-1) (, ,) (NN CD54) (-RRB- -RRB-) (NN /MAC-1) (-LRB- -LRB-) (NN CD11b/CD18) (-RRB- -RRB-)) (JJ dependent)) (NN adhesion)) (PP (IN of) (NP (JJ polymorphonuclear) (NNS cells))) (PP (TO to) (NP (ADJP (NN IL-1) (JJ activated)) (JJ human) (JJ umbilical) (NN vein) (JJ endothelial) (NNS cells)))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN mechanism)) (PP (IN of) (NP (NN inhibition)))) (VP (VBZ is) (ADJP (JJ related) (PP (TO to) (NP (NP (DT the) (NN surface) (NN expression)) (PP (IN of) (NP (JJ several) (NN cell) (NN adhesion) (NNS molecules))))))) (. .))))
(S1 (S (S (NP (NP (NN Flow) (NN cytometry) (NNS analyses)) (PP (IN on) (NP (NP (VBN cultured) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (VP (VP (VBN treated) (PP (IN with) (NP (NP (NN tepoxalin)) (CC or) (NP (NP (JJ antisense) (NNS oligonucleotides)) (PP (TO to) (NP (NP (DT the) (NN P65/p50) (NN subunit)) (PP (IN of) (NP (NN NF-kappa) (NN B))))))))) (, ,) (CC and) (RB then) (VP (VBN stimulated) (PP (IN with) (NP (NN PMA)))) (, ,)))))))) (VP (VBD revealed) (NP (NP (NP (DT a) (VBN reduced) (NN expression)) (PP (IN of) (NP (NN CD11b/CD18))) (PP (IN on) (NP (JJ monocytic) (NN HL60) (NNS cells)))) (, ,) (CC and) (NP (NP (NP (NP (JJ endothelial) (NN adhesion) (NN molecule-1)) (PRN (-LRB- -LRB-) (NP (NN CD62E)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ vascular) (NN adhesion) (NN molecule-1)) (PRN (-LRB- -LRB-) (NP (NN CD106)) (-RRB- -RRB-)))) (PP (IN on) (NP (JJ human) (JJ umbilical) (NN vein) (JJ endothelial) (NNS cells)))))) (. .))))
(S1 (S (S (NP (NP (NN Expression)) (PP (IN of) (NP (NP (JJ other) (NN adhesion) (NNS molecules)) (PP (JJ such) (IN as) (NP (NP (NP (NN lymphocyte) (NN function) (NN associated-antigen-1)) (PRN (-LRB- -LRB-) (NP (NN CD11a/CD18)) (-RRB- -RRB-))) (CC and) (NP (NN CD54))))))) (VP (VBD were) (ADJP (JJ unaffected))) (. .))))
(S1 (S (S (NP (NN Tepoxalin)) (ADVP (RB also)) (VP (VBD inhibited) (NP (NP (DT the) (NN secretion)) (PP (IN of) (NP (NP (DT a) (ADJP (NP (NN NF-kappa) (NN B)) (JJ regulated)) (NN chemokine)) (, ,) (NP (NN IL-8)) (, ,) (NP (NP (DT a) (JJ known) (NN inducer)) (PP (IN of) (NP (NN CD11b/CD18) (NN expression)))))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (NP (NP (DT the) (NN suppression)) (PP (IN of) (NP (NN CD11b/CD18) (NN expression))) (PP (IN by) (NP (NN tepoxalin)))) (VP (MD may) (VP (VB involve) (NP (NN IL-8)))) (. .))))
(S1 (S (S (NP (PRP$ Our) (NNS results)) (VP (VBP suggest) (SBAR (SBAR (IN that) (S (PP (IN by) (S (VP (VBG inhibiting) (NP (NN NF-kappa) (NN B) (NN activation))))) (, ,) (NP (NP (NN surface) (NN expression)) (PP (IN of) (NP (JJ several) (NN adhesion) (NNS molecules)))) (VP (MD can) (VP (VB be) (VP (VBN modulated)))))) (CC and) (SBAR (IN that) (S (NP (NN tepoxalin)) (VP (MD may) (VP (VB be) (ADJP (JJ useful)) (PP (IN in) (S (VP (VBG treating) (NP (NP (VBN selected) (ADJP (NN adhesion) (JJ mediated)) (NNS events)) (PP (JJ such) (IN as) (NP (NP (NN leukocyte) (NN migration)) (CC or) (NP (JJ atherosclerotic) (NN plaque) (NN formation)))))))))))))) (. .))))
(S1 (S (NP (NP (NP (NP (NN Characterization)) (PP (IN of) (NP (DT the) (NP (JJ human) (JJ platelet/endothelial) (NN cell) (NN adhesion) (NN molecule-1) (NN promoter)))) (: :)) (NP (NP (NN identification)) (PP (IN of) (NP (NP (DT a) (NP (NN GATA-2) (NN binding) (NN element))) (VP (VBN required) (PP (IN for) (NP (ADJP (ADJP (JJ optimal)) (ADJP (JJ transcriptional))) (NN activity))))))) (. .)))))
(S1 (S (S (S (NP (NP (JJ Platelet/endothelial) (NN cell) (NN adhesion) (NN molecule-1)) (PRN (-LRB- -LRB-) (NP (NN PECAM-1)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (NP (DT a) (NP (JJ 130-kD) (NN member))) (PP (IN of) (NP (DT the) (NP (NN Ig) (NN gene) (NN superfamily))))) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN expressed) (PP (IN on) (NP (NP (NNS platelets)) (, ,) (NP (JJ endothelial) (NNS cells)) (, ,) (CC and) (NP (JJ certain) (NP (NN leukocyte) (NNS subsets))))))))))) (. .)))))
(S1 (S (S (S (VP (TO To) (VP (VB examine) (NP (NP (DT the) (NNS factors)) (VP (VBG controlling) (NP (NP (JJ vascular-specific) (NN expression)) (PP (IN of) (NP (NN PECAM-1))))))))) (, ,) (S (NP (PRP we)) (VP (VP (VBD cloned) (NP (NP (DT the) (NP (JJ 5'-flanking) (NN region))) (PP (IN of) (NP (DT the) (NP (NN PECAM-1) (NN gene)))))) (CC and) (VP (VBD analyzed) (NP (PRP$ its) (JJ transcriptional) (NN activity))))) (. .))))
(S1 (S (S (NP (NP (NP (NP (JJ 5'-Rapid) (NN amplification)) (PP (IN of) (NP (NN cDNA) (NNS ends)))) (PRN (-LRB- -LRB-) (NP (NNS 5'-RACE)) (-RRB- -RRB-))) (NN analysis)) (VP (VBD showed) (SBAR (IN that) (S (NP (NN transcription) (NN initiation)) (VP (VBD occurred) (PP (IN at) (NP (NP (ADJP (ADJP (JJ several)) (ADJP (RB closely) (JJ spaced))) (NN nearby) (NNS sites)) (VP (VBG originating) (PP (NP (RB approximately) (NP (CD 204) (NN bp) (RB upstream))) (IN from) (NP (DT the) (NP (NN translation) (NN start) (NN site))))))))))) (. .))))
(S1 (S (S (S (NP (NP (NN Analysis)) (PP (IN of) (NP (NP (DT the) (NN sequence)) (ADVP (RB immediately) (JJ upstream) (PP (IN from) (NP (DT the) (NP (NP (NN transcription) (NN initiation) (NN site)) (PRN (-LRB- -LRB-) (NP (NN TIS)) (-RRB- -RRB-))))))))) (VP (VBD showed) (NP (DT no) (JJ canonical) (NP (NP (NN TATA))) (CC or) (NP (NN CAAT) (NNS elements))))) (, ,) (RB however) (S (NP (NP (DT an) (NN initiator) (NN element)) (VP (ADVP (RB commonly)) (VBN found) (PP (IN in) (NP (JJ TATA-less) (NNS promoters))))) (VP (VBD encompassed) (NP (DT the) (NP (NN TIS))))) (. .))))
(S1 (S (S (NP (NP (RB 5'-serially) (VBN truncated) (NN PECAM-1) (NN promoter) (NNS segments)) (VP (VBN cloned) (PP (IN in) (NP (NP (NN front)) (PP (IN of) (NP (DT a) (NP (NN luciferase) (NN reporter)))))))) (VP (VBD drove) (NP (NN transcription)) (PP (IN in) (NP (CC both) (DT a) (ADJP (ADJP (NN lineage-)) (CC and) (ADJP (JJ orientation-specific))) (NN manner)))) (. .))))
(S1 (S (S (NP (NP (JJ Putative) (NP (JJ cis-acting) (NN control) (NNS elements))) (ADJP (JJ present) (PP (IN within) (NP (DT a) (NP (JJ 300-bp) (NN core) (NN promoter)))))) (VP (VBD included) (NP (NP (CD two) (NP (NN ets) (NNS sites))) (, ,) (NP (DT an) (NP (NN Sp1) (NN site))) (, ,) (NP (JJ tandem) (NP (NN E-box) (NNS domains))) (, ,) (NP (CD two) (NP (NP (JJ GATA-associated) (NNS sites)) (PRN (-LRB- -LRB-) (NP (NN CACCC)) (-RRB- -RRB-)))) (, ,) (NP (DT an) (NP (NN AP-2) (NN binding) (NN site))) (, ,) (CC and) (NP (NP (DT a) (NP (NN GATA) (NN element))) (PP (IN at) (NP (CD -24)))))) (. .))))
(S1 (S (S (S (NP (JJ Mutational) (NN analysis)) (VP (VBD showed) (SBAR (IN that) (S (NP (ADJP (ADJP (JJ optimal)) (ADJP (JJ transcriptional))) (NN activity)) (VP (VBD required) (NP (NP (DT the) (NP (NN GATA) (NN sequence))) (PP (IN at) (NP (NN position) (NP (CD -24)))))))))) (, ,) (CC and) (S (NP (JJ gel-shift) (NNS assays)) (ADVP (RB further)) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (DT the) (NP (NN GATA-2) (NN transcription) (NN factor))) (, ,) (CONJP (CC but) (RB not)) (NP (NN GATA-1)) (, ,)) (VP (VBD bound) (PP (TO to) (NP (NP (DT this) (NN region)) (PP (IN of) (NP (DT the) (NP (NN PECAM-1) (NN promoter))))))))))) (. .))))
(S1 (S (S (S (VP (VBG Understanding) (NP (NP (DT the) (NP (JJ cis-)) (CC and) (NP (VBG transacting) (NNS factors))) (SBAR (WHNP (WDT that)) (S (VP (VBP regulate) (NP (NP (DT the) (JJ tissue-specific) (NN expression)) (PP (IN of) (NP (NN PECAM-1)))))))))) (VP (MD should) (VP (VB increase) (NP (NP (PRP$ our) (NN understanding)) (PP (IN of) (NP (NP (DT the) (NNS mechanisms)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (JJ vascular-specific) (NN gene) (NN expression)) (VP (VBZ is) (VP (VBN achieved)))))))))) (. .))))
(S1 (S (NP (NP (NP (ADJP (ADJP (JJ Rapid)) (ADJP (JJ Ca2+-mediated))) (NN activation)) (PP (IN of) (NP (NN Rap1))) (PP (IN in) (NP (JJ human) (NNS platelets))) (. .)))))
(S1 (S (S (S (NP (NN Rap1)) (VP (VBZ is) (NP (NP (DT a) (JJ small) (, ,) (NP (JJ Ras-like) (NN GTPase))) (SBAR (WHNP (WP$ whose) (NP (NP (NN function)) (CC and) (NP (NN regulation)))) (S (VP (VBP are) (ADVP (RB still)) (ADJP (RB largely) (JJ unknown))))))) (. .)))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN developed) (NP (NP (DT a) (JJ novel) (NN assay)) (SBAR (S (VP (TO to) (VP (VB monitor) (NP (NP (DT the) (JJ active) (, ,) (NP (JJ GTP-bound) (NN form))) (PP (IN of) (NP (NN Rap1)))) (PP (VBN based) (PP (IN on) (NP (NP (DT the) (JJ differential) (NN affinity)) (PP (IN of) (NP (NP (NN Rap1GTP)) (CC and) (NP (NN Rap1GDP)))) (PP (IN for) (NP (NP (NP (DT the) (NP (NN Rap) (NN binding) (NN domain))) (PP (IN of) (NP (NN RalGDS)))) (PRN (-LRB- -LRB-) (NP (NN RBD)) (-RRB- -RRB-)))))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Stimulation)) (PP (IN of) (NP (NN blood) (NNS platelets))) (PP (IN with) (NP (NP (NN alpha-thrombin)) (CC or) (NP (JJ other) (NN platelet) (NNS activators))))) (VP (VBD caused) (NP (NP (NP (DT a) (ADJP (ADJP (JJ rapid)) (CC and) (NP (JJ strong))) (NN induction)) (PP (IN of) (NP (NN Rap1)))) (SBAR (WHNP (WDT that)) (S (VP (VBD associated) (PP (IN with) (NP (NN RBD))) (ADVP (FW in) (FW vitro))))))) (. .))))
(S1 (S (S (NP (NP (NN Binding)) (PP (TO to) (NP (NN RBD)))) (VP (VBD increased) (PP (IN from) (NP (NP (JJ undetectable) (NNS levels)) (PP (IN in) (NP (VBG resting) (NNS platelets))))) (PP (TO to) (NP (QP (JJR &gt;) (CD 50)) (NN %)) (PP (IN of) (NP (JJ total) (NP (NN Rap1))))) (PP (IN within) (NP (NP (CD 30) (NN s)) (PP (IN after) (NP (NN stimulation)))))) (. .))))
(S1 (S (S (NP (NP (DT An) (NN increase)) (PP (IN in) (NP (DT the) (JJ intracellular) (NN Ca2+) (NN concentration)))) (VP (VBZ is) (ADJP (CC both) (ADJP (JJ necessary)) (CC and) (ADJP (JJ sufficient)) (PP (IN for) (NP (NP (NN Rap1)) (NN activation)))) (SBAR (IN since) (S (NP (PRP it)) (VP (VBD was) (VP (VP (VBN induced) (PP (IN by) (NP (NP (NNS agents)) (SBAR (WHNP (WDT that)) (S (VP (VBP increase) (NP (JJ intracellular) (NN Ca2+)))))))) (CC and) (VP (VBN inhibited) (PP (IN by) (NP (DT a) (JJ Ca2+-chelating) (NN agent))))))))) (. .))))
(S1 (S (S (NP (CC Neither) (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (NN translocation)) (PP (IN of) (NP (NN Rap1))) (PP (TO to) (NP (DT the) (NN cytoskeleton)))))) (CC nor) (NP (NP (NN inhibition)) (PP (IN of) (NP (NN platelet) (NN aggregation))))) (VP (VBD affected) (NP (NP (JJ thrombin-induced) (NN activation)) (PP (IN of) (NP (NN Rap1))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (NP (NN prostaglandin) (NN I2)) (PRN (-LRB- -LRB-) (NP (NN PGI2)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (JJ strong) (JJ negative) (NN regulator)) (PP (IN of) (NP (NP (NN platelet)) (NN function)))) (, ,)) (VP (VBD inhibited) (NP (NP (NP (ADJP (JJ agonist-induced))) (CONJP (RB as) (RB well) (IN as)) (NP (ADJP (JJ Ca2+-induced))) (NP (NN activation))) (PP (IN of) (NP (NN Rap1))))) (. .))))
(S1 (S (S (PP (IN From) (NP (PRP$ our) (NNS results))) (, ,) (NP (PRP we)) (VP (VBP conclude) (SBAR (SBAR (IN that) (S (NP (NP (NP (NN Rap1)) (NN activation)) (PP (IN in) (NP (NNS platelets)))) (VP (VBZ is) (NP (NP (DT an) (ADJP (ADJP (JJ important)) (ADJP (JJ common))) (NN event)) (PP (IN in) (NP (ADJP (ADJP (JJ early)) (ADJP (JJ agonist-induced))) (NN signalling))))))) (, ,) (CC and) (SBAR (IN that) (S (NP (DT this) (NN activation)) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (DT an) (VBN increased) (JJ intracellular) (NN Ca2+) (NN concentration))))))))) (. .))))
(S1 (S (NP (NP (NN Expression)) (PP (IN of) (NP (JJ erythroid-specific) (NNS genes))) (PP (IN in) (NP (JJ megakaryoblastic) (NNS disorders))) (. .))))
(S1 (S (S (NP (ADJP (RB Currently) (JJ available)) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (S (NP (ADJP (ADJP (JJ erythroid)) (CC and) (ADJP (JJ megakaryocytic))) (NN differentiation) (NNS pathways)) (VP (VBP are) (ADJP (RB closely) (JJ related) (PP (TO to) (NP (DT each) (JJ other)))))) (, ,) (CC and) (S (NP (EX there)) (VP (MD may) (VP (VB exist) (NP (NP (NN progenitor) (NNS cells)) (ADJP (JJ common) (PP (TO to) (NP (DT those) (CD two) (NNS lineages))))))) (MD may) (VB exist))))) (. .))))
(S1 (S (S (NP (NP (NP (JJ Acute) (JJ megakaryoblastic) (NN leukemia)) (PRN (-LRB- -LRB-) (NP (NN AML-M7)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (JJ transient) (JJ myeloproliferative) (NN disorder)) (PP (IN in) (NP (NP (NN Down) (POS 's)) (NN syndrome)))) (PRN (-LRB- -LRB-) (NP (NN TMD)) (-RRB- -RRB-)))) (VP (VBP are) (VP (VBN characterized) (PP (IN by) (NP (NP (JJ rapid) (NN growth)) (PP (IN of) (NP (NP (JJ abnormal) (NN blast) (NNS cells)) (SBAR (WHNP (WDT which)) (S (VP (VBP express) (NP (JJ megakaryocytic) (NNS markers))))))))))) (. .))))
(S1 (S (S (NP (DT These) (NN blast) (NNS cells)) (VP (VP (VP (VBP express) (NP (NP (JJ lineage-specific) (NN transcription) (NNS factors)) (PP (JJ such) (IN as) (NP (NP (NN GATA-1)) (ADJP (JJ common) (PP (TO to) (NP (DT these) (NNS lineages)))))))) (CC and) (VP (ADVP (RB frequently)) (VBP express) (NP (NP (JJ erythroid-specific) (NNS mRNAs)) (PP (JJ such) (IN as) (NP (NP (NN gamma-globin)) (CC and) (NP (NP (JJ erythroid) (NN delta-aminolevulinate) (NN synthase)) (PRN (-LRB- -LRB-) (NP (NN ALAS-E)) (-RRB- -RRB-)))))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (JJS most)) (PP (IN of) (NP (NP (DT the) (NNS blasts)) (PP (IN in) (NP (NP (NP (NN M7)) (CC and) (NP (NN TMD))) (NNS cases)))))) (VP (VBP have) (NP (ADJP (ADJP (JJ erythroid)) (CC and) (ADJP (JJ megakaryocytic))) (NNS phenotypes)))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NNS blasts)) (PP (IN in) (NP (NP (NN M7)) (CC and) (NP (NN TMD))))) (VP (MD may) (VP (VB correspond) (PP (TO to) (NP (NP (NNS progenitors)) (PP (IN of) (NP (ADJP (CC both) (ADJP (JJ erythroid)) (CC and) (ADJP (JJ megakaryocytic))) (NNS lineages)))))))))) (. .))))
(S1 (S (S (NP (JJ Nuclear) (NN NF-ATp)) (VP (VBZ is) (NP (NP (DT a) (NN hallmark)) (PP (IN of) (NP (NP (JJ unstimulated) (NN B) (NNS cells)) (PP (IN from) (NP (NN B-CLL) (NNS patients))))))) (. .))))
(S1 (S (S (NP (NP (NN B) (NNS lymphocytes)) (PP (IN from) (NP (NP (DT the) (JJ peripheral) (NN blood)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (JJ chronic) (JJ lymphocytic) (NN leukaemia)) (PRN (-LRB- -LRB-) (NP (NN CLL)) (-RRB- -RRB-))))))))) (VP (VBD were) (VP (VBN analysed) (PP (IN for) (NP (NP (DT the) (NP (NP (JJ nuclear) (NN presence)) (CC and) (NP (NN DNA) (NN binding)))) (PP (IN of) (NP (NP (DT a) (NN panel)) (PP (IN of) (NP (NP (NN transcription) (NNS factors)) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN gene) (NN control)) (PP (IN of) (NP (JJ lymphoid) (NNS cells))))))))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ following) (NN transcription) (NNS factors))) (VP (VBD were) (VP (VBN studied) (: :) (NP (NP (DT the) (NN Octamer) (NNS factors) (NP (NP (NN Oct-1)) (CC and) (NP (NN Oct-2)))) (, ,) (NP (NP (NNS members)) (PP (IN of) (NP (DT the) (NN AP-1) (NN factor) (NN family)))) (, ,) (NP (NP (NN NF-AT) (NNS factors)) (, ,) (NP (PP (IN in) (NP (JJ particular))) (NN NF-ATp))) (, ,) (CC and) (NP (NP (NNS members)) (PP (IN of) (NP (DT the) (NN Rel/NF-kB) (NN family))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (JJ constitutive) (JJ nuclear) (NN translocation)) (PP (IN of) (NP (NP (NN NF-ATp)) (, ,) (NP (NP (DT a) (NN member)) (PP (IN of) (NP (NP (DT the) (VBG growing) (NN family)) (PP (IN of) (NP (NN NF-AT) (NNS factors)))))) (, ,)))) (VP (VBZ is) (NP (NP (DT a) (NN hallmark)) (PP (IN of) (NP (NP (JJ nonstimulated) (NN B) (NNS cells)) (PP (IN from) (NP (NN CLL) (NNS patients))))) (SBAR (WHNP (WDT that)) (S (VP (VBZ distinguishes) (NP (NN B-CLL) (NNS cells)) (PP (IN from) (NP (`` ') (JJ normal) ('' ') (NN B) (NNS lymphocytes))))))))))) (. .))))
(S1 (S (S (NP (JJ Constitutive) (JJ nuclear) (NN appearance)) (VP (VBD was) (ADVP (RB also)) (VP (VBN observed) (PP (IN for) (NP (NN NF-kB2/p52))))) (. .))))
(S1 (S (S (NP (NP (JJ Constitutive) (NN binding)) (PP (IN of) (NP (NP (JJ further) (NN factor) (NNS proteins)))) (PP (TO to) (NP (NN DNA))) (, ,) (PP (JJ such) (IN as) (NP (NP (NN JunD)) (, ,) (NP (NN c-Fos)) (CC and) (NP (NN FosB)))) (, ,)) (VP (VBD was) (VP (VBN detected) (PP (IN in) (NP (JJ several) (NNS patients))) (SBAR (IN whereas) (S (NP (NP (DT the) (NP (NP (NN localisation)) (CC and) (NP (NN DNA) (NN binding)))) (PP (IN of) (NP (NP (JJ other) (NNS factors)) (PP (JJ such) (IN as) (NP (NP (NN c-Jun)) (, ,) (NP (NN RelA/p65)) (CC and) (NP (NN c-Rel))))))) (VP (VBD was) (ADJP (JJ unaltered))))))) (. .))))
(S1 (S (S (NP (NP (PRP It))) (VP (VBZ is) (ADJP (JJ remarkable)) (SBAR (IN that) (S (PP (IN in) (NP (JJ B-CLL) (NNS cells))) (NP (NP (DT the) (NP (NP (JJ nuclear) (NN appearance)) (CC and) (NP (NN DNA) (NN binding)))) (PP (IN of) (NP (JJ specific) (NN transcription) (NNS factors)))) (VP (VBZ is) (ADVP (RB dramatically)) (VP (JJ affected) (SBAR (IN whereas) (S (NP (NP (JJ other) (NNS members)) (PP (IN of) (NP (DT the) (JJ same) (NN factor) (NN family)))) (VP (VBD remained) (ADJP (JJ unaltered)) (PP (IN in) (NP (DT these) (JJ leukemic) (NNS cells))))))))))) (. .))))
(S1 (S (S (NP (PRP It)) (VP (VBZ remains) (S (VP (TO to) (VP (VB be) (VP (VBN shown) (SBAR (WHNP (WDT which) (JJ molecular) (NNS events)) (S (VP (VBP lead) (PP (TO to) (NP (NP (NP (DT the) (JJ specific) (`` ') (NN pre-activation) ('' ')) (, ,) (NP (ADVP (FW i.e.)) (NP (NP (JJ constitutive) (JJ nuclear) (NN translocation)) (CC and) (NP (NN DNA) (NN binding)))) (, ,)) (PP (IN of) (NP (NP (DT these) (NNS members)) (PP (IN of) (NP (NP (NP (NN NF-AT)) (, ,) (NP (NN NF-kB)) (CC and) (NP (NN AP-1))) (NN factor) (NNS families))))))))))))))) (. .))))
(S1 (S (NP (NP (NP (ADJP (ADJP (JJ Physical)) (CC and) (ADJP (JJ functional))) (NN interaction)) (PP (IN between) (NP (NP (DT the) (NP (JJ human) (NN T-cell) (JJ lymphotropic) (NN virus) (NN type) (CD 1) (NN Tax1) (NN protein))) (CC and) (NP (NP (DT the) (NP (NN CCAAT) (NN binding) (NN protein))) (NP (NN NF-Y))))) (. .)))))
(S1 (S (S (S (NP (NP (NN Tax1)) (, ,) (NP (NP (DT a) (JJ potent) (NN activator)) (PP (IN of) (NP (NP (NP (JJ human) (NN T-cell) (JJ lymphotropic) (NN virus) (NN type) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN HTLV-1)) (-RRB- -RRB-))) (NN transcription)))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB modulate) (NP (NP (NN expression)) (PP (IN of) (NP (JJ many) (NP (JJ cellular) (NNS genes))))))))))) (. .)))))
(S1 (S (S (NP (NN Tax1)) (VP (VP (VBZ does) (RB not) (VP (VB bind) (NP (NN DNA)) (ADVP (RB directly)))) (CC but) (VP (VBZ regulates) (NP (NP (NN transcription)) (PP (IN through) (NP (NP (JJ protein-protein) (NNS interactions)) (PP (IN with) (NP (JJ sequence-specific) (NN transcription) (NNS factors)))))))) (. .))))
(S1 (S (S (S (VP (VBG Using) (NP (DT the) (NN yeast) (JJ two-hybrid) (NN system)) (S (VP (TO to) (VP (VB screen) (PP (IN for) (NP (NP (NNS proteins)) (SBAR (WHNP (WDT which)) (S (VP (VBP interact) (PP (IN with) (NP (NN Tax1))))))))))))) (, ,) (S (NP (PRP we)) (VP (VBD isolated) (NP (NP (DT the) (NP (NN B) (NN subunit))) (PP (IN of) (NP (NP (DT the) (NP (NN CCAAT) (NN binding) (NN protein))) (NP (NN NF-Y))))) (PP (IN from) (NP (DT a) (NP (NN HeLa) (NN cDNA) (NN library)))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN interaction)) (PP (IN of) (NP (NN Tax1))) (PP (IN with) (NP (NN NF-YB)))) (VP (VBD was) (ADJP (JJ specific) (PP (IN in) (SBAR (IN that) (S (NP (NN NF-YB)) (VP (VBD did) (RB not) (VP (VB interact) (PP (PP (IN with) (NP (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ other) (NP (NN transcription) (NNS factors))))) (, ,) (PP (VBG including) (NP (NP (JJ human) (NN immunodeficiency) (NN virus) (NN Tat)) (, ,) (NP (JJ human) (NN papillomavirus) (NN E6)) (, ,) (CC and) (NP (NN Bicoid)))))) (, ,) (CC or) (PP (IN with) (NP (DT the) (NP (NN M7) (-LRB- -LRB-) (NN amino) (NNS acids) (NN 29CP-AS) (-RRB- -RRB-) (NN Tax1) (NN mutant)))))))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NN NF-YB)) (VP (VBD did) (VP (VBP interact) (PP (IN with) (NP (NP (DT the) (NP (JJ C-terminal) (NN Tax1) (NNS mutants))) (NP (NP (NP (NN M22)) (PRN (-LRB- -LRB-) (NP (NN 130TL-AS)) (-RRB- -RRB-))) (CC and) (NP (NP (NN M47)) (PRN (-LRB- -LRB-) (NP (NN 319LL-RS)) (-RRB- -RRB-)))))))) (. .))))
(S1 (S (S (NP (PRP We)) (ADVP (RB also)) (VP (VBP show) (SBAR (IN that) (S (NP (ADJP (FW in) (JJ vitro-translated)) (NP (NN NF-YB))) (ADVP (RB specifically)) (VP (VBD bound) (PP (TO to) (NP (DT a) (NP (NN glutathione) (NN S-transferase-Tax1) (NN fusion) (NN protein)))))))) (. .))))
(S1 (S (S (ADVP (RB Further)) (, ,) (NP (NN Tax1)) (VP (VBD coimmunoprecipitated) (PP (IN with) (NP (NP (NN NF-Y)) (PP (IN from) (NP (NP (JJ nuclear) (NNS extracts)) (PP (IN of) (NP (JJ HTLV-1-transformed) (NNS cells))))))) (, ,) (S (VP (VBG providing) (NP (NP (NN evidence)) (PP (IN for) (NP (NP (ADJP (FW in) (FW vivo)) (NN interaction)) (PP (IN of) (NP (NP (NN Tax1)) (CC and) (NP (NN NF-YB)))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (ADVP (RB further)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN Tax1)) (ADVP (RB specifically)) (VP (VBD activated) (NP (NP (DT the) (NP (JJ NF-Y-responsive) (NN DQbeta) (NN promoter))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT a) (NP (JJ minimal) (NN promoter))) (SBAR (WHNP (WDT which)) (S (VP (VBZ contains) (NP (RB only) (DT the) (NP (NN Y-box) (NN element)))))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NP (NN mutation)) (PP (IN of) (NP (DT the) (NP (NN Y-box) (NN element))))) (ADVP (RB alone))) (VP (VBD abrogated) (NP (JJ Tax1-mediated) (NN activation))) (. .))))
(S1 (S (S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (S (NP (DT these) (NNS data)) (VP (VBP indicate) (SBAR (SBAR (IN that) (S (NP (NN Tax1)) (VP (VBZ interacts) (PP (IN with) (NP (NN NF-Y))) (PP (IN through) (NP (DT the) (NP (NN B) (NN subunit))))))) (CC and) (SBAR (IN that) (S (NP (DT this) (NN interaction)) (VP (VBZ results) (PP (IN in) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (NP (JJ major) (NN histocompatibility) (NN complex) (NN class) (CD II) (NN promoter)))))))))))) (. .))))
(S1 (S (S (PP (IN Through) (NP (NP (NN activation)) (PP (IN of) (NP (NP (DT this)) (CC and) (NP (JJ other) (NP (NN NF-Y)) (JJ driven) (NP (NNS promoters))))))) (, ,) (NP (DT the) (NN Tax1-NF-Y) (NN interaction)) (VP (MD may) (VP (VB play) (NP (DT a) (JJ critical) (NN role)) (PP (IN in) (S (VP (VBG causing) (NP (NP (JJ cellular) (NN transformation)) (CC and) (NP (NN HTLV-1) (NN pathogenesis)))))))) (. .))))
(S1 (S (NP (NP (NP (NN Cloning)) (PP (IN of) (NP (DT the) (NP (JJ novel) (JJ human) (JJ myeloid-cell-specific) (NN C/EBP-epsilon) (NN transcription) (NN factor)))) (. .)))))
(S1 (S (S (S (NP (NP (NN Chicken) (NN NF-M) (NN transcription) (NN factor)) (, ,) (PP (IN in) (NP (NP (NN cooperation)) (PP (IN with) (NP (CC either) (NP (NN c-Myb)) (CC or) (NP (NN v-Myb)))))) (, ,)) (VP (VBZ is) (ADJP (JJ active) (PP (IN in) (NP (NP (DT the) (JJ combinatorial) (NN activation)) (PP (IN of) (NP (JJ myeloid-cell-specific) (NNS genes))) (PP (IN in) (NP (NP (JJ heterologous) (NN cell) (NNS types)) (, ,) (PP (JJ such) (IN as) (NP (JJ embryonic) (NNS fibroblasts))))))))) (. .)))))
(S1 (S (S (PP (IN In) (NP (NNS humans))) (, ,) (NP (JJ similar) (NNS effects)) (VP (VBD were) (VP (VBN observed) (PP (IN with) (NP (NP (NP (JJ homologous) (NNS members)) (PP (IN of) (NP (NP (DT the) (NP (JJ CCAAT/enhancer-binding) (NN protein) (-LRB- -LRB-) (NN C/EBP) (-RRB- -RRB-) (NN family))) (PP (IN of) (NP (JJ transcriptional) (NNS regulators)))))) (, ,) (ADVP (RB especially)) (NP (NP (NP (DT the) (JJ human) (NN homolog)) (PP (IN of) (NP (NN chicken) (NN NF-M)))) (, ,) (NP (NP (NN C/EBP-beta)) (PRN (-LRB- -LRB-) (NP (NN NF-IL6)) (-RRB- -RRB-)))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (DT the) (NP (NN NF-IL6) (NN gene))) (VP (VP (VBZ is) (VP (VBN expressed) (PP (IN in) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ nonmyeloid) (NN cell) (NNS types))))))) (CC and) (VP (VBZ is) (ADJP (RB strongly) (JJ inducible) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (JJ inflammatory) (NNS stimuli)))))) (, ,) (S (VP (VBG making) (S (NP (PRP it)) (NP (NP (DT an) (JJ unlikely) (NN candidate)) (SBAR (S (VP (TO to) (VP (VB have) (NP (NP (DT an) (JJ exclusive) (NN role)) (PP (IN as) (NP (DT a) (JJ combinatorial) (NN differentiation) (NN switch)))) (PP (IN during) (NP (NP (NN myelopoiesis)) (PP (IN in) (NP (JJ human) (NNS cells))))))))))))))) (. .))))
(S1 (S (S (PP (IN By) (S (VP (VBG using) (NP (NP (DT a) (ADJP (JJ reverse) (JJ transcription-PCR-based)) (NN approach)) (CC and) (NP (NP (DT a) (NN set)) (PP (IN of) (NP (NP (NNS primers)) (ADJP (JJ specific) (PP (IN for) (NP (NP (DT the) (NP (JJ DNA-binding) (NNS domains))) (PP (IN of) (NP (NP (ADJP (RB highly) (JJ homologous)) (NNS members)) (PP (IN of) (NP (NP (DT the) (NP (NN C/EBP) (NN family))) (PP (IN of) (NP (JJ transcriptional) (NNS regulators))))))))))))))))) (, ,) (NP (PRP we)) (VP (VBP have) (VP (VBN cloned) (NP (NP (NP (DT a) (NP (JJ novel) (JJ human) (NN gene))) (VP (VBG encoding) (NP (NP (DT a) (NN member)) (PP (IN of) (NP (DT the) (NP (NN C/EBP) (NN gene) (NN family))))))) (, ,) (VP (VBN identified) (PP (IN as) (NP (NP (NP (DT the) (JJ human) (NN homolog)) (PP (IN of) (NP (NN CRP1)))) (, ,) (NP (NN C/EBP-epsilon)))))))) (. .))))
(S1 (S (S (NP (NP (DT A) (NP (JJ 1.2-kb) (NN cDNA))) (VP (VBG encoding) (NP (JJ full-length) (NP (JJ human) (NN C/EBP-epsilon))))) (VP (VBD was) (VP (VBN cloned) (PP (IN from) (NP (DT a) (NP (JJ promyelocyte-late) (JJ myeloblast-derived) (NN lambda) (NN gt11) (NN library)))))) (. .))))
(S1 (S (S (NP (NP (JJ Molecular) (NN analysis)) (PP (IN of) (NP (DT the) (NP (NN cDNA)) (CC and) (NP (ADJP (JJ genomic))) (NP (NNS clones))))) (VP (VBD indicated) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (CD two) (NP (NNS exons))) (VP (VBG encoding) (NP (NP (DT a) (NN protein)) (PP (IN with) (NP (NP (NP (DT an) (JJ apparent) (JJ molecular) (NN mass)) (PP (IN of) (NP (CD 32) (NN kDa)))) (CC and) (NP (NP (DT a) (NN pI)) (PP (IN of) (NP (CD 9.5)))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Primer) (NN extension) (NN analysis)) (PP (IN of) (NP (NN C/EBP-epsilon) (NN mRNA)))) (VP (VBD detected) (NP (NP (DT a) (JJ single) (JJ major) (NP (NN transcription) (NN start) (NN site))) (ADVP (NP (QP (RB approximately) (CD 200)) (NN bp)) (RB upstream) (PP (IN of) (NP (DT the) (NP (NN start) (NN codon))))))) (. .))))
(S1 (S (S (NP (DT The) (JJ putative) (NN promoter) (NN area)) (VP (VBZ is) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT those)) (PP (IN of) (NP (ADJP (JJ several) (JJ other) (JJ myeloid-cell-specific)) (NNS genes))))) (PP (IN in) (SBAR (IN that) (S (NP (PRP it)) (VP (VP (VBZ contains) (NP (DT no) (NP (NN TATAAA) (NN box)))) (CC but) (VP (VBZ has) (NP (NP (NP (DT a) (NN number)) (PP (IN of) (NP (JJ purine-rich) (NNS stretches)))) (PP (IN with) (NP (NP (JJ multiple) (NNS sites)) (PP (IN for) (NP (NP (DT the) (NNS factors)) (PP (IN of) (NP (NP (DT the) (NP (NN Ets) (NN family))) (PP (IN of) (NP (JJ transcriptional) (NNS regulators))))))))))))))))) (. .))))
(S1 (S (S (NP (NN Northern) (NN blot) (NNS analyses)) (VP (VBD indicated) (NP (NP (DT a) (ADJP (RB highly) (JJ restricted)) (NN mRNA) (NN expression) (NN pattern)) (, ,) (PP (IN with) (S (NP (DT the) (JJS strongest) (NN expression)) (VP (VBG occurring) (PP (IN in) (NP (NP (NN promyelocyte)) (CC and) (NP (ADJP (JJ late-myeloblast-like))) (NP (NN cell) (NNS lines))))))))) (. .))))
(S1 (S (S (NP (NP (NP (NN Western) (NN blot)) (CC and) (NP (NN immunoprecipitation)) (NP (NNS studies))) (VP (VBG using) (NP (NP (NN rabbit) (JJ anti-C/EBP-epsilon) (NNS antibodies)) (VP (VBN raised) (PP (IN against) (NP (NP (NP (DT the) (NP (JJ N-terminal) (NN portion))) (PP (IN of) (NP (NN C/EBP-epsilon)))) (PRN (-LRB- -LRB-) (NP (NN amino) (NNS acids) (CD 1) (TO to) (CD 115)) (-RRB- -RRB-)))))))) (VP (VBD showed) (SBAR (IN that) (S (NP (NN C/EBP-epsilon)) (VP (VBZ is) (NP (DT a) (NP (JJ 32-kDa) (JJ nuclear) (NN phosphoprotein))))))) (. .))))
(S1 (S (S (NP (DT The) (JJ human) (NP (NN C/EBP-epsilon)) (NN protein)) (VP (VBD exhibited) (NP (NP (ADJP (ADJP (JJ strong)) (CC and) (ADJP (JJ specific))) (NN binding)) (PP (TO to) (NP (JJ double-stranded) (NN DNA) (VBG containing) (NN consensus) (NN C/EBP) (NNS sites))))) (. .))))
(S1 (S (S (NP (NP (NN Cotransfection)) (PP (IN of) (NP (DT the) (NP (NN C/EBP-epsilon)) (NP (NN sense)) (CC and) (NP (JJ antisense)) (NP (NN expression) (NNS constructs)))) (PP (ADVP (RB together)) (IN with) (NP (NP (NN chloramphenicol) (NN acetyltransferase) (NN reporter) (NNS vectors)) (VP (VBG containing) (NP (NP (JJ myeloid-cell-specific) (NN c-mim)) (CC and) (NP (ADJP (JJ human) (JJ myeloperoxidase))) (NP (NNS promoters))))))) (VP (VBD suggested) (NP (NP (DT a) (NN role)) (PP (IN for) (NP (NP (NN C/EBP-epsilon)) (NP (NN transcription) (NN factor)))) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NP (DT a) (NN subset)) (PP (IN of) (NP (JJ myeloid-cell-specific) (NNS genes))))))))) (. .))))
(S1 (S (S (NP (NP (JJ Transient) (NN tranfection)) (PP (IN of) (NP (NP (DT a) (NP (NN promyelocyte) (NN cell) (NN line))) (PRN (-LRB- -LRB-) (NP (NN NB4)) (-RRB- -RRB-)))) (PP (IN with) (NP (DT a) (NP (NN C/EBP-epsilon) (NN expression) (NN plasmid))))) (VP (VBD increased) (NP (NN cell) (NN growth)) (PP (IN by) (NP (RB sevenfold))) (, ,) (SBAR (IN while) (S (NP (JJ antisense) (NP (NN C/EBP-epsilon))) (VP (VBD caused) (NP (NP (DT a) (JJ fivefold) (NN decrease)) (PP (IN in) (NP (NP (JJ clonal) (NN growth)) (PP (IN of) (NP (DT these) (NNS cells)))))))))) (. .))))
(S1 (S (NP (NP (NP (NP (JJ Transcriptional) (NN regulation)) (PP (IN of) (NP (DT the) (NP (NN ferritin) (JJ heavy-chain) (NN gene)))) (: :)) (S (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (DT the) (NP (NN CCAAT) (NN binding) (NN factor) (NN NF-Y))))) (VP (VBZ is) (VP (VBN modulated) (PP (PP (IN in) (NP (JJ heme-treated) (NN Friend) (NN leukemia) (NNS cells))) (CC and) (PP (IN during) (NP (JJ monocyte-to-macrophage) (NN differentiation))))))) (. .)))))
(S1 (S (S (S (NP (DT The) (NP (NN ferritin) (JJ H-chain) (NN gene) (NN promoter)) (NN regulation)) (VP (VBD was) (VP (VBN analyzed) (PP (PP (IN in) (NP (NP (JJ heme-treated) (NN Friend) (NN leukemia) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NNS FLCs)) (-RRB- -RRB-)))) (CC and) (PP (IN during) (NP (JJ monocyte-to-macrophage) (NN differentiation)))))) (. .)))))
(S1 (S (S (PP (IN In) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (NP (NN cell) (NNS lines)) (VP (VBN studied)))))) (, ,) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NP (NN ferritin)) (NN expression)))) (VP (VBD was) (VP (VBN exerted) (PP (ADVP (RB mostly)) (IN at) (NP (DT the) (JJ translational) (NN level))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (PP (PP (IN in) (NP (NP (VBG differentiating) (JJ erythroid) (NNS cells)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD must) (VP (VB incorporate) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NN iron))))) (S (VP (TO to) (VP (VB sustain) (NP (NP (NN hemoglobin)) (NN synthesis)))))))))) (, ,) (CC and) (PP (IN in) (NP (NP (NNS macrophages)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBN involved) (PP (IN in) (NP (NN iron) (NN storage)))))))))) (, ,) (NP (JJ transcriptional) (NN regulation)) (VP (VBD seemed) (S (VP (TO to) (VP (VB be) (NP (DT a) (JJ relevant) (NN mechanism)))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP show) (ADVP (RB here)) (SBAR (IN that) (S (NP (NP (DT the) (JJ minimum) (NN region)) (PP (IN of) (NP (NP (DT the) (NP (NN ferritin) (NN H-gene) (NN promoter))) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADJP (JJ able) (S (VP (TO to) (VP (VB confer) (NP (JJ transcriptional) (NN regulation)) (PP (IN by) (NP (NP (NN heme)) (PP (IN in) (NP (NNS FLCs))))) (PP (TO to) (NP (DT a) (NP (NN reporter) (NN gene)))))))))))))) (VP (VBZ is) (NP (NP (CD 77) (NNS nucleotides) (JJ upstream)) (PP (IN of) (NP (DT the) (NP (NN TATA) (NN box))))))))) (. .))))
(S1 (S (S (NP (DT This) (NP (JJ cis) (NN element))) (VP (VBZ binds) (NP (NP (DT a) (NN protein) (NN complex)) (VP (VBN referred) (PP (TO to)) (PP (IN as) (NP (NP (NP (NN HRF)) (PRN (-LRB- -LRB-) (NP (JJ heme-responsive) (NN factor)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADVP (RB greatly)) (VP (VBN enhanced) (PP (CC both) (PP (IN in) (NP (JJ heme-treated) (NP (NNS FLCs)))) (CC and) (PP (IN during) (NP (JJ monocyte-to-macrophage) (NN differentiation))))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NP (NN CCAAT) (NN element))) (ADJP (JJ present) (PP (IN in) (NP (JJ reverse) (NN orientation))) (PP (IN in) (NP (NP (DT this) (NN promoter) (NN region)) (PP (IN of) (NP (DT the) (NP (NN ferritin) (JJ H-chain) (NN gene)))))))) (VP (VBZ is) (ADJP (JJ necessary) (PP (PP (IN for) (NP (NN binding))) (CC and) (PP (IN for) (NP (NN gene) (NN activity))))) (, ,) (SBAR (IN since) (S (NP (DT a) (JJ single) (NN point) (NN mutation)) (VP (VBZ is) (ADJP (JJ able) (S (VP (TO to) (VP (VB abolish) (NP (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NN HRF)))) (CC and) (NP (NP (DT the) (JJ transcriptional) (NN activity)) (PP (IN in) (NP (VBN transfected) (NNS cells))))))))))))) (. .))))
(S1 (S (S (PP (IN By) (NP (NP (NN competition) (NNS experiments)) (CC and) (NP (NN supershift) (NNS assays)))) (, ,) (NP (PRP we)) (VP (VBD identified) (NP (DT the) (VBN induced) (NP (NN HRF))) (PP (IN as) (S (VP (VBG containing) (NP (ADVP (IN at) (JJS least)) (NP (NP (DT the) (JJ ubiquitous) (NP (NN transcription) (NN factor))) (NP (NN NF-Y)))))))) (. .))))
(S1 (S (S (NP (NN NF-Y)) (VP (VBZ is) (VP (VBN formed) (PP (IN by) (NP (NP (NP (CD three) (NP (NNS subunits))) (, ,) (NP (NP (DT A)) (, ,) (NP (NN B)) (, ,) (CC and) (NP (NN C)))) (, ,) (SBAR (WHNP (NP (DT all)) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (VBP are) (ADJP (JJ necessary) (PP (IN for) (NP (NN DNA) (NN binding))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Cotransfection)) (PP (IN with) (NP (NP (DT a) (NP (JJ transdominant) (JJ negative) (NN mutant))) (PP (IN of) (NP (DT the) (NP (NN NF-YA) (NN subunit))))))) (VP (VBZ abolishes) (NP (NP (DT the) (JJ transcriptional) (NN activation)) (PP (IN by) (NP (NN heme)))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NN NF-Y)) (VP (VBZ plays) (NP (DT an) (JJ essential) (NN role)) (PP (IN in) (NP (DT this) (NN activation))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB also)) (VP (VBN observed) (NP (NP (DT a) (JJ differential) (NN expression)) (PP (IN of) (NP (DT the) (NP (NN NF-YA) (NN subunit)))) (PP (PP (IN in) (NP (NP (ADJP (JJ heme-treated))) (CC and) (NP (JJ control)) (NP (NNS FLCs)))) (CC and) (PP (IN during) (NP (JJ monocyte-to-macrophage) (NN differentiation))))))) (. .))))
(S1 (S (NP (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (DT a) (NP (JJ mutant) (NN cell) (NN line))) (SBAR (WHNP (WDT that)) (S (VP (VBZ does) (RB not) (VP (VB activate) (NP (NN NF-kappaB)) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (JJ multiple) (NNS stimuli))))))))))) (. .)))))
(S1 (S (S (S (NP (NP (JJ Numerous) (NNS genes)) (VP (VBN required) (PP (IN during) (NP (NP (DT the) (NP (ADJP (JJ immune))) (CC or) (NP (NN inflammation)) (NP (NN response))) (CONJP (RB as) (RB well) (IN as)) (NP (DT the) (NN adhesion) (NN process)))))) (VP (VBP are) (VP (VBN regulated) (PP (IN by) (NP (NP (JJ nuclear) (NN factor) (NN kappaB)) (PRN (-LRB- -LRB-) (NP (NN NF-kappaB)) (-RRB- -RRB-)))))) (. .)))))
(S1 (S (S (S (VP (VBN Associated) (PP (IN with) (NP (NP (PRP$ its) (NN inhibitor)) (, ,) (NP (NN I) (NN kappaB)))))) (, ,) (S (NP (NN NF-kappaB)) (VP (VBZ resides) (PP (IN as) (NP (DT an) (JJ inactive) (NN form))) (PP (IN in) (NP (DT the) (NN cytoplasm))))) (. .))))
(S1 (S (S (PP (IN Upon) (NP (NP (NN stimulation)) (PP (IN by) (NP (JJ various) (NNS agents))))) (, ,) (S (S (NP (NN I) (NN kappaB)) (VP (VBZ is) (VP (VBN proteolyzed)))) (CC and) (S (NP (NN NF-kappaB)) (VP (VBZ translocates) (PP (TO to) (NP (NP (DT the) (NN nucleus)) (, ,) (SBAR (WHADVP (WRB where)) (S (NP (PRP it)) (VP (VBZ activates) (NP (PRP$ its) (NN target) (NNS genes)))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN transduction) (NNS pathways)) (SBAR (WHNP (WDT that)) (S (VP (VBP lead) (PP (TO to) (NP (NP (NN I) (NN kappaB)) (NN inactivation))))))) (VP (VBP remain) (ADVP (RB poorly)) (VP (VBN understood))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBP have) (VP (VBN characterized) (NP (NP (NP (DT a) (JJ cellular) (NN mutant)) (, ,) (NP (DT the) (NP (JJ 70/Z3-derived) (NN 1.3E2) (JJ murine) (JJ pre-B) (NN cell) (NN line)))) (, ,) (SBAR (WHNP (WDT that)) (S (VP (VBZ does) (RB not) (VP (VB activate) (NP (NN NF-kappaB)) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (JJ several) (NNS stimuli)))))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP demonstrate) (SBAR (IN that) (S (PP (IN upon) (NP (NP (NN stimulation)) (PP (IN by) (NP (NP (NN lipopolysaccharide)) (, ,) (NP (NN Taxol)) (, ,) (NP (NN phorbol) (NN myristate) (NN acetate)) (, ,) (NP (NN interleukin-1)) (, ,) (CC or) (NP (JJ double-stranded) (NN RNA)))))) (, ,) (NP (NN I) (NN kappaB) (NN alpha)) (VP (VBZ is) (RB not) (VP (VBN degraded) (, ,) (PP (IN as) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (NP (DT an) (NN absence)) (PP (IN of) (NP (NP (VBN induced) (NN phosphorylation)) (PP (IN on) (NP (NNS serines) (NP (CD 32)) (CC and) (NP (CD 36))))))))))))))) (. .))))
(S1 (S (S (NP (CC Neither) (NP (NP (DT a) (NN mutation)) (PP (IN in) (NP (NN I) (NN kappaB) (NN alpha)))) (CC nor) (NP (NP (DT a) (NN mutation)) (PP (IN in) (NP (NP (NP (NN p50)) (CC or) (NP (NN relA))) (, ,) (NP (NP (DT the) (CD two) (JJ major) (NNS subunits)) (PP (IN of) (NP (NP (NN NF-kappaB)) (PP (IN in) (NP (DT this) (NN cell) (NN line))))))))) (, ,)) (VP (VBZ accounts) (PP (IN for) (NP (DT this) (NN phosphorylation) (NN defect)))) (. .))))
(S1 (S (S (SBAR (RB As) (RB well) (IN as) (S (VP (VBG culminating) (PP (IN in) (NP (NP (DT the) (JJ inducible) (NN phosphorylation)) (PP (IN of) (NP (NP (NN I) (NN kappaB)) (NN alpha))) (PP (IN on) (NP (NNS serines) (NP (CD 32)) (CC and) (NP (CD 36))))))))) (, ,) (S (NP (NP (PDT all) (DT the) (NNS stimuli)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (JJ inactive) (PP (IN on) (NP (NN 1.3E2) (NNS cells)))))))) (VP (VBP exhibit) (NP (NP (DT a) (NN sensitivity)) (PP (TO to) (NP (NP (DT the) (JJ antioxidant)) (NP (NP (NN pyrrolidine) (NN dithiocarbamate)) (PRN (-LRB- -LRB-) (NP (NN PDTC)) (-RRB- -RRB-)))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (NNS stimuli)) (PP (JJ such) (IN as) (NP (NP (NP (JJ hyperosmotic) (NN shock)) (CC or) (NP (NN phosphatase) (NNS inhibitors))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP use) (NP (JJ PDTC-insensitive) (NNS pathways))))))) (, ,)) (VP (VBP induce) (NP (NP (NN I) (NN kappaB)) (NN alpha) (NN degradation)) (PP (IN in) (NP (NN 1.3E2)))) (. .))))
(S1 (S (S (NP (NP (NN Analysis)) (PP (IN of) (NP (NP (DT the) (JJ redox) (NN status)) (PP (IN of) (NP (NN 1.3E2)))))) (VP (VBZ does) (RB not) (VP (VB reveal) (NP (NP (DT any) (NN difference)) (PP (IN from) (NP (JJ wild-type) (NN 70Z/3)))))) (. .))))
(S1 (S (S (NP (PRP We)) (ADVP (RB also)) (VP (VBP report) (SBAR (IN that) (S (NP (DT the) (NP (JJ human) (NN T-cell) (NN leukemia) (NN virus) (NN type) (CD 1) (-LRB- -LRB-) (NN HTLV-1) (-RRB- -RRB-) (JJ -derived) (NN Tax) (NN trans-activator))) (VP (VBZ induces) (NP (NP (NN NF-kappaB)) (NN activity)) (PP (IN in) (NP (NN 1.3E2))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (DT this) (JJ viral) (NN protein)) (VP (VBZ does) (RB not) (VP (VB operate) (PP (IN via) (NP (DT the) (JJ defective) (NN pathway))))))))))))) (. .))))
(S1 (S (S (ADVP (RB Finally)) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (CD two) (JJ other) (NP (NN I) (NN kappaB) (NNS molecules))) (, ,) (NP (NP (NN I) (NN kappaB) (NN beta)) (CC and) (NP (DT the) (ADJP (RB recently) (VBN identified)) (NP (NN I) (NN kappaB) (NN epsilon)))) (, ,)) (VP (VBP are) (RB not) (VP (VBN degraded) (PP (IN in) (NP (DT the) (NP (NN 1.3E2)) (NN cell) (NN line))) (PP (VBG following) (NP (NN stimulation)))))))) (. .))))
(S1 (S (S (NP (PRP$ Our) (NNS results)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN 1.3E2)) (VP (VBZ is) (NP (NP (DT a) (NP (JJ cellular) (NN transduction) (NN mutant))) (VP (VBG exhibiting) (NP (DT a) (NN defect)) (PP (IN in) (NP (NP (DT a) (NN step)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN required) (PP (IN by) (NP (ADJP (JJ several) (JJ different)) (NNS stimuli)))) (S (VP (TO to) (VP (VB activate) (NP (NN NF-kappaB)))))))))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (DT this) (NN analysis)) (VP (VBZ suggests) (NP (NP (DT a) (JJ common) (NN step)) (PP (IN in) (NP (NP (DT the) (NN signaling) (NNS pathways)) (SBAR (WHNP (WDT that)) (S (VP (VBP trigger) (NP (NP (NP (NN I) (NN kappaB) (NN alpha))) (, ,) (NP (NP (NN I) (NN kappaB) (NN beta))) (, ,) (CC and) (NP (NP (NN I) (NN kappaB) (NN epsilon))) (NP (NN degradation)))))))))) (. .))))
(S1 (S (S (S (NP (NP (NN Transcription)) (VP (VBN mediated) (PP (IN by) (NP (NN NFAT))))) (VP (VBZ is) (ADJP (RB highly) (JJ inducible) (PP (PP (IN in) (NP (NN effector) (NP (JJ CD4+) (NN T) (NN helper) (CD 2) (-LRB- -LRB-) (NN Th2) (-RRB- -RRB-) (NNS cells)))) (CC but) (PP (RB not) (IN in) (NP (NN Th1) (NNS cells)))))) (. .)))))
(S1 (S (S (S (NP (NP (JJ Transcriptional) (NNS factors)) (PP (IN of) (NP (DT the) (NP (NN NFAT) (NN family))))) (VP (VBP play) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (S (VP (VBG regulating) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (JJ several) (NP (NN cytokine) (NNS genes)))) (PP (IN during) (NP (DT the) (JJ immune) (NN response)))))))) (, ,) (PP (JJ such) (IN as) (NP (NP (DT the) (NNS genes)) (PP (IN for) (NP (NP (NP (NN interleukin) (CD 2)) (PRN (-LRB- -LRB-) (NP (NN IL-2)) (-RRB- -RRB-))) (CC and) (NP (NN IL-4)))) (, ,) (PP (IN among) (NP (NNS others))))) (. .)))))
(S1 (S (S (PP (IN Upon) (NP (NN antigen) (NN stimulation))) (, ,) (NP (NN precursor) (NP (JJ CD4+) (NN T) (NN helper) (-LRB- -LRB-) (NN pTh) (-RRB- -RRB-) (NNS cells))) (VP (VP (VBP proliferate)) (CC and) (VP (VBP differentiate) (PP (IN into) (NP (NP (NP (CD two) (NNS populations)) (PP (IN of) (NP (NN effector) (NNS cells)))) (PRN (-LRB- -LRB-) (NP (NP (NN eTh1)) (CC and) (NP (NN eTh2))) (-RRB- -RRB-)))) (, ,) (S (NP (DT each) (NN one)) (VP (VBG expressing) (NP (NP (NP (DT a) (JJ specific) (NN pattern)) (PP (IN of) (NP (NNS cytokines)))) (SBAR (WHNP (WDT that)) (S (VP (VBZ distinguishes) (NP (PRP them)) (PP (IN from) (NP (PRP$ their) (NNS precursors))))))))))) (. .))))
(S1 (S (S (NP (NN eTh2) (NNS cells)) (VP (VBP are) (NP (NP (DT the) (JJ major) (NN source)) (PP (IN of) (NP (NN IL-4)))) (, ,) (SBAR (IN while) (S (NP (NN gamma) (NN interferon)) (VP (VBZ is) (VP (VBN produced) (PP (IN by) (NP (NN eTh1) (NNS cells)))))))) (. .))))
(S1 (S (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP have) (VP (VBN used) (NP (NN reporter) (JJ transgenic) (NNS mice))) (S (VP (TO to) (VP (VB show) (SBAR (IN that) (S (NP (NP (NN DNA) (NN binding)) (CC and) (NP (NP (JJ transcriptional) (NNS activities)) (PP (IN of) (NP (NN NFAT))))) (VP (VBP are) (ADVP (RB transiently)) (VP (VBN induced) (PP (IN during) (NP (NP (DT the) (NN differentiation)) (PP (IN of) (NP (NN pTh) (NNS cells))) (PP (IN into) (NP (CC either) (NP (NP (NN eTh1))) (CC or) (NP (NN eTh2) (NNS cells))))))) (S (VP (TO to) (VP (VB mediate) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN IL-2)))) (PP (IN as) (NP (NP (DT a) (JJ common) (NN growth) (NN factor)) (PP (IN in) (NP (CC both) (NNS pathways))))))))))))))) (. .))))
(S1 (S (S (S (ADVP (RB However)) (, ,) (SBAR (IN although) (S (NP (NP (NN NFAT)) (NN DNA) (NN binding)) (VP (VBZ is) (ADVP (RB similarly)) (VP (VBN induced) (PP (IN in) (NP (CC both) (NP (NP (NN eTh1))) (CC and) (NP (NN eTh2) (NNS cells)))) (PP (IN upon) (NP (NN antigen) (NN stimulation))))))) (, ,) (S (NP (NP (RB only) (DT the) (NP (NN NFAT) (NNS complexes))) (ADJP (JJ present) (PP (IN in) (NP (NN eTh2) (NNS cells))))) (VP (VBP are) (ADJP (JJ able) (S (VP (TO to) (VP (VB mediate) (NP (JJ high-level) (NN transcription))))))))) (, ,) (CC and) (S (NP (ADJP (RB relatively) (JJ little)) (NP (NN NFAT)) (JJ transcriptional) (NN activity)) (VP (VBD was) (VP (VBN induced) (PP (IN in) (NP (NN eTh1) (NNS cells)))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (NN contrast)) (PP (TO to) (NP (VBN activated) (NP (NN pTh) (NNS cells)))))) (, ,) (S (S (NP (CC neither) (NP (NP (NN eTh1))) (CC nor) (NP (NN eTh2) (NNS cells))) (VP (VBD produced) (NP (JJ significant) (NP (NN IL-2))) (PP (IN upon) (NP (NN stimulation))))) (, ,) (CC but) (S (NP (NP (DT the) (JJ high) (NNS levels)) (PP (IN of) (NP (NP (NN NFAT)) (JJ transcriptional) (NNS activities)))) (ADVP (RB directly)) (VP (VBP correlate) (PP (IN with) (NP (NP (DT the) (NP (NN IL-4)) (NN production)) (VP (VBN induced) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NP (NN antigen) (NN stimulation)) (PP (IN in) (NP (NN eTh2) (NNS cells))))))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS data)) (VP (VBP suggest) (SBAR (SBAR (IN that) (S (NP (VBN activated) (NP (NN NFAT))) (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN effector) (NN function)) (PP (IN of) (NP (NN eTh2) (NNS cells))))))))) (CC and) (SBAR (IN that) (S (NP (NP (DT the) (NN failure)) (PP (IN of) (NP (NN eTh1) (NNS cells))) (S (VP (TO to) (VP (VB produce) (NP (NN IL-4)) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (DT an) (NN antigen))))))))) (VP (VBZ is) (ADJP (JJ due) (, ,) (ADVP (ADVP (IN at) (JJS least)) (RB partially)) (, ,) (PP (TO to) (NP (NP (DT a) (NN failure)) (S (VP (TO to) (VP (VB induce) (NP (NP (JJ high-level) (NN transcription)) (PP (IN of) (NP (DT the) (NP (NN IL-4) (NN gene)))) (PP (IN by) (NP (NN NFAT))))))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Regulation)) (PP (IN of) (NP (NN NFAT)))) (VP (MD could) (VP (VB be) (ADVP (RB therefore)) (NP (DT a) (JJ critical) (NN element)) (PP (IN in) (NP (NP (DT the) (NN polarization)) (PP (TO to) (NP (NP (NN eTh1)) (CC or) (NP (NN eTh2)))))))) (. .))))
(S1 (S (S (S (S (NP (NP (JJ Constitutive) (NN expression)) (PP (IN of) (NP (NN p50) (NN homodimer))) (PP (IN in) (NP (RB freshly) (VBN isolated) (JJ human) (NNS monocytes)))) (VP (VBZ decreases) (PP (IN with) (NP (NP (ADJP (FW in) (FW vitro))) (CC and) (NP (ADJP (FW in) (FW vivo))) (NP (NN differentiation)))))) (: :) (NP (NP (DT a) (JJ possible) (NN mechanism)) (VP (VBG influencing) (NP (NP (JJ human) (NN immunodeficiency) (NN virus) (NN replication)) (PP (IN in) (NP (NP (NNS monocytes)) (CC and) (NP (JJ mature) (NNS macrophages))))))) (. .)))))
(S1 (S (S (S (NP (NP (JJ Human) (NN immunodeficiency) (NN virus) (NN type) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN HIV-1)) (-RRB- -RRB-))) (VP (VBZ replicates) (ADVP (ADVP (RBR more) (RB efficiently)) (ADVP (FW in) (FW vitro)) (PP (IN in) (NP (VBN differentiated) (NNS macrophages))) (PP (IN than) (PP (IN in) (NP (RB freshly) (VBN isolated) (NNS monocytes)))))) (. .)))))
(S1 (S (S (NP (PRP We)) (VP (VBD investigated) (SBAR (IN whether) (S (NP (DT this)) (VP (MD may) (VP (VB be) (ADVP (RB partly)) (VP (VBN explained) (PP (IN by) (NP (NP (NNS changes)) (PP (IN in) (NP (NP (NN expression)) (PP (IN of) (NP (NN NF-kappaB))))) (PP (IN with) (NP (NN monocyte) (NN differentiation))))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (JJ constitutive) (NN expression)) (PP (IN of) (NP (NN NF-kappaB))) (PP (IN in) (NP (JJ primary) (JJ human) (NNS monocytes)))) (VP (VBD changed) (ADVP (RB significantly)) (PP (IN with) (NP (NP (NP (NP (NN differentiation)) (ADJP (FW in) (FW vitro))) (PP (TO to) (NP (NP (JJ monocyte-derived) (NNS macrophages)) (PRN (-LRB- -LRB-) (NP (NNS MDMs)) (-RRB- -RRB-))))) (CC and) (NP (NP (NP (NN differentiation)) (ADJP (FW in) (FW vivo))) (PP (TO to) (NP (NP (JJ alveolar) (NNS macrophages)) (PRN (-LRB- -LRB-) (NP (NNS AMs)) (-RRB- -RRB-))))))))))) (. .))))
(S1 (S (S (NP (RB Freshly) (VBN isolated) (NNS monocytes)) (ADVP (RB constitutively)) (VP (VBD expressed) (NP (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (RB transcriptionally) (JJ inactive) (NN p50) (NN homodimer)))) (SBAR (WHNP (WDT which)) (S (VP (VBD decreased) (PP (IN with) (NP (NP (NN time)) (PP (IN in) (NP (NN culture))))) (PP (IN in) (NP (NP (NN favor)) (PP (IN of) (NP (DT the) (ADJP (RB transcriptionally) (JJ active)) (NP (NN p50/p65)) (CC and) (NP (NN p50/RelB)) (NP (NNS heterodimers))))))))))) (. .))))
(S1 (S (S (PP (IN As) (PP (IN in) (NP (NNS MDMs)))) (, ,) (NP (NNS AMs)) (ADVP (RB constitutively)) (VP (VBD expressed) (NP (NP (NN p50/p65)) (CC and) (NP (NN p50/RelB))) (SBAR (IN although) (FRAG (PP (IN at) (NP (JJR lower) (NNS levels)))))) (. .))))
(S1 (S (S (NP (NP (NN HIV) (NN infection)) (PP (IN of) (NP (JJ fresh) (NP (NNS monocytes))))) (VP (VBD failed) (S (VP (TO to) (VP (VB induce) (NP (NN p50/p65))))) (SBAR (IN as) (S (VP (VBN seen) (PP (IN in) (NP (NNS MDMs))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN replacement)) (PP (IN of) (NP (NN p50) (NNS homodimers))) (PP (IN with) (NP (ADJP (RB transcriptionally) (JJ active)) (NNS heterodimers))) (PP (VBG following) (NP (NP (NN time)) (PP (IN in) (NP (NN culture)))))) (VP (MD may) (ADVP (RB partially)) (VP (VB explain) (NP (NP (DT the) (JJ progressive) (NN increase)) (PP (IN in) (NP (NP (NN susceptibility)) (PP (IN of) (NP (NNS monocytes))) (PP (TO to) (NP (NN HIV) (NN infection))) (PP (IN during) (NP (ADJP (FW in) (FW vitro)) (NN culture)))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN change)) (PP (IN in) (NP (NN NF-kappaB) (NNS components))) (PP (IN with) (NP (NP (NN monocyte) (NN differentiation)) (ADJP (FW in) (FW vivo))))) (VP (MD may) (ADVP (RB also)) (VP (VB explain) (NP (NP (DT the) (ADJP (ADJP (JJ different)) (ADJP (JJ transcriptional))) (NNS activities)) (PP (IN of) (NP (NP (DT these) (NN cell) (NNS populations)) (PP (IN in) (NP (JJ HIV-infected) (NNS individuals)))))))) (. .))))
(S1 (S (NP (NP (NP (NN Identification)) (PP (IN of) (NP (NP (NN nucleotide) (NNS sequences)) (SBAR (WHNP (WDT that)) (S (VP (VBP regulate) (NP (NP (NN transcription)) (PP (IN of) (NP (DT the) (NN MCF13) (JJ murine) (NN leukemia) (NN virus) (NP (JJ long) (JJ terminal) (NN repeat)))) (PP (IN in) (NP (VBN activated) (NP (NN T) (NNS cells)))))))))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (NN region)) (ADVP (ADVP (ADVP (JJ downstream) (PP (IN of) (NP (DT the) (NP (NN enhancer))))) (PRN (-LRB- -LRB-) (NP (NN DEN)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (DT the) (NP (JJ long) (JJ terminal) (NN repeat))) (PP (IN of) (NP (DT the) (ADJP (ADJP (NN mink) (NN cell) (JJ focus-forming)) (ADJP (JJ murine))) (NN leukemia) (NN virus))))))) (VP (VBZ is) (ADJP (JJ important) (PP (IN for) (NP (JJ viral) (NN pathogenicity))))) (. .)))))
(S1 (S (S (S (NP (NP (DT Another) (JJ important) (NN activity)) (PP (IN of) (NP (NN DEN)))) (VP (VBZ is) (NP (NP (PRP$ its) (NN control)) (PP (IN of) (NP (NP (NN transcription)) (PP (IN in) (NP (VBN activated) (NN T) (NNS cells)))))))) (, ,) (CC and) (S (NP (PRP we)) (VP (VBP have) (VP (VBN determined) (SBAR (IN that) (S (NP (DT an) (NP (NN NF-kappaB)) (NN site)) (VP (VBZ is) (ADJP (JJ critical) (PP (IN for) (NP (DT this) (NN activity)))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Activation)) (PP (IN of) (NP (DT the) (NP (NN NF-kappaB)) (NP (NN transcription) (NN factor)))) (PP (IN in) (NP (DT a) (NP (JJ T-lymphocytic) (NN cell) (NN line)))) (PP (IN by) (NP (JJ hypochlorous) (NN acid))) (. .)))))
(S1 (S (S (S (NP (NP (NP (JJ Reactive) (NN oxygen) (NNS species)) (PRN (-LRB- -LRB-) (NP (NNS ROS)) (-RRB- -RRB-))) (PP (JJ such) (IN as) (NP (NN hydrogen) (NN peroxide)))) (VP (VBP serve) (PP (IN as) (NP (JJ second) (NNS messengers))) (PP (PP (IN in) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NP (DT the) (NP (NN transcription) (NN factor))) (NP (NN NF-kappaB)))))) (, ,) (CC and) (ADVP (RB hence)) (PP (IN in) (NP (NP (DT the) (NP (NN activation)) (CC and) (NP (NN replication))) (PP (IN of) (NP (NP (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN HIV-1)) (-RRB- -RRB-)))) (PP (IN in) (NP (JJ human) (NNS cells))))))) (. .)))))
(S1 (S (S (PP (IN During) (NP (JJ inflammatory) (NNS reactions))) (, ,) (NP (JJ many) (JJ oxidative) (NNS species)) (VP (VBP are) (VP (VBN produced))) (, ,) (SBAR (WHNP (NP (CD one)) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (VBZ is) (NP (NP (NP (JJ hypochlorous) (NN acid)) (PRN (-LRB- -LRB-) (NP (NN HOCl)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (JJ responsible) (PP (IN for) (NP (NP (DT the) (JJ microbicidal) (NNS effects)) (PP (IN of) (NP (VBN activated) (NP (JJ human) (JJ polymorphonuclear) (NNS leukocytes)))))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Treatment)) (PP (IN of) (NP (DT a) (NP (JJ T-lymphocytic) (NN cell) (NN line)))) (PP (IN with) (NP (NP (JJ micromolar) (NNS concentrations)) (PP (IN of) (NP (NN HOCl)))))) (VP (VBD promoted) (NP (NP (DT the) (NN appearance)) (PP (IN of) (NP (NP (NP (NN transcription) (NN factor)) (NP (NN NF-kappaB))) (PRN (-LRB- -LRB-) (NP (DT the) (NP (NN heterodimer) (NN p50/p65))) (-RRB- -RRB-)))) (PP (IN in) (NP (NP (DT the) (NN nucleus)) (PP (IN of) (NP (DT the) (NNS cells))))) (, ,) (PP (ADVP (RB even)) (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (ADJP (FW de) (FW novo)) (NN protein) (NN synthesis))))))) (. .))))
(S1 (S (S (NP (NP (NN Western) (NN blot) (NN analysis)) (PP (IN of) (NP (NP (DT the) (NP (NN NF-kappaB) (JJ inhibitory) (NNS subunits))) (PRN (-LRB- -LRB-) (NP (NN IkappaB)) (-RRB- -RRB-))))) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (CC both) (NP (NN IkappaB-alpha) (NN proteolysis)) (CC and) (NP (NP (NN p105)) (NN processing))) (VP (VBD were) (VP (VBN induced) (PP (IN by) (NP (DT the) (NN treatment)))))))) (. .))))
(S1 (S (S (NP (NP (NN NF-kappaB)) (NN activation)) (VP (VBD was) (ADJP (RB very) (JJ effective)) (SBAR (WHADVP (WRB when)) (S (NP (NNS cells)) (VP (VBD were) (VP (VBN subjected) (PP (TO to) (NP (NN hyperthermia)))) (SBAR (IN before) (S (VP (VBG being) (VP (VBN treated) (PP (IN with) (NP (NN HOCl))))))))))) (. .))))
(S1 (S (S (NP (NP (JJ Various) (NNS antioxidants)) (, ,) (PP (JJ such) (IN as) (NP (NP (NN pyrrolidine) (NN dithiocarbamate)) (, ,) (NP (NN p-bromophenacyl-bromide)) (CC and) (NP (JJ nordihydroguaiaretic) (NN acid))))) (VP (MD could) (ADVP (RB strongly)) (VP (VB reduce) (NP (NP (NN NF-kappaB)) (NN translocation))) (, ,) (S (VP (VBG demonstrating) (NP (NP (DT the) (NN importance)) (PP (IN of) (NP (JJ oxidative) (NNS species))) (PP (IN in) (NP (DT the) (NN transduction) (NN mechanism))))))) (. .))))
(S1 (S (S (ADVP (RB Moreover)) (, ,) (NP (NP (NN ACH-2) (NNS cells)) (VP (VBN treated) (PP (IN with) (NP (NP (NN HOCl)) (CC or) (NP (NN H2O2)))))) (VP (VBD released) (NP (NP (NN tumour) (NN necrosis) (NN factor-alpha)) (PRN (-LRB- -LRB-) (NP (NN TNF-alpha)) (-RRB- -RRB-))) (PP (IN in) (NP (DT the) (NNS supernatants)))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN importance)) (PP (IN of) (NP (NP (NP (NN TNF-alpha)) (NN release)) (PP (IN in) (NP (NP (NN NF-kappaB)) (NN induction))) (PP (IN by) (NP (NP (NN HOCl)) (CC or) (NP (NN H2O2))))))) (VP (VBD was) (VP (VBN demonstrated) (PP (IN by) (NP (NP (DT the) (NN fact)) (SBAR (IN that) (S (: :) (S (LST (-LRB- -LRB-) (LS 1) (-RRB- -RRB-)) (NP (NP (DT the) (JJ nuclear) (NN appearance)) (PP (IN of) (NP (NN NF-kappaB)))) (VP (VBD was) (VP (VBN promoted) (PP (IN in) (NP (JJ untreated) (NNS cells)))))) (: ;) (CC and) (S (LST (-LRB- -LRB-) (LS 2) (-RRB- -RRB-)) (NP (NP (NN synergism)) (PP (IN between) (NP (NP (NN TNF-alpha)) (CC and) (NP (NN HOCl))))) (VP (VBD was) (VP (VBN detected)))))))))) (. .))))
(S1 (S (S (ADVP (RB Collectively)) (, ,) (NP (DT these) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN HOCl)) (VP (MD should) (VP (VB be) (VP (VBN considered) (PP (IN as) (NP (NP (DT an) (JJ oxidative) (NNS species)) (ADJP (JJ capable) (PP (IN of) (S (VP (VP (VBG inducing) (NP (NN NF-kappaB)) (PP (IN in) (NP (DT a) (NP (JJ T-lymphocytic) (NN cell) (NN line)))) (PP (IN through) (NP (NP (DT a) (NN transduction) (NN mechanism)) (VP (VBG involving) (NP (NNS ROS)))))) (, ,) (CC and) (VP (VBG having) (NP (DT a) (JJ long-distance) (NN effect)) (PP (IN through) (NP (JJ subsequent) (NP (NN TNF-alpha)) (NN release)))))))))))))))) (. .))))
(S1 (S (NP (NP (NP (NN NF-kappa) (JJ B-independent) (NN suppression)) (PP (IN of) (NP (NN HIV) (NN expression))) (PP (IN by) (NP (JJ ascorbic) (NN acid))) (. .)))))
(S1 (S (S (S (NP (NP (JJ Ascorbic) (NN acid)) (PRN (-LRB- -LRB-) (NP (NP (NN ascorbate)) (CC or) (NP (NN vitamin) (NN C))) (-RRB- -RRB-))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB suppress) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NN HIV))) (PP (IN in) (NP (RB latently) (JJ infected) (NN T) (JJ lymphocytic) (NNS cells)))) (PP (VBG following) (NP (NP (NN stimulation)) (PP (IN with) (NP (NP (NP (DT a) (NN tumor) (NN promoter)) (PRN (-LRB- -LRB-) (NP (NN PMA)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ inflammatory) (NN cytokine)) (PRN (-LRB- -LRB-) (NP (NN TNF-alpha)) (-RRB- -RRB-))))))))))))) (. .)))))
(S1 (S (S (S (VP (TO To) (VP (VB assess) (SBAR (IN whether) (S (NP (DT this) (NN inhibition)) (VP (VBD was) (VP (VBN mediated) (PP (IN via) (NP (NP (NN modulation)) (PP (IN of) (NP (NP (DT the) (NP (JJ cellular) (NN transcription) (NN factor))) (, ,) (NP (NN NF-kappa) (NN B))))))))))))) (, ,) (S (NP (PRP we)) (VP (VBD carried) (PRT (RP out)) (NP (NP (NN gel) (NN shift) (NN analysis)) (PP (IN on) (NP (NP (JJ nuclear) (NNS extracts)) (VP (VBN prepared) (PP (IN under) (NP (NP (JJ different) (NNS conditions)) (PP (IN of) (NP (NN cell) (NN stimulation))))) (PP (IN in) (NP (DT the) (NP (NN presence)) (CC or) (NP (NN absence)) (PP (IN of) (NP (NP (NN ascorbate)) (, ,) (NP (NP (NN N-acetylcysteine)) (PRN (-LRB- -LRB-) (NP (NN NAC)) (-RRB- -RRB-))) (, ,) (CC or) (NP (NP (NN zidovudine)) (PRN (-LRB- -LRB-) (NP (NN AZT)) (-RRB- -RRB-))))))))))))) (. .))))
(S1 (S (S (NP (NP (NP (NN Pretreatment)) (PP (IN of) (NP (NN ACH-2) (NN T) (NNS cells))) (PP (IN by) (NP (NN NAC)))) (VP (VBN followed) (PP (IN by) (NP (NP (NN stimulation)) (PP (IN with) (NP (NP (NN PMA)) (, ,) (NP (NN TNF-alpha)) (, ,) (CC or) (NP (NP (NN hydrogen) (NN peroxide)) (PRN (-LRB- -LRB-) (NP (NN H2O2)) (-RRB- -RRB-))))))))) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ strong) (NN suppression)) (PP (IN of) (NP (NP (NN NF-kappa) (NN B)) (NN activation)))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (CC neither) (NP (NN ascorbate)) (CC nor) (NP (NN AZT))) (VP (VBD affected) (NP (NP (NN NF-kappa) (NN B)) (NN activity)) (PP (IN under) (NP (DT all) (CD three) (NN induction) (NNS conditions))) (PP (IN in) (NP (DT the) (NP (NN ACH-2) (NN cell) (NN line))))) (. .))))
(S1 (S (S (NP (NP (NN Ascorbate)) (CC and) (NP (NN AZT))) (ADVP (RB also)) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (NN NF-kappa) (NN B)) (NN activation))) (PP (VBG following) (NP (NP (NP (NN TNF-alpha-)) (CC or) (NP (JJ PMA-induced)) (NP (NN stimulation))) (PP (IN of) (NP (NN U1) (JJ promonocytic) (NNS cells)))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT the) (JJ molecular) (NN mechanism)) (PP (IN of) (NP (NP (NN HIV) (NN inhibition)) (PP (IN by) (NP (NN ascorbate)))))) (VP (VBZ is) (RB not) (VP (VBN mediated) (PP (IN via) (NP (NP (NN NF-kappa) (NN B)) (NN inhibition))) (, ,) (PP (IN unlike) (NP (NP (DT that)) (VP (VBN seen) (PP (IN with) (NP (JJ other) (NNS antioxidants))))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Involvement)) (PP (IN of) (NP (NN Egr-1/RelA) (NN synergy))) (PP (IN in) (S (VP (VBG distinguishing) (NP (NN T) (NN cell) (NN activation)) (PP (IN from) (NP (NN tumor) (NN necrosis) (JJ factor-alpha-induced) (NP (NN NF-kappa) (NN B1)) (NN transcription)))))) (. .)))))
(S1 (S (S (S (NP (NN NF-kappa) (NN B)) (VP (VBZ is) (NP (NP (DT an) (JJ important) (NP (NN transcription) (NN factor))) (VP (VBN required) (PP (IN for) (NP (NP (NN T) (NN cell) (NN proliferation)) (CC and) (NP (JJ other) (JJ immunological) (NNS functions))))))) (. .)))))
(S1 (S (S (NP (DT The) (NP (NN NF-kappa) (NN B1) (NN gene))) (VP (VBZ encodes) (NP (NP (DT a) (NP (JJ 105-kD) (NN protein))) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (NP (NP (DT the) (NN precursor)) (PP (IN of) (NP (NP (DT the) (NP (NN p50) (NN component))) (PP (IN of) (NP (NN NF-kappa) (NN B))))))))))) (. .))))
(S1 (S (S (ADVP (RB Previously)) (, ,) (NP (NP (PRP we)) (CC and) (NP (NNS others))) (VP (VBP have) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (NN NF-kappa) (NN B)) (VP (VBZ regulates) (NP (DT the) (NP (NN NF-kappa) (NN B1) (NN gene)))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT this) (NN manuscript))) (NP (PRP we)) (VP (VBP have) (VP (VBN investigated) (NP (NP (DT the) (JJ molecular) (NNS mechanisms)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (NP (NN T) (NN cell) (NNS lines)) (VP (VBN stimulated) (PP (IN with) (NP (NP (NP (NN phorbol) (NN 12-myristate) (NN 13-acetate)) (PRN (-LRB- -LRB-) (NP (NN PMA)) (-RRB- -RRB-))) (CC and) (NP (NP (NN phytohemagglutin)) (PRN (-LRB- -LRB-) (NP (NN PHA)) (-RRB- -RRB-))))))) (VP (VBP display) (NP (NP (NP (ADJP (RB significantly) (JJR higher)) (NNS levels)) (PP (IN of) (NP (NP (NN NF-kappa) (NN B1)) (NN encoding) (NP (NNS transcripts))))) (PP (IN than) (NP (NP (NNS cells)) (VP (VBN stimulated) (PP (IN with) (NP (NN tumor) (NN necrosis) (NN factor-alpha))))))) (, ,) (PP (IN despite) (NP (DT the) (NN fact) (SBAR (IN that) (S (NP (DT both) (NNS stimuli)) (VP (VBP activate) (NP (NN NF-kappa) (NN B))))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Characterization)) (PP (IN of) (NP (DT the) (NP (NN NF-kappa) (NN B1) (NN promoter))))) (VP (VBD identified) (NP (NP (DT an) (NP (NN Egr-1) (NN site))) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB be) (ADJP (JJ essential) (PP (IN for) (NP (CC both) (NP (DT the) (JJ PMA/PHA-mediated) (NN induction)) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT the) (JJ synergistic) (NN activation)) (VP (VBN observed) (PP (IN after) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (NP (DT the) (NN RelA) (NN subunit)) (PP (IN of) (NP (NN NF-kappa) (NN B)))) (CC and) (NP (NN Egr-1)))))))))))))))))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (NP (NN Egr-1)) (NN induction)) (VP (VBD was) (VP (VBN required) (PP (IN for) (NP (JJ endogenous) (NP (NN NF-kappa) (NN B1)) (NN gene) (NN expression)))) (, ,) (SBAR (IN since) (S (NP (NP (JJ PMA/PHA-stimulated) (NN T) (NN cell) (NNS lines)) (VP (VBG expressing) (NP (JJ antisense) (NP (NN Egr-1) (NN RNA))))) (VP (VBD were) (VP (VBN inhibited) (PP (IN in) (NP (PRP$ their) (NN ability) (S (VP (TO to) (VP (VB upregulate) (NP (NN NF-kappa) (NN B1) (NN transcription)))))))))))) (. .))))
(S1 (S (S (NP (PRP$ Our) (NNS studies)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (JJ transcriptional) (NN synergy)) (VP (VBN mediated) (PP (IN by) (NP (NP (NN activation)) (PP (IN of) (NP (CC both) (NP (NN Egr-1)) (CC and) (NP (NN NF-kappa) (NN B)))))))) (VP (MD may) (VP (VBP have) (NP (NP (JJ important) (NNS ramifications)) (PP (IN in) (NP (NN T) (NN cell) (NN development)))) (PP (IN by) (S (VP (VBG upregulating) (NP (NP (NN NF-kappa) (NN B1)) (NN gene) (NN expression)))))))))) (. .))))
(S1 (S (NP (NP (NP (DT The) (NP (NN synthesis)) (CC and) (NP (NN immunogenicity))) (PP (IN of) (NP (NP (NP (NN varicella-zoster) (NN virus) (NN glycoprotein) (NN E)) (CC and) (NP (NP (JJ immediate-early) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN IE62)) (-RRB- -RRB-)))) (VP (VBN expressed) (PP (IN in) (NP (JJ recombinant) (NN herpes) (NN simplex) (NN virus-1)))))) (. .)))))
(S1 (S (S (S (SBAR (IN In) (NN order) (S (VP (TO to) (VP (VB evaluate) (NP (NP (DT the) (NNS conditions)) (PP (IN for) (NP (NP (NP (JJ optimal) (NN expression)) (CC and) (NP (NN immunogenicity))) (PP (IN of) (NP (JJ varicella-zoster) (NN virus) (-LRB- -LRB-) (NN VZV) (-RRB- -RRB-) (NNS proteins))) (PP (IN in) (NP (DT a) (NP (NP (NN herpes) (NN simplex) (NN virus-1)) (PRN (-LRB- -LRB-) (NP (NN HSV-1)) (-RRB- -RRB-))) (NN vector)))))))))) (, ,) (S (NP (PRP we)) (VP (VBD selected) (NP (NP (NP (DT the) (NP (NN VZV) (NN glycoprotein) (NN E))) (PRN (-LRB- -LRB-) (NP (NN gE)) (-RRB- -RRB-))) (, ,) (VP (VBN encoded) (PP (IN by) (NP (NP (NN ORF) (CD 68)) (CC and) (NP (NP (NP (DT the) (NP (NN VZV) (NN product))) (PP (IN of) (NP (NN ORF) (CD 62)))) (, ,) (NP (NP (DT an) (NP (JJ immediate-early) (JJ major) (NN tegument) (NN protein))) (PRN (-LRB- -LRB-) (NP (NN IE62)) (-RRB- -RRB-)))))))))) (. .)))))
(S1 (S (S (S (NP (CD Three) (NP (NN HSV/VZV) (NNS recombinants))) (VP (VBD were) (VP (VBN generated)))) (: :) (S (S (LST (-LRB- -LRB-) (LS 1) (-RRB- -RRB-)) (NP (NP (NN VZV) (NN gE) (NN protein) (NN coding) (NNS sequences)) (PP (IN along) (PP (IN with) (NP (DT the) (NP (NN promoter) (NN region)))))) (VP (VBD were) (VP (VBN inserted) (PP (IN into) (NP (NP (DT the) (NP (NN thymidine) (NN kinase) (-LRB- -LRB-) (NN TK) (-RRB- -RRB-) (NN gene))) (PP (IN of) (NP (NN HSV-1) (NN strain) (NN KOS)))))))) (: ;) (S (LST (-LRB- -LRB-) (LS 2) (-RRB- -RRB-)) (NP (NP (NN VZV) (NN gE)) (VP (VBN expressed) (PP (IN from) (NP (DT the) (NP (NN HSV-1) (NN ICP4) (NN promoter)))))) (VP (VBD was) (VP (VBN inserted) (PP (IN into) (NP (NP (DT the) (NP (NN glycoprotein) (NN C) (-LRB- -LRB-) (NN gC) (-RRB- -RRB-) (NN gene))) (PP (IN of) (NP (NN HSV-1) (NN strain) (NN F)))))))) (: ;) (CC and) (S (LST (-LRB- -LRB-) (LS 3) (-RRB- -RRB-)) (NP (NP (NN VZV) (NN IE62) (NN protein) (NN coding) (NNS sequences)) (PP (IN under) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (DT the) (NP (NN HSV-1) (NN ICP4) (NN promoter))))))) (VP (VBD were) (VP (VBN inserted) (PP (IN into) (NP (NP (DT the) (NP (NN gC) (NN gene))) (PP (IN of) (NP (NN HSV-1) (NN strain) (NN F))))))))) (. .))))
(S1 (S (S (NP (NP (NN Immunoblot) (NN analysis)) (CC and) (NP (NP (NN immunoperoxidase) (NN staining)) (PP (IN of) (NP (JJ infected) (NN cell) (NNS monolayers))))) (VP (VBD demonstrated) (NP (NP (NN vector) (NN expression)) (PP (IN of) (NP (NN VZV) (NNS proteins))))) (. .))))
(S1 (S (S (PP (VBG Following) (NP (NP (JJ intracranial) (NN inoculation)) (PP (IN in) (NP (NNS mice))))) (, ,) (NP (CC both) (NP (NP (NN VZV) (NN gE-HSV)) (PRN (-LRB- -LRB-) (NP (NN TK)) (-RRB- -RRB-))) (CC and) (NP (NP (NN VZV) (NN IE62-HSV)) (PRN (-LRB- -LRB-) (NP (NN gC)) (-RRB- -RRB-)))) (VP (VBD induced) (NP (DT an) (NP (NN IgG)) (NN response)) (PP (IN against) (NP (NP (NN VZV) (NN gE)) (CC or) (NP (NN VZV) (NN IE62))))) (. .))))
(S1 (S (S (SBAR (WHADVP (WRB When)) (S (VP (VBN tested) (PP (IN in) (NP (NP (NN cytotoxicity) (NNS assays)) (VP (VBG using) (NP (NP (NNS T-lymphocytes)) (PP (IN from) (NP (NN VZV) (JJ immune) (JJ human) (NNS donors)))))))))) (, ,) (S (NP (NP (DT the) (NN range)) (PP (IN of) (NP (NP (NN precursor) (NNS frequencies)) (PP (IN for) (NP (NP (NNS T-lymphocytes)) (SBAR (WHNP (WDT that)) (S (VP (VBD recognized) (NP (NP (NN VZV) (NN gE)) (CC or) (NP (NN VZV) (NN IE62))))))))))) (VP (VBD was) (ADJP (JJ similar)) (SBAR (IN whether) (S (NP (DT these) (NNS proteins)) (VP (VBD were) (VP (VBN expressed) (PP (IN by) (NP (NP (NN HSV-1)) (CC or) (NP (DT a) (NN vaccinia) (NN vector)))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS experiments)) (VP (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN HSV-1)) (VP (VBZ is) (NP (NP (DT a) (JJ competent) (NN vector)) (PP (IN for) (NP (NP (NN expression)) (PP (IN of) (NP (DT these) (NP (NN VZV) (NNS proteins))))))))))) (CC and) (VP (VBP support) (NP (NP (DT the) (NN feasibility)) (PP (IN of) (S (VP (VBG engineering) (NP (NP (DT a) (JJ combined) (NN vaccine)) (PP (IN for) (NP (DT these) (ADJP (RB closely) (JJ related)) (NNS alpha-herpesviruses)))))))))) (. .))))
(S1 (S (PRN (PRN (-LRB- -LSB-) (NP (NP (NN Correlation)) (PP (IN of) (NP (NP (JJ lymphocytic) (NN infiltration)) (PP (IN of) (NP (NN tumor) (NN tissue))))) (PP (IN with) (NP (NP (DT the) (NP (ADJP (JJ hormonal))) (CC and) (NP (ADJP (JJ metabolic))) (NP (NN state))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN breast) (NN cancer)))))))) (-RRB- -RSB-)))))
(S1 (S (S (S (NP (NP (NN Lymphocyte) (NN infiltration)) (PP (IN of) (NP (NN tumor)))) (VP (VBD was) (VP (VBN studied) (PP (FW vis-a-vis) (NP (NP (NN hormone) (JJ metabolic) (NN status)) (, ,) (NP (NN tumor) (NN tissue) (NN hormone) (NN sensitivity)) (CC and) (NP (NN tobacco) (NN smoking)))) (, ,) (PP (IN in) (NP (NP (CD 113) (NN breast) (NN cancer) (NNS patients)) (, ,) (ADJP (JJ aged) (NP (CD 25-77))))))) (. .)))))
(S1 (S (S (PP (IN On) (NP (DT the) (NN average))) (, ,) (NP (DT no) (NN correlation)) (VP (VBD was) (VP (VBN established) (PP (IN between) (NP (NP (NP (NP (NN degree)) (PP (IN of) (NP (NN lymphocyte) (NN infiltration)))) (PP (IN in) (NP (NN breast) (NN tumor)))) (CC and) (NP (NN age)) (CC and) (NP (NN menopause) (NN onset)))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN smoking) (JJ menopausal) (NNS patients))) (, ,) (NP (NN lymphocyte) (NN infiltration)) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB be) (ADJP (ADJP (JJR higher)) (PP (IN than) (PP (IN in) (NP (NP (NNS non-smokers)) (PRN (-LRB- -LRB-) (NP (NP (NN p)) (ADJP (JJR &lt;) (NP (CD 0.05)))) (-RRB- -RRB-))))))))))) (. .))))
(S1 (S (S (NP (EX There)) (VP (VBD was) (NP (NP (DT a) (JJ direct) (NN correlation)) (PP (IN between) (NP (NP (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (NN lymphocyte) (NN infiltration)))) (CC and) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN progesterone) (NNS receptors))))) (PP (IN in) (NP (NN tumor))))))) (. .))))
(S1 (S (S (NP (DT Some) (NNS subgroups)) (VP (VBD displayed) (NP (NP (DT a) (JJ direct) (NN correlation)) (PP (IN between) (NP (NP (NN infiltration)) (CC and) (NP (NP (NP (NP (JJ sex-binding) (NN globulin)) (, ,) (NP (NN cholesterol)) (, ,) (NP (JJ luteinizing) (NN hormone))) (PP (IN in) (NP (NN blood))))) (, ,) (CC and) (NP (JJ lean) (NN body) (NN mass)))))) (. .))))
(S1 (S (S (NP (PRP It)) (VP (VBD was) (VP (VBN matched) (PP (IN by) (NP (NP (DT an) (JJ inverse) (NN correlation)) (PP (IN between) (NP (NP (NN lymphocyte) (NN infiltration)) (CC and) (NP (NP (NP (JJ blood-thyroid) (NN hormone) (NN concentration)) (, ,) (NP (NN urine) (NNS catecholamines)) (CC and) (NP (JJ free) (NN cortisol) (NN excretion))) (CC and) (NP (JJ fat/lean) (NN body) (NN mass) (NN ratio))))))))) (. .))))
(S1 (S (S (PP (VBG Considering) (NP (NP (DT the) (VBN abovesaid)) (CONJP (RB as) (RB well) (IN as)) (NP (DT the) (NN lymphocyte) (NN ability) (S (VP (TO to) (VP (VB perform) (NP (NP (DT the) (JJ dual) (NN function)) (PP (IN of) (NP (NP (NNS immunocytes)) (CC and) (NP (NNS hormonocytes))))))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN suggested) (SBAR (IN that) (S (NP (DT the) (NNS results)) (VP (MD may) (VP (VB be) (VP (VBN used) (PP (IN in) (NP (CC both) (NP (NP (DT the) (NN study)) (PP (IN of) (NP (NN lymphocyte) (NN infiltration)))) (CC and) (NP (NP (NN research)) (PP (IN in) (NP (NP (NNS means)) (PP (IN of) (NP (PRP$ its) (NN control))))))))))))))) (. .))))
(S1 (S (S (S (NP (NNS Thymocytes)) (VP (VBP control) (NP (DT the) (NP (NN CD4) (NN gene))) (ADVP (RB differently) (PP (IN from) (NP (JJ mature) (NN T) (NNS lymphocytes))))) (. .)))))
(S1 (S (S (S (NP (PRP We)) (VP (VBD analyzed) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NP (NP (DT the) (NP (NN enhancer))) (, ,) (NP (DT the) (NP (NN promoter))) (CC and) (NP (DT the) (NP (NN silencer)))) (PP (IN of) (NP (DT the) (NP (JJ human) (NN CD4) (NN gene)))))) (PP (IN during) (NP (NN T) (NN cell) (NN development)))) (S (VP (VBG using) (NP (JJ transgenic) (NNS mice))))) (. .)))))
(S1 (S (S (NP (NP (NN Immunofluorescence) (NNS studies)) (PP (IN on) (NP (NP (JJ thymic) (NNS populations)) (PP (IN of) (NP (NP (NNS mice)) (VP (VBG carrying) (NP (NP (NNS transgenes)) (PP (IN in) (NP (NP (JJ various) (NNS combinations)) (PP (IN of) (NP (DT these) (NP (JJ regulatory) (NN DNA) (NNS elements))))))))))))) (VP (VBD revealed) (SBAR (IN that) (S (NP (NNS thymocytes)) (VP (VBP control) (NP (DT the) (NP (NN CD4) (NN gene))) (PP (IN in) (NP (NP (DT a) (JJ different) (NN manner)) (PP (IN than) (NP (JJ mature) (NP (JJ peripheral) (NN T) (NNS lymphocytes)))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NP (JJ 5'-positive) (JJ regulatory) (NN unit))) (, ,) (VP (VBG consisting) (PP (IN of) (NP (NP (DT the) (NP (NN promoter))) (CC and) (NP (DT the) (NP (JJ 5') (NN enhancer)))))) (, ,)) (VP (VBZ is) (ADJP (RB already) (JJ active) (PP (IN at) (NP (NP (DT the) (ADJP (JJ CD4-CD8-double-negative) (PRN (-LRB- -LRB-) (ADJP (JJ DN)) (-RRB- -RRB-))) (NN stage)) (PP (IN of) (NP (NN development))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (PRP$ its) (NN activity)) (VP (VBZ becomes) (ADJP (JJR lower) (PP (IN in) (NP (NP (DT the) (JJ double-positive)) (CC and) (NP (NP (DT a) (NN fraction)) (PP (IN of) (NP (DT the) (NP (JJ CD4+) (JJ CD8int/-) (NN cell) (NN population)))))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (DT an) (JJ additional) (NN enhancer)) (, ,) (ADJP (JJ located) (PP (IN in) (NP (NP (CC either) (NP (DT the) (JJ first)) (CC or) (NP (DT the) (JJ third)) (NP (NN intron))) (PP (IN of) (NP (DT the) (NP (NN CD4) (NN gene))))))) (, ,)) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (NP (NN CD4) (NN gene)) (NN expression)) (PP (IN in) (NP (DT this) (NN population)))))))))))) (. .))))
(S1 (S (S (NP (DT The) (JJ other) (VBN studied) (NP (JJ regulatory) (NN element))) (VP (VBZ is) (NP (NP (DT the) (NP (JJ minimal) (NN CD4) (NN silencer))) (SBAR (WHNP (WDT which)) (S (VP (VBZ inhibits) (NP (NP (NP (NN CD4) (NN gene)) (NN expression)) (PP (IN in) (NP (JJ peripheral) (NN CD8) (NN T) (NNS lymphocytes))))))))) (. .))))
(S1 (S (S (NP (DT This) (NN silencer)) (VP (VBZ is) (ADJP (JJ inactive) (PP (IN in) (NP (NP (DT the) (RBS most) (NP (JJ immature) (JJ DN) (NNS thymocytes))) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB probably)) (VP (VBP use) (NP (DT a) (JJ distinct) (NN silencer) (NN mechanism)) (SBAR (S (VP (TO to) (VP (VB down-regulate) (NP (NP (NN CD4) (NN gene)) (NN expression))))))))))))) (. .))))
(S1 (S (S (ADVP (RB Unexpectedly)) (, ,) (NP (DT the) (NP (NN CD4) (NN silencer))) (VP (VBZ is) (ADVP (RB also)) (ADJP (JJ active) (PP (IN in) (NP (NP (JJ CD4+) (JJ CD8int/-) (NNS cells)) (PP (IN of) (NP (DT the) (NN thymus)))))) (, ,) (S (VP (VBG implying) (SBAR (IN that) (S (NP (DT an) (NN anti-silencer)) (VP (MD may) (VP (VB be) (VP (VBN required))) (S (VP (TO to) (VP (VB resume) (NP (NP (NP (NN CD4)) (NN expression)) (PP (IN in) (NP (DT this) (NN cell) (NN population))))))))))))) (. .))))
(S1 (S (S (ADVP (RB Altogether)) (, ,) (NP (DT the) (NP (NN CD4) (NN gene))) (VP (VBZ is) (VP (VBN regulated) (PP (IN by) (NP (NP (JJ several) (NP (ADJP (JJ positive))) (CC and) (NP (ADJP (JJ negative))) (NP (JJ regulatory) (NNS mechanisms))) (SBAR (WHNP (WDT which)) (S (VP (VBP come) (PP (IN into) (NP (NN play))) (PP (IN in) (NP (DT a) (ADJP (RB developmentally) (VBN coordinated)) (NN manner)))))))))) (. .))))
(S1 (S (S (S (NP (NP (NN Heat-shock)) (CC and) (NP (NN cadmium) (NN chloride))) (VP (VBP increase) (NP (NP (DT the) (NP (NN vimentin) (NN mRNA)) (CC and) (NP (NN protein)) (NP (NNS levels))) (PP (IN in) (NP (NN U-937) (JJ human) (JJ promonocytic) (NNS cells))))) (. .)))))
(S1 (S (S (S (NP (NP (NP (NN Heat-shock)) (PP (IN for) (NP (CD 2) (NNS hours))) (PP (IN at) (NP (CD 42) (NNS degrees) (NN C)))) (, ,) (CC or) (NP (NP (DT the) (NN administration)) (PP (IN for) (NP (CD 3) (NNS hours))) (PP (IN of) (NP (ADJP (QP (CD 100) (CC or) (CD 150)) (NN microM)) (NN cadmium) (NN chloride)))) (, ,)) (VP (VP (VBD inhibited) (NP (DT the) (NP (JJ subsequent) (NN proliferation) (NN activity)))) (, ,) (VP (VBD induced) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (JJ functional) (NP (NN differentiation) (NNS markers)))))) (, ,) (CC and) (VP (VBD caused) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NP (DT the) (NP (JJ stress-responsive) (NN HSP70) (NN protein))) (PP (IN in) (NP (NN U-937) (JJ human) (JJ promonocytic) (NNS cells)))))))))) (. .)))))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (CC both) (NP (NN heat)) (CC and) (NP (NN cadmium))) (VP (VBD produced) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (DT the) (NP (JJ intermediate) (NN filament) (NN protein)) (NP (NN vimentin))))))) (, ,) (SBAR (IN as) (S (VP (VBN determined) (PP (IN by) (NP (NP (NN immunoblot)) (CC and) (NP (NN immunofluorescence)) (NP (NNS assays)))))))) (. .))))
(S1 (S (S (PP (IN By) (NP (NN contrast))) (, ,) (NP (NP (DT the) (NNS amounts)) (PP (IN of) (NP (NP (NN actin)) (CC and) (NP (NN beta-tubulin))))) (VP (VBD were) (RB not) (ADVP (RB significantly)) (VP (VBN altered))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN amount)) (PP (IN of) (NP (NN vimentin) (NN mRNA)))) (VP (VBD was) (ADVP (RB also)) (VP (VBN increased) (PP (IN during) (NP (NP (NN recovery)) (PP (IN from) (NP (NN stress)))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (NN vimentin)) (NN expression)) (VP (VBD was) (RB not) (ADVP (RB exclusively)) (VP (VBN regulated) (PP (IN at) (NP (DT the) (NN protein) (NN level)))))))))) (. .))))
(S1 (S (S (SBAR (IN Although) (S (NP (NN cadmium)) (VP (VBD caused) (NP (NP (NP (DT an) (ADJP (ADJP (JJ early)) (, ,) (NP (JJ transient))) (NN stimulation)) (PP (IN of) (NP (NN c-jun)))) (CC and) (NP (NP (NN c-fos)) (NN expression)) (CC and) (NP (NP (NN AP-1)) (NN binding) (NN activity)))))) (, ,) (NP (NN heat-shock)) (VP (VBD failed) (S (VP (TO to) (VP (VB alter) (NP (CC both) (NP (NP (NN protooncogene)) (NN expression)) (CC and) (NP (NN transcription) (NN factor) (NN binding)))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (DT the) (JJ stress-induced) (NP (NN vimentin)) (NN increase)) (VP (VBD was) (RB not) (NP (NP (DT the) (NN result)) (PP (IN of) (NP (JJ AP-1-mediated) (JJ transcriptional) (NN activation)))))))))) (. .))))
(S1 (S (S (ADVP (RB Finally)) (, ,) (NP (PRP it)) (VP (VBD was) (VP (VBN observed) (SBAR (IN that) (S (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (NP (NN decay)) (PP (IN of) (NP (NN vimentin) (NN mRNA))) (PP (IN upon) (NP (NN actinomycin) (NN D) (NN administration)))))) (VP (VBD was) (VP (VBN decreased) (PP (IN in) (NP (NP (NN heat-)) (CC and) (NP (JJ cadmium-pretreated)) (NP (NNS cells)))) (PP (IN in) (NP (NP (NN comparison)) (PP (TO to) (NP (JJ untreated) (NNS cells))))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN stress) (NNS treatments)) (VP (VBP cause) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (NP (NN vimentin)) (NNS levels)) (PP (IN in) (NP (JJ promonocytic) (NNS cells))))))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB be) (VP (VBN explained) (PP (ADVP (IN at) (JJS least)) (IN in) (NP (NN part))) (PP (IN by) (NP (NN transcript) (NN stabilization))))))))) (. .))))
(S1 (S (S (S (NP (NP (NN Jak1)) (NN expression)) (VP (VBZ is) (VP (VBN required) (PP (IN for) (S (VP (VBG mediating) (NP (NP (JJ interleukin-4-induced) (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NP (NN insulin) (NN receptor) (NN substrate)) (CC and) (NP (NP (NN Stat6)) (NP (NN signaling) (NNS molecules))))))))))) (. .)))))
(S1 (S (S (S (NP (DT The) (NP (NN Jak1)) (, ,) (NP (NN Jak2)) (, ,) (NP (NN Jak3)) (, ,) (CC and) (NP (NN Fes)) (NP (NN tyrosine) (NNS kinases))) (VP (VBP have) (VP (VBN been) (VP (VBN demonstrated) (S (VP (TO to) (VP (VB undergo) (NP (NN tyrosine) (NN phosphorylation)) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NP (NP (NN interleukin) (-LRB- -LRB-) (NN IL) (-RRB- -RRB-) (CD -4)) (NN stimulation)) (PP (IN in) (NP (JJ different) (NN cell) (NNS systems))))))))))))) (. .)))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (PRP it))) (VP (VBZ is) (RB not) (ADJP (JJ clear)) (SBAR (WHNP (WHNP (WDT which)) (, ,) (SBAR (IN if) (FRAG (NP (DT any)))) (, ,) (PP (IN of) (NP (DT these) (NNS kinases)))) (S (VP (VBP are) (ADJP (JJ responsible) (PP (IN for) (S (VP (VBG initiating) (NP (NP (JJ IL-4-induced) (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (JJ intracellular) (NNS substrates)))) (ADVP (FW in) (FW vivo)))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP (PRP we)) (VP (VBP have) (VP (VBN utilized) (NP (NP (NP (DT a) (NP (JJ mutant) (JJ Jak1-deficient) (NN HeLa) (NN cell) (NN line))) (, ,) (NP (NN E1C3))) (, ,) (CC and) (NP (NP (PRP$ its) (NP (JJ parental) (JJ Jak1-expressing) (NN counterpart))) (, ,) (NP (NN 1D4))))) (, ,) (S (VP (TO to) (VP (VB analyze) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN Jak1))) (PP (IN in) (S (VP (VBG mediating) (NP (JJ IL-4-induced) (NN tyrosine) (NN phosphorylation) (NNS events)))))))))) (. .))))
(S1 (S (S (NP (NN IL-4) (NN treatment)) (ADVP (RB rapidly)) (VP (VBD induced) (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NP (NN insulin) (NN receptor) (NN substrate) (-LRB- -LRB-) (NN IRS) (-RRB- -RRB-) (CD -1)) (CC and) (NP (NN IRS-2))))) (PP (PP (IN in) (NP (NP (NN 1D4)))) (CC but) (PP (RB not) (IN in) (NP (NN E1C3) (NNS cells))))) (. .))))
(S1 (S (S (NP (NP (JJ IL-4-mediated) (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NN Stat6)))) (VP (VBD was) (VP (VBN pronounced) (PP (IN in) (NP (NN 1D4) (NNS cells)))) (, ,) (SBAR (IN while) (S (NP (DT no) (JJ IL-4-induced) (NP (NN Stat6)) (NN phosphorylation)) (VP (VBD was) (VP (VBN detected) (PP (IN in) (NP (NN E1C3) (NNS cells)))))))) (. .))))
(S1 (S (S (NP (NN IL-4)) (ADVP (RB also)) (VP (VBD induced) (NP (NP (NN Stat6)) (NN DNA) (NN binding) (NN activity)) (PP (IN from) (NP (NP (NNS lysates)) (PP (IN of) (NP (NP (NP (NN 1D4))) (CONJP (CC but) (RB not)) (NP (NN E1C3) (NNS cells)))))) (S (VP (VBG utilizing) (NP (NP (DT a) (NP (VBN radiolabeled) (NN immunoglobulin) (JJ heavy) (NN chain) (NN germline) (NN epsilon) (NN promotor) (NN sequence))) (PRN (-LRB- -LRB-) (NP (NN Iepsilon)) (-RRB- -RRB-))) (PP (IN in) (NP (DT an) (JJ electrophoretic) (NN mobility) (NN shift) (NN assay)))))) (. .))))
(S1 (S (S (NP (NP (NN Reconstitution)) (PP (IN of) (NP (NP (NP (NN Jak1)) (NN expression)) (PP (IN in) (NP (NN E1C3) (NNS cells)))))) (VP (VBD restored) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN IL-4))) (S (VP (TO to) (VP (VB induce) (NP (NP (NP (NN IRS))) (CC and) (NP (NP (NN Stat6))) (NP (NN tyrosine) (NN phosphorylation)))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP provide) (NP (NN evidence) (SBAR (IN that) (S (NP (NP (NN Jak1)) (NN expression)) (VP (VBZ is) (VP (VBN required) (PP (IN for) (S (VP (VBG mediating) (NP (NP (NN tyrosine) (NN phosphorylation)) (CC and) (NP (NP (NN activation)) (PP (IN of) (NP (NP (JJ crucial) (NNS molecules)) (VP (VBN involved) (PP (IN in) (NP (NP (NN IL-4)) (NN signal) (NN transduction))))))))))))))))) (. .))))
(S1 (S (NP (NP (NP (JJ Immune) (NN hyperactivation)) (PP (IN of) (NP (JJ HIV-1-infected) (NN T) (NNS cells))) (VP (VBN mediated) (PP (IN by) (NP (NP (NN Tat)) (CC and) (NP (DT the) (NP (NN CD28)) (NN pathway))))) (. .)))))
(S1 (S (S (S (NP (NP (NP (JJ Human) (NN immunodeficiency) (NN virus-type) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN HIV-1)) (-RRB- -RRB-))) (NN infection)) (VP (VBZ is) (VP (VBN characterized) (PP (IN by) (NP (NP (DT a) (JJ chronic) (NN state)) (PP (IN of) (NP (JJ immune) (NN hyperactivation))) (PP (IN in) (NP (NNS patients))))))) (. .)))))
(S1 (S (S (NP (NP (NN Infection)) (PP (IN of) (NP (JJ human) (JJ peripheral) (NN blood) (NNS lymphocytes))) (PP (IN with) (NP (NN HIV-1))) (ADVP (FW in) (FW vitro))) (VP (VBD resulted) (PP (IN in) (NP (NP (VBN increased) (NP (NP (NN interleukin-2)) (PRN (-LRB- -LRB-) (NP (NN IL-2)) (-RRB- -RRB-))) (NN secretion)) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NP (NN T) (NN cell) (NN activation)) (PP (IN via) (NP (DT the) (NP (NN CD3)) (CC and) (NP (NN CD28)) (NP (NNS receptors))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Expression)) (PP (IN of) (NP (NP (DT the) (NP (NN HIV-1) (NN transactivator))) (NP (NN Tat))))) (VP (VP (VBD recapitulated) (NP (DT this) (NN phenotype))) (CC and) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (VBN increased) (NP (NN IL-2)) (NN secretion)) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NP (NN costimulation)) (PP (IN with) (NP (NP (NN CD3)) (CC plus) (NP (NN CD28))))))))))))) (. .))))
(S1 (S (S (NP (NP (NP (NN IL-2)) (NN superinduction)) (PP (IN by) (NP (NN Tat)))) (VP (VP (VBD occurred) (PP (IN at) (NP (DT the) (JJ transcriptional) (NN level)))) (, ,) (VP (VBD was) (VP (VBN mediated) (PP (IN by) (NP (NP (DT the) (NP (JJ CD28-responsive) (NN element))) (PP (IN in) (NP (DT the) (NP (NN IL-2) (NN promoter)))))))) (, ,) (CC and) (VP (VBD was) (ADJP (RB exclusively) (JJ dependent) (PP (IN on) (NP (NP (DT the) (NP (CD 29) (NN amino) (NNS acids))) (VP (VBN encoded) (PP (IN by) (NP (DT the) (NP (JJ second) (NN exon) (IN of) (NN Tat)))))))))) (. .))))
(S1 (S (S (S (NP (NN c-Rel)) (VP (VBZ is) (NP (NP (DT a) (NN target)) (PP (IN of) (NP (NP (JJ pentoxifylline-mediated) (NN inhibition)) (PP (IN of) (NP (NN T) (NN lymphocyte) (NN activation))))))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (ADJP (ADJP (JJ possible)) (ADJP (JJ clinical))) (NN use)) (PP (IN of) (NP (NP (DT the) (NN methyl) (NN xanthine) (JJ derivative)) (, ,) (NP (NP (NN pentoxifylline)) (PRN (-LRB- -LRB-) (NP (NN PF)) (-RRB- -RRB-))))) (, ,) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NN T) (JJ cell-dependent) (NNS diseases)))))) (VP (VBZ is) (VP (VBG being) (VP (VBN noted) (PP (IN with) (NP (VBG increasing) (NN interest)))))) (. .)))))
(S1 (S (S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBD studied) (NP (NP (DT the) (JJ molecular) (NNS consequences)) (PP (IN of) (NP (NN PF) (NN treatment))) (PP (IN during) (NP (NN lymphocyte) (NN activation))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NN T) (NNS cells))) (, ,) (NP (JJ anti-CD3-induced) (NP (NN c-Rel)) (NN expression)) (VP (VBD was) (VP (VBN blocked) (PP (IN by) (NP (NN PF)))) (, ,) (SBAR (IN whereas) (S (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (JJ other) (NP (NN NF-kappaB) (NN family) (NNS members))))) (VP (VBD was) (RB not) (ADVP (RB significantly)) (VP (VBN affected))))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (NP (NN induction)) (PP (IN of) (NP (NN NF-AT)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (NP (NP (DT the) (JJ same) (NN signaling) (NNS requirements)) (PP (IN as) (NP (NP (NN c-Rel)) (NN induction))))))) (, ,)) (VP (VBD was) (RB not) (VP (VBN inhibited) (PP (IN by) (NP (NN PF))))) (. .))))
(S1 (S (S (PP (IN Among) (NP (NP (NNS genes)) (SBAR (WHNP (WDT that)) (S (VP (VBP respond) (PP (TO to) (NP (DT these) (NP (NN transcription) (NNS factors))))))))) (, ,) (NP (NP (NN IL-2) (NN mRNA)) (NN induction)) (VP (VBD was) (VP (VBN suppressed) (PP (IN by) (NP (NN PF)))) (, ,) (SBAR (IN whereas) (S (NP (NP (NN IL-2R) (-LRB- -LRB-) (NN alpha) (-RRB- -RRB-) (NN chain) (NN mRNA)) (NN induction)) (VP (VBD was) (RB not) (VP (VBN affected)))))) (. .))))
(S1 (S (S (NP (DT These) (NNS observations)) (VP (VBD implicated) (NP (NN c-Rel)) (PP (IN as) (NP (NP (DT an) (NP (NN IL-2) (NN promoter) (IN factor))) (, ,) (SBAR (WHPP (IN for) (WHNP (WDT which))) (S (NP (JJ experimental) (NN support)) (VP (VBD was) (VP (VBN obtained) (PP (IN from) (NP (JJ transient) (NN transfection) (NNS experiments)))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (NN contrast)) (PP (IN with) (NP (NP (DT the) (NN observation)) (PP (IN in) (NP (NN T) (NNS cells))))))) (, ,) (NP (NP (NN c-Rel)) (NN induction)) (VP (VBD was) (RB not) (VP (VBN blocked) (PP (IN by) (NP (NN PF))) (PP (IN in) (NP (NN B) (NNS cells))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJR greater) (NN selectivity)) (PP (IN of) (NP (NN PF))) (, ,) (PP (VBN compared) (PP (IN with) (NP (NN FK506)))) (, ,) (PP (IN at) (NP (CC both) (DT the) (NP (ADJP (JJ molecular))) (CC and) (NP (ADJP (JJ cellular))) (NP (NNS levels))))) (VP (MD may) (VP (VB prove) (ADJP (JJ advantageous) (PP (IN in) (S (VP (VBG manipulating) (NP (NP (NN T) (NN cell) (NNS responses)) (ADVP (FW in) (FW vivo))))))))) (. .))))
(S1 (S (S (S (NP (NP (DT A) (NP (NN T) (JJ cell-specific) (NN enhancer))) (PP (IN in) (NP (DT the) (NP (NN interleukin-3) (NN locus))))) (VP (VBZ is) (VP (VBN activated) (ADVP (RB cooperatively)) (PP (IN by) (NP (NP (NP (NN Oct)) (CC and) (NP (NN NFAT)) (NP (NNS elements))) (PP (IN within) (NP (DT a) (NP (NN DNase) (JJ I-hypersensitive) (NN site)))))))) (. .)))))
(S1 (S (S (S (NP (NP (NN Interleukin-3)) (PRN (-LRB- -LRB-) (NP (NN IL-3)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (NP (NN cytokine))) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN expressed) (PP (ADVP (RB primarily)) (IN in) (NP (VBN activated) (NN T) (NNS cells))))))))) (. .)))))
(S1 (S (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBD identified) (NP (NP (NP (DT an) (JJ inducible) (NP (NN T) (JJ cell-specific) (NN enhancer))) (ADVP (NP (CD 14) (NN kb)) (RB upstream)) (PP (IN of) (NP (DT the) (NP (NN IL-3) (NN gene))))) (SBAR (WHNP (WDT that)) (S (VP (VBD responded) (PP (TO to) (NP (NP (NN activation)) (PP (IN of) (NP (NP (NN T) (NN cell) (NN receptor)) (NN signaling) (NNS pathways)))))))))) (. .))))
(S1 (S (S (NP (DT The) (NP (NN IL-3)) (NN enhancer)) (VP (VBD spanned) (NP (NP (DT an) (JJ inducible) (NP (NN cyclosporin) (JJ A-sensitive) (NN DNase) (JJ I-hypersensitive) (NN site))) (VP (VBN found) (PP (ADVP (RB only)) (IN in) (NP (NN T) (NNS cells)))))) (. .))))
(S1 (S (S (NP (CD Four) (NP (JJ NFAT-like) (NNS elements))) (VP (VBP exist) (PP (IN within) (NP (DT the) (NN enhancer)))) (. .))))
(S1 (S (S (NP (DT The) (CD two) (ADJP (RBS most) (JJ active)) (NP (JJ NFAT-like) (NNS elements))) (VP (VBD were) (ADJP (JJ located) (PP (IN at) (NP (NP (DT the) (NN center)) (PP (IN of) (NP (DT the) (NP (NN DNase) (JJ I-hypersensitive) (NN site)))))))) (. .))))
(S1 (S (S (NP (NP (CD One)) (PP (IN of) (NP (DT these) (NP (JJ NFAT-like) (NNS elements))))) (VP (VBD encompassed) (NP (NP (VBG overlapping) (NP (NN Oct-)) (CC and) (NP (JJ NFATp/c-binding)) (NP (NNS sites))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD functioned) (PP (IN in) (NP (DT a) (ADJP (RB highly) (JJ synergistic)) (NN manner)))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT the) (NN T) (NN cell-) (JJ specific) (NN expression)) (PP (IN of) (NP (DT the) (NP (NN IL-3) (NN gene))))) (VP (VBZ is) (ADVP (RB partly)) (VP (VBN controlled) (PP (IN through) (NP (DT the) (NN enhancer))) (PP (IN by) (NP (NP (NN cooperation)) (PP (IN between) (NP (NP (NN Oct)) (CC and) (NP (NN NFAT)) (NP (NN family) (NNS proteins))))))))))) (. .))))
(S1 (S (NP (NP (NP (NP (NN TRAMP)) (, ,) (NP (NP (DT a) (JJ novel) (NP (JJ apoptosis-mediating) (NN receptor))) (PP (IN with) (NP (NP (NN sequence) (NN homology)) (PP (TO to) (NP (NP (NN tumor) (NN necrosis) (NN factor) (NN receptor) (CD 1)) (CC and) (NP (NP (NN Fas)) (PRN (-LRB- -LRB-) (NP (NN Apo-1/CD95)) (-RRB- -RRB-))))))))) (. .)))))
(S1 (S (S (S (NP (NP (NP (DT A) (JJ novel) (NN member)) (PP (IN of) (NP (DT the) (NP (NN tumor) (NN necrosis) (NN factor) (-LRB- -LRB-) (NN TNF) (-RRB- -RRB-) (NN receptor) (NN family))))) (, ,) (VP (VBN designated) (S (NP (NN TRAMP)))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN identified)))) (. .)))))
(S1 (S (S (NP (NP (DT The) (JJ structural) (NN organization)) (PP (IN of) (NP (DT the) (NP (CD 393) (NN amino) (NN acid) (JJ long) (JJ human) (NN TRAMP))))) (VP (VBZ is) (ADJP (RBS most) (JJ homologous) (PP (TO to) (NP (NN TNF) (NN receptor) (CD 1))))) (. .))))
(S1 (S (S (NP (NN TRAMP)) (VP (VBZ is) (ADVP (RB abundantly)) (VP (VBN expressed) (PP (IN on) (NP (NP (NNS thymocytes)) (CC and) (NP (NNS lymphocytes)))))) (. .))))
(S1 (S (S (S (NP (PRP$ Its) (JJ extracellular) (NN domain)) (VP (VBZ is) (VP (VBN composed) (PP (IN of) (NP (CD four) (NP (JJ cysteine-rich) (NNS domains))))))) (, ,) (CC and) (S (NP (DT the) (NP (JJ cytoplasmic) (NN region))) (VP (VBZ contains) (NP (NP (DT a) (NP (NN death) (NN domain))) (VP (VBN known) (PP (TO to) (NP (NN signal) (NN apoptosis))))))) (. .))))
(S1 (S (S (NP (NP (NN Overexpression)) (PP (IN of) (NP (NN TRAMP)))) (VP (VBZ leads) (PP (TO to) (NP (NP (CD two) (JJ major) (NNS responses)) (, ,) (NP (NP (NP (NN NF-kappaB)) (NN activation)) (CC and) (NP (NN apoptosis)))))) (. .))))
(S1 (S (S (NP (JJ TRAMP-induced) (NN cell) (NN death)) (VP (VBZ is) (VP (VBN inhibited) (PP (PP (IN by) (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (JJ ICE-like) (NNS proteases))))) (, ,) (CC but) (PP (RB not) (IN by) (NP (NN Bcl-2)))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NN TRAMP)) (VP (VBZ does) (RB not) (VP (VB appear) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NP (DT any)) (PP (IN of) (NP (NP (DT the) (JJ known) (NP (JJ apoptosis-inducing) (NNS ligands))) (PP (IN of) (NP (DT the) (NP (NN TNF) (NN family))))))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Regulation)) (PP (IN of) (NP (DT the) (NP (NN tissue) (NN factor) (NN gene)))) (PP (IN in) (NP (JJ human) (JJ monocytic) (NNS cells))) (. .)))))
(S1 (S (NP (NP (NN Role)) (PP (IN of) (NP (NP (NP (NN AP-1))) (, ,) (NP (NP (NN NF-kappa) (NN B/Rel))) (, ,) (CC and) (NP (NP (NN Sp1))) (NP (NNS proteins)))) (PP (IN in) (NP (NP (ADJP (JJ uninduced))) (CC and) (NP (ADJP (JJ lipopolysaccharide-induced))) (NP (NN expression)))) (. .))))
(S1 (S (S (S (NP (NP (NP (NP (NN Tissue) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN TF)) (-RRB- -RRB-))) (NN expression)) (PP (IN by) (NP (JJ peripheral) (NN blood) (NNS monocytes))) (PP (IN during) (NP (NN sepsis)))) (VP (VBZ initiates) (NP (JJ intravascular) (NN thrombosis))) (. .)))))
(S1 (S (S (NP (NP (JJ Bacterial) (NN lipopolysaccharide)) (PRN (-LRB- -LRB-) (NP (NN LPS)) (-RRB- -RRB-))) (VP (ADVP (RB rapidly)) (VBZ induces) (NP (NP (NN TF) (NN gene)) (NN transcription)) (PP (IN in) (NP (NNS monocytes)))) (. .))))
(S1 (S (S (NP (DT The) (NP (JJ human) (NN TF) (NN promoter))) (VP (VBZ contains) (NP (NP (VBG binding) (NNS sites)) (PP (IN for) (NP (NP (DT the) (NN transcription) (NNS factors)) (NP (NP (NN AP-1)) (, ,) (NP (NN c-Rel/p65)) (, ,) (NP (NN Egr-1)) (, ,) (CC and) (NP (NN Sp1))))))) (. .))))
(S1 (S (S (NP (NN NF-kappa) (NN B/Rel) (NNS proteins)) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (ADVP (RB physically)) (VP (VB interact) (PP (IN with) (NP (CC both) (NP (NN AP-1)) (CC and) (NP (NN Sp1)) (NP (NNS proteins)))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBD investigated) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (DT these) (NP (NN transcription) (NNS factors)))) (PP (IN in) (NP (NP (NP (ADJP (JJ uninduced))) (CC and) (NP (ADJP (JJ LPS-induced))) (NP (NP (NN TF) (NN gene)) (NN expression))) (PP (IN in) (NP (JJ human) (JJ monocytic) (NN THP-1) (NNS cells))))))) (. .))))
(S1 (S (S (NP (JJ Deletional) (NN analysis)) (VP (VBD indicated) (SBAR (IN that) (S (NP (CD five) (NP (NN Sp1) (NNS sites))) (VP (VBD mediated) (NP (NP (JJ basal) (NN expression)) (PP (IN in) (NP (JJ uninduced) (NNS cells)))))))) (. .))))
(S1 (S (S (NP (DT The) (CD two) (NP (NN AP-1) (NNS sites))) (VP (VBD bound) (NP (NP (NN c-Fos/c-Jun) (NNS heterodimers)) (PP (IN in) (NP (CC both) (NP (ADJP (JJ unstimulated))) (CC and) (NP (ADJP (JJ LPS-stimulated))) (NP (NNS cells)))))) (. .))))
(S1 (S (S (NP (NP (JJ Maximal) (NN LPS) (NN induction)) (PP (IN of) (NP (DT the) (NP (NN TF) (NN promoter))))) (VP (VBD required) (NP (NP (NP (DT the) (CD two) (NP (NN AP-1)) (NNS sites)) (CC and) (NP (DT the) (NP (NN kappa) (NN B) (NN site)))) (PP (IN within) (NP (DT the) (NP (NN LPS) (NN response) (NN element)))))) (. .))))
(S1 (S (S (NP (NP (NN Disruption)) (PP (IN of) (NP (NP (DT the) (VBN conserved) (NN spacing)) (PP (IN between) (NP (NP (DT the) (NP (JJ proximal) (NN AP-1) (NN site))) (CC and) (NP (DT the) (NP (NN kappa) (NN B) (NN site)))))))) (VP (VBD abolished) (NP (NN LPS) (NN induction))) (. .))))
(S1 (S (S (NP (NP (NN Replacement)) (PP (IN of) (NP (DT the) (CD two) (NP (NN AP-1) (NNS sites)))) (PP (IN with) (NP (ADJP (RB intrinsically) (JJ bent)) (NN DNA)))) (ADVP (RB partially)) (VP (VBD restored) (NP (NN LPS) (NN induction)) (, ,) (S (VP (VBG suggesting) (NP (DT an) (ADJP (ADJP (JJ additional)) (ADJP (JJ structural))) (NN role)) (PP (IN for) (NP (DT the) (NP (NN AP-1) (NNS sites))))))) (. .))))
(S1 (S (S (NP (NP (JJ Synergistic) (NN transactivation)) (PP (IN of) (NP (DT the) (NP (NN LPS) (NN response) (NN element)))) (PP (IN in) (NP (FW Drosophila) (NN Schneider) (NNS cells))) (PP (IN by) (NP (NP (NN coexpression)) (PP (IN of) (NP (NP (NN c-Fos)) (, ,) (NP (NN c-Jun)) (, ,) (NP (NN c-Rel)) (, ,) (CC and) (NP (NP (NN p65)) (CC or) (NP (NP (NN c-Jun)) (CC and) (NP (NN p65))))))))) (VP (VBD required) (NP (NP (DT the) (NP (NN transactivation) (NNS domains))) (PP (IN of) (NP (NP (NN c-Jun)) (CC and) (NP (NN p65)))))) (. .))))
(S1 (S (S (NP (DT These) (NNS data)) (VP (VBD indicated) (SBAR (IN that) (S (NP (NP (NN c-Fos/c-Jun)) (, ,) (NP (NN c-Rel/p65)) (, ,) (CC and) (NP (NN Sp1))) (VP (VBP regulate) (NP (NP (NP (NN TF) (NN gene)) (NN expression)) (PP (IN in) (NP (JJ human) (JJ monocytic) (NNS cells)))))))) (. .))))
(S1 (S (S (S (NP (NP (NN AML1a)) (CONJP (CC but) (RB not)) (NP (NN AML1b))) (VP (VP (VBZ inhibits) (NP (NP (JJ erythroid) (NN differentiation)) (VP (VBN induced) (PP (IN by) (NP (NN sodium) (NN butyrate)))))) (CC and) (VP (VBZ enhances) (NP (NP (DT the) (JJ megakaryocytic) (NN differentiation)) (PP (IN of) (NP (NN K562) (NN leukemia) (NNS cells)))))) (. .)))))
(S1 (S (S (S (NP (NN AML1)) (VP (MD may) (VP (VB play) (NP (NP (DT a) (NN role)) (PP (IN in) (NP (NP (NP (NN growth)) (CC and) (NP (NN differentiation))) (PP (IN of) (NP (NP (NNS cells)) (PP (IN along) (NP (NP (ADJP (JJ erythroid))) (CC and/or) (NP (ADJP (JJ megakaryocytic))) (NP (NNS lineages)))))))))) (, ,) (SBAR (IN because) (S (NP (NP (DT a) (JJ significant) (NN level)) (PP (IN of) (NP (DT the) (NP (NN AML1)) (NN gene)))) (VP (VBZ is) (VP (VBN expressed) (PP (IN in) (NP (DT these) (NNS cells)))))))) (. .)))))
(S1 (S (S (NP (PRP We)) (VP (VBD overexpressed) (NP (NP (NP (NN AML1a)) (PRN (-LRB- -LRB-) (PP (IN without) (NP (DT the) (NP (JJ transcription-activating) (NN domain)))) (-RRB- -RRB-))) (CC and) (NP (NP (NN AML1b)) (PRN (-LRB- -LRB-) (PP (IN with) (NP (DT the) (NN domain))) (-RRB- -RRB-))) (NP (NNS proteins))) (PP (IN in) (NP (NP (NN K562) (NN leukemia) (NNS cells)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB be) (VP (VBN induced) (S (VP (TO to) (VP (VB differentiate) (PP (IN into) (NP (NP (JJ hemoglobin-producing) (NNS cells)) (CC and) (NP (NNS megakaryocytes))))))))))))))) (. .))))
(S1 (S (S (NP (DT The) (NP (JJ AML1a-transfected) (NN K562) (NNS cells))) (VP (VBD had) (NP (DT a) (VBN reduced) (NN capacity) (S (VP (TO to) (VP (VB differentiate) (PP (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN sodium) (NN n-butyrate))))) (CC but) (PP (RB not) (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (JJ other) (NNS inducers)) (, ,) (PP (JJ such) (IN as) (NP (NP (NN hemin)) (, ,) (NP (NN 1-beta-D-arabinofuranosylcytosine)) (, ,) (CC and) (NP (NN herbimycin) (NN A)))))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NP (NN AML1)) (JJ antisense) (NN oligodeoxynucleotide)) (CONJP (CC but) (RB not)) (NP (DT the) (NN sense) (NN oligomer))) (VP (VBD recovered) (NP (PRP$ its) (JJ differentiation-inducing) (NN capacity)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN butyrate)))))) (. .))))
(S1 (S (S (PP (IN On) (NP (DT the) (JJ other) (NN hand))) (, ,) (NP (NN AML1b)) (VP (VBD conferred) (NP (DT a) (ADJP (ADJP (JJ similar)) (ADJP (JJ differentiation-inducing))) (NN capacity)) (PP (IN upon) (NP (NP (NN K562) (NNS cells)) (VP (VBN transfected) (PP (IN with) (NP (NP (NN vector)) (ADVP (RB alone)))))))) (. .))))
(S1 (S (S (NP (NP (NN AML1a)) (NN expression)) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (VBN enhanced) (NN sensitivity)) (PP (TO to) (NP (NP (JJ megakaryocytic) (NN differentiation)) (VP (VBN induced) (PP (IN by) (NP (NN phorbol) (NN ester)))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP provide) (NP (NN evidence) (SBAR (IN that) (S (NP (NP (NN AML1)) (NNS proteins)) (VP (VBP play) (NP (DT a) (NN role)) (PP (IN in) (NP (NP (ADJP (JJ erythroid))) (CC and) (NP (ADJP (JJ megakaryocytic))) (NP (NN differentiation))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Differentiation)) (PP (IN of) (NP (NN U-937) (JJ promonocytic) (NNS cells))) (PP (IN by) (NP (NP (NP (NN etoposide)) (CC and) (NP (NN ICRF-193))) (, ,) (NP (NP (CD two) (JJ antitumour) (NP (NN DNA) (NN topoisomerase) (CD II)) (NNS inhibitors)) (PP (IN with) (NP (NP (JJ different) (NNS mechanisms)) (PP (IN of) (NP (NN action)))))))) (. .)))))
(S1 (S (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN compared) (NP (NP (DT the) (NN action)) (PP (IN on) (NP (NN U-937) (JJ human) (JJ promonocytic) (NN leukemia) (NNS cells))) (PP (IN of) (NP (NP (CD two) (NP (NN DNA) (NN topoisomerase) (CD II)) (NNS inhibitors)) (, ,) (ADVP (RB namely)) (NP (NP (DT the) (NN epipodophyllotoxin) (NN etoposide)) (CC and) (NP (DT the) (NN bisdioxopiperazine) (NN ICRF-193)))))))) (. .)))))
(S1 (S (S (NP (NP (ADJP (CD One) (NN hour)) (NN pulse-treatment)) (PP (IN with) (NP (ADJP (CD 3) (NN microM)) (NN etoposide)))) (VP (VBD caused) (NP (NP (ADJP (ADJP (NP (NN topoisomerase)) (JJ associated)) (, ,) (ADJP (JJ primary))) (NN DNA) (NN breakage)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (ADVP (RB rapidly)) (VP (VBN followed) (PP (IN by) (NP (NN apoptosis))))))))) (. .))))
(S1 (S (S (PP (IN By) (NP (NN contrast))) (, ,) (NP (DT these) (NNS effects)) (VP (VBD were) (RB not) (VP (VBN observed) (PP (IN upon) (NP (NP (NN pulse-treatment)) (PP (IN with) (NP (ADJP (CD 6) (NN microM)) (NN ICRF-193))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (JJ continuous) (NNS treatments)) (PP (IN with) (NP (NP (JJ subcytotoxic) (NNS concentrations)) (PP (IN of) (NP (NP (NP (NN etoposide)) (PRN (-LRB- -LRB-) (NP (CD 0.15) (NN microM)) (-RRB- -RRB-))) (CC and) (NP (NP (NN ICRF-193)) (PRN (-LRB- -LRB-) (NP (CD 0.3) (NN microM)) (-RRB- -RRB-)))))))) (VP (VBD produced) (NP (NP (ADJP (JJ several) (JJ similar)) (NNS effects)) (, ,) (ADVP (RB namely)) (NP (NP (VBN decreased) (NN cell) (NN proliferation)) (, ,) (NP (NP (NN accumulation)) (PP (IN of) (NP (NNS cells))) (PP (IN at) (NP (NN G2)))) (, ,) (NP (NP (NN increase)) (PP (IN in) (NP (NN cell) (NN mass)))) (, ,) (CC and) (NP (NP (NN induction)) (PP (IN of) (NP (NN differentiation))))))) (. .))))
(S1 (S (S (PP (IN Under) (NP (DT these) (NNS conditions))) (, ,) (NP (NN etoposide)) (VP (VBD produced) (NP (NP (NP (DT a) (JJ biphasic) (NN activation)) (PP (IN of) (NP (NN protein) (NN kinase) (NN C)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD consisted) (PP (IN in) (NP (NP (NP (NP (DT an) (ADJP (ADJP (JJ early)) (ADJP (JJ transient))) (NN activation)) (PRN (-LRB- -LRB-) (PP (IN from) (NP (NNS hours) (QP (CD 1) (TO to) (CD 6)))) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (NP (JJ membrane-bound) (NN enzyme))))) (VP (VBN followed) (PP (IN by) (NP (NP (NP (DT a) (JJ later) (NN activation)) (PRN (-LRB- -LRB-) (NP (NN hour) (CD 48)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (JJ total) (, ,) (NP (ADJP (JJ membrane-bound))) (CC and) (NP (ADJP (JJ cytosolic))) (NP (NN enzyme)))))))))))))) (. .))))
(S1 (S (S (PP (IN By) (NP (NN contrast))) (, ,) (NP (NN ICRF-193)) (VP (ADVP (RB only)) (VBD provoked) (NP (NP (NP (DT a) (JJ late) (NN activation)) (PRN (-LRB- -LRB-) (PP (IN from) (NP (NNS hours) (QP (CD 72) (TO to) (CD 96)))) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (JJ total) (NN enzyme))))) (. .))))
(S1 (S (S (SBAR (WHADVP (WRB When)) (S (VP (VBN used) (PP (IN at) (NP (JJ differentiation-inducing) (NNS concentrations)))))) (, ,) (S (NP (DT both) (NP (NN topoisomerase)) (NNS inhibitors)) (VP (VBD caused) (NP (NP (NP (DT a) (JJ great) (NN stimulation)) (PP (IN of) (NP (NP (NN AP-1)) (NN binding) (NN activity)))) (, ,) (PP (IN with) (NP (NP (JJ maximum) (NN value)) (PP (PP (IN at) (NP (NN hour) (CD 12))) (PP (IN in) (NP (JJ etoposide-treated) (NNS cells))) (CC and) (PP (IN at) (NP (NN hour) (CD 48))) (PP (IN in) (NP (JJ ICRF-193-treated) (NNS cells))))))))) (. .))))
(S1 (S (S (PP (IN By) (NP (NN contrast))) (, ,) (NP (NP (DT the) (NN binding) (NN activity)) (PP (IN of) (NP (NP (DT the) (NP (NN NF-kappa) (-LRB- -LRB-) (NN B) (-RRB- -RRB-))) (CC and) (NP (NP (NN EGR-1))) (NP (NN transcription) (NNS factors))))) (VP (VBD was) (ADVP (RB little)) (VP (VBN affected))) (. .))))
(S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN concluded) (SBAR (IN that) (S (NP (NN topoisomerase) (CD II) (NNS inhibitors)) (VP (MD may) (VP (VB induce) (NP (NP (DT the) (NN differentiation)) (PP (IN of) (NP (JJ promonocytic) (NNS cells)))) (, ,) (ADVP (RB independently) (PP (IN of) (NP (PRP$ their) (NN capacity) (S (VP (TO to) (VP (VB cause) (NP (NN DNA) (NN strand) (NN breaks)))))))))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (EX there)) (VP (VBP are) (NP (NP (JJ other) (NNS effects)) (, ,) (PP (JJ such) (IN as) (NP (NP (DT the) (JJ early) (NN activation)) (PP (IN of) (NP (NN protein) (NN kinase) (NN C))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (ADVP (RB probably)) (VP (VBN derived) (PP (IN from) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (JJ primary) (NN DNA) (NN breakage))) (PP (IN by) (NP (DT some) (JJ anti-topoisomerase) (NNS drugs))))))))))) (. .))))
(S1 (S (S (S (NP (JJ Nuclear) (NP (NN Rel-A)) (CC and) (NP (NN c-Rel)) (NP (NN protein) (NNS complexes))) (VP (VBP are) (ADVP (RB differentially)) (VP (VBN distributed) (PP (IN within) (NP (JJ human) (NNS thymocytes))))) (. .)))))
(S1 (S (S (S (NP (JJ Nuclear) (NN factor-kappa) (NN B) (-LRB- -LRB-) (NN NF-kappa) (NN B) (-RRB- -RRB-) (NN /Rel) (NNS proteins)) (VP (VBP are) (NP (NP (JJ inducible) (NP (JJ transcriptional) (NNS regulators))) (PP (IN of) (NP (JJ numerous) (NP (JJ cellular) (NNS genes)))))) (. .)))))
(S1 (S (S (NP (PRP They)) (VP (VP (VBP are) (ADJP (RB particularly) (JJ abundant) (PP (IN in) (NP (JJ lymphoid) (NNS tissues))))) (CC and) (VP (VBP are) (VP (VBN thought) (S (VP (TO to) (VP (VB be) (ADJP (JJ critical) (PP (IN for) (NP (NP (DT the) (NN transcription)) (PP (IN of) (NP (NP (NNS genes)) (VP (VBN involved) (PP (IN in) (NP (NP (ADJP (JJ immune))) (CC and) (NP (ADJP (JJ inflammatory))) (NP (NNS responses)))))))))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN reported) (ADVP (RB previously)) (SBAR (IN that) (S (NP (DT a) (JJ nuclear) (NP (NN NF-kappa) (NN B)) (NN activity)) (VP (VBD was) (ADJP (JJ present) (PP (IN in) (NP (NP (ADJP (RB freshly) (VBN extracted)) (NP (JJ human) (NNS thymocytes))) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NP (ADJP (FW in) (FW vitro)) (NN treatment)) (PP (IN of) (NP (DT these) (NNS cells))))))))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT the) (JJ present) (NN report))) (, ,) (NP (PRP we)) (VP (VBD identified) (NP (NP (NN NF-kappa) (NN B) (NNS proteins)) (VP (VBN extracted) (PP (IN from) (NP (JJ human) (NN thymocyte) (NNS nuclei))))) (PP (IN as) (S (VP (VBG being) (NP (NP (NN p50/p65)) (CC and) (NP (NN p50/c-Rel)) (NP (NNS complexes))))))) (. .))))
(S1 (S (S (NP (NP (ADJP (JJ Immunochemical))) (CC and) (NP (ADJP (JJ immunofluorescent))) (NP (NP (NN staining)) (PP (IN of) (NP (NN thymus) (NNS sections))) (VP (VBG using) (NP (JJ specific) (NNS Abs))))) (VP (VBD allowed) (NP (NP (NN visualization)) (PP (IN of) (NP (JJ nuclear) (NN NF-kappa) (NN B) (NNS proteins))) (PP (IN in) (NP (CC both) (NP (NNS thymocytes)) (CC and) (NP (JJ nonthymocyte) (NNS cells)))))) (. .))))
(S1 (S (S (NP (DT This) (NN detection)) (VP (VBD suggested) (NP (NP (DT a) (JJ preferential) (NN activation)) (PP (IN of) (NP (NN p50/c-Rel))) (PP (IN in) (NP (JJ medullary) (NNS thymocytes)))) (, ,) (SBAR (IN whereas) (S (NP (NN p50/p65)) (VP (VBD was) (ADJP (JJ present) (PP (IN in) (NP (NP (CC both) (NP (ADJP (JJ cortical))) (CC and) (NP (ADJP (JJ medullary))) (NP (NNS regions))) (PP (IN of) (NP (JJ human) (NN thymus) (NNS lobules)))))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (NN intensity)) (PP (IN of) (NP (NP (NN p65)) (NN labeling)))) (VP (VBD was) (ADJP (RB much) (JJR higher) (PP (IN in) (NP (NP (JJ several) (NP (NNS thymocytes))) (PP (IN from) (NP (DT the) (NN medulla))))))) (. .))))
(S1 (S (S (NP (NP (NN p65)) (, ,) (NP (NN p50)) (, ,) (CC and) (NP (NN c-Rel)) (NP (NNS activities))) (VP (VBD were) (VP (VBN found) (PP (IN in) (NP (CC both) (NP (NN CD4-)) (CC and) (NP (JJ CD8-positive)) (NP (NNS thymocytes)))))) (. .))))
(S1 (S (S (NP (DT These) (NNS observations)) (VP (VBP suggest) (SBAR (SBAR (IN that) (S (NP (NP (NN p65)) (CC and) (NP (NN c-Rel)) (NP (NNS complexes))) (VP (VBP play) (NP (JJ distinct) (NNS roles)) (PP (IN in) (NP (NN gene) (NN expression)))))) (CC and) (SBAR (IN that) (S (NP (NP (DT both) (NNS forms)) (PP (IN of) (NP (NN NF-kappa) (NN B)))) (VP (VBP play) (NP (JJ critical) (NNS roles)) (PP (IN during) (NP (NP (JJ late) (NNS stages)) (PP (IN of) (NP (NP (DT the) (JJ intrathymic) (NN maturation)) (PP (IN of) (NP (NN T) (NNS cells)))))))))))) (. .))))
(S1 (S (S (S (NP (NP (NN Alteration)) (PP (IN of) (NP (DT a) (JJ single) (NN serine))) (PP (IN in) (NP (NP (DT the) (NP (JJ basic) (NN domain))) (PP (IN of) (NP (DT the) (NP (JJ Epstein-Barr) (NN virus) (NN ZEBRA) (NN protein))))))) (VP (VBZ separates) (NP (NP (PRP$ its) (NNS functions)) (PP (IN of) (NP (NP (JJ transcriptional) (NN activation)) (CC and) (NP (NP (NN disruption)) (PP (IN of) (NP (NN latency)))))))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (NP (NN ZEBRA) (NN protein))) (PP (IN from) (NP (NP (JJ Epstein-Barr) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN EBV)) (-RRB- -RRB-))))) (VP (VBZ activates) (NP (NP (DT a) (NN switch)) (PP (IN from) (NP (DT the) (ADJP (JJ latent)))) (PP (TO to) (NP (NP (DT the) (JJ lytic) (NN expression) (NN program)) (PP (IN of) (NP (DT the) (NN virus))))))) (. .)))))
(S1 (S (S (NP (NP (NN ZEBRA)) (, ,) (NP (NP (DT a) (NN member)) (PP (IN of) (NP (NP (DT the) (NP (NN bZIP) (NN family))) (PP (IN of) (NP (JJ DNA-binding) (NNS proteins)))))) (, ,)) (VP (VBZ is) (NP (NP (DT a) (JJ transcriptional) (NN activator)) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG inducing) (NP (NN expression)) (PP (IN from) (NP (JJ viral) (JJ lytic) (NN cycle) (NNS promoters))))))))) (. .))))
(S1 (S (S (NP (PRP It)) (VP (VBD had) (ADVP (RB previously)) (VP (VBN been) (VP (VBN thought) (SBAR (IN that) (S (NP (NP (NP (NN ZEBRA)) (POS 's)) (NN capacity) (S (VP (TO to) (VP (VB disrupt) (NP (NN EBV) (NN latency)))))) (VP (VBD resided) (PP (ADVP (RB primarily)) (IN in) (NP (PRP$ its) (NN ability) (S (VP (TO to) (VP (VB activate) (NP (NP (NN transcription)) (PP (IN of) (NP (NP (NNS genes)) (SBAR (WHNP (WDT that)) (S (VP (VBP encode) (NP (NP (NNS products)) (VP (VBN required) (PP (IN for) (NP (JJ lytic) (NN replication)))))))))))))))))))))) (. .))))
(S1 (S (S (S (NP (PRP We)) (VP (VBD generated) (NP (NP (NP (NP (DT a) (NN point) (NN mutant)) (PP (IN of) (NP (NN ZEBRA)))) (, ,) (NP (NN Z) (-LRB- -LRB-) (NN S186A) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (RB not) (ADJP (JJ impaired) (PP (IN in) (NP (PRP$ its) (NN ability) (S (VP (TO to) (VP (VB activate) (NP (NN transcription)))))))))))))) (: ;) (S (ADVP (RB however)) (, ,) (NP (DT this) (NN mutation)) (VP (VBD abolished) (NP (PRP$ its) (NN ability) (S (VP (TO to) (VP (VB initiate) (NP (DT the) (ADJP (ADJP (JJ viral)) (ADJP (JJ lytic))) (NN cascade)))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN mutant)) (, ,) (VP (VBG containing) (NP (DT a) (JJ serine-to-alanine) (NN substitution)) (PP (IN in) (NP (NP (DT the) (NP (JJ DNA-binding) (NN domain))) (PP (IN of) (NP (DT the) (NN protein)))))) (, ,)) (VP (VP (VP (VBD bound) (PP (TO to) (NP (JJ several) (JJ known) (NP (JJ ZEBRA-binding) (NNS sites))))) (CC and) (VP (VBD activated) (NP (NN transcription)) (PP (IN from) (NP (NP (NNS reporters)) (VP (VBG bearing) (NP (JJ known) (NP (JJ ZEBRA-responsive) (NNS promoters)))))))) (CC but) (VP (VBD did) (RB not) (VP (VB disrupt) (NP (NP (NN latency)) (PP (IN in) (NP (JJ EBV-infected) (NN cell) (NNS lines))))))) (. .))))
(S1 (S (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (NN initiation)) (PP (IN of) (NP (DT the) (NN EBV) (JJ lytic) (NN cycle))) (PP (IN by) (NP (DT the) (NP (NN ZEBRA) (NN protein))))) (VP (VBZ requires) (NP (NP (DT a) (NN function)) (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (JJ transcriptional) (NN activation)))))))) (: ;) (S (NP (NP (DT a) (NN change)) (PP (IN of) (NP (NN serine) (CD 186))) (PP (TO to) (NP (NN alanine))) (PP (IN in) (NP (NP (DT the) (NP (JJ DNA-binding) (NN domain))) (PP (IN of) (NP (NN ZEBRA)))))) (VP (VP (VBD abolished) (NP (DT this) (JJ additional) (NN function))) (CC and) (VP (VBD uncovered) (NP (NP (DT a) (JJ new) (NN role)) (PP (IN for) (NP (DT the) (NP (NN ZEBRA) (NN protein))))) (PP (IN in) (NP (NP (NN disruption)) (PP (IN of) (NP (NN EBV) (NN latency)))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ additional) (NN function)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (NN initiation)) (PP (IN of) (NP (DT the) (ADJP (ADJP (JJ lytic)) (ADJP (JJ viral))) (NN life) (NN cycle)))))))))) (VP (VBZ is) (ADJP (JJ likely) (S (VP (TO to) (VP (VB require) (NP (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NP (NN serine) (CD 186)) (PP (IN of) (NP (DT the) (NP (NN ZEBRA) (NN protein))))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB influence) (NP (NP (CC either) (NP (NN DNA) (NN recognition)) (CC or) (NP (JJ transcriptional) (NN activation))) (PP (IN of) (NP (JJ lytic) (JJ viral) (NNS promoters))) (PP (IN in) (NP (DT a) (NP (VBN chromatinized) (JJ viral) (NN episome))))))))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Redox) (NN regulation)) (PP (IN of) (NP (DT the) (NP (JJ mitogen-activated) (NN protein) (NN kinase)) (NN pathway))) (PP (IN during) (NP (NN lymphocyte) (NN activation))) (. .)))))
(S1 (S (S (S (NP (PRP We)) (VP (VP (VBP have) (ADVP (RB previously)) (VP (VBN demonstrated) (NP (NP (DT an) (JJ obligatory) (NN requirement)) (PP (IN for) (NP (NP (ADJP (JJ intracellular) (JJ reactive)) (NN oxygen) (NNS species) (NN generation)) (PP (IN during) (NP (NN T) (NN lymphocyte) (NN activation)))))))) (, ,) (CC and) (VP (VBP have) (VP (VBN proposed) (SBAR (IN that) (S (NP (ADJP (JJ intracellular) (JJ reactive)) (NN oxygen) (NNS species)) (VP (MD may) (VP (VB act) (PP (IN as) (NP (NN signalling) (NNS agents))) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NP (ADJP (JJ certain) (JJ cellular)) (NNS processes)) (, ,) (PP (IN for) (NP (NN example))) (, ,) (PP (IN during) (NP (NN cell) (NN cycle) (NN entry)))))))))))))) (. .)))))
(S1 (S (S (S (VP (TO To) (VP (VB test) (NP (DT this) (NN hypothesis))))) (, ,) (S (NP (PRP we)) (VP (VBP have) (VP (VBN been) (VP (VBN interested) (S (VP (TO to) (VP (VB determine) (SBAR (WHNP (WP which)) (, ,) (SBAR (IN if) (FRAG (NP (DT any)))) (, ,) (NP (NN cell) (NN cycle) (NN entry) (NNS events)) (S (VP (VBP are) (VP (VBN affected) (PP (IN by) (NP (JJ oxidative) (NN signalling)))))))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (JJR earlier) (NNS studies))) (, ,) (NP (PRP we)) (VP (VP (VBP have) (VP (VBN identified) (NP (NP (DT the) (NP (NN transcription) (NNS factors))) (NP (NP (NN NF-kappa) (NN B)) (CC and) (NP (NN AP-1)))) (PP (IN as) (NP (NP (JJ molecular) (NNS targets)) (PP (IN for) (NP (JJ oxidative) (NN signalling) (NNS processes))) (PP (IN during) (NP (NN cell) (NN cycle) (NN entry))))))) (, ,) (CC and) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (JJ oxidative) (NN signalling)) (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NP (JJ early) (NNS changes)) (PP (IN in) (NP (NN gene) (NN expression))) (PP (IN during) (NP (DT the) (NP (NP (NN G0)) (PP (TO to) (NP (NN G1)))) (NN phase) (NN transition)))))))))))))) (. .))))
(S1 (S (S (S (VP (TO To) (VP (VB extend) (NP (DT these) (JJ initial) (NNS observations))))) (, ,) (S (NP (PRP we)) (VP (VBP have) (VP (VBN examined) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (JJ antioxidant) (NN treatment))) (PP (IN on) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NP (DT the) (NP (JJ mitogen-activated) (NN protein) (NNS kinases))) (NP (NP (NN erk1)) (CC and) (NP (NN erk2)))))))) (, ,) (PP (IN as) (NP (NP (NNS members)) (PP (IN of) (NP (NP (DT a) (NN signal) (NN transduction) (NN pathway)) (VP (VBN known) (S (VP (TO to) (ADVP (RB directly)) (VP (VB regulate) (NP (NN transcription) (NN factor) (NN function))))))))))))) (. .))))
(S1 (S (S (S (VP (VBG Using) (PP (IN as) (NP (DT a) (NN probe))) (NP (NP (NN cysteamine)) (, ,) (NP (NP (DT an) (NN aminothiol) (NN compound)) (PP (IN with) (NP (CC both) (NP (ADJP (JJ antioxidant))) (CC and) (NP (ADJP (JJ antiproliferative))) (NP (NN activity)))))))) (, ,) (S (NP (PRP we)) (VP (VBP have) (VP (VBN identified) (NP (NP (NN erk2)) (, ,) (NP (NP (DT a) (JJ key) (NN element)) (PP (IN of) (NP (DT the) (NN MAP) (NN kinase) (NN pathway))))) (, ,) (PP (IN as) (S (VP (VBG being) (ADJP (JJ responsive) (PP (TO to) (NP (JJ oxidative) (NN signalling))) (PP (IN during) (NP (NN lymphocyte) (NN activation)))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS observations)) (VP (VP (VBP provide) (NP (JJ further) (NN evidence) (S (VP (TO to) (VP (VB suggest) (NP (NP (DT a) (NN role)) (PP (IN for) (NP (ADJP (JJ intracellular) (JJ oxidant)) (NN generation))) (PP (IN as) (NP (DT a) (JJ regulatory) (NN mechanism))) (PP (IN during) (NP (NN cell) (NN cycle) (NN entry))))))))) (, ,) (CC and) (VP (VBP establish) (NP (NP (DT a) (NN link)) (PP (IN between) (NP (NP (JJ oxidative) (NN signalling)) (CC and) (NP (NP (JJ other) (NNS aspects)) (PP (IN of) (NP (NP (DT the) (JJ intracellular) (NN signalling) (NN network)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN activated) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (JJ mitogenic) (NN stimulation))))))))))))))))) (. .))))
(S1 (S (NP (NP (NP (NP (ADJP (JJ Common))) (CC and) (NP (ADJP (JJ distinct))) (NP (JJ intracellular) (NN signaling) (NNS pathways))) (PP (IN in) (NP (JJ human) (NNS neutrophils))) (VP (VBN utilized) (PP (IN by) (NP (NP (NN platelet) (NN activating) (NN factor)) (CC and) (NP (NN FMLP))))) (. .)))))
(S1 (S (S (S (NP (NP (NN Stimulation)) (PP (IN of) (NP (JJ human) (NNS neutrophils))) (PP (IN with) (NP (NP (NNS chemoattractants)) (NP (NP (NN FMLP)) (CC or) (NP (NP (NN platelet) (NN activating) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN PAF)) (-RRB- -RRB-))))))) (VP (VBZ results) (PP (IN in) (NP (ADJP (ADJP (JJ different)) (CC but) (ADJP (VBG overlapping))) (JJ functional) (NNS responses)))) (. .)))))
(S1 (S (S (NP (PRP We)) (VP (VBD questioned) (SBAR (IN whether) (S (NP (DT these) (NNS differences)) (VP (MD might) (VP (VB reflect) (NP (NP (NNS patterns)) (PP (IN of) (NP (JJ intracellular) (NN signal) (NN transduction))))))))) (. .))))
(S1 (S (S (NP (NP (NN Stimulation)) (PP (IN with) (NP (CC either) (NP (NN PAF)) (CC or) (NP (NN FMLP))))) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ equivalent) (NN phosphorylation)) (CC and) (NP (NP (NN activation)) (PP (IN of) (NP (NP (DT the) (NP (JJ mitogen-activated) (NN protein) (NN kinase) (-LRB- -LRB-) (NN MAPk) (-RRB- -RRB-) (NN homologue))) (NP (NP (JJ 38-kD) (JJ murine) (NN MAP) (NN kinase)) (ADJP (JJ homologous) (PP (TO to) (NP (NN HOG-1) (-LRB- -LRB-) (NN p38) (-RRB- -RRB-) (NN MAPk))))))))))) (. .))))
(S1 (S (S (NP (CC Neither) (NP (NN FMLP)) (CC nor) (NP (NN PAF))) (VP (VBD activated) (NP (NP (NN c-jun) (JJ NH2-terminal) (NN MAPk)) (PRN (-LRB- -LRB-) (NP (NNS JNKs)) (-RRB- -RRB-)))) (. .))))
(S1 (S (S (PP (IN Under) (NP (JJ identical) (NNS conditions))) (, ,) (NP (NP (NN FMLP)) (CONJP (CC but) (RB not)) (NP (NN PAF)) (, ,)) (VP (VBD resulted) (PP (IN in) (NP (JJ significant) (NP (NN p42/44) (-LRB- -LRB-) (NN ERK) (-RRB- -RRB-) (NN MAPk)) (NN activation)))) (. .))))
(S1 (S (S (NP (CC Both) (NP (NN FMLP)) (CC and) (NP (NN PAF))) (VP (VBD activated) (NP (NP (NP (NN MAP) (NN kinase) (NN kinase-3)) (PRN (-LRB- -LRB-) (NP (NN MKK3)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (JJ known) (NN activator)) (PP (IN of) (NP (NN p38) (NN MAPk)))))) (. .))))
(S1 (S (S (NP (CC Both) (NP (NP (NN MAP) (NN ERK) (NN kinase) (NN kinase-1)) (PRN (-LRB- -LRB-) (NP (NN MEKK1)) (-RRB- -RRB-))) (CC and) (NP (NN Raf))) (VP (VBP are) (VP (VBN activated) (PP (PP (ADVP (RB strongly)) (IN by) (NP (NN FMLP))) (, ,) (CC but) (PP (ADVP (RB minimally)) (IN by) (NP (NN PAF)))))) (. .))))
(S1 (S (S (NP (NN Pertussis) (NN toxin)) (VP (VBD blocked) (NP (NP (NP (JJ FMLP-induced) (NN activation)) (PP (IN of) (NP (DT the) (NP (NN p42/44) (-LRB- -LRB-) (NN ERK) (-RRB- -RRB-) (NN MAPk)) (NN cascade)))) (, ,) (CONJP (CC but) (RB not)) (NP (NP (DT that)) (PP (IN of) (NP (NN p38) (NN MAPk)))))) (. .))))
(S1 (S (S (NP (NP (DT A) (JJ specific) (NP (NN p38) (NN MAPk)) (NN inhibitor)) (PRN (-LRB- -LRB-) (NP (NN SK&amp;F) (CD 86002)) (-RRB- -RRB-))) (VP (VP (VBD blocked) (NP (NN superoxide) (NN anion) (NN production)) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NN FMLP)))))) (CC and) (VP (VBD reduced) (NP (NP (NN adhesion)) (CC and) (NP (NN chemotaxis))) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NP (NN PAF)) (CC or) (NP (NN FMLP)))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VP (VBP demonstrate) (NP (NP (JJ distinct) (NNS patterns)) (PP (IN of) (NP (JJ intracellular) (NN signaling))) (PP (IN for) (NP (CD two) (NP (NNS chemoattractants)))))) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (JJ selective) (NN activation)) (PP (IN of) (NP (JJ intracellular) (NN signaling) (NNS cascades)))) (VP (MD may) (VP (VB underlie) (NP (NP (JJ different) (NNS patterns)) (PP (IN of) (NP (JJ functional) (NNS responses)))))))))) (. .))))
(S1 (S (NP (NP (NP (JJ Selective) (NN expression)) (PP (IN of) (NP (DT an) (NP (NN interleukin-12) (NN receptor) (NN component)))) (PP (IN by) (NP (JJ human) (NN T) (NN helper) (CD 1) (NNS cells))) (. .)))))
(S1 (S (S (S (NP (NP (NP (NN Interleukin-12)) (PRN (-LRB- -LRB-) (NP (NN IL-12)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NP (JJ heterodimeric) (NN cytokine))) (VP (VBN produced) (PP (IN by) (NP (NP (VBN activated) (NNS monocytes)) (CC and) (NP (JJ dendritic) (NNS cells)))))) (, ,)) (VP (VBZ plays) (NP (DT a) (JJ crucial) (NN role)) (PP (PP (IN in) (S (VP (VBG regulating) (NP (NP (NN interferon) (-LRB- -LRB-) (NN IFN) (-RRB- -RRB-) (NN -gamma)) (NN production))))) (CC and) (PP (IN in) (NP (NP (DT the) (NN generation)) (PP (IN of) (NP (JJ IFN-gamma-producing) (NN T) (NN helper) (CD 1) (-LRB- -LRB-) (NN Th1) (-RRB- -RRB-) (NNS cells))))))) (. .)))))
(S1 (S (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (NP (NN IL-12) (NN receptor) (-LRB- -LRB-) (NN IL-12R) (-RRB- -RRB-) (NN beta) (CD 2) (NN subunit))) (, ,) (NP (NP (DT a) (RB recently) (VBN cloned) (NP (NN binding)) (CC and) (NP (NN signal) (NN transducing)) (NP (NN component))) (PP (IN of) (NP (DT the) (NP (NN IL-12R))))) (, ,)) (VP (VP (VBZ is) (VP (VBN expressed) (PP (IN on) (NP (ADJP (JJ human)) (NP (NN Th1)) (CONJP (CC but) (RB not)) (NP (NN Th2)) (NP (NNS clones)))))) (CC and) (VP (VBZ is) (VP (VBN induced) (PP (IN during) (NP (NP (NN differentiation)) (PP (IN of) (NP (NP (JJ human) (JJ naive) (NNS cells)) (PP (IN along) (NP (NP (DT the) (NN Th1)) (CONJP (CC but) (RB not)) (NP (DT the) (NN Th2)) (NP (NN pathway)))))))))))))) (. .))))
(S1 (S (S (NP (NP (NN IL-12)) (CC and) (NP (NP (NN type) (CD I)) (CONJP (CC but) (RB not)) (NP (NN type) (CD II)) (NP (NNS interferons)))) (VP (VBP induce) (NP (NP (NN expression)) (PP (IN of) (NP (DT the) (NP (NN IL-12R) (NN beta) (CD 2) (NN chain)))) (PP (IN during) (NP (NP (ADJP (FW in) (FW vitro)) (NN T) (NN cell) (NN differentiation)) (PP (IN after) (NP (NN antigen) (NN receptor) (NN triggering))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ selective) (NP (NN expression)) (CC and) (NP (NN regulation))) (PP (IN of) (NP (DT the) (NP (NN IL-12R) (NN beta) (CD 2) (NN subunit))))) (VP (VP (MD may) (VP (VB help) (S (VP (TO to) (VP (VB understand) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (NN Th1/Th2) (NN differentiation))))))))) (CC and) (VP (MD may) (VP (VB provide) (NP (NP (JJ therapeutic) (NNS options)) (PP (IN for) (S (VP (VBG altering) (NP (DT the) (NN Th1/Th2) (NN balance)) (PP (IN in) (NP (NP (JJ several) (JJ immuno-pathological) (NNS conditions)) (PP (JJ such) (IN as) (NP (NP (JJ autoimmune) (NNS diseases)) (CC and) (NP (NNS allergies))))))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Activation)) (PP (IN of) (NP (NP (DT the) (NP (NN transcription) (NN factor))) (NP (NN NF-kappaB)))) (PP (IN in) (NP (JJ lipopolysaccharide-stimulated) (NN U937) (NNS cells))) (. .)))))
(S1 (S (S (S (PP (IN During) (NP (NP (DT the) (NN course)) (PP (IN of) (NP (ADJP (ADJP (JJ serious)) (ADJP (JJ bacterial))) (NNS infections))))) (, ,) (NP (NP (NN lipopolysaccharide)) (PRN (-LRB- -LRB-) (NP (NN LPS)) (-RRB- -RRB-))) (VP (VBZ interacts) (PP (IN with) (NP (NN monocyte/macrophage) (NNS receptors))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (DT the) (NN generation)) (PP (IN of) (NP (JJ inflammatory) (NNS cytokines)))))))) (. .)))))
(S1 (S (S (NP (NP (NN Transcription) (NN factor)) (NP (NN NF-kappaB))) (VP (VBZ is) (ADJP (JJ crucial) (PP (IN in) (S (VP (VBG activating) (NP (NP (DT the) (NN transcription)) (PP (IN of) (NP (NP (NNS genes)) (VP (VBG encoding) (NP (JJ proinflammatory) (NNS cytokines))))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN NF-kappaB))) (PP (IN by) (NP (NN LPS))) (PP (IN in) (NP (NP (DT a) (NP (JJ promonocytic) (NN cell) (NN line))) (PRN (-LRB- -LRB-) (NP (NN U937)) (-RRB- -RRB-))))) (VP (VBD followed) (NP (DT a) (ADJP (RB rather) (JJ slow)) (NN kinetics)) (, ,) (PP (VBG depending) (PP (IN on) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (NP (NN IkappaB-alpha)) (NN inhibitor) (NN hydrolysis)))))))))) (. .))))
(S1 (S (S (NP (NP (DT No) (NN degradation)) (PP (IN of) (NP (NP (NN p105)) (CC and) (NP (NN p100)) (NP (NNS inhibitors))))) (VP (VBD was) (VP (VBN observed) (PP (IN under) (NP (DT these) (NNS conditions))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN transduction) (NN pathway)) (VP (VBG leading) (PP (TO to) (NP (NP (NP (NN NF-kappaB)) (NN activation)) (PP (IN in) (NP (NN U937) (NNS cells))))))) (VP (VBD involved) (NP (NP (DT the) (JJ intracellular) (NN generation)) (PP (IN of) (NP (NP (JJ reactive) (NN oxygen) (NNS species)) (PRN (-LRB- -LRB-) (NP (NNS ROS)) (-RRB- -RRB-))))) (, ,) (SBAR (IN as) (S (VP (VBN demonstrated) (PP (IN by) (NP (NP (NP (DT the) (ADJP (ADJP (JJ concomitant)) (ADJP (JJ inhibitory))) (NNS effects)) (PP (IN of) (NP (NNS antioxidants))) (PP (IN on) (NP (NP (NN NF-kappaB)) (NN activation)))) (CC and) (NP (NP (DT the) (NN emission)) (PP (IN of) (NP (NP (DT a) (JJ fluorescent) (NN probe)) (VP (VBG reacting) (ADVP (RB intracellularly)) (PP (IN with) (NP (NN hydrogen) (NN peroxide))))))))))))) (. .))))
(S1 (S (S (NP (DT This) (NNS ROS) (NN pathway)) (VP (VBD was) (ADVP (RB also)) (VP (VBN characterized) (PP (IN by) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (JJ other) (NNS inhibitors))))))) (. .))))
(S1 (S (S (NP (DT This) (NN finding)) (VP (VBZ indicates) (SBAR (IN that) (S (NP (NP (NN phospholipase) (NN A2)) (CC and) (NP (NN 5-lipoxygenase))) (VP (VBP are) (ADVP (RB also)) (VP (VBN involved)))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (NP (NN NF-kappaB)) (NN activation) (NN pathway)) (VP (VBG involving) (NP (NP (DT the) (NP (JJ acidic) (NN sphingomyelinase))) (PP (IN of) (NP (DT the) (JJ endolysosomial) (NN membrane)))))) (VP (VBD did) (RB not) (VP (VB seem) (S (VP (TO to) (VP (VB participate) (PP (IN in) (NP (NP (DT the) (JJ LPS-induced) (NP (NN NF-kappaB)) (NN activation)) (PP (IN in) (NP (NN U937) (NNS cells)))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Detection)) (PP (IN of) (NP (NN adenovirus) (NN DNA))) (PP (IN in) (NP (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells))) (PP (IN by) (NP (NN polymerase) (NN chain) (NN reaction) (NN assay))) (. .)))))
(S1 (S (S (S (NP (NN Adenovirus)) (VP (MD can) (VP (VB establish) (NP (NP (JJ persistent) (NNS infections)) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VP (VB reactivate)) (CC and) (VP (VB cause)) (NP (NP (NN disease)) (PP (IN in) (NP (JJ immunocompromised) (NNS hosts))))))))))) (. .)))))
(S1 (S (S (NP (NNS Lymphocytes)) (VP (VBP have) (VP (VBN been) (VP (VBN postulated) (S (VP (TO to) (VP (VB serve) (PP (IN as) (NP (NP (DT a) (NN site)) (PP (IN of) (NP (JJ adenoviral) (NN persistence))))) (PP (VBN based) (PP (IN upon) (NP (DT the) (NN ability) (S (VP (VP (TO to) (VP (VB isolate) (NP (NN adenovirus)) (PP (IN from) (NP (NNS tonsils))))) (CC and) (VP (TO to) (VP (VB detect) (NP (NN adenovirus) (NN DNA)))) (PP (IN by) (NP (NN Southern) (NN blot) (NN hybridization))) (PP (IN in) (NP (NP (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN PBMC)) (-RRB- -RRB-))))))))))))))) (. .))))
(S1 (S (S (S (VP (TO To) (VP (VB test) (NP (DT this) (NN hypothesis))))) (, ,) (S (NP (NP (DT a) (ADJP (RBR more) (ADJP (JJ sensitive)) (CC and) (ADJP (JJ specific))) (NP (NN polymerase) (NN chain) (NN reaction)) (PRN (-LRB- -LRB-) (NP (NN PCR)) (-RRB- -RRB-))) (NN assay)) (VP (VBD was) (VP (VBN developed)) (S (VP (TO to) (VP (VB detect) (NP (NN adenovirus) (NN DNA))))))) (. .))))
(S1 (S (S (NP (NP (CD Two) (NNS sets)) (PP (IN of) (NP (VBD nested) (NNS primers)))) (VP (VBD were) (VP (VBN designed) (PP (TO to) (NP (NP (VBN conserved) (NNS sequences)) (PP (IN in) (NP (DT the) (NN adenovirus) (NP (NN E1A)) (CC and) (NP (NN hexon)) (NP (NNS genes)))))))) (. .))))
(S1 (S (S (NP (DT The) (NP (NN E1A)) (CC and) (NP (NN hexon)) (NP (NNS primers))) (VP (VBD amplified) (NP (NP (NN DNA)) (PP (IN from) (NP (NP (ADJP (ADJP (JJ representative)) (ADJP (JJ adenoviral))) (NNS serotypes)) (PP (IN in) (NP (NP (DT all) (CD six) (JJ adenoviral) (NNS groups)) (PRN (-LRB- -LRB-) (NP (NNS A-F)) (-RRB- -RRB-)))))))) (. .))))
(S1 (S (S (NP (DT Both) (NNS primers)) (VP (VP (VBD detected) (NP (NP (DT a) (JJ single) (NN copy)) (PP (IN of) (NP (DT the) (NP (NN adenovirus) (NN type) (CD 2) (NN genome)))))) (CC but) (VP (VBD were) (ADJP (RBR less) (JJ sensitive) (PP (IN for) (NP (DT the) (NN group) (NN B) (NN type) (CD 35)))))) (. .))))
(S1 (S (S (NP (NP (NP (NN None)) (PP (IN of) (NP (NP (CD 33) (NP (NN PBMC)) (NNS specimens)) (PP (IN from) (NP (JJ healthy) (NNS adults)))))) (CC and) (NP (NP (RB only) (CD one)) (PP (IN of) (NP (CD 40) (JJ pediatric) (NNS samples))))) (VP (VBD was) (ADJP (JJ positive) (PRN (-LRB- -LRB-) (PP (IN at) (NP (DT a) (JJ low) (NN level))) (-RRB- -RRB-)) (PP (IN for) (NP (NN adenovirus) (NN DNA))) (PP (IN by) (NP (JJ nested) (NN PCR) (NN assay))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN comparison))) (, ,) (NP (NP (NN PBMC)) (PP (IN from) (NP (NP (CD two) (NNS children)) (PP (IN with) (NP (ADJP (ADJP (JJ fatal)) (ADJP (JJ adenoviral))) (NN infection)))))) (VP (VBD were) (ADVP (RB both)) (ADJP (RB strongly) (JJ positive) (PP (IN for) (NP (NN adenovirus) (NN DNA))))) (. .))))
(S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN concluded) (SBAR (IN that) (S (, ,) (PP (IN in) (NP (NP (NN contrast)) (PP (TO to) (NP (DT a) (JJ previous) (NN study))))) (, ,) (NP (NN PBMC)) (VP (VBP are) (RB not) (NP (NP (DT a) (JJ common) (NN site)) (PP (IN of) (NP (JJ persistent) (NN group) (NN C) (JJ adenoviral) (NN infection))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NN assay)) (PP (IN of) (NP (NN PBMC))) (PP (IN by) (NP (DT the) (JJ adenovirus-specific) (NN PCR)))) (VP (MD may) (VP (VB help) (S (VP (VP (VB detect) (NP (ADJP (ADJP (JJ early)) (ADJP (JJ invasive))) (NN disease))) (CC and) (VP (VBZ warrants) (NP (JJ further) (NN evaluation))))))) (. .))))
(S1 (S (NP (NP (NP (NN Control)) (PP (IN of) (NP (NP (NN NFATx1)) (JJ nuclear) (NN translocation))) (PP (IN by) (NP (DT a) (NP (JJ calcineurin-regulated) (JJ inhibitory) (NN domain)))) (. .)))))
(S1 (S (S (S (NP (DT The) (NP (NP (JJ nuclear) (NN factor) (IN of) (VBN activated) (NN T) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN NFAT)) (-RRB- -RRB-)))) (VP (VBZ regulates) (NP (NP (NP (NN cytokine) (NN gene)) (NN expression)) (PP (IN in) (NP (NN T) (NNS cells)))) (PP (IN through) (NP (NP (JJ cis-acting) (NNS elements)) (ADJP (JJ located) (PP (IN in) (NP (NP (DT the) (NP (NNS promoters))) (PP (IN of) (NP (JJ several) (NP (NN cytokine) (NNS genes)))))))))) (. .)))))
(S1 (S (S (NP (NP (NN NFATx1)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADVP (RB preferentially)) (VP (VBN expressed) (PP (IN in) (NP (NP (DT the) (NN thymus)) (CC and) (NP (JJ peripheral) (NN blood) (NNS leukocytes)))))))) (, ,)) (VP (VBZ is) (NP (NP (CD one)) (PP (IN of) (NP (NP (CD four) (NNS members)) (PP (IN of) (NP (NP (DT the) (NP (NN NFAT) (NN family))) (PP (IN of) (NP (NN transcription) (NNS factors))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN performed) (NP (NP (NN domain) (NN analysis)) (PP (IN of) (NP (NN NFATx1)))) (PP (IN by) (S (VP (VBG examining) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN deletion) (NNS mutations))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (SBAR (IN that) (S (NP (NP (NN NFATx1)) (NP (NN DNA) (NN binding) (NN activity)) (CC and) (NP (NP (NN interaction)) (PP (IN with) (NP (NN AP-1) (NNS polypeptides))))) (VP (VBD were) (ADJP (JJ dependent) (PP (IN on) (NP (PRP$ its) (NP (JJ central) (NN Rel) (NN similarity) (NN region)))))))) (CC and) (SBAR (IN that) (S (NP (JJ transcriptional) (NN activation)) (VP (VBD was) (VP (VBN reduced) (PP (IN by) (NP (NP (NNS deletions)) (PP (IN of) (NP (CC either) (NP (PRP$ its) (NP (JJ N-terminal) (NN domain))) (CC or) (NP (PRP$ its) (NP (JJ C-terminal) (NN domain)))))))))))) (, ,) (S (VP (VBG suggesting) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ intrinsic) (JJ transcriptional) (NN activation) (NNS motifs))) (PP (IN in) (NP (DT both) (NNS regions))))))) (. .))))
(S1 (S (S (NP (PRP We)) (ADVP (RB also)) (VP (VBD identified) (NP (NP (DT a) (JJ potent) (NP (JJ inhibitory) (NN sequence))) (PP (IN within) (NP (PRP$ its) (NP (JJ N-terminal) (NN domain)))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (NN inactivation)) (PP (IN of) (NP (DT the) (NN inhibition)))) (VP (VBD was) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NP (NN calcineurin)) (, ,) (NP (DT a) (NP (JJ calcium-calmodulin-dependent) (NN phosphatase)))))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (ADVP (RB also)) (VP (VBP show) (SBAR (IN that) (S (NP (NN calcineurin)) (VP (VP (VBD associated) (PP (IN with) (NP (NP (DT the) (NP (JJ N-terminal) (NN domain))) (PP (IN of) (NP (NN NFATx1))))) (PP (IN at) (NP (JJ multiple) (NN docking) (NNS sites)))) (CC and) (VP (VBD caused) (NP (NP (DT a) (NN reduction)) (PP (IN of) (NP (NN size))) (, ,) (ADJP (JJ indicative) (PP (IN of) (NP (NN dephosphorylation)))) (, ,) (PP (IN in) (NP (NN NFATx1))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN mapped) (NP (DT the) (JJ inhibitory) (NN activity)) (PP (TO to) (NP (NP (JJR less) (IN than) (NP (CD 60) (NNS residues))) (, ,) (VP (VBG containing) (NP (NP (NNS motifs)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN conserved) (PP (IN in) (NP (DT all) (NP (NN NFAT) (NNS proteins)))))))))))))) (. .))))
(S1 (S (S (ADVP (RB Finally)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (NN deletion)) (PP (IN in) (NP (NN NFATx1))) (PP (IN of) (NP (DT the) (VBN mapped) (NP (CD 60) (NNS residues))))) (VP (VBZ leads) (PP (TO to) (NP (NP (PRP$ its) (JJ nuclear) (NN translocation)) (ADJP (JJ independent) (PP (IN of) (NP (NN calcium) (NN signaling)))))))))) (. .))))
(S1 (S (S (NP (PRP$ Our) (NNS results)) (VP (VBP support) (NP (NP (DT the) (NN model)) (VP (VBG proposing) (SBAR (IN that) (S (NP (DT the) (NP (JJ N-terminal) (NN domain))) (VP (VBZ confers) (NP (NP (JJ calcium-signaling) (NN dependence)) (PP (IN on) (NP (NP (NN NFATx1)) (NN transactivation) (NN activity)))) (PP (IN by) (S (VP (VBG regulating) (NP (PRP$ its) (JJ intracellular) (NN localization)) (PP (IN through) (NP (NP (DT a) (NN protein) (NN module)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBZ associates) (PP (IN with) (NP (NN calcineurin)))) (CC and) (VP (VBZ is) (NP (NP (DT a) (NN target)) (PP (IN of) (NP (PRP$ its) (NP (NN phosphatase)) (NN activity))))))))))))))))))) (. .))))
(S1 (S (S (S (NP (DT A) (NP (NN PMLRARalpha) (NN transgene))) (VP (VBZ initiates) (NP (JJ murine) (JJ acute) (JJ promyelocytic) (NN leukemia))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (NP (JJ malignant) (NNS cells))) (PP (IN of) (NP (NP (JJ acute) (JJ promyelocytic) (NN leukemia)) (PRN (-LRB- -LRB-) (NP (NN APL)) (-RRB- -RRB-))))) (VP (VBP contain) (NP (NP (DT a) (ADJP (ADJP (JJ reciprocal)) (ADJP (JJ chromosomal))) (NN translocation)) (SBAR (WHNP (WDT that)) (S (VP (VBZ fuses) (NP (DT the) (NP (NP (JJ promyelocytic) (NN leukemia) (NN gene)) (PRN (-LRB- -LRB-) (NP (NN PML)) (-RRB- -RRB-)))) (PP (IN with) (NP (DT the) (NP (NP (JJ retinoic) (NN acid) (NN receptor) (NN alpha) (NN gene)) (PRN (-LRB- -LRB-) (NP (NN RAR) (NN alpha)) (-RRB- -RRB-)))))))))) (. .)))))
(S1 (S (S (S (VP (TO To) (VP (VB test) (NP (DT the) (NN hypothesis) (SBAR (IN that) (S (NP (DT the) (NP (NN chimera) (NN PMLRAR) (NN alpha))) (VP (VBZ plays) (NP (DT a) (NN role)) (PP (IN in) (NP (NN leukemogenesis)))))))))) (, ,) (S (NP (PRP we)) (VP (VBD expressed) (NP (DT a) (NP (NN PMLRAR) (NN alpha) (NN cDNA))) (PP (IN in) (NP (NP (JJ myeloid) (NNS cells)) (PP (IN of) (NP (JJ transgenic) (NNS mice))))))) (. .))))
(S1 (S (S (NP (NN PMLRAR) (NN alpha) (JJ transgenic) (NNS mice)) (VP (VBD exhibited) (NP (NP (JJ impaired) (NN neutrophil) (NN maturation)) (PP (ADVP (RB early)) (IN in) (NP (NN life))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD progressed) (PP (IN at) (NP (DT a) (JJ low) (NN frequency))) (PP (IN over) (NP (NP (DT the) (NN course)) (PP (IN of) (NP (JJ several) (NNS months))) (PP (TO to) (NP (JJ overt) (NN APL)))))))))) (. .))))
(S1 (S (S (S (NP (CC Both) (NP (DT the) (JJ preleukemic) (NN state)) (CC and) (NP (DT the) (NN leukemia))) (VP (MD could) (VP (VB be) (VP (VBN transplanted) (PP (TO to) (NP (JJ nontransgenic) (NNS mice))))))) (, ,) (CC and) (S (NP (DT the) (VBN transplanted) (NN preleukemia)) (VP (MD could) (VP (VB progress) (PP (TO to) (NP (NN APL)))))) (. .))))
(S1 (S (S (NP (DT The) (NN APL)) (VP (VBD recapitulated) (NP (NP (NNS features)) (PP (IN of) (NP (DT the) (JJ human) (NN disease))) (, ,) (PP (VBG including) (NP (NP (DT a) (NN response)) (PP (TO to) (NP (JJ retinoic) (NN acid))))))) (. .))))
(S1 (S (S (NP (JJ Retinoic) (NN acid)) (VP (VBD caused) (S (NP (DT the) (NP (JJ leukemic) (NNS cells))) (VP (TO to) (VP (VB differentiate) (ADVP (ADVP (FW in) (FW vitro)) (CC and) (ADVP (FW in) (FW vivo)))))) (, ,) (S (VP (VBG eliciting) (NP (NP (NNS remissions)) (PP (IN of) (NP (NP (CC both) (NP (DT the) (JJ preleukemic) (NN state)) (CC and) (NP (NN APL))) (PP (IN in) (NP (NNS mice))))))))) (. .))))
(S1 (S (S (NP (PRP$ Our) (NNS results)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN PMLRAR) (NN alpha)) (VP (VP (VBZ impairs) (NP (NN neutrophil) (NN differentiation))) (CC and) (VP (VBZ initiates) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NN APL))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ transgenic) (NNS mice)) (VP (VBN described) (ADVP (RB here)))) (VP (VBP provide) (NP (NP (DT an) (ADJP (RB apparently) (JJ accurate)) (NN model)) (PP (IN for) (NP (JJ human) (NN APL))) (SBAR (WHNP (WDT that)) (S (VP (VBZ includes) (NP (NP (JJ clear) (NN evidence)) (PP (IN of) (NP (NN tumor) (NN progression))))))))) (. .))))
(S1 (S (S (NP (DT The) (NN model)) (VP (MD should) (VP (VB be) (ADJP (JJ useful) (PP (PP (IN for) (S (VP (VBG exploring) (NP (NP (NP (DT the) (JJ molecular) (NN pathogenesis)) (PP (IN of) (NP (NN APL)))) (CC and) (NP (NP (DT the) (NNS mechanisms)) (PP (IN of) (NP (NP (DT the) (JJ therapeutic) (NN response)) (PP (TO to) (NP (JJ retinoic) (NN acid)))))))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (PP (IN for) (NP (NP (JJ preclinical) (NNS studies)) (PP (IN of) (NP (JJ therapeutic) (NNS regimens))))))))) (. .))))
(S1 (S (S (S (S (NP (NP (NN Signal) (NN transducer) (CC and) (NN activator) (IN of) (NN transcription-3)) (PRN (-LRB- -LRB-) (NP (NN STAT3)) (-RRB- -RRB-))) (VP (VBZ is) (VP (VP (ADVP (RB constitutively)) (VBN activated) (PP (IN in) (NP (JJ normal) (, ,) (NP (JJ self-renewing) (NN B-1) (NNS cells))))) (CC but) (VP (ADVP (RB only) (RB inducibly)) (VBN expressed) (PP (IN in) (NP (JJ conventional) (NP (NN B) (NNS lymphocytes)))))))) (S (-LRB- -LSB-) (VP (VB see) (NP (NNS comments))) (-RRB- -RSB-))))))
(S1 (S (S (S (NP (NP (NP (NN Cytokine)) (CC and) (NP (NN growth) (NN factor) (NN receptor))) (NN engagement)) (VP (VBZ leads) (PP (TO to) (NP (NP (NP (DT the) (JJ rapid) (NP (NN phosphorylation)) (CC and) (NP (NN activation))) (PP (IN of) (NP (JJ latent) (, ,) (NP (JJ cytosolic) (NN signal) (NNS transducers) (CC and) (NNS activators) (IN of) (NN transcription) (-LRB- -LRB-) (NN STAT) (-RRB- -RRB-) (NNS proteins))))) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB then)) (VP (VBP translocate) (PP (TO to) (NP (NP (DT the) (NN nucleus)) (SBAR (WHADVP (WRB where)) (S (NP (PRP they)) (VP (VBP regulate) (NP (NP (JJ transcriptional) (NNS events)) (PP (IN from) (NP (JJ specific) (NN promoter) (NNS sequences))))))))))))))) (. .)))))
(S1 (S (S (NP (NP (NN STAT3)) (NN expression)) (PP (IN in) (NP (JJ particular))) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (NP (NP (NN Abl)) (, ,) (NP (NN Src)) (, ,) (CC and) (NP (NN HTLV-1))) (NN transformation)) (PP (IN of) (NP (JJ normal) (NNS cells)))))))) (. .))))
(S1 (S (S (NP (NN B-1) (NNS lymphocytes)) (VP (VBP are) (NP (NP (JJ self-renewing) (, ,) (NP (JJ CD5+) (NN B) (NNS cells))) (SBAR (WHNP (WDT that)) (S (VP (VP (VBP display) (NP (NP (DT a) (NN propensity)) (PP (IN for) (NP (JJ malignant) (NN transformation))))) (CC and) (VP (VBP are) (NP (NP (DT the) (JJ normal) (NN counterpart)) (PP (TO to) (NP (JJ human) (JJ chronic) (JJ lymphocytic) (NNS leukemias)))))))))) (. .))))
(S1 (S (S (ADVP (RB Further)) (, ,) (NP (NN B-1) (NNS cells)) (VP (VBP are) (VP (VBN characterized) (PP (IN by) (NP (NP (JJ aberrant) (JJ intracellular) (NN signaling)) (, ,) (PP (VBG including) (NP (NP (NN hyperresponsiveness)) (PP (TO to) (NP (NN phorbol) (NN ester) (NN PKC) (NNS agonists))))))))) (. .))))
(S1 (S (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN B-1) (NNS lymphocytes)) (ADVP (RB constitutively)) (VP (VBP express) (NP (NP (JJ nuclear) (VBN activated) (NN STAT3)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (RB not) (VP (VBN expressed) (PP (IN by) (NP (JJ unmanipulated) (JJ conventional) (-LRB- -LRB-) (NN B-2) (-RRB- -RRB-) (NNS lymphocytes)))))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (NN STAT3)) (NN activation)) (VP (VBZ is) (VP (VBN induced) (PP (IN in) (NP (NN B-2) (NNS cells))) (PP (IN after) (NP (NP (NN antigen) (NN receptor) (NN engagement)) (PP (PP (IN in) (NP (DT a) (JJ delayed) (NN fashion))) (PRN (-LRB- -LRB-) (PP (IN after) (NP (CD 3) (NN h))) (-RRB- -RRB-))))))) (. .))))
(S1 (S (S (NP (NP (NN Induction)) (PP (IN of) (NP (NN STAT3)))) (VP (VP (VBZ is) (VP (VBN inhibited) (PP (IN by) (NP (CC both) (NP (NP (DT the) (NN serine/threonine) (NN protein) (NN kinase) (NN inhibitor)) (NP (NN H-7))) (CC and) (NP (NP (DT the) (JJ immunosuppressive) (NN drug)) (NP (NN rapamycin))))))) (CC and) (VP (VBZ requires) (NP (ADJP (FW de) (FW novo)) (NN protein) (NN synthesis)) (, ,) (S (VP (VBG demonstrating) (NP (NP (JJ novel) (NN coupling)) (PP (IN between) (NP (NP (NN sIg)) (CC and) (NP (NN STAT) (NNS proteins)))) (SBAR (WHNP (WDT that)) (S (VP (VBZ differs) (PP (IN from) (NP (NP (DT the) (JJ classical) (NN paradigm)) (PP (IN for) (NP (NP (NP (NN STAT)) (NN induction)) (PP (IN by) (NP (NN cytokine) (NNS receptors))))))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN inability)) (PP (IN of) (NP (NP (NP (JJ prolonged) (NN stimulation)) (PP (IN of) (NP (JJ conventional) (NP (NN B-2) (NNS cells)))) (PP (IN with) (NP (NN anti-Ig)))) (, ,) (NP (NP (DT a) (NN treatment)) (ADJP (JJ sufficient) (S (VP (VP (TO to) (VP (VB induce) (NP (NP (NN CD5)) (NN expression)))) (, ,) (VP (TO to) (VP (VB result) (PP (IN in) (NP (JJ sustained) (NP (NN STAT3)) (NN activation)))))))))))) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NN STAT3)) (VP (VBZ is) (NP (NP (DT a) (JJ specific) (JJ nuclear) (NN marker)) (PP (IN for) (NP (NN B-1) (NNS cells)))))))) (. .))))
(S1 (S (S (S (ADVP (RB Thus)) (, ,) (NP (NN STAT3)) (VP (MD may) (VP (VB play) (NP (DT a) (NN role)) (PP (IN in) (NP (NN B) (NN cell) (JJ antigen-specific) (NN signaling) (NNS responses)))))) (, ,) (CC and) (S (NP (PRP$ its) (JJ constitutive) (NN activation)) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (JJ normal) (NN cell) (NN population)) (VP (VBG exhibiting) (NP (JJ intrinsic) (JJ proliferative) (NN behavior)))))))) (. .))))
(S1 (S (S (S (NP (NP (DT The) (NP (NN T) (NN cell) (NN activation) (NN factor))) (NP (NN NF-ATc))) (ADVP (RB positively)) (VP (VBZ regulates) (NP (NP (NN HIV-1) (NP (NN replication)) (CC and) (NP (NN gene) (NN expression))) (PP (IN in) (NP (NN T) (NNS cells))))) (. .)))))
(S1 (S (S (S (NP (NP (JJ Clinical) (NN deterioration)) (PP (IN in) (NP (NP (NP (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN HIV-1)) (-RRB- -RRB-))) (NN infection)))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (NP (VBN increased) (NNS levels)) (PP (IN of) (NP (JJ viral) (NN replication)))) (CC and) (NP (NP (NN burden)) (PP (IN in) (NP (DT the) (NP (JJ peripheral) (NN blood)) (CC and) (NP (JJ lymphoid) (NNS organs))))))))) (. .)))))
(S1 (S (S (NP (NP (NN T) (NN cell) (NN activation)) (CC and) (NP (JJ ensuing) (JJ cellular) (NN gene) (NN activation))) (VP (MD can) (VP (VB be) (ADJP (JJ critical) (PP (IN for) (NP (NN HIV-1) (NN replication)))))) (. .))))
(S1 (S (S (NP (DT The) (NN hypothesis) (SBAR (IN that) (S (NP (NP (DT the) (NP (JJ nuclear) (NN factor) (IN of) (VBN activated) (NN T) (NNS cells))) (PRN (-LRB- -LRB-) (NP (NN NF-AT)) (-RRB- -RRB-))) (VP (MD may) (VP (VB influence) (NP (NN HIV-1) (NN replication))))))) (VP (VBZ is) (ADVP (RB therefore)) (ADJP (JJ compelling) (PP (VBN given) (NP (NP (DT the) (JJ tight) (NN correlation)) (PP (IN of) (NP (NN HIV-1) (JJ transcriptional) (NN induction))) (PP (TO to) (NP (NN T) (NN cell) (NN activation))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP report) (SBAR (IN that) (S (NP (JJ certain) (NP (NN NF-AT) (-LRB- -LRB-) (NN Rel) (-RRB- -RRB-) (NN family) (NNS members))) (VP (VP (ADVP (RB productively)) (VBP bind) (NP (DT the) (NP (NN kappaB) (JJ regulatory) (NNS elements)))) (, ,) (VP (VBP synergize) (PP (IN with) (NP (NP (NP (NN NF-kappaB)) (CC and) (NP (NN Tat))) (PP (IN in) (NP (NP (JJ transcriptional) (NN activation)) (PP (IN of) (NP (NN HIV-1)))))))) (, ,) (CC and) (VP (VBP enhance) (NP (NP (NN HIV-1) (NN replication)) (PP (IN in) (NP (NN T) (NNS cells))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP link) (NP (NP (JJ regulatory) (NNS factors)) (ADJP (JJ critical) (PP (TO to) (NP (NN T) (NN cell) (NN commitment))))) (ADVP (RB directly)) (PP (TO to) (NP (NN HIV-1) (NN replication)))) (. .))))
(S1 (S (S (S (NP (NP (NN ALY)) (, ,) (NP (NP (DT a) (NP (JJ context-dependent) (NN coactivator))) (PP (IN of) (NP (NP (NN LEF-1)) (CC and) (NP (NN AML-1))))) (, ,)) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (NN TCRalpha) (NN enhancer)) (NN function))))) (. .)))))
(S1 (S (S (S (NP (NN LEF-1)) (VP (VBZ is) (NP (NP (DT a) (NN transcription) (NN factor)) (SBAR (WHNP (WDT that)) (S (VP (VBZ participates) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (DT the) (NP (NN T-cell) (NN receptor) (NN alpha) (-LRB- -LRB-) (NN TCR) (NN alpha) (-RRB- -RRB-) (NN enhancer)))))) (PP (IN by) (S (VP (VBG facilitating) (NP (NP (DT the) (NN assembly)) (PP (IN of) (NP (JJ multiple) (NNS proteins)))) (PP (IN into) (NP (DT a) (JJR higher) (NN order) (NP (NN nucleoprotein) (NN complex)))))))))))) (. .)))))
(S1 (S (S (NP (NP (DT The) (NN function)) (PP (IN of) (NP (NN LEF-1)))) (VP (VBZ is) (ADJP (JJ dependent) (, ,) (PP (IN in) (NP (NN part))) (, ,) (PP (PP (IN on) (NP (NP (DT the) (NP (NN HMG) (NN domain))) (SBAR (WHNP (WDT that)) (S (VP (VBZ induces) (NP (DT a) (JJ sharp) (NN bend)) (PP (IN in) (NP (DT the) (NN DNA) (NN helix)))))))) (, ,) (CC and) (PP (IN on) (NP (NP (DT an) (NP (NN activation) (NN domain))) (SBAR (WHNP (WDT that)) (S (VP (VBZ stimulates) (NP (NN transcription)) (PP (ADVP (RB only)) (IN in) (NP (NP (DT a) (JJ specific) (NN context)) (PP (IN of) (NP (JJ other) (NP (JJ enhancer-binding) (NNS proteins)))))))))))))) (. .))))
(S1 (S (S (PP (IN With) (NP (NP (DT the) (NN aim)) (PP (IN of) (S (VP (VBG gaining) (NP (NP (NN insight)) (PP (IN into) (NP (NP (DT the) (NN function)) (PP (IN of) (NP (JJ context-dependent) (NN activation) (NNS domains))))))))))) (, ,) (NP (PRP we)) (VP (VBD cloned) (NP (NP (NN ALY)) (, ,) (NP (DT a) (JJ novel) (NP (JJ LEF-1-interacting) (NN protein))))) (. .))))
(S1 (S (S (NP (NN ALY)) (VP (VBZ is) (NP (NP (NP (DT a) (ADJP (ADJP (RB ubiquitously) (VBN expressed)) (, ,) (ADJP (JJ nuclear))) (NN protein)) (SBAR (WHNP (WDT that)) (S (ADVP (RB specifically)) (VP (VBZ associates) (PP (IN with) (NP (NP (DT the) (NP (NN activation) (NNS domains))) (PP (IN of) (NP (NP (NN LEF-1)) (CC and) (NP (NN AML-1)))) (PRN (-LRB- -LRB-) (NP (NP (NN CBF) (NN alpha2)) (, ,) (NP (NP (NN PEBP2) (NN alpha)) (-LRB- -LRB-) (NN B) (-RRB- -RRB-)))))))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (NP (NP (DT another) (NN protein) (NN component)) (PP (IN of) (NP (DT the) (NP (NN TCR) (NN alpha) (NN enhancer) (NN complex)))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NN ALY)) (VP (MD can) (VP (VB increase) (NP (NN DNA) (NN binding)) (PP (IN by) (NP (CC both) (NP (NP (NN LEF-1))) (CC and) (NP (NN AML) (NNS proteins)))))) (. .))))
(S1 (S (S (NP (NP (NN Overexpression)) (PP (IN of) (NP (NN ALY)))) (VP (VBZ stimulates) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NP (DT the) (NP (NN TCR) (NN alpha) (NN enhancer) (NN complex))) (VP (VBN reconstituted) (PP (IN in) (NP (VBN transfected) (JJ nonlymphoid) (NN HeLa) (NNS cells))))))) (, ,) (SBAR (IN whereas) (S (NP (NP (NN down-regulation)) (PP (IN of) (NP (NN ALY))) (PP (IN by) (NP (JJ anti-sense) (NNS oligonucleotides)))) (ADVP (RB virtually)) (VP (VBZ eliminates) (NP (NP (NP (NN TCR) (NN alpha) (NN enhancer)) (NN activity)) (PP (IN in) (NP (NN T) (NNS cells)))))))) (. .))))
(S1 (S (S (ADVP (JJ Similar) (PP (TO to) (NP (NN LEF-1)))) (, ,) (S (NP (NN ALY)) (VP (MD can) (VP (VB stimulate) (NP (NN transcription)) (PP (IN in) (NP (NP (DT the) (NN context)) (PP (IN of) (NP (DT the) (NP (NN TCR) (NN alpha) (NN enhancer))))))) (PRN (CC but) (ADVP (RB apparently)) (RB not) (SBAR (WHADVP (WRB when)) (S (VP (VBN tethered) (PP (TO to) (NP (NN DNA))) (PP (IN through) (NP (DT an) (NP (JJ heterologous) (JJ DNA-binding) (NN domain)))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP propose) (SBAR (IN that) (S (NP (NN ALY)) (VP (VBZ mediates) (NP (ADJP (ADJP (JJ context-dependent)) (ADJP (JJ transcriptional))) (NN activation)) (PP (IN by) (S (VP (VBG facilitating) (NP (NP (DT the) (JJ functional) (NN collaboration)) (PP (IN of) (NP (JJ multiple) (NNS proteins)))) (PP (IN in) (NP (DT the) (NP (NN TCR) (NN alpha) (NN enhancer) (NN complex))))))))))) (. .))))
(S1 (S (NP (NP (NP (NP (NN Differentiation)) (PP (IN of) (NP (NN T-helper) (NNS lymphocytes))) (: :)) (NP (NP (JJ selective) (NN regulation)) (PP (IN by) (NP (NP (NNS members)) (PP (IN of) (NP (NP (DT the) (NP (NN STAT) (NN family))) (PP (IN of) (NP (NN transcription) (NNS factors)))))))) (. .)))))
(S1 (S (S (S (NP (NP (NP (NN Interleukin-4)) (PRN (-LRB- -LRB-) (NP (NN IL-4)) (-RRB- -RRB-))) (CC and) (NP (NP (NN interleukin-12)) (PRN (-LRB- -LRB-) (NP (NN IL-12)) (-RRB- -RRB-)))) (VP (VBP control) (NP (NP (DT the) (NN differentiation)) (PP (IN of) (NP (NN T-helper) (NNS cells))))) (. .)))))
(S1 (S (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP summarize) (NP (NP (NNS studies)) (SBAR (WHNP (WDT which)) (S (VP (VBP investigate) (NP (NP (DT the) (NN mechanism)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (DT these) (NP (NNS cytokines))) (ADVP (RB selectively)) (VP (VBP reprogramme) (NP (NP (NN gene) (NN expression)) (PP (IN in) (NP (NNS T-lymphocytes))))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Cytokine)) (NN stimulation)) (VP (VBZ leads) (PP (TO to) (NP (NP (DT the) (NN phosphorylation)) (PP (IN of) (NP (JJ specific) (NN tyrosine) (NNS residues))) (PP (IN within) (NP (NP (DT the) (NP (JJ intracellular) (NN domain))) (PP (IN of) (NP (DT the) (JJ corresponding) (NP (NN cytokine) (NN receptor))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS phosphotyrosines)) (VP (VBP serve) (PP (IN as) (NP (NP (NN docking) (NNS sites)) (PP (IN for) (NP (NP (JJ latent) (, ,) (NP (JJ cytoplasmic) (NN transcription) (NNS factors))) (VP (VBN known) (PP (IN as) (NP (NN signal) (NNS transducers) (CC and) (NNS activators) (IN of) (NN transcription) (-LRB- -LRB-) (NN Stat) (-RRB- -RRB-) (NNS proteins))))))))) (. .))))
(S1 (S (S (NP (NN Receptor/Stat) (NN interaction)) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (NP (DT the) (NP (NN src) (NN homology) (CD 2) (-LRB- -LRB-) (NN SH2) (-RRB- -RRB-) (NN domain))) (PP (IN of) (NP (DT the) (JJ corresponding) (NP (NN Stat) (NN protein)))))))) (. .))))
(S1 (S (S (SBAR (IN Although) (S (NP (NP (NN Stat)) (VP (VBG binding) (PP (TO to) (NP (NP (DT the) (NP (JJ intracellular) (NN domain))) (PP (IN of) (NP (DT the) (NP (NN cytokine) (NN receptor)))))))) (ADVP (RB strongly)) (VP (VBZ depends) (PP (IN on) (NP (DT the) (NN phosphotyrosine) (NN residue)))))) (, ,) (S (NP (NP (DT the) (NN recruitment)) (PP (IN of) (NP (DT a) (JJ specific) (NP (NN Stat) (NN protein))))) (VP (VBZ is) (VP (VBN dictated) (PP (IN by) (NP (NN amino) (NN acid) (NNS residues) (JJ C-terminal))) (PP (TO to) (NP (DT the) (NN phosphotyrosine)))))) (. .))))
(S1 (S (S (NP (NP (JJ Specific) (NP (NN docking) (NNS sites))) (PP (IN within) (NP (JJ individual) (NP (NN cytokine) (NNS receptors))))) (VP (VBP have) (VP (VBN been) (VP (VBN identified) (PP (IN for) (NP (ADJP (RB almost) (DT all)) (NP (NN Stat) (NNS proteins))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ direct) (NN coupling)) (PP (IN between) (NP (NP (NN cytokine) (NN receptor)) (CC and) (NP (NN transcription) (NN factor))))) (VP (VBZ helps) (S (VP (TO to) (VP (VB explain) (SBAR (WHNP (WHADJP (WRB how) (JJ different)) (NP (NNS cytokines))) (S (VP (VBP elicit) (NP (NP (JJ distinct) (NNS patterns)) (PP (IN of) (NP (NN gene) (NN expression))))))))))) (. .))))
(S1 (S (S (S (NP (JJ Cell-to-cell) (NN contact)) (VP (VBZ activates) (NP (NP (DT the) (NP (JJ long) (JJ terminal) (NN repeat))) (PP (IN of) (NP (JJ human) (NN immunodeficiency) (NN virus) (CD 1)))) (PP (IN through) (NP (PRP$ its) (NP (NN kappaB) (NN motif))))) (. .)))))
(S1 (S (S (S (NP (NP (JJ Cell-to-cell) (NN contact)) (PP (IN between) (NP (NP (JJ peripheral) (NN blood) (NNS lymphocytes)) (CC and) (NP (VBN transfected) (JJ human) (JJ colonic) (NN carcinoma) (NN cell) (NN line) (NN HT29))))) (VP (VBZ activates) (NP (NP (NN transcription)) (PP (IN of) (NP (NP (DT the) (NP (NP (JJ long) (JJ terminal) (NNS repeats)) (PRN (-LRB- -LRB-) (NP (NNS LTR)) (-RRB- -RRB-)))) (PP (IN of) (NP (JJ human) (NN immunodeficiency) (NN virus))))))) (. .)))))
(S1 (S (S (NP (NP (NN HIV-1) (NNS LTR)) (NN transcription)) (VP (VBZ is) (VP (VBN controlled) (PP (IN by) (NP (NP (DT a) (JJ complex) (NN array)) (PP (IN of) (NP (NP (ADJP (JJ virus-encoded))) (CC and) (NP (ADJP (JJ cellular))) (NP (NNS proteins)))))))) (. .))))
(S1 (S (S (S (VP (VBG Using) (NP (NP (JJ various) (NNS constructs)) (VP (VBG expressing) (NP (DT a) (NP (NN lacZ) (NN reporter) (NN gene))) (PP (IN under) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (NP (NP (DT the) (JJ intact)) (CC or) (NP (CD three) (JJ deleted)) (NP (NNS forms))) (PP (IN of) (NP (NN HIV-1) (NNS LTR))))))))))) (, ,) (S (NP (PRP we)) (VP (VBD obtained) (NP (NN evidence) (SBAR (IN that) (S (NP (NP (DT the) (NP (NN kappaB) (JJ regulatory) (NNS elements))) (ADJP (JJ located) (PP (IN in) (NP (DT the) (NP (NN U3) (NN region)))))) (VP (VBP are) (VP (VBN involved) (PP (IN in) (NP (NP (JJ cell-to-cell) (NN activation)) (PP (IN of) (NP (NN HIV-1) (NNS LTR)))))))))))) (. .))))
(S1 (S (S (NP (JJ Cell-to-cell) (NN contact)) (VP (VBZ activates) (NP (NP (ADJP (FW in) (FW vitro)) (NN binding)) (PP (IN of) (NP (DT the) (NP (JJ nuclear) (NN factor) (NN kappaB) (-LRB- -LRB-) (NN NF-kappaB) (-RRB- -RRB-) (NN p50/p65) (NN heterodimer)))) (PP (TO to) (NP (DT an) (NN HIV-1) (NN kappaB) (NN oligonucleotide))))) (. .))))
(S1 (S (S (NP (NP (JJ Cell-to-cell) (NN contact) (NN activation)) (PP (IN of) (NP (NN NF-kappaB)))) (VP (VP (VBD was) (ADVP (RB only) (RB partially)) (VP (VBN inhibited) (PP (IN by) (NP (ADJP (CD 100) (NN microM)) (NN pyrrolidine) (NN dithiocarbamate))))) (CC and) (VP (VBD was) (RB not) (VP (VBN correlated) (PP (IN with) (NP (NP (DT a) (JJ significant) (NN decrease)) (PP (IN of) (NP (JJ cellular) (NN inhibitor) (NN kappaB) (NN alpha)))))))) (. .))))
(S1 (S (S (NP (NP (NN NF-kappaB)) (JJ nuclear) (NN activation)) (VP (VP (VBD was) (RB not) (ADJP (JJ detectable) (PP (IN before) (NP (NP (CD 1) (NN h)) (PP (IN after) (NP (NN cell) (NN contact))))))) (CC and) (VP (VBD was) (ADJP (JJ dependent) (PP (IN on) (NP (NN protein) (NN synthesis)))))) (. .))))
(S1 (S (NP (NP (NP (NP (NN Lineage-)) (CC and) (NP (JJ stage-specific)) (NP (NN expression))) (PP (IN of) (NP (NN runt) (NN box) (NNS polypeptides))) (PP (IN in) (NP (NP (ADJP (JJ primitive))) (CC and) (NP (ADJP (JJ definitive))) (NP (NN hematopoiesis)))) (. .)))))
(S1 (S (S (S (NP (NP (NNS Translocations)) (VP (VBG involving) (NP (DT the) (NP (JJ human) (NN CBFA2) (NN locus))))) (VP (VBP have) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NN leukemia)))))) (. .)))))
(S1 (S (S (NP (NP (DT This) (NN gene)) (, ,) (VP (ADVP (RB originally)) (VBN named) (S (NP (NN AML1)))) (, ,)) (VP (VBZ is) (NP (NP (DT a) (JJ human) (NN homologue)) (PP (IN of) (NP (NP (DT the) (NP (FW Drosophila) (NN gene) (NN runt))) (SBAR (WHNP (WDT that)) (S (VP (VBZ controls) (NP (NP (JJ early) (NNS events)) (PP (IN in) (NP (NN fly) (NN embryogenesis))))))))))) (. .))))
(S1 (S (S (S (VP (TO To) (VP (VB clarify) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (JJ mammalian) (NN runt) (NNS products))) (PP (IN in) (NP (NP (ADJP (JJ normal))) (CC and) (NP (ADJP (JJ leukemic))) (NP (NN hematopoiesis)))))))) (, ,) (S (NP (PRP we)) (VP (VBP have) (VP (VBN studied) (NP (NP (PRP$ their) (NN pattern)) (PP (IN of) (NP (NP (NN expression)) (PP (PP (IN in) (NP (NP (NN mouse) (JJ hematopoietic) (NNS tissues)) (PP (IN in) (NP (DT the) (JJ adult))))) (CC and) (PP (IN during) (NP (NN ontogeny)))))))) (S (VP (VBG using) (NP (DT an) (JJ anti-runt) (NN box) (NN antiserum)))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT the) (JJ adult) (NN bone) (NN marrow))) (, ,) (NP (PRP we)) (VP (VBD found) (NP (NP (NN expression)) (PP (IN of) (NP (NN runt) (NNS polypeptides))) (PP (PP (IN in) (NP (VBG differentiating) (JJ myeloid) (NNS cells))) (CC and) (PP (IN in) (NP (NN B) (NNS lymphocytes)))))) (. .))))
(S1 (S (S (PP (IN Within) (NP (DT the) (NP (JJ erythroid) (NN lineage)))) (, ,) (NP (NN runt) (NN expression)) (VP (VBZ is) (ADJP (ADJP (ADJP (JJ biphasic)) (, ,) (ADJP (RB clearly) (JJ present) (PP (IN in) (NP (NP (DT the) (NP (NNS erythroblasts))) (PP (PP (IN of) (NP (JJ early) (NN blood) (NNS islands))) (CC and) (PP (IN of) (NP (DT the) (JJ fetal) (NN liver)))))))) (, ,) (CC but) (ADJP (JJ absent) (PP (IN in) (NP (DT the) (NN adult)))))) (. .))))
(S1 (S (S (NP (NP (JJ Biochemical) (NN analysis)) (PP (IN by) (NP (NP (NN Western) (NN blotting)) (PP (IN of) (NP (NP (ADJP (JJ fetal))) (CC and) (NP (ADJP (JJ adult))) (NP (JJ hematopoietic) (NNS populations))))))) (VP (VBZ shows) (NP (JJ several) (NP (JJ runt) (NNS isoforms)))) (. .))))
(S1 (S (S (NP (NP (ADVP (IN At) (JJS least)) (CD one)) (PP (IN of) (NP (PRP them)))) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (ADJP (JJ myeloid) (JJ specific)))))) (. .))))
(S1 (S (NP (NP (NP (NN Cytokine) (NN signal) (NNS networks)) (CC and) (NP (NP (DT a) (JJ new) (NN era)) (PP (IN in) (NP (JJ biomedical) (NN research)))) (. .)))))
(S1 (S (S (S (NP (NP (NN Elucidation)) (PP (IN of) (NP (NP (DT the) (JJ biochemical) (NN nature)) (PP (IN of) (NP (NP (DT the) (NN signal) (NN transduction) (NN pathway)) (SBAR (WHNP (WDT that)) (S (VP (VBP regulate) (NP (NP (NN transcription)) (CC and) (NP (NN replication))))))))))) (VP (VBZ is) (NP (NP (DT the) (NN focus)) (PP (IN of) (NP (NP (NN attention)) (PP (IN in) (NP (JJ molecular) (NN biology))))))) (. .)))))
(S1 (S (S (NP (DT This) (NN research)) (VP (MD may) (VP (VB make) (NP (NP (NP (JJ feasible) (NN manipulation)) (PP (IN of) (NP (NP (NP (NN growth)) (CC and) (NP (NN differentiation))) (PP (IN of) (NP (JJ mammalian) (NNS cells)))))) (, ,) (SBAR (WHNP (WDT which)) (S (PP (IN in) (NP (NN turn))) (VP (MD would) (VP (VB have) (NP (JJ profound) (NN implication)) (PP (IN in) (NP (NP (NP (JJ biomedical) (NN research)) (PP (IN on) (NP (NP (NN cell)) (CC and) (NP (NN gene)) (NP (NN therapy))))) (, ,) (CC and) (NP (NP (NN development)) (PP (IN of) (NP (JJ pharmaceutical) (NNS products))))))))))))) (. .))))
(S1 (S (S (NP (NNS Cytokines)) (VP (VP (VBP control) (NP (NP (NP (NN growth)) (, ,) (NP (NN differentiation)) (, ,) (NP (NN death)) (, ,) (CC and) (NP (NN function))) (PP (IN of) (NP (NP (NNS cells)) (PP (IN of) (NP (NP (ADJP (JJ lymphocytic))) (, ,) (NP (ADJP (JJ hemopoietic))) (NP (NNS systems)))))))) (, ,) (CC and) (PP (ADVP (RB together)) (IN with) (NP (JJ nerve) (NNS cells))) (VP (VBP provide) (NP (NP (DT a) (JJ pertinent) (NN model)) (SBAR (S (VP (TO to) (VP (VB study) (NP (NP (JJ intercellular) (NNS communications)) (CC and) (NP (JJ intercellular) (NN signal) (NNS networks)))))))))) (. .))))
(S1 (S (S (S (S (NP (DT This) (NN review)) (VP (VBZ outlines) (NP (NP (JJ general) (NNS features)) (PP (IN of) (NP (NN signal) (NN transduction)))))) (CC and) (S (NP (NP (JJ several) (NNS aspects)) (PP (IN of) (NP (NN cytokine) (NNS networks)))) (VP (VBP are) (VP (VBN discussed) (PP (IN with) (NP (NP (NN emphasis)) (PP (IN on)))))))) (: :) (NP (NP (NP (JJ transcriptional) (NN regulation)) (PP (IN of) (NP (NP (NN Th1)) (CC and) (NP (ADJP (JJ Th2-specific))) (NP (NN cytokine) (NNS genes)))) (PP (IN in) (NP (NN T) (NNS cells)))) (, ,) (NP (NP (DT the) (NNS roles)) (PP (IN of) (NP (NP (NNS cytokines)) (CC and) (NP (PRP$ their) (NNS receptors)))) (PP (IN in) (NP (NP (NP (NN growth)) (CC and) (NP (NN differentiation))) (PP (IN of) (NP (JJ hemopoietic) (NNS cells)))))) (, ,) (CC and) (NP (NP (DT the) (NN manipulation)) (PP (IN of) (NP (NN cytokine) (NNS networks))))) (. .))))
(S1 (S (S (S (NP (JJ Nuclear) (NN factor-kappa) (NN B)) (ADVP (RB potently)) (VP (VBZ up-regulates) (NP (NP (DT the) (NN promoter) (NN activity)) (PP (IN of) (NP (NP (NN RANTES)) (, ,) (NP (NP (DT a) (NN chemokine)) (SBAR (WHNP (WDT that)) (S (VP (VBZ blocks) (NP (NN HIV) (NN infection)))))))))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (JJ complex) (NN network)) (PP (IN of) (NP (NP (NNS cytokines)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN involved) (PP (IN in) (NP (NP (ADJP (JJ inflammatory))) (CC and) (NP (ADJP (JJ immunoregulatory))) (NP (NNS responses))))))))))) (VP (VBZ plays) (NP (DT a) (JJ critical) (NN role)) (PP (IN in) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP (NN HIV) (NN infection)))))) (. .)))))
(S1 (S (S (S (NP (NP (NN RANTES)) (PRN (-LRB- -LRB-) (NP (VBN regulated) (IN upon) (NN activation) (, ,) (JJ normal) (NN T) (NN cell) (VBN expressed) (CC and) (VBN secreted)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (NP (NN cytokine))) (SBAR (WHNP (WDT that)) (S (VP (VBZ belongs) (PP (TO to) (NP (DT the) (NP (NN beta-chemokine) (NN family)))))))))) (: ;) (S (S (NP (PRP it)) (VP (VBZ is) (ADJP (JJ chemoattractant) (PP (IN for) (NP (JJ CD4+/CD45RO) (NN T) (NNS cells)))))) (, ,) (S (NP (PRP it)) (VP (VP (VBZ is) (VP (VBN produced) (PP (IN by) (NP (NP (JJ various) (NN cell) (NNS types)) (PP (VBG including) (NP (NP (NP (JJ CD8+)) (CC and) (NP (JJ CD4+)) (NP (NN T) (NNS cells))) (CONJP (RB as) (RB well) (IN as)) (NP (NNS monocytes/macrophages)))))))) (, ,) (CC and) (VP (VBZ has) (ADVP (RB recently)) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB suppress) (NP (NP (NN replication)) (PP (IN of) (NP (NP (JJ macrophage-tropic) (NNS strains)) (PP (IN of) (NP (NN HIV))))) (PP (IN in) (NP (JJ CD4+) (NN T) (NNS cells))))))))))))) (. .))))
(S1 (S (S (S (VP (TO To) (VP (VB investigate) (NP (NP (DT the) (JJ molecular) (NNS mechanisms)) (PP (IN of) (NP (NP (NN RANTES)) (NN expression))))))) (, ,) (S (NP (DT the) (NP (NN RANTES) (NN promoter) (NN region))) (VP (VBD was) (VP (VBN analyzed) (PP (IN by) (NP (NP (JJ transient) (NN expression)) (CC and) (NP (JJ gel-mobility) (NN shift)) (NP (NNS assays))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP demonstrate) (SBAR (IN that) (: :) (S (S (LST (LS 1) (-RRB- -RRB-)) (NP (NP (NN RANTES)) (NN promoter) (NN activity)) (VP (VBZ is) (VP (VBN up-regulated) (PP (IN by) (NP (NP (NP (NN PMA)) (CC plus) (NP (NN ionomycin))) (, ,) (NP (NP (NN coexpression)) (PP (IN of) (NP (NP (DT the) (NP (NN p65) (NN subunit))) (PP (IN of) (NP (JJ nuclear) (NN factor) (-LRB- -LRB-) (NN NF) (-RRB- -RRB-) (NN -kappa) (NN B)))))) (, ,) (NP (NP (DT the) (NP (JJ proinflammatory) (NNS cytokines))) (NP (NP (NN TNF-alpha)) (CC and) (NP (NN IL-1) (NN beta)))) (, ,) (CC and) (NP (DT the) (NP (NN CD28)) (JJ costimulatory) (NN pathway))))))) (: ;) (S (LST (LS 2) (-RRB- -RRB-)) (NP (DT the) (NP (NN RANTES) (NN promoter) (NN region))) (VP (VBZ contains) (NP (CD four) (NP (NN NF-kappa) (NN B) (NN binding) (NNS sites))) (PP (IN at) (NP (NP (NNS positions) (NP (CD -30)) (, ,) (NP (CD -44)) (, ,) (NP (CD -213)) (, ,) (CC and) (NP (CD -579))) (ADJP (JJ relative) (PP (TO to) (NP (DT the) (NP (NN transcription) (NN start) (NN site))))))))) (: ;) (S (LST (LS 3) (-RRB- -RRB-)) (S (NP (NP (CD one) (NN site)) (PRN (-LRB- -LRB-) (NP (CD -213)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT an) (NP (NN NF-AT) (-LRB- -LRB-) (JJ nuclear) (NN factor) (IN of) (VBN activated) (NN T) (NNS cells) (-RRB- -RRB-) (NN binding) (NN site))) (SBAR (WHNP (WDT that)) (S (ADVP (RB also)) (VP (VBZ has) (NP (NP (JJ weak) (NN affinity)) (PP (TO to) (NP (NN NF-kappa) (NN B)))))))))) (, ,) (CC and) (S (NP (NP (DT the) (ADJP (RBS most) (JJ distal)) (NN site)) (PRN (-LRB- -LRB-) (NP (CD -579)) (-RRB- -RRB-))) (ADVP (RB also)) (VP (VBZ serves) (PP (IN as) (NP (DT a) (NP (JJ CD28-responsive) (NN element))))))) (: ;) (CC and) (S (LST (LS 4) (-RRB- -RRB-)) (NP (NP (NP (NN mutation)) (PP (IN on) (NP (NP (DT any)) (PP (IN of) (NP (DT those) (NP (NN NF-kappa) (NN B) (NNS sites))))))) (CC or) (NP (NP (NN coexpression)) (PP (IN of) (NP (NP (NN I) (NN kappa) (NN B) (NN alpha)) (PRN (-LRB- -LRB-) (NP (JJ cytoplasmic) (NN inhibitor) (IN of) (NN NF-kappa) (NN B)) (-RRB- -RRB-)))))) (ADVP (RB markedly)) (VP (VBD reduced) (NP (DT the) (NN promoter) (NN activity))))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NP (NN NF-kappa) (NN B)) (, ,) (NP (NP (DT a) (ADJP (ADJP (JJ potent)) (ADJP (JJ transcriptional))) (NN activator)) (PP (IN of) (NP (NN HIV) (NN expression)))) (, ,)) (VP (VBZ is) (ADVP (RB also)) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (NN RANTES)) (, ,) (NP (NP (DT a) (NP (NN chemokine))) (SBAR (WHNP (WDT that)) (S (VP (VBZ blocks) (NP (NP (NN infection)) (PP (IN by) (NP (NP (JJ macrophage-tropic) (NNS strains)) (PP (IN of) (NP (NN HIV)))))))))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Response)) (PP (TO to) (NP (JJ intranasal) (NN fluticasone) (NN propionate))) (PP (IN in) (NP (ADJP (JJ perennial) (JJ allergic)) (NN rhinitis))) (VP (RB not) (VBN associated) (PP (IN with) (NP (NP (NN glucocorticoid) (NN receptor)) (NNS characteristics)))) (. .)))))
(S1 (S (NP (NP (NN BACKGROUND) (: :)) (S (NP (NP (DT The) (NN reduction)) (PP (IN of) (NP (NNS symptoms))) (ADJP (JJ due) (PP (TO to) (NP (NP (NN treatment)) (PP (IN with) (NP (NNS corticosteroids))))))) (VP (VBZ varies) (PP (IN among) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ perennial) (NN rhinitis)))))) (. .)))))
(S1 (S (S (S (NP (JJS Most) (NNS patients)) (VP (MD will) (VP (VB respond)))) (CC but) (S (NP (DT a) (JJ few) (NNS patients)) (VP (VBP respond) (ADVP (RBR less)) (PP (TO to) (NP (DT these) (NNS drugs))))) (. .))))
(S1 (S (NP (NP (NN OBJECTIVE) (: :)) (S (S (VP (TO To) (VP (VB investigate) (NP (NP (DT the) (NN association)) (PP (IN in) (NP (NP (NN reduction)) (PP (IN of) (NP (NNS symptoms))) (ADJP (JJ due) (PP (TO to) (NP (NP (NNS glucocorticoids)) (CC and) (NP (NP (NN glucocorticoid) (NN receptor)) (NNS characteristics))))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (ADJP (JJ perennial) (JJ allergic)) (NN rhinitis))))))))))) (, ,) (S (S (NP (ADJP (FW in) (FW vitro)) (NP (NN glucocorticoid) (NN receptor)) (NN binding) (NNS studies)) (VP (VBD were) (VP (VBN performed) (PP (IN with) (NP (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells)))) (S (VP (VBG using) (NP (NN dexamethasone)))))) (CC and) (S (NP (NP (ADJP (FW in) (FW vitro)) (NN production)) (PP (IN of) (NP (NNS mediators)))) (VP (VBD were) (VP (VBN measured)))))) (. .))))
(S1 (S (NP (NP (NNS METHODS) (: :)) (S (PP (IN During) (NP (DT a) (ADJP (JJ double-blind) (JJ placebo-controlled)) (JJ crossover) (NN study))) (, ,) (NP (NP (NP (ADJP (CD 200) (NNS micrograms)) (NN fluticasone) (JJ propionate) (JJ aqueous) (JJ nasal) (NN spray)) (PRN (-LRB- -LRB-) (PP (IN in) (NP (DT the) (JJ active) (NN treatment) (NN period))) (-RRB- -RRB-))) (CC and) (NP (NP (NN placebo)) (PRN (-LRB- -LRB-) (PP (IN in) (NP (DT the) (NN placebo) (NN treatment) (NN period))) (-RRB- -RRB-)))) (VP (VBD were) (VP (VBN administered) (ADVP (RB twice) (RB daily)) (PP (IN for) (NP (CD 2) (NNS weeks))) (PP (TO to) (NP (NP (CD 22) (NNS patients)) (ADJP (JJ allergic) (PP (TO to) (NP (NN house) (NN dust) (NN mite))))))))) (. .))))
(S1 (S (S (PP (IN At) (NP (NP (DT the) (NN end)) (PP (IN of) (NP (DT both) (NN treatment) (NNS periods))))) (NP (NNS symptoms)) (VP (VBD were) (VP (VBN scored) (PP (PP (IN after) (NP (NP (NN allergen) (NN provocation)) (PRN (-LRB- -LRB-) (NP (NP (CD 100)) (, ,) (NP (CD 1000)) (, ,) (NP (CD 10000)) (NP (NN BU/mL))) (-RRB- -RRB-)))) (CC and) (PP (IN during) (NP (NP (DT the) (CD 9.5) (NNS hours)) (PP (IN after) (NP (DT this) (NN challenge)))))))) (. .))))
(S1 (S (S (NP (NP (NN Receptor) (NN binding) (NNS studies)) (PP (IN with) (NP (NN dexamethasone)))) (VP (VBD were) (VP (VBN performed) (PP (IN with) (NP (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells))))) (. .))))
(S1 (S (S (NP (NP (NP (NN Leukotriene) (NN B4)) (VP (VBN produced) (PP (IN by) (NP (NNS monocytes))) (ADVP (FW in) (FW vitro)))) (CC and) (NP (NP (JJ soluble) (NP (NN interleukin-2) (NN receptor))) (VP (VBN released) (PP (IN by) (NP (NNS lymphocytes))) (ADVP (FW in) (FW vitro)))) (CC and) (NP (NP (NN cortisol) (NNS levels)) (PP (IN in) (NP (NN plasma))))) (VP (VBD were) (VP (VBN determined))) (. .))))
(S1 (S (NP (NP (NNS RESULTS) (: :)) (S (NP (NP (DT No) (ADJP (ADJP (JJ significant)) (ADJP (JJ partial))) (NNS correlations)) (PP (IN of) (NP (NP (NP (NP (DT the) (NN number)) (PP (IN of) (NP (DT the) (NP (JJ peripheral) (NN blood) (JJ mononuclear) (NN cell) (NN glucocorticoid) (NNS receptors))))) (PRN (-LRB- -LRB-) (NP (NP (QP (CD 6821) (CC +/-) (CD 5669)) (VBG binding) (NNS sites)) (PP (IN per) (NP (NN cell)))) (-RRB- -RRB-))) (CC and) (NP (NP (NP (DT the) (NN affinity)) (PRN (-LRB- -LRB-) (NP (NP (NN Kd)) (: :) (NP (QP (CD 16.5) (CC +/-) (CD 13.51)) (NN nmol/L))) (-RRB- -RRB-))) (PP (IN for) (NP (DT the) (NP (NN glucocorticoid) (NNS receptors))))))) (PP (IN with) (NP (NP (NP (DT the) (NN symptom) (NN score)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN placebo)) (: :) (NP (QP (CD 4.3) (CC +/-) (CD 2.45)) (NNS pts))) (: ;) (NP (NP (NN fluticasone)) (: :) (NP (QP (CD 2.4) (CC +/-) (CD 1.55)) (NNS pts)))) (-RRB- -RRB-))) (PP (IN after) (NP (JJ active) (NN treatment)))))) (VP (VBD were) (VP (VBN found)))) (. .))))
(S1 (S (S (ADVP (RB Also)) (NP (NP (DT no) (ADJP (ADJP (ADJP (JJ significant)) (ADJP (JJ partial)))) (NNS correlations)) (PP (IN of) (NP (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NP (NP (NP (NN leukotriene) (NN B4)) (PRN (-LRB- -LRB-) (NP (ADJP (QP (CD 45.6) (CC +/-) (CD 105.3)) (CD ng/10-LRB-6-RRB-)) (NNS cells)) (-RRB- -RRB-))) (VP (VBN produced) (PP (IN by) (NP (NNS monocytes))) (ADVP (FW in) (FW vitro)))) (, ,) (NP (NP (NP (JJ soluble) (NP (NN interleukin-2) (NN receptor))) (PRN (-LRB- -LRB-) (NP (ADJP (QP (CD 734) (CC +/-) (CD 237)) (CD ng/10-LRB-6-RRB-)) (NNS cells)) (-RRB- -RRB-))) (VP (VBN released) (PP (IN by) (NP (NNS lymphocytes))) (ADVP (FW in) (FW vitro))))))) (CC and) (NP (NP (NP (NN cortisol) (NNS levels)) (PRN (-LRB- -LRB-) (NP (QP (CD 571) (CC +/-) (CD 236)) (NN ng/mL)) (-RRB- -RRB-))) (PP (IN in) (NP (NN plasma)))))) (PP (IN with) (NP (NP (DT the) (NN symptom) (NN score)) (PP (IN after) (NP (JJ active) (NN treatment)))))) (VP (VBD were) (VP (VBN found))) (. .))))
(S1 (S (NP (NP (NNS CONCLUSIONS) (: :)) (S (NP (NP (DT The) (NN reduction)) (PP (IN of) (NP (NNS symptoms))) (ADJP (JJ due) (PP (TO to) (NP (JJ topical) (NN fluticasone) (NN propionate)))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN rhinitis)) (CC and) (NP (NP (NN allergy)) (PP (TO to) (NP (NN house) (NN dust) (NN mite))))))))) (VP (VBZ is) (RB not) (VP (VBN correlated) (PP (IN with) (NP (NP (DT the) (NNS characteristics)) (PP (IN of) (NP (DT the) (NP (NN glucocorticoid) (NN receptor))))))))) (. .))))
(S1 (S (S (S (NP (NN HIV)) (VP (VBZ does) (RB not) (VP (VB replicate) (PP (IN in) (NP (NP (JJ naive) (NN CD4) (NN T) (NNS cells)) (VP (VBN stimulated) (PP (IN with) (NP (NN CD3/CD28)))))))) (. .)))))
(S1 (S (S (S (PP (IN In) (NP (DT this) (NN report))) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (NP (DT the) (NN T) (NN cell) (JJ tropic) (NN strain)) (PP (IN of) (NP (NN HIV)))) (, ,) (NP (NN LAI)) (, ,)) (VP (VBZ does) (RB not) (VP (VB replicate) (PP (IN in) (NP (NP (JJ naive) (NN CD4) (NN T) (NNS cells)) (VP (VBN stimulated) (PP (IN by) (S (VP (JJ cross-linking) (NP (NP (NN CD3)) (CC and) (NP (NN CD28)))))))))))))) (. .)))))
(S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NN LAI)) (VP (VBZ replicates) (ADVP (RB well)) (PP (IN in) (NP (NP (NN memory) (NN CD4) (NN T) (NNS cells)) (VP (VBN stimulated) (PP (IN in) (NP (DT the) (JJ same) (NN way))))))) (. .))))
(S1 (S (S (PP (IN Unlike) (NP (DT this) (ADJP (RB physiologically) (JJ relevant)) (NN stimulation))) (, ,) (NP (NN PHA)) (VP (VBZ stimulates) (NP (NP (JJ productive) (NN LAI) (NN replication)) (PP (IN in) (NP (CC both) (NP (ADJP (JJ naive))) (CC and) (NP (NN memory)) (NP (NN T) (NNS cells)))))) (. .))))
(S1 (S (S (NP (DT These) (NNS studies)) (VP (VBD were) (VP (VBN conducted) (PP (IN with) (NP (NP (NP (ADJP (ADJP (RB highly) (VBN purified)) (PRN (-LRB- -LRB-) (ADJP (JJ FACS-isolated)) (-RRB- -RRB-))) (NNS subsets)) (PP (IN of) (NP (NN CD4) (NN T) (NNS cells)))) (VP (VBN identified) (PP (IN by) (NP (NP (NN expression)) (PP (IN of) (NP (CC both) (NP (NN CD45RA)) (CC and) (NP (NN CD62L))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Remixing)) (PP (IN of) (NP (VBN purified) (NN T) (NNS cells)))) (VP (VBD showed) (SBAR (SBAR (IN that) (S (NP (JJ naive) (NN T) (NNS cells)) (VP (VBP do) (RB not) (VP (VB suppress) (NP (NP (NN LAI) (NN replication)) (PP (IN in) (NP (NN memory) (NN T) (NNS cells)))))))) (CC and) (SBAR (IN that) (S (NP (NN memory) (NN T) (NNS cells)) (VP (VBP do) (RB not) (VP (VB restore) (NP (NP (NN LAI) (NN expression)) (PP (IN in) (NP (JJ naive) (NN T) (NNS cells)))))))))) (. .))))
(S1 (S (S (S (NP (NP (DT The) (NN suppression)) (PP (IN of) (NP (NP (JJ productive) (NN LAI) (NN replication)) (PP (IN in) (NP (JJ naive) (NN T) (NNS cells)))))) (VP (VBZ is) (RB not) (ADJP (JJ due) (PP (TO to) (NP (NP (JJ differential) (NN expression)) (PP (IN of) (NP (JJ viral) (NNS coreceptors)))))))) (, ,) (CC nor) (SINV (VBZ is) (NP (PRP it)) (ADJP (JJ due) (PP (TO to) (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (NN activation)) (PP (IN of) (NP (NP (DT the) (JJ important) (NN HIV) (NP (NN transcription) (NNS factors))) (, ,) (NP (NP (JJ nuclear) (NN factor-kappaB)) (CC and) (NP (NN activator) (NN protein-1))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ inherent) (NN resistance)) (PP (IN of) (NP (JJ naive) (NN T) (NNS cells))) (PP (TO to) (NP (JJ productive) (NN HIV) (NN infection))) (, ,) (VP (VBN coupled) (PP (IN with) (NP (PRP$ their) (JJ proliferative) (NN advantage))) (SBAR (IN as) (S (VP (VBN demonstrated) (ADVP (RB here)))))) (, ,)) (VP (VBZ provides) (NP (NP (DT a) (JJ sound) (NN basis)) (PP (IN for) (NP (NP (ADJP (ADJP (JJ proposed)) (ADJP (JJ clinical))) (NNS therapies)) (VP (VBG using) (NP (NP (ADJP (FW ex) (FW vivo)) (NP (NN expansion)) (CC and) (NP (NN reinfusion))) (PP (IN of) (NP (NP (NN CD4) (NN T) (NNS cells)) (PP (IN from) (NP (JJ HIV-infected) (NNS adults))))))))))) (. .))))
(S1 (S (S (S (NP (DT The) (NP (NN Pax-5) (NN gene))) (VP (VBZ is) (ADVP (RB alternatively)) (VP (VBN spliced) (PP (IN during) (NP (NN B-cell) (NN development))))) (. .)))))
(S1 (S (S (S (NP (DT The) (NP (NN transcription) (NN factor) (NN Pax-5))) (VP (VP (VBZ is) (VP (VBN expressed) (PP (IN during) (NP (NP (DT the) (JJ early) (NNS stages)) (PP (IN of) (NP (NN B-cell) (NN differentiation))))))) (CC and) (VP (VBZ influences) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (JJ several) (NP (JJ B-cell-specific) (NNS genes))))))) (. .)))))
(S1 (S (S (PP (IN In) (NP (NP (NN addition)) (PP (TO to) (NP (NP (DT the) (VBG existing) (NN isoform)) (PRN (-LRB- -LRB-) (NP (NP (NN Pax-5)) (, ,) (SBAR (WHNP (WDT which)) (S (NP (PRP we)) (VP (VBP have) (VP (VBN named) (S (NP (NN Pax-5a)))))))) (-RRB- -RRB-)))))) (, ,) (NP (PRP we)) (VP (VBP have) (VP (VBN isolated) (NP (NP (CD three) (JJ new) (NNS isoforms)) (, ,) (NP (NP (NN Pax-5b)) (, ,) (NP (NN Pax-5d)) (, ,) (CC and) (NP (NN Pax-5e)))) (, ,) (PP (IN from) (NP (NP (JJ murine) (NN spleen)) (CC and) (NP (JJ B-lymphoid) (NN cell) (NNS lines))))) (S (VP (VBG using) (NP (NP (NN library) (NNS screenings)) (CC and) (NP (NN polymerase) (NN chain) (NN reaction) (NN amplification)))))) (. .))))
(S1 (S (S (NP (NP (NNS Isoforms)) (NP (NP (NN Pax-5b)) (CC and) (NP (NN Pax-5e)))) (VP (VBP have) (VP (VBN spliced) (PRT (RP out)) (NP (PRP$ their) (JJ second) (NN exon))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (NNS proteins)) (PP (IN with) (NP (RB only) (DT a) (JJ partial) (NP (JJ DNA-binding) (NN domain))))))))) (. .))))
(S1 (S (S (NP (NP (NNS Isoforms)) (NP (NP (NN Pax-5d)) (CC and) (NP (NN Pax-5e)))) (VP (VBP have) (VP (VP (VBN deleted) (NP (NP (DT the) (NP (NN 3'-region))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ encodes) (NP (DT the) (VBG transactivating) (NN domain))))))) (, ,) (CC and) (VP (VBN replaced) (NP (PRP it)) (PP (IN with) (NP (DT a) (JJ novel) (NN sequence)))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN existence)) (PP (IN of) (NP (JJ alternative) (NP (NN Pax-5) (NNS transcripts))))) (VP (VBD was) (VP (VBN confirmed)) (S (VP (VBG using) (NP (NP (NN RNase)) (NN protection) (NNS assays))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (NP (NP (NN Pax-5a))) (CC and) (NP (NN Pax-5b) (NNS proteins))) (VP (VBD were) (VP (VBN detected)) (S (VP (VBG using) (NP (NN Western) (NN blot) (NN analysis))))) (. .))))
(S1 (S (S (S (NP (NN Pax-5a)) (VP (VBD was) (ADJP (JJ detectable) (PP (PP (IN in) (NP (NP (JJ pro-)) (, ,) (NP (JJ pre-)) (, ,) (CC and) (NP (ADJP (JJ mature))) (NP (NN B-cell) (NNS lines)))) (, ,) (CC but) (PP (RB not) (IN in) (NP (CD two) (NNS plasmacytomas))))))) (: ;) (S (NP (NN Pax-5b)) (VP (VBD was) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (ADJP (JJ present) (PP (IN at) (NP (JJ low) (NNS levels))) (PP (PP (PP (IN in) (NP (JJ mature) (NN B-cell) (NNS lines))) (CC and) (, ,) (ADVP (RB unexpectedly)) (, ,) (PP (IN in) (NP (CD one) (NN plasma) (NN cell) (NN line)))) (, ,) (CC but) (PP (RB not) (IN in) (NP (NP (JJ pro-B-cell)) (CC or) (NP (NN T-cell)) (NP (NNS lines)))))))))))) (. .))))
(S1 (S (S (NP (NN Mobility) (NN shift) (NNS assays)) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (ADVP (FW in) (FW vitro)) (VBN translated) (NP (NN Pax-5a)) (CC and) (NP (NN Pax-5d))) (, ,) (CONJP (CC but) (RB not)) (NP (NP (NN Pax-5b)) (CC or) (NP (NN Pax-5e))) (, ,)) (VP (MD could) (VP (VB interact) (PP (IN with) (NP (NP (DT a) (NP (JJ B-cell-specific) (NN activator) (JJ protein-binding) (NN site))) (PP (IN on) (NP (DT the) (NP (NN blk) (NN promoter))))))))))) (. .))))
(S1 (S (S (S (VP (VBG Using) (NP (DT this) (NN assay)))) (, ,) (S (NP (PRP we)) (ADVP (RB also)) (VP (VBD showed) (SBAR (IN that) (S (NP (NN Pax-5d)) (VP (VP (VBD was) (ADJP (JJ present) (PP (IN in) (NP (NP (JJ nuclear) (NNS extracts)) (PP (IN of) (NP (NP (ADJP (DT some))) (PRN (-LRB- -LRB-) (CC but) (NP (ADJP (RB not) (DT all))) (-RRB- -RRB-)) (NP (JJ B-lymphoid) (NNS lines)))))))) (CC and) (VP (VBZ interacts) (PP (IN with) (NP (DT the) (NP (JJ B-cell-specific) (NN activator) (JJ protein-binding) (NN site)))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN pattern)) (PP (IN of) (NP (NP (JJ differential) (NN expression)) (PP (IN of) (NP (RB alternatively) (VBN spliced) (NN Pax-5) (NNS isoforms)))))) (VP (VBZ suggests) (SBAR (IN that) (S (NP (PRP they)) (VP (MD may) (VP (VB be) (NP (JJ important) (NP (NNS regulators) (IN of) (NN transcription))) (PP (IN during) (NP (NN B-cell) (NN maturation)))))))) (. .))))
(S1 (S (NP (NP (NP (NN Oxidant-regulation)) (PP (IN of) (NP (NP (NN gene) (NN expression)) (PP (IN in) (NP (DT the) (ADJP (RB chronically) (JJ inflamed)) (NN intestine))))) (. .)))))
(S1 (S (S (S (NP (NP (PRP It))) (VP (VBZ is) (VP (VBG becoming) (ADJP (RB increasingly) (JJ apparent)) (SBAR (IN that) (S (NP (NP (DT the) (JJ chronic) (NN gut) (NN inflammation)) (VP (VBN observed) (PP (IN in) (NP (NP (DT the) (ADJP (JJ idiopathic) (JJ inflammatory)) (NN bowel) (NNS diseases)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (NP (NP (JJ ulcerative) (NN colitis)) (, ,) (NP (NN Crohn) (POS 's) (NN disease))) (-RRB- -RRB-)))))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (VBN enhanced) (NN production)) (PP (IN of) (NP (JJ leukocyte-derived) (NNS oxidants))))))))))) (. .)))))
(S1 (S (S (NP (NP (NNS Oxidants)) (PP (JJ such) (IN as) (NP (NN hydrogen) (NN peroxide)))) (VP (VBP are) (VP (VBN known) (S (VP (TO to) (VP (VB activate) (NP (NP (JJ certain) (NP (NN transcription) (NNS factors))) (PP (JJ such) (IN as) (NP (JJ nuclear) (NN transcription) (NN factor) (NN kappa) (NN beta))))))))) (. .))))
(S1 (S (S (NP (NP (JJ Nuclear) (NN transcription) (NN factor) (NN kB)) (PRN (-LRB- -LRB-) (NP (NN NF-kappa) (NN B)) (-RRB- -RRB-))) (VP (VBZ is) (NP (DT a) (NP (NP (JJ ubiquitous) (NN transcription) (NN factor)) (CC and) (NP (JJ pleiotropic) (NN regulator))) (PP (IN of) (NP (NP (JJ numerous) (NNS genes)) (VP (VBN involved) (PP (IN in) (NP (DT the) (NP (ADJP (JJ immune))) (CC and) (NP (ADJP (JJ inflammatory))) (NP (NNS responses))))))))) (. .))))
(S1 (S (S (NP (DT This) (NP (NN transcription) (NN factor))) (VP (VBZ is) (VP (VBN activated) (PP (IN via) (NP (NP (DT the) (JJ selective) (NP (NN phosphorylation)) (, ,) (NP (NN ubiquination)) (CC and) (NP (NN degradation))) (PP (IN of) (NP (PRP$ its) (NP (NN inhibitor) (NN protein) (NN I-kB))))))) (S (ADVP (RB thereby)) (VP (VBG allowing) (NP (NP (NN translocation)) (PP (IN of) (NP (NN NF-kappa) (NN B))) (PP (IN into) (NP (NP (DT the) (NN nucleus)) (SBAR (WHADVP (WRB where)) (S (NP (PRP it)) (VP (VBZ upregulates) (NP (NP (DT the) (NN transcription)) (PP (IN of) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NP (NP (NN adhesion) (NNS molecules)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (NP (NP (NN ICAM-1)) (, ,) (NP (NN VCAM-1))) (-RRB- -RRB-))) (, ,) (NP (NP (NNS cytokines)) (PRN (-LRB- -LRB-) (NP (NP (NN TNF)) (, ,) (NP (NN IL-1)) (, ,) (NP (NN IL-6))) (-RRB- -RRB-))) (CC and) (NP (NP (NNS enzymes)) (PRN (-LRB- -LRB-) (NP (NN iNOS)) (-RRB- -RRB-))))))))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ proteolytic) (NN degradation)) (PP (IN of) (NP (DT the) (ADJP (RB post-translationally) (VBN modified)) (NP (NN I-kappa) (NN B))))) (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB be) (VP (VBN mediated) (PP (IN by) (NP (DT the) (NP (NN 26S) (NN proteasome) (NN complex)))))))))) (. .))))
(S1 (S (S (PP (VBN Based) (PP (IN upon) (NP (NP (NN work)) (PP (IN from) (NP (PRP$ our) (NN laboratory)))))) (, ,) (NP (PRP we)) (VP (VBP propose) (SBAR (IN that) (S (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (NN NF-kappa) (NN B)) (NN activation)))) (VP (VBZ produces) (NP (NP (ADJP (ADJP (JJ significant)) (ADJP (JJ anti) (JJ inflammatory))) (NN activity)) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB be) (VP (VBN mediated) (PP (IN by) (NP (NP (DT the) (NN inhibition)) (PP (IN of) (NP (NP (NN transcription)) (PP (IN of) (NP (JJ certain) (NP (JJ pro-inflammatory) (NNS mediators)) (CC and) (NP (NN adhesion) (NNS molecules)))))))))))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Expression)) (PP (IN of) (NP (NN LAZ3/BCL6))) (PP (IN in) (NP (NP (NP (NP (NP (JJ follicular) (NN center)) (PRN (-LRB- -LRB-) (NP (NN FC)) (-RRB- -RRB-))) (NN B) (NNS cells)) (PP (IN of) (NP (JJ reactive) (NN lymph) (NNS nodes)))) (CC and) (NP (JJ FC-derived) (JJ non-Hodgkin) (NNS lymphomas)))) (. .)))))
(S1 (S (S (S (NP (NP (JJ Chromosomal) (NN translocation)) (VP (VBG resulting) (PP (IN in) (NP (NP (JJ abnormal) (NN expression)) (PP (IN of) (NP (DT the) (NP (NN LAZ3/BCL6) (NN gene)))) (PP (IN in) (NP (NN B) (NNS cells))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NP (DT the) (NN tumorigenesis)) (PP (IN of) (NP (NP (JJ non-Hodgkin) (NN lymphoma)) (PRN (-LRB- -LRB-) (NP (NN NHL)) (-RRB- -RRB-))))))))) (. .)))))
(S1 (S (S (ADVP (RB Therefore)) (NP (PRP we)) (VP (VBD studied) (NP (NP (DT the) (NN expression) (NN pattern)) (PP (IN of) (NP (NN LAZ3/BCL6)))) (PP (IN by) (NP (NP (ADJP (FW in) (FW situ)) (NN hybridization)) (PP (IN with) (NP (JJ synthetic) (NN oligonucleotide) (NNS probes)))))) (PP (IN in) (NP (NP (VBN frozen) (NN tissue) (NNS sections)) (PP (IN from) (NP (NP (CD five) (JJ reactive) (NN lymph) (NNS nodes)) (CC and) (NP (CD 38) (NP (NP (NN B) (NN cell)) (CC and) (NP (JJ non-B) (NN NHL)))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP we)) (VP (VBD investigated) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN LAZ3/BCL6)))) (PP (IN by) (NP (NN Northern) (NN blot) (NN analysis)))) (PP (IN on) (NP (JJ multiple) (JJ human) (NNS tissues))) (. .))))
(S1 (S (S (NP (DT The) (NP (NN LAZ3/BCL6) (NN transcript))) (VP (VBD was) (VP (VBN found) (PP (PP (IN in) (NP (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NNS tissues)))) (, ,) (PP (VBG including) (NP (NP (JJ skeletal) (NN muscle)) (, ,) (NP (JJ peripheral) (NN blood) (NNS leukocytes)))))) (, ,) (CC and) (PP (ADVP (RB weakly)) (IN in) (NP (JJ normal) (NN lymph) (NNS nodes)))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT the) (NN tumor) (NNS samples))) (, ,) (NP (NP (NN expression)) (PP (IN of) (NP (NN LAZ3/BCL6)))) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (NP (NP (CD 68) (NN %)) (PP (IN of) (NP (DT all) (NN B) (NN cell) (NN NHL)))) (CC and) (NP (NP (NN none)) (PP (IN of) (NP (DT the) (JJ non-B) (NNS lymphomas)))))))) (. .))))
(S1 (S (S (NP (NP (DT All) (NNS cases)) (PP (IN of) (NP (NP (ADJP (JJ follicular))) (, ,) (NP (ADJP (JJ mixed)) (NP (ADJP (JJ small))) (CC and) (NP (ADJP (JJ large))) (NP (NN cell) (NNS lymphomas)))))) (VP (VBD showed) (NP (NP (NP (NN LAZ3/BCL6)) (NN expression)) (VP (VBN confined) (PP (TO to) (NP (DT the) (JJ neoplastic) (NNS follicles)))))) (. .))))
(S1 (S (S (NP (DT A) (JJ follicular) (NN expression) (NN pattern)) (VP (VBD was) (ADVP (RB also)) (VP (VBN found) (PP (IN in) (NP (DT all) (ADJP (ADJP (JJ non-malignant)) (ADJP (JJ reactive))) (NN lymph) (NNS nodes))))) (. .))))
(S1 (S (S (ADVP (RB Hence)) (, ,) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN LAZ3/BCL6)))) (VP (VP (VBZ does) (RB not) (VP (VB correlate) (PP (TO to) (NP (NN malignancy))))) (, ,) (CC but) (VP (VBZ reflects) (NP (NP (DT the) (NN origin)) (PP (IN of) (NP (NP (NN B) (NNS cells)) (PP (IN from) (NP (DT the) (JJ germinal) (NNS centers)))))))) (. .))))
(S1 (S (NP (NP (NP (NP (NN Estrogen)) (CC and) (NP (NN progesterone) (NNS receptors))) (PP (IN in) (NP (JJ vernal) (NN keratoconjunctivitis))) (. .)))))
(S1 (S (NP (NP (NN PURPOSE) (: :)) (S (NP (JJ Sex-related) (NNS influences)) (VP (VBP have) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP (NP (NP (JJ vernal) (NN keratoconjunctivitis)) (PRN (-LRB- -LRB-) (NP (NN VKC)) (-RRB- -RRB-))) (, ,) (NP (DT an) (ADJP (JJ allergic) (JJ eosinophilic)) (NN disease))))))))) (. .)))))
(S1 (S (NP (NP (NNS METHODS) (: :)) (S (NP (DT The) (NNS authors)) (VP (VBD evaluated) (NP (NP (NP (ADJP (JJ tarsal))) (CC and) (NP (ADJP (JJ bulbar))) (NP (JJ conjunctival) (NNS biopsies))) (PP (IN from) (NP (NP (CD seven) (NNS patients)) (PP (IN with) (NP (ADJP (ADJP (JJ severe)) (CC and) (ADJP (JJ symptomatic))) (NN VKC)))))) (PP (IN for) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (NN estrogen)) (CC and) (NP (NN progesterone) (NNS receptors)))))) (PP (IN by) (S (VP (VBG using) (NP (JJ monoclonal) (NNS antibodies)) (PP (IN with) (NP (DT a) (JJ peroxidase-antiperoxidase) (NN technique)))))))) (. .))))
(S1 (S (NP (NP (NNS RESULTS) (: :)) (S (NP (NP (NP (CC Both) (DT the) (NP (NN epithelium)) (CC and) (NP (NN subepithelium))) (PP (IN of) (NP (NP (DT the) (NP (ADJP (JJ tarsal))) (CC and) (NP (ADJP (JJ bulbar))) (NP (NN conjunctiva))) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NN VKC)))))))) (, ,) (CONJP (CC but) (RB not)) (NP (NP (DT those)) (PP (IN of) (NP (CD four) (JJ nonatopic) (JJ control) (NNS subjects)))) (, ,)) (VP (VBD showed) (NP (NP (ADJP (ADJP (JJ intense)) (ADJP (JJ positive))) (NN staining)) (PP (IN for) (NP (NP (NN estrogen)) (CC and) (NP (NN progesterone) (NNS receptors))))))) (. .))))
(S1 (S (S (NP (NP (NN Immunofluorescence) (NN colocalization)) (PP (IN of) (NP (CC both) (NP (NN estrogen)) (CC and) (NP (NN progesterone) (NNS receptors)))) (PP (IN with) (NP (NN eosinophil) (JJ cationic) (NN protein)))) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (QP (RB approximately) (CD 70)) (NN %)) (PP (IN of) (NP (JJ positive) (NNS cells)))) (VP (VBD were) (NP (NNS eosinophils)))))) (. .))))
(S1 (S (NP (NP (NNS CONCLUSIONS) (: :)) (S (NP (NP (JJ Sexual) (NNS hormones)) (, ,) (PP (IN through) (NP (PRP$ their) (NP (NNS receptors)))) (, ,)) (VP (MD may) (VP (VB influence) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NP (NNS eosinophils)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN VKC))))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Use)) (PP (IN of) (NP (ADJP (ADJP (JJ new)) (ADJP (JJ biologic))) (NNS markers))) (PP (IN in) (NP (DT the) (NN ovulation) (NN induction))) (. .)))))
(S1 (S (S (S (NP (NP (NP (JJ Biological) (NNS markers)) (PP (IN of) (NP (NN ovulation)))) (, ,) (PP (IN after) (NP (NP (DT a) (JJ great)) (PP (IN in) (NP (DT the) (NN past))))) (, ,)) (VP (VBP have) (VP (VBN been) (VP (VBN fallen) (PP (IN into) (NP (NP (NN disuse)) (PP (IN for) (NP (NP (DT the) (JJ large) (NN diffusion)) (PP (IN of) (NP (NP (ADJP (JJ biochemical))) (CC and) (NP (ADJP (JJ biophysical))) (NP (NNS ones))))))))))) (. .)))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (JJ real) (NN effect)) (PP (IN of) (NP (NP (NNS hormones)) (VP (VBN involved) (PP (IN in) (NP (NN ovulation))))))) (VP (VBZ is) (VP (VBN expressed) (PP (IN by) (NP (NP (JJ biological) (NNS modifications)) (PP (IN on) (NP (NN target) (NNS tissues))))))) (. .))))
(S1 (S (S (S (VP (TO To) (VP (VB explore) (NP (NP (DT the) (NNS modifications)) (PP (IN of) (NP (ADJP (RB not) (JJ reproductive)) (NN target) (NNS tissues)))) (PP (IN as) (NP (NN ovulation) (NNS markers)))))) (S (NP (PRP we)) (VP (VBD studied) (NP (NP (DT the) (NN behaviour)) (PP (IN of) (NP (NP (NP (NN Albuminemia)) (, ,) (NP (NP (NN Platelet) (NN Factor) (CD IV)) (PRN (-LRB- -LRB-) (PP (IN as) (NP (NP (NN indicator)) (PP (IN of) (NP (NN Platelet) (NN Aggregation))))) (-RRB- -RRB-))) (, ,) (NP (NN Type) (CD II) (JJ estrogenic) (NNS receptors))) (PP (IN in) (NP (NP (CD 42) (ADJP (NN ovulation) (JJ induced)) (NNS women)) (, ,) (VP (VBG undergoing) (NP (PRP$ our) (NN observation)))))))))) (. .))))
(S1 (S (S (S (NP (NP (CD 33)) (PP (IN of) (NP (PRP them)))) (VP (VBD had) (NP (NN ovulation)))) (CC and) (S (NP (CD 9)) (VP (VBD developed) (NP (DT a) (NN LUF) (NN syndrome)))) (, ,) (S (VP (VBG constituting) (NP (NP (CD two) (JJ biological) (NNS models)) (PP (IN of) (NP (DT an) (JJ opposite) (NN situation)))) (PP (IN for) (NP (NP (DT the) (CD three) (NNS markers)) (VP (VBN observed)))))) (. .))))
(S1 (S (S (S (NP (NP (PDT All) (DT the) (NNS markers)) (VP (VBN considered))) (VP (VBD were) (ADJP (RB sufficiently) (JJ sensitive)))) (, ,) (CC but) (S (PP (IN among) (NP (PRP them))) (, ,) (NP (NN Platelet) (NN Factor) (CD IV)) (VP (VBD was) (ADJP (DT the) (RBS most) (JJ reliable) (PP (TO to) (NP (DT the) (ADJP (JJ hormonal) (JJ ovulatory)) (NN situation)))))) (. .))))
(S1 (S (NP (NP (NP (NN Induction)) (PP (IN of) (NP (NP (NP (NN relA) (-LRB- -LRB-) (NN p65) (-RRB- -RRB-))) (CC and) (NP (NP (NN I) (NN kappa) (NN B) (NN alpha) (NN subunit))) (NP (NN expression)))) (PP (IN during) (NP (NP (NN differentiation)) (PP (IN of) (NP (JJ human) (JJ peripheral) (NN blood) (NNS monocytes))) (PP (TO to) (NP (NNS macrophages))))) (. .)))))
(S1 (S (S (S (NP (PRP We)) (VP (VBD evaluated) (NP (NP (DT the) (NP (NN expression)) (CC and) (NP (NN DNA) (NN binding) (NN activity))) (PP (IN of) (NP (JJ nuclear) (NN factor) (-LRB- -LRB-) (NN NF) (-RRB- -RRB-) (NN -kappa) (NN B) (NNS subunits))) (PP (PP (IN in) (NP (JJ human) (JJ peripheral) (NN blood) (NNS monocytes))) (CC and) (PP (IN in) (NP (NP (JJ monocyte-derived) (NNS macrophages)) (PRN (-LRB- -LRB-) (NP (NNS MDMs)) (-RRB- -RRB-))))))) (. .)))))
(S1 (S (S (NP (NP (JJ Constitutive) (NN DNA) (NN binding) (NN activity)) (VP (VBG consisting) (PP (IN of) (NP (NN p50) (NNS homodimers))))) (VP (VBD was) (VP (VBN detected) (PP (IN in) (NP (NP (JJ nuclear) (NNS extracts)) (PP (IN from) (NP (DT both) (NN cell) (NNS types))))))) (. .))))
(S1 (S (S (NP (NP (DT An) (JJ additional) (NN complex)) (VP (VBN composed) (PP (IN of) (NP (NN p50/RelA) (-LRB- -LRB-) (NN p65) (-RRB- -RRB-) (NNS heterodimers))))) (VP (VBD appeared) (PP (ADVP (RB only)) (IN in) (NP (NP (JJ nuclear) (NNS extracts)) (PP (IN from) (NP (JJ 7-day) (NP (NNS MDMs))))))) (. .))))
(S1 (S (S (NP (NN Immunoblot) (NN analysis)) (VP (VBD showed) (SBAR (IN that) (S (NP (DT the) (NN p50) (NN subunit)) (VP (VBD was) (ADVP (RB constitutively)) (VP (VBN expressed) (PP (IN in) (NP (NP (NNS monocytes)) (CC and) (NP (NNS MDMs))))))))) (. .))))
(S1 (S (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (DT the) (NP (NN RelA) (-LRB- -LRB-) (NN p65) (-RRB- -RRB-) (NN subunit))) (VP (VBD was) (ADJP (RB barely) (JJ detectable) (PP (IN in) (NP (NNS monocytes)))))) (, ,) (CC but) (S (NP (PRP$ its) (NN level)) (VP (VBD increased) (ADVP (RB markedly)) (PP (IN in) (NP (NNS MDMs))))) (. .))))
(S1 (S (S (NP (NP (NN Analysis)) (PP (IN of) (NP (NN RelA) (-LRB- -LRB-) (NN p65) (-RRB- -RRB-) (NN mRNA)))) (VP (VBD revealed) (SBAR (IN that) (S (NP (NP (DT the) (NN stability)) (PP (IN of) (NP (NN RelA) (-LRB- -LRB-) (NN p65) (-RRB- -RRB-) (NN mRNA)))) (VP (VBD was) (ADJP (RB significantly) (JJR higher) (PP (IN in) (NP (NNS MDMs))) (, ,) (PP (VBN compared) (PP (IN with) (NP (NNS monocytes))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NNS MDMs))) (, ,) (NP (NP (NP (DT an) (NN upregulation)) (PP (IN of) (NP (NP (NN I) (NN kappa) (NN B) (NN alpha)) (NN synthesis)))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT the) (NN appearance)) (PP (IN of) (NP (NP (DT a) (JJ novel) (ADJP (NN M-LRB-r-RRB-) (CD 40,000)) (NN form)) (PP (IN of) (NP (NN I) (NN kappa) (NN B) (NN alpha))))))) (VP (VBD were) (ADVP (RB also)) (VP (VBN observed))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN macrophage) (NN differentiation)) (VP (VBZ results) (PP (IN in) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (JJ active) (NP (NN p50/RelA) (-LRB- -LRB-) (NN p65) (-RRB- -RRB-) (NNS heterodimers))) (PP (IN with) (NP (DT the) (NN capacity) (S (VP (TO to) (VP (VB activate) (NP (NN target) (NN gene) (NN expression))))))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ parallel) (NN induction)) (PP (IN of) (NP (NP (NN I) (NN kappa) (NN B) (NN alpha)) (NN synthesis)))) (VP (MD may) (VP (VB allow) (PP (IN for) (NP (NP (DT the) (JJ continuous) (NN presence)) (PP (IN of) (NP (NP (DT a) (JJ cytoplasmic) (NN reservoir)) (PP (IN of) (NP (NP (NN p50/RelA) (-LRB- -LRB-) (NN p65) (-RRB- -RRB-) (NNS complexes)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (RB readily) (JJ available) (PP (IN for) (NP (JJ inducer-mediated) (NN stimulation))))))))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Requirement)) (PP (IN of) (NP (JJ prestimulated) (NN THP-1) (JJ monocytic) (NNS cells))) (PP (IN for) (NP (NP (JJ endothelial) (NN cell)) (NN activation))) (. .)))))
(S1 (S (NP (NP (NN Involvement)) (PP (IN of) (NP (NN TNF) (NN alpha))) (. .))))
(S1 (S (S (S (NP (NN Blood) (NNS monocytes)) (ADVP (RB spontaneously)) (VP (VBP activate) (NP (NP (JJ endothelial) (NNS cells)) (PP (IN in) (NP (NN culture)))) (, ,) (S (VP (VBG leading) (PP (TO to) (NP (NP (NP (NN adhesion)) (PP (IN of) (NP (JJ monocytic) (NNS cells))) (PP (IN onto) (NP (DT the) (JJ endothelial) (NN surface)))) (CC and) (NP (NP (NN overproduction)) (PP (IN of) (NP (NP (JJ endothelial) (NNS proteins) (PP (JJ such) (IN as) (NP (NP (NP (NN von) (NN Willebrand) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN vWf)) (-RRB- -RRB-))) (CC and) (NP (NP (NN plasminogen) (NN activator) (NN inhibitor) (NN type) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN PAI-1)) (-RRB- -RRB-)))))))))))))) (. .)))))
(S1 (S (S (S (VP (TO To) (VP (VB overcome) (NP (NP (DT the) (NN difficulty)) (PP (IN in) (S (VP (VBG obtaining) (NP (JJ quiescent) (NNS monocytes))))))))) (, ,) (S (NP (PRP we)) (VP (VBD studied) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (JJ promonocytic) (NN THP-1) (NNS cells))) (S (VP (TO to) (VP (VB activate) (NP (JJ endothelial) (NNS cells)))))))) (. .))))
(S1 (S (S (NP (NP (ADJP (NN Lipopolysaccharide) (-LRB- -LRB-) (NN LPS) (-RRB- -RRB-) (JJ -prestimulated))) (CC and) (NP (ADJP (JJ untreated))) (NP (NN THP-1) (NNS cells))) (VP (VBD were) (VP (VBN cocultured) (PP (IN with) (NP (NP (VBG resting) (JJ human) (JJ umbilical) (NN vein) (JJ endothelial) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NNS HUVEC)) (-RRB- -RRB-)))) (PP (IN for) (NP (QP (CD 3) (CC and) (CD 24)) (NN h))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN colimycin)))))) (S (VP (TO to) (VP (VB neutralize) (NP (NN LPS) (NNS traces)))))) (. .))))
(S1 (S (S (NP (NP (NN Addition)) (PP (IN of) (NP (JJ untreated) (NP (NN THP-1) (NNS cells))))) (VP (VBD had) (NP (JJ little) (NN effect)) (PP (IN on) (NP (NP (NNS HUVEC)) (NN adhesiveness)))) (. .))))
(S1 (S (S (NP (NP (NN Addition)) (PP (IN of) (NP (JJ prestimulated) (NP (NN THP-1) (NNS cells))))) (VP (VBD was) (VP (VBN followed) (PP (IN by) (NP (DT a) (JJ noticeable) (NN adhesion))) (PP (IN after) (NP (CD 3) (NN h))))) (SBAR (WHNP (WDT which)) (S (VP (VBD reversed) (PP (TO to) (NP (JJ basal) (NNS values))) (PP (IN within) (NP (CD 24) (NN h)))))) (. .))))
(S1 (S (S (PP (IN Under) (NP (DT these) (NNS conditions))) (NP (NP (NNS HUVEC) (NN adhesion) (NNS molecules)) (, ,) (NP (NP (NN E-selectin)) (, ,) (NP (NN VCAM-1)) (CC and) (NP (NN ICAM-1))) (, ,)) (VP (VBD were) (VP (VBN increased) (PP (IN at) (NP (CD 3) (NN h))) (PP (IN with) (S (NP (RB only) (NP (NN ICAM-1))) (VP (VBG remaining) (VP (VBN overexpressed) (PP (IN at) (NP (CD 24) (NN h))))))))) (. .))))
(S1 (S (S (NP (NP (JJ Diffusible) (JJ endothelial) (NNS proteins)) (PP (JJ such) (IN as) (NP (JJ soluble) (NP (NN E-selectin)) (, ,) (NP (NN PAI-1)) (CC and) (NP (NP (NN vWf)) (PP (TO to) (NP (DT a) (JJ minimal) (NN extent)))))) (, ,)) (VP (VBD increased) (PP (IN in) (NP (NP (NNS supernatants)) (PP (IN from) (NP (NP (NNS HUVEC)) (VP (VBN cocultured) (PP (IN for) (NP (CD 24) (NN h))) (PP (IN with) (NP (JJ prestimulated) (NP (NN THP-1) (NNS cells)))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT those) (NNS cocultures))) (, ,) (NP (NP (NN TNF) (NN alpha)) (NNS concentrations)) (VP (VBD peaked) (PP (IN at) (NP (CD 3) (NN h))) (SBAR (IN whereas) (S (NP (NN IL-1) (NN beta) (NNS levels) (ADVP (RB progressively)) (VP (VBD rose) (PP (IN until) (NP (CD 24) (NN h)))))))) (. .))))
(S1 (S (S (NP (NP (NN Addition)) (PP (IN of) (NP (DT an) (NP (JJ anti-TNF) (NN alpha) (NN antibody))))) (VP (VP (VBD decreased) (PP (IN by) (NP (CD 40) (NN %))) (NP (NP (NP (NN E-selectin))) (CC and) (NP (NP (NN ICAM-1))) (NP (NN induction)))) (CC and) (VP (VBD suppressed) (NP (NP (NN PAI-1)) (NN overproduction)) (PP (IN with) (NP (NP (DT a) (JJ weak) (NN effect)) (PP (IN on) (NP (NN vWf))))))) (. .))))
(S1 (S (S (NP (DT An) (NP (JJ anti-IL-1) (NN beta) (NN antibody))) (VP (VBD had) (NP (JJ negligible) (NNS effects)) (PP (IN on) (NP (NP (NNS HUVEC) (NN adhesion) (NNS molecules)) (, ,) (NP (NP (NP (NN PAI-1))) (CC or) (NP (NP (NN vWf))) (NP (NN production)))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP provide) (NP (NN evidence) (SBAR (SBAR (IN that) (S (NP (JJ promonocytic) (NN THP-1) (NNS cells)) (VP (VBP require) (NP (NN prestimulation)) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB activate) (NP (NNS HUVEC))))))))) (CC and) (SBAR (IN that) (S (NP (NN TNF) (NN alpha)) (VP (VBZ contributes) (PP (TO to) (NP (DT this) (NN phenomenon))))))))) (. .))))
(S1 (S (NP (NP (NP (NP (NN c-Jun)) (CC and) (NP (NN GST-pi)) (NP (NN expression))) (PP (IN in) (NP (JJ human) (NN plasma) (NNS cells))) (. .)))))
(S1 (S (S (S (NP (NP (NN Bone) (NN marrow) (NNS samples)) (PP (IN from) (NP (NP (NP (CD 33) (NNS patients)) (VP (VBN affected) (PP (IN by) (NP (NP (NN MM)) (CC and) (NP (NN MGUS)))))) (, ,) (CC and) (NP (NP (CD 8) (NNS patients)) (VP (RB not) (VBN affected) (PP (IN by) (NP (JJ lymphoproliferative) (NNS diseases)))))))) (VP (VBD were) (VP (VBN studied) (PP (IN for) (NP (NP (NN expression)) (PP (IN of) (NP (NP (NP (NN c-Jun)) (PRN (-LRB- -LRB-) (NP (NP (DT a) (NN component)) (PP (IN of) (NP (NP (DT the) (NP (NN transcription) (NN factor))) (NP (NN AP-1))))) (-RRB- -RRB-))) (CC and) (NP (NP (NN glutathione-S-transferase) (NN pi)) (PRN (-LRB- -LRB-) (NP (NN GST-pi)) (-RRB- -RRB-)))))))) (S (VP (VBG using) (NP (JJ immunocytochemical) (NNS methods))))) (. .)))))
(S1 (S (S (NP (NP (DT A) (ADJP (ADJP (JJ high)) (CC and) (ADJP (JJ frequent))) (NN expression)) (PP (IN of) (NP (DT these) (CD two) (NNS proteins)))) (VP (VBD was) (VP (VBN found) (PP (CC both) (PP (IN in) (NP (NP (NP (NN MM)) (CC and) (NP (NN MGUS)) (NP (NNS patients))) (PRN (-LRB- -LRB-) (NP (NP (NP (QP (CD 31/33)) (NNS patients)) (ADJP (JJ positive) (PP (IN for) (NP (NN c-Jun))))) (CC and) (NP (NP (QP (CD 29/33)) (NNS patients)) (ADJP (JJ positive) (PP (IN for) (NP (NN GST-pi)))))) (-RRB- -RRB-)))) (CC and) (PP (IN in) (NP (NP (NNS controls)) (VP (RB not) (VBN affected) (PP (IN by) (NP (JJ monoclonal) (NN gammopathy)))) (PRN (-LRB- -LRB-) (NP (NP (QP (CD 7/8)) (NNS patients)) (ADJP (JJ positive) (PP (IN for) (NP (CC both) (NP (NN c-Jun)) (CC and) (NP (NN GST-pi)))))) (-RRB- -RRB-))))))) (. .))))
(S1 (S (S (NP (DT No) (ADJP (RB statistically) (JJ significant)) (NN correlation)) (VP (VBD was) (VP (VBN found) (PP (IN between) (NP (NP (NN c-Jun-)) (CC and) (NP (ADJP (JJ GST-pi-positive))) (NP (NN plasma) (NNS cells)))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN expression)) (PP (IN of) (NP (DT these) (CD two) (NNS proteins)))) (VP (VBD was) (RB not) (ADJP (JJ related) (PP (TO to) (NP (NP (ADJP (JJ clinical))) (CC or) (NP (NN laboratory)) (NP (NNS data)))))) (. .))))
(S1 (S (S (NP (PRP$ Our) (NNS results)) (VP (VBP seem) (S (VP (TO to) (VP (VB confirm) (NP (NP (DT a) (JJ possible) (NN role)) (PP (IN of) (NP (NP (DT the) (NP (JJ transcriptional) (NN complex))) (NP (NN AP-1)))) (PP (IN in) (S (VP (VBG activating) (NP (NP (NN GST-pi) (NN promoter)) (PP (IN in) (NP (JJ human) (NN plasma) (NNS cells)))))))))))) (. .))))
(S1 (S (S (S (NP (NP (CD Two) (JJ distinct) (NNS pathways)) (PP (IN of) (NP (NP (NP (NN interleukin-5)) (NN synthesis)) (PP (IN in) (NP (JJ allergen-specific) (JJ human) (NN T-cell) (NNS clones)))))) (VP (VBP are) (VP (VBN suppressed) (PP (IN by) (NP (NNS glucocorticoids))))) (. .)))))
(S1 (S (S (S (NP (NP (NNS Glucocorticoids)) (PRN (-LRB- -LRB-) (NP (NNS GC)) (-RRB- -RRB-))) (VP (VBP have) (ADVP (RB long)) (VP (VBN been) (VP (VBN used) (PP (IN as) (NP (NP (DT the) (ADJP (RBS most) (JJ effective)) (NNS agents)) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NP (JJ allergic) (NNS diseases)) (VP (VBN accompanied) (PP (IN by) (NP (NP (NN eosinophilia)) (PP (JJ such) (IN as) (NP (NP (JJ chronic) (NN asthma)) (CC and) (NP (JJ atopic) (NN dermatitis)))))))))))))))) (. .)))))
(S1 (S (S (NP (NP (DT The) (NN development)) (PP (IN of) (NP (ADJP (JJ chronic) (JJ eosinophilic)) (NN inflammation)))) (VP (VBZ is) (ADJP (JJ dependent) (PP (IN on) (NP (NP (NP (NP (NN interleukin-5)) (PRN (-LRB- -LRB-) (NP (NN IL-5)) (-RRB- -RRB-))) (, ,) (NP (DT a) (NP (JJ selective) (JJ eosinophil-activating) (NN factor)))) (, ,) (VP (VBN produced) (PP (IN by) (NP (NN helper) (NN T) (NNS cells)))))))) (. .))))
(S1 (S (S (S (VP (TO To) (VP (VB delineate) (NP (NP (DT the) (JJ regulatory) (NNS mechanisms)) (PP (IN of) (NP (JJ human) (NP (NN IL-5)) (NN synthesis))))))) (, ,) (S (NP (PRP we)) (VP (VBD established) (NP (JJ allergen-specific) (JJ CD4+) (NN T-cell) (NNS clones)) (PP (IN from) (NP (JJ asthmatic) (NNS patients))))) (. .))))
(S1 (S (S (NP (NNS GC)) (ADVP (RB efficiently)) (VP (VBD suppressed) (NP (NP (NP (NN IL-5)) (NN synthesis)) (PP (IN of) (NP (NN T-cell) (NNS clones))) (VP (VBN activated) (PP (IN via) (NP (CC either) (NP (NP (NN T-cell) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN TCR)) (-RRB- -RRB-))) (CC or) (NP (NP (NN IL-2) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN IL-2R)) (-RRB- -RRB-)))))))) (. .))))
(S1 (S (S (NP (NP (NN Induction)) (PP (IN of) (NP (NN IL-5) (NN mRNA))) (PP (IN upon) (NP (NP (NP (NN TCR))) (CC and) (NP (NP (NN IL-2R))) (NP (NN stimulation))))) (VP (VBD was) (ADVP (RB totally)) (VP (VBN inhibited) (PP (IN by) (NP (NN dexamethasone))))) (. .))))
(S1 (S (S (NP (NP (JJ Human) (NP (NN IL-5)) (NN promoter/enhancer-luciferase) (NN gene) (NN construct)) (VP (VBN transfected) (PP (TO to) (NP (NN T-cell) (NNS clones))))) (VP (VP (VBD was) (VP (VBN transcribed) (PP (IN on) (NP (CC either) (NP (NP (NN TCR))) (CC or) (NP (NP (NN IL-2R))) (NP (NN stimulation)))))) (CC and) (VP (VBD was) (ADVP (RB clearly)) (VP (VBN downregulated) (PP (IN by) (NP (NN dexamethasone))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (DT the) (RB approximately) (NP (JJ 500-bp) (JJ human) (NN IL-5) (NN gene) (NN segment))) (ADJP (JJ located) (PP (NP (RB 5') (RB upstream)) (IN of) (NP (DT the) (VBG coding) (NN region))))) (VP (VBZ contains) (NP (NP (JJ activation-inducible) (NN enhancer) (NNS elements)) (ADJP (JJ responsible) (PP (IN for) (NP (NP (DT the) (NN regulation)) (PP (IN by) (NP (NNS GC))))))))))))) (. .))))
(S1 (S (S (NP (JJ Electrophoretic) (NN mobility) (NN shift) (NN assay) (NN analysis)) (VP (VBD suggested) (SBAR (IN that) (S (NP (NP (NN AP-1)) (CC and) (NP (NN NF-kappaB))) (VP (VBP are) (PP (IN among) (NP (NP (DT the) (JJ possible) (NNS targets)) (PP (IN of) (NP (NP (NNS GC) (NNS actions)) (PP (IN on) (NP (JJ TCR-stimulated) (NN T) (NNS cells))))))))))) (. .))))
(S1 (S (S (NP (NP (NN NF-AT)) (CC and) (NP (NN NF-kappaB))) (VP (VBD were) (RB not) (ADVP (RB significantly)) (VP (VBN induced) (PP (IN by) (NP (NP (NN IL-2)) (NN stimulation))))) (. .))))
(S1 (S (S (NP (NP (PRP$ Our) (NNS results)) (VP (VBG showing) (SBAR (IN that) (S (NP (NNS GC)) (VP (VBD suppressed) (NP (NP (NN IL-5)) (NN production)) (PP (IN by) (NP (NP (JJ human) (JJ CD4+) (NN T) (NNS cells)) (VP (VBN activated) (PP (IN by) (NP (NP (CD two) (JJ distinct) (NNS stimuli)) (, ,) (NP (NP (NP (NN TCR))) (CC and) (NP (NP (NN IL-2R))) (NP (NN stimulation)))))))))))) (, ,)) (VP (VBP underscore) (NP (NP (DT the) (NN efficacy)) (PP (IN of) (NP (NNS GC))) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (JJ allergic) (NNS diseases))) (PP (IN via) (NP (NP (NN suppression)) (PP (IN of) (NP (NN T-cell) (NP (NN IL-5)) (NN synthesis))))))))) (. .))))
(S1 (S (NP (NP (NP (NP (JJ Experimental) (NN expression)) (PP (IN in) (NP (NNS mice)))) (CC and) (NP (NP (JJ spontaneous) (NN expression)) (PP (IN in) (NP (JJ human) (NN SLE))) (PP (IN of) (NP (NN polyomavirus) (NN T-antigen)))) (. .)))))
(S1 (S (NP (NP (DT A) (JJ molecular) (NN basis)) (PP (IN for) (NP (NP (NN induction)) (PP (IN of) (NP (NP (NNS antibodies)) (PP (TO to) (NP (NP (NN DNA)) (CC and) (NP (JJ eukaryotic) (NN transcription) (NNS factors)))))))) (. .))))
(S1 (S (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB previously)) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (NP (JJ experimental) (NN expression)) (PP (IN of) (NP (DT the) (NP (NN polyomavirus) (NN transcription) (NN factor) (NN T-antigen))))) (VP (VBZ has) (NP (DT the) (NN potential) (S (VP (TO to) (VP (VB induce) (NP (JJ anti-DNA) (NNS antibodies)) (PP (IN in) (NP (NNS mice)))))))))))) (. .)))))
(S1 (S (S (NP (NP (CD Two) (NNS sets)) (PP (IN of) (NP (JJ independent) (NNS evidences)))) (VP (VBP are) (VP (VBN presented) (ADVP (RB here)))) (SBAR (WHNP (WDT that)) (S (VP (VBP demonstrate) (NP (NP (DT a) (JJ biological) (NN relevance)) (PP (IN for) (NP (DT this) (NN model))))))) (. .))))
(S1 (S (S (ADVP (RB First)) (, ,) (NP (PRP we)) (VP (VBP describe) (NP (NP (NNS results)) (VP (VBG demonstrating) (SBAR (IN that) (S (NP (NP (NNS mice)) (VP (VBN inoculated) (PP (IN with) (NP (JJ T-antigen-expressing) (NNS plasmids))))) (VP (VBD produced) (NP (NP (NNS antibodies)) (, ,) (PP (CONJP (RB not) (RB only)) (PP (TO to) (NP (NP (NN T-antigen)) (CC and) (NP (NN DNA)))) (, ,) (CONJP (CC but) (RB also)) (PP (PP (TO to) (NP (NP (DT the) (NP (JJ DNA-binding) (JJ eukaryotic) (NN transcription) (NNS factors))) (NP (NP (JJ TATA-binding) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN TBP)) (-RRB- -RRB-))))) (, ,) (CC and) (PP (TO to) (NP (DT the) (NP (NP (JJ cAMP-response-element-binding) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN CREB)) (-RRB- -RRB-)))))))))))))) (. .))))
(S1 (S (S (ADVP (RB Secondly)) (, ,) (NP (PRP we)) (VP (VBD investigated) (SBAR (SBAR (IN whether) (S (NP (NN polyomavirus) (NN reactivation)) (VP (VBZ occurs) (PP (IN in) (NP (NN SLE) (NNS patients)))))) (, ,) (CC and) (SBAR (IN whether) (S (NP (NP (NNS antibodies)) (PP (PP (TO to) (NP (NP (NN T-antigen)) (, ,) (NP (NN DNA)))) (, ,) (CC and) (PP (TO to) (NP (NP (NN TBP)) (CC and) (NP (NN CREB)))))) (VP (VBP are) (VP (VBN linked) (PP (TO to) (NP (JJ such) (NNS events))))))))) (. .))))
(S1 (S (S (PP (CC Both) (PP (IN within)) (CC and) (PP (IN among)) (NP (DT these) (NN SLE) (NNS patients))) (, ,) (NP (JJ frequent) (NN polyomavirus) (NNS reactivations)) (VP (VBD were) (VP (VBN observed))) (SBAR (WHNP (WDT that)) (S (VP (MD could) (RB not) (VP (VB be) (VP (VBN explained) (PP (PP (IN by) (NP (NP (JJ certain) (NNS rearrangements)) (PP (IN of) (NP (DT the) (JJ noncoding) (NN control) (NNS regions))))) (, ,) (CC nor) (PP (IN by) (NP (NN corticosteroid) (NN treatment))))))))) (. .))))
(S1 (S (S (S (VP (VBN Linked) (PP (TO to) (NP (DT these) (NNS events))))) (, ,) (S (NP (NP (NNS antibodies)) (PP (TO to) (NP (NP (NN T-antigen)) (, ,) (NP (NN DNA)) (, ,) (NP (NN TBP)) (, ,) (CC and) (NP (NN CREB))))) (VP (VBD were) (VP (VBN detected)) (, ,) (ADVP (JJ identical) (PP (TO to) (SBAR (WHNP (WP what)) (S (NP (PRP we)) (VP (VBD observed) (PP (IN in) (NP (NNS mice)))))))))) (. .))))
(S1 (S (S (NP (NP (NNS Antibodies)) (VP (VBG recognizing) (NP (JJ double-stranded) (NN DNA)))) (VP (VBD were) (VP (VBN confined) (PP (TO to) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ frequent) (NN polyomavirus) (NNS reactivations))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NNS results)) (VP (VBN described) (ADVP (RB here)))) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (JJ cognate) (NN interaction)) (PP (IN of) (NP (NP (NP (NN B) (NNS cells)) (VP (VBG recognizing) (NP (NP (NN DNA)) (CC or) (NP (JJ DNA-associated) (NNS proteins))))) (CC and) (NP (NP (NN T) (NNS cells)) (VP (VBG recognizing) (NP (NN T) (NN antigen))))))) (VP (VBD had) (VP (VBN taken) (NP (NN place)) (PP (IN as) (NP (NP (DT a) (NN consequence)) (PP (IN of) (NP (NP (JJ complex) (NN formation)) (PP (IN between) (NP (NP (NN T) (NN ag)) (CC and) (NP (NN DNA)))) (ADVP (FW in) (FW vivo)))))) (PP (IN in) (NP (NP (DT the) (NN context)) (PP (IN of) (NP (NN polyomavirus) (NNS reactivations)))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Involvement)) (PP (IN of) (NP (DT an) (NP (JJ SAF-like) (NN transcription) (NN factor)))) (PP (IN in) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN serum) (NN amyloid) (NN A) (NN gene))) (PP (IN in) (NP (NN monocyte/macrophage) (NNS cells))) (PP (IN by) (NP (NN lipopolysaccharide))))) (. .)))))
(S1 (S (S (S (NP (NP (NN Serum) (NN amyloid) (NN A)) (PRN (-LRB- -LRB-) (NP (NN SAA)) (-RRB- -RRB-))) (VP (VBZ has) (VP (VBN been) (VP (VBN linked) (PP (TO to) (NP (NN atherosclerosis))) (PP (IN because) (IN of) (NP (NP (PRP$ its) (NN ability) (S (VP (TO to) (VP (VB remodel) (NP (JJ high-density) (NN lipoprotein)) (PP (IN by) (NP (NP (DT the) (NN depletion)) (PP (IN of) (NP (NN apolipoprotein) (NN A1))))))))) (, ,) (NP (PRP$ its) (NN ability) (S (VP (TO to) (VP (VB bind) (NP (NN cholesterol)))))) (, ,) (CC and) (NP (NP (PRP$ its) (NN presence)) (PP (IN in) (NP (NP (DT the) (JJ atherosclerotic) (NNS plaques)) (PP (IN of) (NP (NP (ADJP (JJ coronary))) (CC and) (NP (ADJP (JJ carotid))) (NP (NNS arteries)))))))))))) (. .)))))
(S1 (S (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP (PRP we)) (VP (VBD investigated) (NP (NP (DT the) (NN induction) (NN mechanism)) (PP (IN of) (NP (NN SAA) (NN gene))) (PP (IN in) (NP (NP (NN THP-1) (NN monocyte/macrophage) (NNS cells)) (SBAR (WHNP (WDT which)) (S (VP (VBP play) (NP (DT a) (JJ critical) (NN role)) (PP (IN in) (NP (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ atherosclerotic) (JJ fatty) (NN streak)))) (CC and) (NP (NN plaque) (NN formation))))))))))) (. .))))
(S1 (S (S (NP (NP (PRP We)) (CC and) (NP (NNS others))) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (NN SAA)) (NN gene)) (VP (VBZ is) (VP (VBN induced) (PP (IN in) (NP (NN monocyte/macrophage) (NNS cells))) (PP (IN by) (NP (NP (NN lipopolysaccharide)) (PRN (-LRB- -LRB-) (NP (NN LPS)) (-RRB- -RRB-)))))))))) (. .))))
(S1 (S (S (PP (IN By) (NP (NN promoter) (NN function) (NN analysis))) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (NP (NN SAA) (NN promoter) (NN sequence))) (PP (IN between) (NP (NP (CD -280) (CC and) (CD -226))))) (VP (MD can) (VP (VB confer) (NP (NN LPS) (NN responsiveness))))))) (. .))))
(S1 (S (S (NP (NN Gel) (JJ electrophoretic) (NN mobility) (NN shift) (NN assay)) (VP (VBD detected) (NP (NP (DT an) (VBN induced) (NN DNA-binding) (NN activity)) (PP (IN in) (NP (DT these) (NNS cells))) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NN LPS))))))) (. .))))
(S1 (S (S (NP (NP (NP (NN Characterization)) (PP (IN of) (NP (DT the) (NP (JJ DNA-binding) (NN protein)))) (PP (IN by) (NP (NN UV) (NN cross-linking)))) (, ,) (NP (NP (NN Southwestern) (NN blot)) (, ,) (CC and) (NP (JJ antibody) (NN ablation/supershift)) (NP (NNS assays)))) (VP (VBD revealed) (SBAR (IN that) (S (NP (PRP it)) (VP (VBZ is) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT a) (ADJP (RB recently) (VBN reported)) (NP (JJ nuclear) (NN factor))) (VP (VBN designated) (S (NP (NN SAF))))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (JJ LPS-mediated) (NP (NN SAA)) (NN gene) (NN induction)) (PP (IN in) (NP (NN monocyte/macrophage) (NNS cells)))) (VP (VBZ is) (ADVP (RB primarily)) (ADJP (JJ due) (PP (TO to) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NP (NN SAF)) (NN activity)))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Expression)) (PP (IN of) (NP (NN NFAT-family) (NNS proteins))) (PP (IN in) (NP (JJ normal) (JJ human) (NN T) (NNS cells))) (. .)))))
(S1 (S (S (S (NP (NN NFAT) (NNS proteins)) (VP (VBP constitute) (NP (NP (DT a) (NN family)) (PP (IN of) (NP (NN transcription) (NNS factors))) (VP (VBN involved) (PP (IN in) (S (VP (VBG mediating) (NP (NN signal) (NN transduction)))))))) (. .)))))
(S1 (S (S (S (VP (VBG Using) (NP (NP (DT a) (NN panel)) (PP (IN of) (NP (JJ specific) (NNS antisera)))) (PP (IN in) (NP (NN immunoprecipitation) (NNS assays))))) (, ,) (S (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (NN NFATp)) (PRN (-LRB- -LRB-) (NP (CD 135) (NN kDa)) (-RRB- -RRB-))) (VP (VBZ is) (ADVP (RB constitutively)) (VP (VBN expressed) (PP (IN in) (NP (JJ normal) (JJ human) (NN T) (NNS cells)))) (, ,) (SBAR (IN while) (S (NP (NP (NN synthesis)) (PP (IN of) (NP (NP (NN NFATc)) (PRN (-LRB- -LRB-) (NP (NP (JJ predominant) (NN form)) (PP (IN of) (NP (CD 86) (NN kDa)))) (-RRB- -RRB-))))) (VP (VBZ is) (VP (VBN induced) (PP (IN by) (NP (NN ionomycin) (NN treatment)))))))))))) (. .))))
(S1 (S (S (S (NP (NN NFAT4/x)) (VP (VBD was) (ADVP (RB very) (RB weakly)) (VP (VBN expressed) (PP (IN in) (NP (JJ unstimulated) (NNS cells)))))) (, ,) (CC and) (S (NP (PRP$ its) (NN level)) (VP (VBD did) (RB not) (VP (VB increase) (PP (IN upon) (NP (NP (NN treatment)) (PP (IN with) (NP (VBG activating) (NNS agents)))))))) (. .))))
(S1 (S (S (NP (NN NFAT3) (NN protein)) (VP (VBD was) (RB not) (VP (VBN observed) (PP (IN under) (NP (DT any) (NNS conditions))))) (. .))))
(S1 (S (S (NP (NP (NP (JJ Higher-molecular-weight) (NNS species)) (PP (IN of) (NP (NN NFATc)))) (PRN (-LRB- -LRB-) (PP (IN of) (NP (NP (CD 110)) (CC and) (NP (CD 140)) (NP (NN kDa)))) (-RRB- -RRB-))) (VP (VBD were) (ADVP (RB also)) (VP (VBN detected))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NN translation)) (PP (IN of) (NP (NN NFATc) (NN mRNA)))) (ADVP (RB apparently)) (VP (VBZ initiates) (PP (IN at) (NP (CD two) (JJ different) (NP (NN AUG) (NNS codons)))) (, ,) (S (VP (VBG giving) (NP (NN rise)) (PP (TO to) (NP (NP (NNS proteins)) (SBAR (WHNP (WDT that)) (S (VP (VBP differ) (PP (IN in) (NP (NN size))) (PP (IN by) (NP (CD 36) (NN amino) (NNS acids))))))))))) (. .))))
(S1 (S (S (NP (NP (JJ Additional) (NN size) (NN heterogeneity)) (PP (IN of) (NP (CC both) (NP (NN NFATc)) (CC and) (NP (NN NFATp))))) (VP (VBZ results) (PP (IN from) (NP (NN phosphorylation)))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (NN contrast)) (PP (TO to) (NP (NN ionomycin) (NN treatment))))) (, ,) (NP (NP (NN exposure)) (PP (IN of) (NP (NNS cells))) (PP (TO to) (NP (NP (NP (NN phorbol) (NN myristate) (NN acetate)) (PRN (-LRB- -LRB-) (NP (NN PMA)) (-RRB- -RRB-))) (CC plus) (NP (NN anti-CD28))))) (VP (VBD did) (RB not) (VP (VB induce) (NP (NN NFATc))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (PP (IN under) (NP (DT these) (NNS conditions))) (, ,) (NP (NP (NP (NN interleukin-2)) (NN synthesis)) (PP (IN by) (NP (DT these) (NNS cells)))) (VP (VBZ is) (ADVP (RB apparently)) (ADJP (JJ independent) (PP (IN of) (NP (NN NFATc)))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN DNA) (NN binding) (NNS assays))) (, ,) (NP (CC both) (NP (NP (NN PMA)) (CC plus) (NP (NN anti-CD28))) (CC and) (NP (NP (NN PMA)) (CC plus) (NP (NN ionomycin)))) (VP (VBD resulted) (PP (IN in) (NP (JJ nuclear) (NN NFAT)))) (. .))))
(S1 (S (S (S (ADVP (RB Surprisingly)) (, ,) (NP (NP (DT the) (JJ PMA-ionomycin-induced) (NN synthesis)) (PP (IN of) (NP (NN NFATc))) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (VP (VBN detected) (PP (IN by) (NP (NN immunoprecipitation)))))))) (VP (VBD was) (RB not) (VP (VBN mirrored) (PP (IN in) (NP (DT the) (NN DNA) (NN binding) (NNS assays)))))) (: :) (S (NP (NP (RB nearly) (DT all)) (PP (IN of) (NP (DT the) (NN activity)))) (VP (VBD was) (ADJP (JJ due) (PP (TO to) (NP (NN NFATp)))))) (. .))))
(S1 (S (S (NP (DT This)) (VP (VBZ is) (NP (NP (DT the) (JJ first) (NN study)) (PP (IN of) (NP (NP (NN expression)) (PP (IN of) (NP (DT all) (NN family) (NNS members))) (PP (IN at) (NP (DT the) (NN protein) (NN level))) (PP (IN in) (NP (JJ normal) (JJ human) (NN T) (NNS cells))))))) (. .))))
(S1 (S (NP (NP (NP (JJ High) (NNS levels)) (PP (IN of) (NP (NP (DT the) (NN DNA-binding) (NN activity)) (PP (IN of) (NP (NN E2F))))) (PP (IN in) (NP (NP (JJ adult) (NN T-cell) (NN leukemia)) (CC and) (NP (JJ human) (NN T-cell) (NN leukemia) (NN virus) (NN type) (JJ I-infected) (NNS cells)))) (: :)) (NP (NP (JJ possible) (NN enhancement)) (PP (IN of) (NP (NP (NN DNA-binding)) (PP (IN of) (NP (NN E2F))))) (PP (IN by) (NP (NP (DT the) (NP (JJ human) (NN T-cell) (NN leukemia) (NN virus) (CD I) (NN transactivating) (NN protein))) (, ,) (NP (NN Tax)))) (. .)))))
(S1 (S (S (S (NP (NP (NN Transcription) (NN factor)) (NP (NN E2F))) (VP (VP (VBZ binds) (PP (TO to) (NP (NP (JJ cellular) (NNS promoters)) (PP (IN of) (NP (JJ certain) (NP (NN growth-)) (CC and) (NP (NN cell)) (NP (JJ cycle-controlling) (NNS genes))))))) (CC and) (VP (VBZ forms) (NP (JJ distinct) (NP (JJ heteromeric) (NNS complexes))) (PP (IN with) (NP (JJ other) (NP (JJ nuclear) (NNS proteins)))))) (. .)))))
(S1 (S (S (NP (PRP It)) (VP (VBZ has) (ADVP (RB therefore)) (VP (VBN been) (VP (VBN proposed) (SBAR (IN that) (S (NP (NN E2F)) (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (JJ cellular) (NN proliferation) (NN control)))))))))) (. .))))
(S1 (S (S (NP (NP (JJ Human) (NN T-cell) (NN leukemia) (NN virus) (NN type) (CD I)) (PRN (-LRB- -LRB-) (NP (NN HTLV-I)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT an) (JJ etiological) (NN agent)) (PP (IN of) (NP (NP (JJ adult) (NN T-cell) (NN leukemia)) (PRN (-LRB- -LRB-) (NP (NN ATL)) (-RRB- -RRB-)))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP show) (ADVP (RB here)) (PP (IN by) (NP (NN mobility-shift) (NN assay))) (SBAR (IN that) (S (NP (JJ E2F-containing) (JJ DNA-binding) (NNS complexes)) (VP (VBD were) (VP (VBN detected) (PP (PP (IN in) (NP (NP (JJ HTLV-I-infected) (NN T-cell) (NNS lines)) (CC and) (NP (NP (JJ leukemic) (NNS cells)) (VP (VBN obtained) (PP (IN from) (NP (NN ATL) (NNS patients))))))) (CC but) (PP (RB not) (IN in) (NP (NP (NP (DT an) (NP (JJ uninfected) (NN T-cell) (NN line))) (, ,) (NP (NN Jurkat))) (, ,) (CC and) (NP (JJ normal) (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells)))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NP (NN Tax) (NN protein))) (, ,) (VP (VBN encoded) (PP (IN by) (NP (NN HTLV-I)))) (, ,)) (VP (VBZ is) (NP (NP (DT a) (JJ potent) (NN transcription) (NN activator)) (PP (IN of) (NP (NP (ADJP (JJ viral))) (CC and) (NP (JJ several)) (NP (JJ cellular) (NNS genes)))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (NN expression)) (PP (IN of) (NP (NN Tax)))) (VP (MD can) (VP (VB induce) (NP (DT the) (NP (JJ E2F-containing) (JJ DNA-binding) (NNS complexes))) (PP (IN in) (NP (NN Jurkat) (NN T) (NNS cells)))))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NP (NN Tax)) (, ,)) (PP (IN through) (NP (NP (NN enhancement)) (PP (IN of) (NP (NP (DT the) (NN DNA-binding) (NN activity)) (PP (IN of) (NP (NN E2F))))))) (, ,) (VP (MD may) (VP (VB be) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG regulating) (NP (NP (JJ cellular) (NN gene) (NN expression)) (VP (VBN implicated) (PP (IN in) (NP (NP (DT the) (NP (NN proliferation)) (CC and) (NP (NN transformation))) (PP (IN of) (NP (NN T) (NNS cells))))))) (PP (IN in) (NP (NN ATL))))))))) (. .))))
(S1 (S (S (NP (DT This) (NN activity)) (VP (MD may) (VP (VB be) (ADJP (JJ relevant) (PP (TO to) (NP (NP (DT the) (NNS mechanisms)) (SBAR (WHADVP (WRB whereby)) (S (NP (NP (NN HTLV-I)) (SBAR (WHNP (WDT which)) (S (VP (VBZ does) (RB not) (VP (VB contain) (NP (NNS oncogenes))))))) (VP (VBZ induces) (NP (NN neoplasia)))))))))) (. .))))
(S1 (S (S (S (NP (NP (JJ Oncogenic) (NNS forms)) (PP (IN of) (NP (NN NOTCH1))) (VP (VBG lacking) (NP (CC either) (NP (NP (DT the) (NP (JJ primary) (VBG binding) (NN site))) (PP (IN for) (NP (NN RBP-Jkappa)))) (CC or) (NP (JJ nuclear) (NN localization) (NNS sequences))))) (VP (VBP retain) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VP (VB associate) (PP (IN with) (NP (NN RBP-Jkappa)))) (CC and) (VP (VB activate) (NP (NN transcription)))))))) (. .)))))
(S1 (S (S (S (NP (NP (JJ Truncated) (NNS forms)) (PP (IN of) (NP (DT the) (NP (NN NOTCH1) (JJ transmembrane) (NN receptor)))) (VP (VBN engineered) (S (VP (TO to) (VP (VB resemble) (NP (NP (JJ mutant) (NNS forms)) (PP (IN of) (NP (NN NOTCH1))) (VP (VBN found) (PP (IN in) (NP (NP (JJ certain) (NNS cases)) (PP (IN of) (NP (NP (JJ human) (NN T) (NN cell) (NN leukemia/lymphoma)) (PRN (-LRB- -LRB-) (NP (NN T-ALL)) (-RRB- -RRB-))))))))))))) (ADVP (RB efficiently)) (VP (VBP induce) (NP (NN T-ALL)) (SBAR (WHADVP (WRB when)) (S (VP (VBN expressed) (PP (IN in) (NP (NP (DT the) (NN bone) (NN marrow)) (PP (IN of) (NP (NNS mice))))))))) (. .)))))
(S1 (S (S (PP (IN Unlike) (NP (JJ full-sized) (NP (NN NOTCH1)))) (, ,) (NP (NP (CD two) (ADJP (JJ such) (JJ truncated)) (NNS forms)) (PP (IN of) (NP (DT the) (NN protein))) (VP (CC either) (VP (VBG lacking) (NP (NP (DT a) (JJ major) (NN portion)) (PP (IN of) (NP (NP (DT the) (NP (JJ extracellular) (NN domain))) (PRN (-LRB- -LRB-) (NP (NN DeltaE)) (-RRB- -RRB-)))))) (CC or) (VP (VBG consisting) (PP (ADVP (RB only)) (IN of) (NP (NP (DT the) (NP (JJ intracellular) (NN domain))) (PRN (-LRB- -LRB-) (NP (NN ICN)) (-RRB- -RRB-))))))) (VP (VBD were) (VP (VBN found) (S (VP (TO to) (VP (VB activate) (NP (NP (NN transcription)) (PP (IN in) (NP (VBN cultured) (NNS cells)))) (, ,) (ADVP (RB presumably)) (PP (IN through) (NP (NP (NP (NN RBP-Jkappa)) (NN response) (NNS elements)) (PP (IN within) (NP (NN DNA)))))))))) (. .))))
(S1 (S (S (NP (CC Both) (JJ truncated) (NNS forms)) (ADVP (RB also)) (VP (VBD bound) (PP (TO to) (NP (NP (DT the) (NP (NN transcription) (NN factor) (NN RBP-Jkappa))) (PP (IN in) (NP (NP (NNS extracts)) (VP (VBN prepared) (PP (IN from) (NP (NP (ADJP (JJ human))) (CC and) (NP (ADJP (JJ murine))) (NP (NN T-ALL) (NN cell) (NNS lines)))))))))) (. .))))
(S1 (S (S (NP (JJ Transcriptional) (NN activation)) (VP (VBD required) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (DT a) (JJ weak) (NP (JJ RBP-Jkappa-binding) (NN site)))) (PP (IN within) (NP (NP (DT the) (NP (NN NOTCH1) (NN ankyrin) (NN repeat) (NN region))) (PP (IN of) (NP (DT the) (NP (JJ intracellular) (NN domain)))))))) (. .))))
(S1 (S (S (ADVP (RB Unexpectedly)) (, ,) (NP (NP (DT a) (ADJP (ADJP (JJ second)) (, ,) (ADJP (JJR stronger))) (NP (JJ RBP-Jkappa-binding) (NN site))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VP (VBZ lies) (PP (IN within) (NP (NP (DT the) (NP (JJ intracellular) (NN domain))) (ADJP (JJ close) (PP (TO to) (NP (DT the) (JJ transmembrane) (NN region))))))) (CC and) (VP (ADVP (RB significantly)) (VBZ augments) (NP (NP (NN association)) (PP (IN with) (NP (NN RBP-Jkappa)))))))) (, ,)) (VP (VBD was) (RB not) (VP (VBN needed) (PP (PP (IN for) (NP (NN oncogenesis))) (CC or) (PP (IN for) (NP (JJ transcriptional) (NN activation)))))) (. .))))
(S1 (S (S (SBAR (IN While) (S (NP (NN ICN)) (VP (VBD appeared) (PP (ADVP (RB primarily)) (IN in) (NP (DT the) (NN nucleus)))))) (, ,) (S (NP (NN DeltaE)) (VP (VBD localized) (PP (TO to) (NP (NP (ADJP (JJ cytoplasmic))) (CC and) (NP (ADJP (JJ nuclear))) (NP (NNS membranes)))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (JJ intranuclear) (NN localization)) (VP (VBZ is) (RB not) (ADJP (JJ essential) (PP (IN for) (NP (NP (NN oncogenesis)) (CC or) (NP (JJ transcriptional) (NN activation)))))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (NN support)) (PP (IN of) (NP (DT this) (NN interpretation))))) (, ,) (NP (NP (NN mutation)) (PP (IN of) (NP (JJ putative) (NP (JJ nuclear) (NN localization) (NNS sequences))))) (VP (VP (VBD decreased) (NP (JJ nuclear) (NN localization))) (CC and) (VP (VBD increased) (NP (JJ transcriptional) (NN activation))) (PP (IN by) (NP (JJ membrane-bound) (NN DeltaE)))) (. .))))
(S1 (S (S (NP (NP (JJ Transcriptional) (NN activation)) (PP (IN by) (NP (NP (DT this) (JJ mutant) (NN form)) (PP (IN of) (NP (JJ membrane-bound) (NN DeltaE)))))) (VP (VBD was) (ADJP (RB approximately) (JJ equivalent) (PP (TO to) (NP (NP (DT that)) (VP (VBN produced) (PP (IN by) (NP (JJ intranuclear) (NN ICN)))))))) (. .))))
(S1 (S (S (S (NP (DT These) (NNS data)) (VP (VBP are) (ADJP (RBS most) (JJ consistent) (PP (IN with) (NP (NP (NN NOTCH1)) (NN oncogenesis)))))) (CC and) (S (NP (JJ transcriptional) (NN activation)) (VP (VBG being) (ADJP (JJ independent) (PP (IN of) (NP (NP (NN association)) (PP (IN with) (NP (NP (NN RBP-Jkappa)) (PP (IN at) (NP (NN promoter) (NNS sites)))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Activation)) (PP (IN of) (NP (DT the) (NP (NN NF-kappaB)) (NN pathway))) (PP (IN by) (NP (JJ inflammatory) (NNS stimuli))) (PP (IN in) (NP (JJ human) (NNS neutrophils))) (. .)))))
(S1 (S (S (S (NP (VBN Activated) (NNS neutrophils)) (VP (VBP have) (NP (DT the) (NN ability) (S (VP (VP (TO to) (VP (VB upregulate) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (JJ many) (NNS genes)) (, ,) (PP (IN in) (NP (JJ particular))) (NP (NP (DT those)) (VP (VBG encoding) (NP (NP (NNS cytokines)) (CC and) (NP (NNS chemokines)))))))))) (, ,) (CC and) (VP (TO to) (ADVP (RB subsequently)) (VP (VB release) (NP (DT the) (JJ corresponding) (NNS proteins)))))))) (. .)))))
(S1 (S (S (SBAR (IN Although) (S (NP (JJ little)) (VP (VBZ is) (VP (VBN known))) (PP (TO to) (NP (NN date))) (PP (VBG concerning) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NP (NN gene) (NN transcription)) (PP (IN in) (NP (NNS neutrophils))))))))) (, ,) (S (NP (NP (PRP it))) (VP (VBZ is) (ADJP (JJ noteworthy)) (SBAR (IN that) (S (NP (NP (JJ many)) (PP (IN of) (NP (DT these) (NNS genes)))) (VP (VBP depend) (PP (IN on) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NP (NN transcription) (NNS factors)) (, ,) (PP (JJ such) (IN as) (NP (NN NF-kappaB))))))) (, ,) (PP (IN for) (NP (JJ inducible) (NN expression)))))))) (. .))))
(S1 (S (S (NP (PRP We)) (ADVP (RB therefore)) (VP (VBD investigated) (UCP (SBAR (IN whether) (S (NP (NN NF-kappaB/Rel) (NNS proteins)) (VP (VBP are) (VP (VBN expressed) (PP (IN in) (NP (JJ human) (NNS neutrophils))))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (PRP$ their) (NN fate)) (PP (IN on) (NP (NN cell) (NN activation)))))) (. .))))
(S1 (S (S (NP (PRP We)) (ADVP (RB now)) (VP (VBP report) (SBAR (SBAR (IN that) (S (NP (NP (NNS dimers)) (VP (VBG consisting) (PP (IN of) (NP (NP (NN p50) (NN NFkappaB1)) (, ,) (NP (NN p65) (NN RelA)) (, ,) (CC and/or) (NP (NN c-Rel)))))) (VP (VBP are) (ADJP (JJ present) (PP (IN in) (NP (NNS neutrophils))))))) (CC and) (SBAR (IN that) (S (NP (NP (DT the) (JJR greater) (NN part)) (PP (IN of) (NP (DT these) (NP (NN protein) (NNS complexes))))) (VP (VBZ is) (ADVP (RB physically)) (VP (VBN associated) (PP (IN with) (NP (NP (JJ cytoplasmic) (NN IkappaB-alpha)) (PP (IN in) (NP (VBG resting) (NNS cells))))))))))) (. .))))
(S1 (S (S (PP (VBG Following) (NP (NP (NN neutrophil) (NN stimulation)) (PP (IN with) (NP (NP (NP (JJ proinflammatory) (NNS agonists)) (PRN (-LRB- -LRB-) (PP (JJ such) (IN as) (NP (NP (NP (NN lipopolysaccharide)) (PRN (-LRB- -LSB-) (NP (NN LPS)) (-RRB- -RSB-))) (, ,) (NP (NP (NN tumor) (NN necrosis) (NN factor-alpha)) (PRN (-LRB- -LSB-) (NP (NN TNF-alpha)) (-RRB- -RSB-))) (, ,) (CC and) (NP (NN fMet-Leu-Phe)))) (-RRB- -RRB-))) (SBAR (WHNP (WDT that)) (S (VP (VBP induce) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NP (NNS cytokines)) (CC and) (NP (NNS chemokines))))) (PP (IN in) (NP (DT these) (NNS cells)))))))))) (, ,) (NP (NN NF-kappaB/Rel) (NNS proteins)) (VP (VBD translocated) (PP (TO to) (NP (JJ nuclear) (NNS fractions))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (DT a) (JJ transient) (NN induction)) (PP (IN of) (NP (NP (NN NF-kappaB)) (NN DNA) (NN binding) (NN activity))))) (, ,) (SBAR (IN as) (S (VP (VBN determined) (PP (IN in) (NP (NN gel) (NN mobility) (NN shift) (NNS assays))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN onset)) (PP (IN of) (NP (DT both) (NNS processes)))) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB be) (UCP (VP (ADVP (RB closely)) (VBN paralleled) (PP (IN by))) (, ,) (CC and) (ADJP (JJ dependent) (PP (IN on))) (, ,) (NP (NP (NN IkappaB-alpha)) (NN degradation)))))))) (. .))))
(S1 (S (S (NP (NP (JJ Proinflammatory) (NN neutrophil)) (NNS stimuli)) (ADVP (RB also)) (VP (VBD promoted) (NP (NP (DT the) (NN accumulation)) (PP (IN of) (NP (NN IkappaB-alpha) (NN mRNA) (NNS transcripts)))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (DT the) (NN reexpression)) (PP (IN of) (NP (DT the) (NP (NN IkappaB-alpha) (NN protein))))))))) (. .))))
(S1 (S (S (PP (TO To) (NP (PRP$ our) (NN knowledge))) (, ,) (NP (DT this)) (VP (VBZ constitutes) (NP (DT the) (JJ first) (NN indication) (SBAR (IN that) (S (NP (NP (NN NF-kappaB)) (NN activation)) (VP (VP (MD may) (VP (VB underlie) (NP (NP (DT the) (NN action)) (PP (IN of) (NP (JJ proinflammatory) (NNS stimuli))) (PP (IN towards) (NP (JJ human) (NN neutrophil) (NN gene) (NN expression)))))) (CC and) (, ,) (SBAR (IN as) (FRAG (ADJP (JJ such)))) (, ,) (VP (VBZ adds) (NP (NP (DT a) (JJ new) (NN facet)) (PP (TO to) (NP (NP (PRP$ our) (NN understanding)) (PP (IN of) (NP (NN neutrophil) (NN biology)))))))))))) (. .))))
(S1 (S (S (S (NP (NP (NN Glucocorticoid-resistance)) (PP (IN in) (NP (JJ peripheral-blood) (NNS lymphocytes)))) (VP (VBZ does) (RB not) (VP (VB correlate) (PP (IN with) (NP (NP (NN number)) (PP (IN of) (NP (NP (NN affinity)) (PP (IN of) (NP (NP (NNS glucocorticoid-receptors)) (PP (IN in) (NP (JJ chronic) (JJ renal) (NN failure) (NNS patients))))))))))) (. .)))))
(S1 (S (S (S (NP (NP (NP (NP (NN Glucocorticoid)) (PRN (-LRB- -LRB-) (NP (NN GC)) (-RRB- -RRB-))) (NN resistance)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (JJ chronic) (JJ renal) (NN failure)) (PRN (-LRB- -LRB-) (NP (NN CRF)) (-RRB- -RRB-))))))) (ADVP (RB seriously)) (VP (VBZ impairs) (NP (JJ successive) (NN GC) (NN therapy)) (PP (IN after) (NP (JJ renal) (NN transplantation)))) (. .)))))
(S1 (S (S (NP (PRP We)) (VP (VBD examined) (NP (NP (DT the) (NN relationship)) (PP (IN between) (NP (NP (NP (NP (NP (NN GC-receptor)) (PRN (-LRB- -LRB-) (NP (NN GC-R)) (-RRB- -RRB-))) (NNS parameters)) (PP (IN in) (NP (NP (JJ peripheral-blood) (JJ mononuclear) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN PBMC)) (-RRB- -RRB-))))) (CC and) (NP (NP (NP (NN PBMC)) (NN resistance)) (PP (TO to) (NP (NN GC))))))) (PP (IN in) (NP (NP (CD 21) (NN CRF) (NNS patients)) (CC and) (NP (CD 18) (JJ healthy) (NNS subjects))))) (. .))))
(S1 (S (S (S (NP (DT Each) (NN subject) (NN group)) (VP (VBD was) (VP (VBN divided) (PP (IN into) (NP (NP (CD two) (NNS subgroups)) (PP (VBG according) (PP (TO to) (NP (NP (NP (NN PBMC)) (NN sensitivity)) (PP (TO to) (NP (NN prednisolone))) (PP (IN in) (NP (DT a) (NN mitogen) (NN assay) (NN procedure))))))))))) (: ;) (PP (FW i.e.)) (, ,) (NP (NP (NP (ADJP (JJ sensitive)) (PRN (-LRB- -LRB-) (NP (NP (NN IC50)) (ADJP (JJR &lt;) (NP (CD 381) (NN ng/mL)))) (-RRB- -RRB-)))) (CC and) (NP (NP (ADJP (JJ resistant)) (PRN (-LRB- -LRB-) (NP (NP (NN IC50)) (ADJP (JJR &gt;) (NP (CD 381) (NN ng/mL)))) (-RRB- -RRB-)))) (NP (NNS groups))) (. .))))
(S1 (S (S (PP (IN In) (NP (JJ healthy) (NNS subjects))) (, ,) (NP (NP (DT the) (NN mean) (NP (NN GC-R)) (NP (NN Bmax)) (CC and) (NP (NN Kd))) (PP (IN in) (NP (NP (JJ quiescent) (NP (NN PBMC))) (PP (IN of) (NP (DT the) (JJ GC-sensitive) (NN group)))))) (VP (VBD were) (NP (NP (QP (CD 2.89) (CC +/-) (CD 1.23)) (NN fmol/10-LRB-6-RRB-) (NNS cells)) (CC and) (NP (QP (CD 4.00) (CC +/-) (CD 2.24)) (NN nM))) (, ,) (ADVP (RB respectively))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN Bmax)) (PP (IN in) (NP (DT these) (NNS subjects)))) (ADVP (RB significantly)) (VP (VBD increased) (PP (TO to) (NP (NP (CD 6.61) (CC +/-) (CD 2.02)) (PRN (-LRB- -LRB-) (NP (QP (CD 257.7) (CC +/-) (CD 107.8)) (NN %)) (-RRB- -RRB-)))) (PP (IN after) (NP (NP (NP (ADJP (CD 24) (NN h)) (NN stimulation)) (PP (IN with) (NP (NN concanavalin) (NN A)))) (PRN (-LRB- -LRB-) (NP (NP (NN p)) (ADJP (JJR &lt;) (NP (CD 0.01)))) (-RRB- -RRB-)))) (, ,) (SBAR (IN while) (S (NP (DT the) (NN Kd) (NN change)) (VP (VBD was) (RB not) (ADJP (JJ significant)))))) (. .))))
(S1 (S (S (NP (DT The) (NP (NN GC-R)) (NP (NP (NN Bmax)) (CC and) (NP (NN Kd))) (PP (IN in) (NP (NP (JJ quiescent) (NP (NN PBMC))) (PP (IN of) (NP (DT the) (JJ GC-resistant) (NN group)))))) (VP (VBD were) (NP (NP (QP (CD 5.33) (CC +/-) (CD 1.37)) (NN fmol/10-LRB-6-RRB-) (NNS cells)) (CC and) (NP (QP (CD 3.20) (CC +/-) (CD 1.39)) (NN nM))) (, ,) (ADVP (RB respectively))) (. .))))
(S1 (S (S (NP (NP (DT Both)) (PP (IN of) (NP (DT these) (NNS parameters))) (, ,)) (ADVP (RB however)) (, ,) (VP (VBD did) (RB not) (VP (VB change) (ADVP (RB significantly)) (PP (IN after) (NP (NP (NN mitogen)) (NN stimulation))))) (. .))))
(S1 (S (S (NP (EX There)) (VP (VBD was) (NP (NP (DT a) (ADJP (ADJP (JJ significant)) (ADJP (JJ negative))) (NN correlation)) (PP (IN between) (NP (NP (NP (NN IC50S)) (PP (IN of) (NP (NN prednisolone)))) (CC and) (NP (NP (NP (NN increase-ratios)) (PRN (-LRB- -LRB-) (NP (JJ post/pre) (NN ratio)) (-RRB- -RRB-))) (PP (IN of) (NP (NN Bmax))))))) (PP (IN after) (NP (NP (NP (NN mitogen)) (NN stimulation)) (PRN (-LRB- -LRB-) (NP (NP (NN p)) (ADJP (JJR &lt;) (NP (CD 0.05)))) (-RRB- -RRB-))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN CRF) (NNS patients))) (, ,) (NP (NP (NP (NN Bmax)) (CC and) (NP (NN Kd))) (PP (IN in) (NP (NP (JJ quiescent) (NP (NN PBMC))) (PP (IN of) (NP (DT the) (JJ GC-sensitive) (NN group)))))) (VP (VBD were) (NP (NP (QP (CD 6.04) (CC +/-) (CD 2.35)) (NN fmol/10-LRB-6-RRB-) (NNS cells)) (CC and) (NP (QP (CD 3.49) (CC +/-) (CD 1.72)) (NN nM))) (, ,) (ADVP (RB respectively)) (, ,) (SBAR (IN while) (S (NP (NP (DT those)) (PP (IN in) (NP (NP (NN PBMC)) (PP (IN of) (NP (DT the) (JJ GC-resistant) (NN group)))))) (VP (VBD were) (NP (NP (QP (CD 5.13) (CC +/-) (CD 2.31)) (NN fmol/10-LRB-6-RRB-) (NNS cells)) (CC and) (NP (QP (CD 4.04) (CC +/-) (CD 1.62)) (NN nM))) (, ,) (ADVP (RB respectively)))))) (. .))))
(S1 (S (S (NP (DT The) (NP (NN Bmax)) (CC and) (NP (NN Kd))) (VP (VBD were) (RB not) (ADVP (RB significantly)) (VP (VBN changed) (PP (IN after) (NP (NP (NP (NN mitogen)) (NN stimulation)) (PP (IN in) (NP (NP (DT both) (NNS subgroups)) (PP (IN of) (NP (NN CRF))))))))) (. .))))
(S1 (S (S (ADVP (RB Moreover)) (, ,) (PP (IN in) (NP (NP (NN contrast)) (PP (TO to) (NP (JJ healthy) (NNS subjects))))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (NN correlation)) (PP (IN between) (NP (NP (NN IC50)) (CC and) (NP (NP (NN GC-R)) (NNS parameters))))) (PP (IN in) (NP (NN CRF)))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBD concluded) (SBAR (IN that) (S (, ,) (PP (IN in) (NP (JJ healthy) (NNS subjects))) (, ,) (NP (VBN decreased) (NP (NN PBMC)) (NN capacity) (S (VP (TO to) (VP (VB amplify) (NP (NP (NN GC-R)) (NNS numbers)) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NN mitogen))))))))) (VP (VBZ is) (VP (VBN correlated) (PP (IN with) (NP (NN GC) (NN resistance)))) (, ,) (SBAR (IN whereas) (S (PP (IN in) (NP (NN CRF) (NNS patients))) (NP (DT the) (JJ resistant) (NN mechanism)) (VP (VBZ is) (RB not) (VP (VBN correlated) (PP (IN with) (NP (NP (NN GC-R)) (NNS parameters))))))))))) (. .))))
(S1 (S (S (NP (DT An) (JJ unknown) (NN event)) (VP (MD might) (VP (VB be) (VP (VBN involved) (PP (IN in) (NP (NP (NN GC-resistance)) (PP (IN of) (NP (NN CRF)))))))) (. .))))
(S1 (S (NP (NP (NP (NN Significance)) (PP (IN of) (NP (NP (JJ quantitative) (NN analysis)) (PP (IN of) (NP (NP (NN AML1/ETO) (NNS transcripts)) (PP (IN in) (NP (NP (JJ peripheral) (NN blood) (NN stem) (NNS cells)) (PP (IN from) (NP (NN t-LRB-8;21-RRB-) (JJ acute) (JJ myelogenous) (NN leukemia))))))))) (. .)))))
(S1 (S (S (S (NP (JJ Autologous) (NP (NP (NP (JJ peripheral) (NN blood) (NN stem) (NN cell)) (NN transplantation)) (PRN (-LRB- -LRB-) (NP (NN PBSCT)) (-RRB- -RRB-)))) (VP (VBZ is) (VP (VBG replacing) (NP (NP (JJ autologous) (NN bone) (NN marrow) (NN transplantation)) (PRN (-LRB- -LRB-) (NP (NN BMT)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NN leukemia))))))) (. .)))))
(S1 (S (S (NP (NP (CD One)) (PP (IN of) (NP (NP (DT the) (JJ potential) (NNS advantages)) (PP (IN of) (NP (JJ autologous) (NN PBSCT)))))) (VP (VBZ is) (NP (DT the) (NN possibility) (SBAR (IN that) (S (NP (NP (JJ peripheral) (NN blood) (NN stem) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NNS PBSC)) (-RRB- -RRB-))) (VP (VBP are) (ADJP (ADJP (RBR less) (JJ likely)) (S (VP (TO to) (VP (VB be) (VP (VBN contaminated) (PP (IN by) (NP (JJ leukemic) (NNS cells))))))) (SBAR (IN than) (S (NP (NN bone) (NN marrow) (NNS grafts)))))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (DT the) (JJ major) (NN problem)) (ADVP (RB still)) (VP (VBZ remains) (NP (NP (DT the) (JJ high) (NN incidence)) (PP (IN of) (NP (NP (JJ leukemic) (NN relapse)) (PP (VBG following) (NP (JJ autologous) (NN PBSCT))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB be) (VP (VBN caused) (PP (IN by) (NP (NP (DT the) (NN reinfusion)) (PP (IN of) (NP (NP (NNS PBSC)) (VP (VBN contaminated) (PP (IN by) (NP (JJ leukemic) (NNS cells))))))))))))))))) (. .))))
(S1 (S (S (ADVP (RB Recently)) (, ,) (NP (PRP we)) (VP (VBP have) (VP (VBN developed) (NP (NP (DT a) (JJ quantitative) (NN assay)) (VP (VBG using) (NP (NP (JJ competitive) (NP (JJ reverse) (NN transcriptase) (NN polymerase)) (NN chain) (NN reaction)) (SBAR (WHNP (WDT that)) (S (VP (VBZ estimates) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NN AML1/ETO) (NNS transcripts))) (PP (IN in) (NP (NN t-LRB-8;21-RRB-) (NP (NP (JJ acute) (JJ myelogenous) (NN leukemia)) (PRN (-LRB- -LRB-) (NP (NN AML)) (-RRB- -RRB-))))))))))))) (, ,) (SBAR (IN in) (NN order) (S (VP (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NN degree)) (PP (IN of) (NP (JJ leukemic) (NN cell) (NN contamination))) (PP (IN in) (NP (NP (NNS PBSC)) (NNS harvests)))))) (, ,) (CC and) (VP (TO to) (VP (VB monitor) (NP (NP (JJ minimal) (JJ residual) (NN disease)) (PRN (-LRB- -LRB-) (NP (NN MRD)) (-RRB- -RRB-))) (ADVP (RB quantitatively)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN t-LRB-8;21-RRB-) (NN AML))))))))))) (. .))))
(S1 (S (S (NP (PRP$ Our) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (SBAR (IN although) (S (NP (NP (NP (NNS PBSC)) (NNS harvests)) (VP (VBN collected) (PP (IN after) (NP (NN consolidation) (NN chemotherapy))))) (VP (VBP are) (VP (VBN contaminated) (PP (IN by) (NP (JJ leukemic) (NNS cells))))))) (, ,) (S (NP (NP (DT the) (NN degree)) (PP (IN of) (NP (JJ leukemic) (NN cell) (NN contamination)))) (VP (VBZ decreases) (PP (IN with) (NP (NP (JJ repeated) (NNS cycles)) (PP (IN of) (NP (NN chemotherapy)))))))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (NP (DT the) (NN MRD)) (PP (IN in) (NP (NP (NNS PBSC)) (NNS harvests)))) (VP (VBZ is) (ADJP (ADJP (JJR less)) (PP (IN than) (PP (IN in) (NP (NP (DT the) (JJ corresponding) (NN bone) (NN marrow)) (VP (VBN obtained) (PP (IN on) (NP (NP (DT the) (NN day)) (PP (IN of) (NP (DT the) (NP (NNS PBSC)) (NN collection))))))))))) (. .))))
(S1 (S (S (NP (EX There)) (VP (VBZ appears) (VP (TO to) (VP (VB be) (NP (NP (DT no) (NN relationship)) (PP (IN between) (NP (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NN AML1/ETO) (NNS transcripts)) (VP (VBN found) (PP (IN in) (NP (DT the) (VBN infused) (NP (NNS PBSC)) (NNS harvests))))))) (CC and) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NP (JJ leukemic) (NN relapse)) (PP (VBG following) (NP (JJ autologous) (NNS PBSCT))))))))) (PP (IN in) (NP (PRP$ our) (NN study)))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (DT a) (JJ substantial) (NN decrease)) (PP (IN of) (NP (NN AML1/ETO) (NNS transcripts)))) (VP (VBD was) (VP (VBN seen) (PP (VBG following) (NP (JJ autologous) (NNS PBSCT))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (JJ quantitative) (NN analysis)) (PP (IN of) (NP (NN AML1/ETO) (NNS transcripts)))) (VP (MD may) (VP (VB be) (ADJP (RB clinically) (JJ useful) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN t-LRB-8;21-RRB-) (NN AML)))))))) (. .))))
(S1 (S (NP (NP (NP (NP (NN DNA) (NN methylation) (NNS changes)) (PP (IN in) (NP (JJ hematologic) (NNS malignancies))) (: :)) (NP (NP (ADJP (JJ biologic))) (CC and) (NP (ADJP (JJ clinical))) (NP (NNS implications))) (. .)))))
(S1 (S (S (S (NP (NN DNA) (NN methylation) (NNS changes)) (VP (VBP are) (PP (IN among) (NP (NP (DT the) (ADJP (RBS most) (JJ common) (JJ detectable)) (NNS abnormalities)) (PP (IN in) (NP (JJ human) (NN neoplasia)))))) (. .)))))
(S1 (S (S (NP (NP (NN Hypermethylation)) (PP (IN within) (NP (NP (DT the) (NP (NNS promoters))) (PP (IN of) (NP (VBN selected) (NNS genes)))))) (VP (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (ADJP (RB especially) (JJ common) (PP (IN in) (NP (NP (DT all) (NNS types)) (PP (IN of) (NP (JJ human) (JJ hematopoietic) (NNS neoplasms)))))))))) (, ,) (CC and) (VP (VBZ is) (ADVP (RB usually)) (VP (VBN associated) (PP (IN with) (NP (NP (NN inactivation)) (PP (IN of) (NP (DT the) (VBN involved) (NN gene) (-LRB- -LRB-) (NNS s) (-RRB- -RRB-)))))))) (. .))))
(S1 (S (S (NP (NP (JJ Such) (JJ hypermethylation-associated) (NN silencing)) (PP (IN of) (NP (NN gene) (NN expression)))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (PP (IN for) (NP (NP (JJ several) (NNS genes)) (VP (VBG regulating) (NP (NP (DT the) (NP (NN growth)) (CC and) (NP (NN differentiation))) (PP (IN of) (NP (NP (JJ hematopoietic) (NNS cells)) (, ,) (PP (VBG including) (NP (NP (DT the) (NP (NN estrogen) (NN receptor) (-LRB- -LRB-) (NN ER) (-RRB- -RRB-) (NN gene))) (, ,) (NP (NN P15)) (, ,) (NP (NN P16)) (CC and) (NP (NNS others))))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Hypermethylation)) (PP (IN within) (NP (NP (DT the) (NP (NNS promoters))) (PP (IN of) (NP (DT some) (NNS genes)))))) (VP (VBP appear) (S (VP (TO to) (VP (VB be) (NP (NP (DT an) (JJ early) (NN event)) (PP (IN in) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP (NP (NN neoplasia)) (PRN (-LRB- -LRB-) (NP (NP (NN ER)) (, ,) (NP (NN P15))) (-RRB- -RRB-)))))))))) (, ,) (SBAR (IN while) (S (NP (JJ other) (NNS genes)) (VP (VBP seem) (S (VP (TO to) (VP (VB become) (VP (VBN methylated) (PP (IN during) (NP (NP (DT the) (NN progression)) (PP (IN of) (NP (NP (NNS leukemias)) (PRN (-LRB- -LRB-) (NP (NP (NN HIC1)) (, ,) (NP (NN c-abl))) (-RRB- -RRB-)))))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ high) (NN prevalence)) (PP (IN of) (NP (NN promoter) (NN methylation)))) (VP (VBZ suggests) (SBAR (IN that) (S (NP (DT this) (JJ molecular) (NN abnormality)) (VP (MD can) (VP (VB be) (VP (VBN used))) (S (VP (TO to) (VP (VB monitor) (NP (NN disease) (NN activity)) (PP (IN during) (NP (NN therapy)))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (JJ new) (NN technology)) (VP (VBZ allows) (NP (NP (DT the) (JJ sensitive) (NN identification)) (PP (IN of) (NP (NN gene) (NN hypermethylation))) (PP (IN in) (NP (NP (DT a) (NN background)) (PP (IN of) (NP (JJ normal) (NNS cells)))))) (, ,) (S (VP (VBG suggesting) (NP (NP (ADJP (ADJP (JJ possible)) (ADJP (JJ new))) (NNS strategies)) (PP (IN for) (NP (NP (DT the) (NN detection)) (PP (IN of) (NP (JJ minimal) (JJ residual) (NN disease))))))))) (. .))))
(S1 (S (S (ADVP (RB Finally)) (, ,) (NP (NP (NN reactivation)) (PP (IN of) (NP (JJ tumor-suppressor) (NN gene) (NN expression))) (PP (IN through) (NP (NP (JJ pharmacologic) (NN inhibition)) (PP (IN of) (NP (NP (NN DNA) (NN methyltransferase)) (CC and) (NP (JJ resultant) (NN DNA) (NN demethylation))))))) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (NP (NP (DT a) (ADJP (ADJP (JJ promising)) (ADJP (JJ new))) (NN avenue)) (PP (IN of) (NP (NN therapy)))) (PP (IN in) (NP (JJ acute) (NN leukemia))))))) (. .))))
(S1 (S (S (S (NP (NP (JJ Transcriptional) (NN induction)) (PP (IN of) (NP (NN collagenase-1))) (PP (IN in) (NP (VBN differentiated) (JJ monocyte-like) (-LRB- -LRB-) (NN U937) (-RRB- -RRB-) (NNS cells)))) (VP (VBZ is) (VP (VBN regulated) (PP (IN by) (NP (NP (NN AP-1)) (CC and) (NP (DT an) (NP (JJ upstream) (NN C/EBP-beta) (NN site))))))) (. .)))))
(S1 (S (S (S (PP (IN In) (NP (DT this) (NN report))) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (DT the) (NP (NN AP-1)) (NN site)) (CC and) (NP (DT a) (NP (JJ distal) (NN promoter) (NN element)))) (VP (VBP regulate) (NP (NP (JJ transcriptional) (NN induction)) (PP (IN of) (NP (NN collagenase-1)))) (PP (IN during) (NP (JJ monocytic) (NN differentiation))))))) (. .)))))
(S1 (S (S (S (NP (NP (NN Chloramphenicol) (NN acetyltransferase) (NN expression) (NNS constructs)) (VP (VBG containing) (NP (NP (NNS regions)) (PP (IN of) (NP (DT the) (NP (JJ human) (NN collagenase-1) (NN promoter))))))) (VP (VBD were) (ADVP (ADVP (RB stably)) (CC or) (ADVP (RB transiently))) (VP (VBN transfected) (PP (IN into) (NP (NN U937) (NNS cells)))))) (, ,) (CC and) (S (NP (NN reporter) (NN activity)) (VP (VBD was) (VP (VBN assessed) (PP (IN at) (NP (NP (JJ various) (NNS times)) (PP (IN after) (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (NN phorbol) (NN 12-myristate) (NN 13-acetate) (-LRB- -LRB-) (NN PMA) (-RRB- -RRB-) (JJ -mediated) (NN differentiation)))))))))) (. .))))
(S1 (S (S (S (NP (NP (ADJP (ADJP (JJ Rapid)) (CC and) (ADJP (JJ strong))) (NN induction)) (PP (IN of) (NP (NN promoter) (NN activity)))) (VP (VBD was) (VP (VBN lost) (PP (IN in) (NP (NP (NNS constructs)) (PP (IN with) (NP (DT a) (NP (JJ mutant) (NN AP-1) (NN element))))))))) (: ;) (S (ADVP (RB however)) (, ,) (PP (IN at) (NP (ADJP (NP (QP (CD 16-96)) (NN h))) (NN post-PMA))) (, ,) (NP (DT the) (NP (JJ mutant) (NN collagenase-1) (NN promoter))) (VP (VBD displayed) (ADJP (ADJP (NP (NN AP-1)) (JJ independent)) (ADJP (JJ PMA-mediated))) (NN transactivation))) (. .))))
(S1 (S (S (NP (DT The) (NP (NN AP-1) (JJ mutant) (NNS constructs))) (ADVP (RB also)) (VP (VBD showed) (NP (NP (VBN delayed) (JJ transcriptional) (NN activation)) (PP (IN in) (NP (JJ PMA-treated) (NNS fibroblasts))))) (. .))))
(S1 (S (S (NP (NP (ADJP (NN Western))) (CC and) (NP (NN supershift)) (NP (NNS analyses))) (VP (VBD indicated) (SBAR (IN that) (S (NP (ADJP (JJ functional)) (NP (NN Jun)) (CC and) (NP (NN Fos)) (NP (NNS proteins))) (VP (VBD were) (ADJP (JJ present) (PP (IN in) (NP (NP (JJ nuclear) (NNS extracts)) (PP (IN of) (NP (JJ PMA-differentiated) (NN U937) (NNS cells)))))))))) (. .))))
(S1 (S (S (NP (NN Promoter) (NN deletion) (NNS constructs)) (VP (VBD demonstrated) (NP (NP (DT the) (JJ potential) (NN role)) (PP (IN of) (NP (JJ distal) (NN promoter) (NNS sequences))) (PP (IN in) (S (VP (VBG regulating) (NP (NP (NN collagenase-1)) (NN transcription))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (JJ particular))) (, ,) (NP (NP (ADJP (NN Western))) (, ,) (NP (NN supershift)) (, ,) (CC and) (NP (NN promoter) (NN deletion)) (NP (NNS analyses))) (VP (VBD suggested) (NP (NP (DT a) (NN role)) (PP (IN for) (NP (NP (JJ CCAAT/enhancer-binding) (NN protein-beta) (-LRB- -LRB-) (NN C/EBP-beta) (-RRB- -RRB-) (NN binding) (NN site)) (PP (IN between) (NP (CD -2010) (CC and) (CD -1954))))) (PP (IN in) (S (VP (VBG regulating) (NP (NP (NN transcription)) (PP (IN of) (NP (NN collagenase-1))) (PP (IN in) (NP (JJ monocytic) (NNS cells))))))))) (. .))))
(S1 (S (S (NP (PRP$ Our) (NNS findings)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (JJ distinct) (NP (JJ regulatory) (NNS elements))) (, ,) (VP (VBG acting) (ADVP (RB somewhat) (RB independently) (PP (IN of) (NP (DT each) (JJ other))))) (, ,)) (VP (VBP control) (NP (NP (NN expression)) (PP (IN of) (NP (NN collagenase-1)))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP$ our) (NNS data)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NP (DT the) (ADJP (ADJP (JJ rapid)) (ADJP (JJ PMA-mediated))) (NN induction)) (PP (IN of) (NP (NP (NN collagenase-1)) (NN transcription)))) (VP (VBZ is) (VP (VBN controlled) (PP (IN by) (NP (NP (DT a) (NN mechanism)) (ADJP (JJ distinct) (PP (IN from) (NP (NP (DT that)) (VP (VBG regulating) (NP (NP (DT the) (JJ sustained) (NN expression)) (PP (IN of) (NP (DT this) (NP (NN proteinase)))) (PP (IN in) (NP (VBN activated) (NNS macrophages))))))))))))))) (. .))))
(S1 (S (S (S (NP (NP (DT The) (NP (NN tumour) (JJ associated) (NN cell) (NN surface) (NN antigen))) (NP (NN A6H))) (VP (VBZ is) (ADJP (JJ costimulatory) (PP (IN for) (NP (ADJP (JJ human)) (NP (JJ CD4+)) (CONJP (CC but) (RB not)) (NP (JJ CD8+)) (NP (NN T) (NNS cells)))))) (. .)))))
(S1 (S (S (S (NP (DT The) (NP (NP (NN A6H) (JJ monoclonal) (NN antibody)) (PRN (-LRB- -LRB-) (NP (NN mAb)) (-RRB- -RRB-)))) (VP (VBZ recognizes) (NP (NP (DT a) (NP (CD 120,000-140,000) (NN MW) (NN antigen))) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN expressed) (PP (IN at) (NP (JJ similar) (NNS densities))) (PP (PP (IN on) (NP (NP (ADJP (CD 85-90)) (NN %)) (PP (IN of) (NP (ADJP (JJ human)) (NP (JJ CD4+)) (CC and) (NP (JJ CD8+)) (NP (NN T) (NNS cells)))))) (CC and) (PP (IN on) (NP (JJ renal) (NN cell) (NNS carcinomas)))))))))) (. .)))))
(S1 (S (S (NP (NP (DT The) (NN binding)) (PP (IN of) (NP (DT the) (NP (NN A6H) (NN mAb))))) (VP (VBD induced) (NP (DT a) (JJ costimulatory) (NN signal)) (PP (IN in) (NP (JJ anti-CD3) (VBN activated) (NN T) (NNS cells)))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT the) (JJ present) (NN report))) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NN A6H)) (VP (VBD costimulated) (NP (NP (NN cell) (NN proliferation)) (CC and) (NP (NP (NN cytokine)) (NN production))) (PP (IN in) (NP (VBN purified) (NP (JJ CD4+) (NN T) (NNS cells)))))))) (. .))))
(S1 (S (S (ADVP (RB Unexpectedly)) (, ,) (NP (DT the) (NP (JJ CD8+) (NN T-cell) (NN subpopulation))) (VP (VBD failed) (S (VP (TO to) (VP (VB respond))))) (. .))))
(S1 (S (S (NP (NP (JJ CD4+) (NN T) (NNS cells)) (VP (VBN costimulated) (PP (IN with) (NP (DT the) (NP (NN A6H) (NN mAb)))))) (VP (VBD upregulated) (NP (NP (NN CD80)) (, ,) (NP (NN CD86)) (, ,) (NP (NN CD71)) (, ,) (NP (NN interleukin-2) (-LRB- -LRB-) (NN IL-2) (-RRB- -RRB-) (NN R) (NN alpha)) (, ,) (NP (NN IL-2R) (NN beta)) (CC and) (NP (NN IL-2R) (NN gamma))) (, ,) (SBAR (IN while) (S (NP (NP (DT no) (JJ corresponding) (NN up-regulation)) (PP (IN of) (NP (DT these) (NP (NN cell) (NN surface) (NNS molecules))))) (VP (VBD was) (VP (VBN seen) (PP (IN in) (NP (JJ CD8+) (NN T) (NNS cells)))))))) (. .))))
(S1 (S (S (SBAR (IN In) (NN order) (S (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (NN nature)) (PP (IN of) (NP (DT the) (NP (NN A6H) (NN mAb)) (NN costimulus)))) (PP (IN at) (NP (DT the) (JJ transcriptional) (NN level))))))) (S (NP (PRP we)) (VP (VBP have) (VP (VBN examined) (NP (NP (NN induction)) (PP (IN of) (NP (NP (NP (DT the) (NP (NN transcription) (NNS factors))) (NP (NP (NN OCT-1)) (, ,) (NP (NN AP-1)) (CC and) (NP (NN NF-kappa) (NN B)))) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBN known) (S (VP (TO to) (VP (VB be) (NP (NP (JJ transcriptional) (NNS regulators)) (PP (IN of) (NP (NP (JJ several) (NP (NP (NN cytokine))) (CC and) (NP (NP (NN cytokine)) (NN receptor)) (NP (NNS genes))) (, ,) (PP (VBG including) (NP (DT the) (NP (NN IL-2)) (CC and) (NP (NN IL-2R)) (NP (NNS genes)))))))))))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Co-ligation)) (PP (IN of) (NP (NP (DT the) (NP (NN A6H)) (NN antigen)) (CC and) (NP (DT the) (NP (NN CD3) (NN complex)))))) (VP (VBD induced) (NP (NP (NN expression)) (PP (IN of) (NP (NP (DT the) (NP (NN transcription) (NN factor))) (NP (NN AP-1))))) (PP (IN in) (NP (JJ CD4+) (NN T) (NNS cells))) (, ,) (SBAR (IN whereas) (S (NP (NP (DT no) (NN increase)) (PP (IN in) (NP (NP (NN NF-kappa) (NN B)) (CC and) (NP (JJ octamer-binding) (-LRB- -LRB-) (NN Oct) (-RRB- -RRB-) (NNS proteins))))) (VP (VBD was) (VP (VBN seen) (PP (VBN compared) (PP (TO to) (NP (NP (NN T) (NNS cells)) (VP (VBN stimulated) (PP (IN with) (NP (NP (NN anti-CD3)) (ADVP (RB alone))))))))))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (NP (DT no) (NN induction)) (PP (IN of) (NP (NN AP-1)))) (VP (VBD was) (VP (VBN seen) (PP (IN in) (NP (ADJP (NP (NN A6H)) (JJ costimulated)) (NP (JJ CD8+) (NN T) (NNS cells)))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (CC both) (NP (NP (JJ proximal) (NNS steps)) (PP (IN in) (NP (JJ CD8+) (NN T-cell) (NN activation)))) (CONJP (RB as) (RB well) (IN as)) (NP (DT the) (JJ later) (NNS phases))) (VP (VBP are) (ADJP (JJ unresponsive) (PP (TO to) (NP (NP (NN A6H)) (NN ligation)))))))) (. .))))
(S1 (S (S (NP (NP (NP (JJ Molecular) (NNS differences)) (PP (IN of) (NP (DT the) (NP (NN A6H) (NN molecule))))) (CC or) (NP (NP (JJ distinct) (NN regulation)) (PP (IN of) (NP (DT the) (ADJP (NP (NN A6H)) (JJ transduced)) (NP (NN AP-1)) (NN activation) (NN pathway))))) (VP (MD may) (VP (VB exist) (PP (IN in) (NP (NP (JJ CD4+)) (CC and) (NP (JJ CD8+)) (NP (NN T) (NN cell) (NNS subpopulations)))))) (. .))))
(S1 (S (S (S (NP (NP (NP (NN Inhibitor)) (PRN (-LRB- -LRB-) (NP (NN IK)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NN IFN-gamma)) (JJ induced) (NP (NN HLA) (NN class) (CD II) (NNS antigens)) (NN expression)))) (ADVP (RB also)) (VP (VBZ inhibits) (NP (NP (NP (NN HLA) (NN class) (CD II)) (JJ constitutive) (NN expression)) (PP (IN in) (NP (DT the) (NP (JJ human) (NN Raji) (NN B) (NN cell) (NN line)))))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (NN expression)) (PP (IN of) (NP (JJ major) (NN histocompatibility) (NN complex) (-LRB- -LRB-) (NN MHC) (-RRB- -RRB-) (NN class) (CD II) (NNS antigens)))) (VP (VP (VBZ is) (ADJP (JJ constitutive) (PP (IN in) (NP (NP (JJ professional) (NN antigen) (NN presenting) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NNS APCs)) (-RRB- -RRB-)))))) (CC but) (VP (MD can) (ADVP (RB also)) (VP (VB be) (VP (VBN induced) (PP (IN by) (NP (NP (NN interferon-gamma)) (PRN (-LRB- -LRB-) (NP (NN IFN-gamma)) (-RRB- -RRB-)))) (PP (IN on) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (NP (DT the) (JJ non) (NP (JJ professional) (NNS APCs))) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (NP (NNS fibroblasts)) (-RRB- -RRB-)))))))))) (. .)))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB recently)) (VP (VBN characterised) (NP (NP (DT a) (JJ new) (NN factor)) (VP (VBN called) (S (NP (NP (NN IK)) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (NP (NP (DT an) (JJ efficient) (NN inhibitor)) (PP (IN of) (NP (NP (NP (NN IFN-gamma)) (NN induction)) (PP (IN of) (NP (NP (NN MHC) (NN class) (CD II) (NNS antigens)) (NN expression))))))))))))))) (. .))))
(S1 (S (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (NP (NP (DT a) (JJ novel) (NN role)) (PP (IN for) (NP (NN IK))) (PP (IN in) (NP (NP (NN MHC) (NN class) (CD II)) (NN expression)))) (SBAR (IN since) (S (NP (NP (NN over-expression)) (PP (IN of) (NP (DT this) (NN protein))) (PP (IN by) (NP (NP (JJ stable) (NN transfection)) (PP (IN into) (NP (JJ human) (NN B) (NNS cells)))))) (VP (VBD led) (PP (TO to) (NP (NP (DT a) (JJ total) (NN disappearance)) (PP (IN of) (NP (JJ constitutive) (NP (NN MHC) (NN class) (CD II) (NN mRNA)) (NN expression))))))))) (. .))))
(S1 (S (S (NP (DT The) (NP (NN class) (CD II) (NN transactivator)) (PRN (-LRB- -LRB-) (NP (NN CIITA)) (-RRB- -RRB-))) (VP (VBZ is) (ADJP (JJ necessary) (PP (IN for) (NP (CC both) (NP (ADJP (JJ constitutive))) (CC and) (NP (NP (NN IFN-gamma)) (JJ induced)) (NP (NP (NN MHC) (NN class) (CD II)) (NNS expressions)))))) (. .))))
(S1 (S (S (NP (NP (NN Examination)) (PP (IN of) (NP (NP (NN CIITA) (NN mRNA)) (PP (IN in) (NP (NP (NN IK)) (RB stably) (VBN transfected) (NNS clones)))))) (VP (VBD revealed) (NP (NP (DT a) (JJ marked) (NN reduction)) (PP (IN of) (NP (NP (NN CIITA) (NN mRNA)) (NN transcription))))) (. .))))
(S1 (S (S (S (VP (VBN Taken) (ADVP (RB together)))) (S (NP (DT these) (NNS results)) (VP (VBP demonstrate) (SBAR (SBAR (IN that) (S (NP (DT the) (NP (NN IK) (NN protein))) (VP (VBZ plays) (NP (DT a) (JJ key) (NN role)) (PP (IN in) (NP (NP (DT the) (JJ constitutive) (NN expression)) (PP (IN of) (NP (NN MHC) (NN class) (CD II) (NNS antigens)))))))) (CC and) (SBAR (IN that) (S (NP (NP (NN inhibition)) (VP (VBN induced) (PP (IN by) (NP (NN IK))))) (VP (VBZ is) (ADVP (JJ upstream) (PP (IN of) (NP (NN CIITA)))) (PP (IN in) (NP (DT this) (JJ regulatory) (NN pathway))))))))) (. .))))
(S1 (S (NP (NP (NP (JJ Molecular) (NNS actions)) (PP (IN of) (NP (NN prolactin))) (PP (IN in) (NP (DT the) (JJ immune) (NN system))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (NP (JJ immunoregulatory)) (NNS properties)) (PP (IN of) (NP (NP (NN prolactin)) (, ,) (NP (DT a) (JJ pituitary) (NN peptide) (NN hormone)))) (, ,)) (VP (VBP have) (VP (VBN received) (NP (JJ renewed) (NN attention)))) (. .)))))
(S1 (S (S (NP (NP (DT The) (NP (NN prolactin) (NN receptor))) (, ,) (NP (NP (DT a) (NN member)) (PP (IN of) (NP (DT the) (NP (NN hematopoietin/cytokine) (NN receptor) (NN superfamily))))) (, ,)) (VP (VBZ is) (ADVP (RB ubiquitously)) (VP (VBN expressed) (PP (IN by) (NP (NNS cells))) (PP (IN in) (NP (DT the) (JJ immune) (NN system))))) (. .))))
(S1 (S (S (NP (NP (JJ Certain) (NNS subpopulations)) (PP (IN of) (NP (NNS lymphocytes)))) (VP (VP (VBP synthesize)) (CC and) (VP (VBP secrete)) (NP (ADJP (RB biologically) (JJ active)) (NN prolactin))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ suggests) (SBAR (IN that) (S (NP (NN prolactin)) (VP (MD can) (VP (VB act) (PP (IN as) (NP (DT an) (ADJP (ADJP (NN autocrine)) (CC and/or) (ADJP (NN paracrine))) (NN factor)))) (S (VP (TO to) (VP (VB modulate) (NP (NP (DT the) (NNS activities)) (PP (IN of) (NP (NP (NNS cells)) (PP (IN of) (NP (DT the) (JJ immune) (NN system))))))))))))))) (. .))))
(S1 (S (S (NP (DT This) (NN review)) (VP (VBZ focuses) (PP (IN on) (NP (NP (DT the) (JJ molecular) (NNS actions)) (PP (IN of) (NP (NN prolactin))) (PP (IN in) (NP (DT the) (JJ immune) (NN system)))))) (. .))))
(S1 (S (S (NP (NN Emphasis)) (VP (VBZ is) (VP (VBN given) (PP (TO to) (NP (NP (JJ recent) (NN information)) (PP (IN about) (NP (NP (NP (DT the) (JJ molecular) (NNS mechanisms)) (PP (IN of) (NP (NN prolactin) (NN receptor) (NN signal) (NN transduction)))) (, ,) (CC and) (NP (NP (NP (DT the) (NP (VBG signaling) (NNS molecules))) (CC and) (NP (JJ prolactin-inducible) (NN target) (NNS genes))) (SBAR (WHNP (WDT that)) (S (VP (VBP participate) (PP (IN in) (NP (DT these) (NNS responses))))))))))))) (. .))))
(S1 (S (NP (PP (IN In) (NP (JJ particular))) (, ,) (NP (NP (DT the) (NP (JJ prolactin-inducible) (NN interferon) (JJ regulatory) (NN factor-1) (NN gene))) (CC and) (NP (NP (PRP$ its) (NNS roles)) (PP (IN in) (S (VP (VBG mediating) (NP (ADJP (ADJP (JJ diverse)) (ADJP (JJ immune))) (NNS responses))))))) (. .))))
(S1 (S (NP (NP (NP (JJ Spontaneous) (NN occurrence)) (PP (IN of) (NP (NP (JJ early) (NN region) (NN 1A) (NN reiteration) (NNS mutants)) (PP (IN of) (NP (NN type) (CD 5) (NN adenovirus))))) (PP (IN in) (NP (RB persistently) (JJ infected) (JJ human) (NNS T-lymphocytes))) (. .)))))
(S1 (S (S (S (NP (NP (NNS Mutants)) (PP (IN of) (NP (NP (NN type) (CD 5) (NN adenovirus)) (PRN (-LRB- -LRB-) (NP (NN Ad5)) (-RRB- -RRB-)))) (PP (IN with) (NP (NP (VBN reiterated) (NN DNA) (NNS sequences)) (PP (IN in) (NP (DT the) (NP (NN E1a) (NN region))))))) (VP (VBD appeared) (PP (IN in) (NP (NP (NP (DT a) (NP (JJ human) (NN T-lymphocyte) (NN cell) (NN line))) (, ,) (NP (NN Molt-4))) (, ,) (VP (ADVP (RB persistently)) (VBN infected) (PP (IN with) (NP (NP (NN H5sub304)) (, ,) (NP (NP (DT a) (NN deletion/substitution) (NN mutant)) (SBAR (WHNP (WDT that)) (S (VP (VBZ has) (NP (DT a) (JJ wild-type) (NN phenotype)) (PP (IN in) (NP (JJ viral) (NN replication))))))))))))) (. .)))))
(S1 (S (S (NP (NP (NP (NN Endonuclease)) (NNS analyses)) (CC and) (NP (NN DNA) (NN sequencing))) (VP (VBD revealed) (NP (NP (NN DNA) (NN reiteration)) (PP (IN in) (NP (DT each) (NN mutant))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (DT the) (CD four) (JJ representative) (NNS mutants)) (VP (VBN investigated)))) (, ,) (NP (DT the) (NP (NN DNA) (NNS reiterations))) (ADVP (DT all)) (VP (VBD started) (PP (IN within) (NP (NP (NP (DT a) (NP (JJ six-base-pair) (NN consensus) (NN sequence))) (, ,) (NP (NP (NN G)) (PRN (-LRB- -LRB-) (CC or) (NP (NN C)) (-RRB- -RRB-)) (NP (NN CTGTG)))) (, ,) (ADJP (JJ located) (PP (IN in) (NP (NP (DT the) (JJ second) (NP (NN exon))) (PP (IN of) (NP (NP (DT the) (NP (NN E1a) (NN region))) (PRN (-LRB- -LRB-) (PP (IN at) (NP (NN nt) (NP (CD 1333)) (, ,) (NP (CD 1367)) (, ,) (CC or) (NP (CD 1419)))) (-RRB- -RRB-)))))))))) (. .))))
(S1 (S (S (NP (EX There)) (VP (VBD was) (RB not) (NP (NP (DT any) (NN DNA) (NN homology)) (PP (IN between) (NP (NP (NP (DT the) (NNS breakpoints)) (PP (IN in) (NP (DT the) (JJ second) (NP (NN exon))))) (CC and) (NP (NP (DT the) (NP (JJ inserting) (NNS sequences))) (PRN (-LRB- -LRB-) (VP (VBG starting) (PP (IN at) (NP (NN nt) (NP (CD 532)) (, ,) (NP (CD 710)) (, ,) (CC or) (NP (CD 792))))) (-RRB- -RRB-))))))) (. .))))
(S1 (S (S (NP (NN Northern) (NNS analyses)) (VP (VBD suggested) (UCP (SBAR (IN that) (S (NP (NP (DT the) (NP (VBN reiterated) (NN splicing) (NNS sites))) (PP (IN of) (NP (DT the) (JJ representative) (NNS mutants)))) (VP (VBD were) (ADVP (DT all)) (VP (VBN used) (PP (IN in) (NP (NN RNA) (NN splicing))))))) (, ,) (CC and) (S (NP (DT the) (JJS closest) (NP (NP (NN donor)) (CC and) (NP (NN recipient))) (NNS joints)) (VP (VBD were) (VP (VBN used) (ADVP (RBS most) (RB frequently))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS observations)) (VP (VBP imply) (SBAR (IN that) (S (PP (IN during) (NP (JJ persistent) (NN infection))) (NP (NN Ad5)) (VP (VBD underwent) (NP (JJ spontaneous) (NNS mutations)) (PP (IN by) (NP (NP (JJ sequence-specific) (NN breakage)) (CC and) (NP (JJ nonhomologous) (JJ end-end) (NN joining) (NN recombination) (NNS events)))))))) (. .))))
(S1 (S (S (S (NP (DT These) (NN E1a) (NN reiteration) (NNS mutants)) (VP (MD could) (VP (VB be) (VP (VBN propagated) (PP (IN in) (NP (NP (NP (NN HeLa))) (, ,) (NP (NP (NN A549))) (, ,) (CC and) (NP (NN KB) (NNS cells)))))))) (: ;) (S (S (NP (PRP they)) (VP (VBD were) (ADJP (RB genetically) (JJ stable)))) (: ;) (CC and) (S (NP (PRP they)) (VP (VBD killed) (NP (NN CREF) (NNS cells)) (PP (IN at) (NP (DT a) (ADJP (RB strikingly) (JJ high)) (NN frequency)))))) (. .))))
(S1 (S (S (NP (JJ Preliminary) (NNS observations)) (VP (VBP tend) (S (VP (TO to) (VP (VB correlate) (NP (DT this) (NN CREF) (NN cell) (NN killing)) (PP (IN with) (NP (NP (DT the) (NN accumulation)) (PP (IN of) (NP (NP (DT the) (NP (JJ early) (JJ viral) (NNS proteins))) (CC and/or) (NP (JJ viral) (NN DNA)))) (PP (IN in) (NP (DT the) (NP (JJ infected) (NNS cells)))))))))) (. .))))
(S1 (S (S (NP (NP (DT This) (NN degree)) (PP (IN of) (NP (NN cell) (NN damage)))) (VP (VBD was) (RB not) (VP (VBN observed) (PP (IN in) (NP (NP (NP (NN Ad5wt)) (CC or) (NP (NN H5sub304)) (NP (NN infection))) (PP (IN of) (NP (NN CREF) (NNS cells))))))) (. .))))
(S1 (S (S (NP (DT The) (VBN observed) (NP (NN E1a) (NNS reiterations))) (VP (VBP provide) (NP (DT a) (NN model) (SBAR (S (VP (TO to) (VP (VB gain) (NP (NP (NN insight)) (PP (IN into) (S (VP (VBG understanding) (NP (NP (DT the) (JJ evolutionary) (NNS events)) (PP (IN of) (NP (DT some) (, ,) (SBAR (IN if) (FRAG (RB not) (ADJP (DT all)))) (, ,) (NN adenovirus) (NNS types))) (PP (IN during) (NP (NP (JJ many) (NNS years)) (PP (IN of) (NP (NP (ADJP (ADJP (JJ symbiotic)) (, ,) (ADJP (JJ persistent))) (NN relationship)) (PP (IN in) (NP (NP (JJ human) (NP (NNS tonsils)) (CC and) (NP (NNS adenoids))) (CC and) (NP (ADJP (ADVP (RB possibly)) (JJ other) (JJ lymphoid)) (NNS organs))))))))))))))))))) (. .))))
(S1 (S (NP (NP (NP (NP (NN Quantification)) (PP (IN of) (NP (NN vitamin) (NN D) (NN receptor) (NN mRNA))) (PP (IN by) (NP (NP (JJ competitive) (NN polymerase) (NN chain) (NN reaction)) (PP (IN in) (NP (NN PBMC))))) (: :)) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN correspondence)) (PP (IN with) (NP (JJ common) (JJ allelic) (NNS variants)))))) (. .)))))
(S1 (S (S (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (ADVP (RB recently)) (VP (VBN claimed) (SBAR (IN that) (S (NP (NP (NN polymorphism)) (PP (IN for) (NP (DT the) (NP (NP (NN vitamin) (NN D) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN VDR)) (-RRB- -RRB-)))))) (VP (VBZ influences) (NP (NP (JJ several) (NNS aspects)) (PP (IN of) (NP (NP (NN calcium)) (CC and) (NP (NN bone)) (NP (NN metabolism))))))))))) (. .)))))
(S1 (S (S (S (VP (TO To) (VP (VB evaluate) (NP (NP (DT the) (JJ physiologic) (NN plausibility)) (PP (IN of) (NP (DT these) (NNS claims))))))) (, ,) (S (NP (PRP we)) (VP (VBD compared) (NP (NP (DT the) (NN abundance)) (PP (IN of) (NP (NP (DT the) (NP (NN VDR) (NN mRNA))) (PP (IN in) (NP (NP (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NNS PBMCs)) (-RRB- -RRB-))))))) (PP (IN between) (NP (JJ different) (NP (NN VDR) (NNS genotypes)))) (S (VP (VBG using) (NP (DT a) (JJ quantitative) (JJ reverse) (VBN transcribed) (NN polymerase) (NN chain) (JJ reaction-based) (NN method)))))) (. .))))
(S1 (S (S (S (NP (DT The) (NN method)) (VP (VBZ is) (VP (VBN based) (PP (IN on) (NP (NP (DT the) (NN coamplification)) (PP (IN of) (NP (NP (NN VDR) (NN cDNA)) (CC and) (NP (NP (DT an) (JJ internal) (NN standard)) (VP (VBG consisting) (PP (IN of) (NP (NP (JJ known) (NNS concentrations)) (PP (IN of) (NP (NP (DT a) (NP (JJ human) (NN VDR) (NN CDNA))) (VP (VBN mutated) (PP (IN at) (NP (DT a) (NP (NN BglII) (NN restriction) (NN site)))))))))))))))))) (: ;) (S (NP (NP (DT the) (JJ interassay) (NN coefficient)) (PP (IN of) (NP (NN variation)))) (VP (VBZ is) (NP (CD 11) (NN %)))) (. .))))
(S1 (S (S (S (VP (TO To) (VP (VB validate) (NP (DT the) (NN method))))) (, ,) (S (NP (PRP we)) (VP (VBD made) (NP (NN use)) (PP (IN of) (NP (NP (JJR earlier) (NN receptor) (NN binding) (NNS studies)) (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (JJ normal) (JJ human) (NNS monocytes)) (CC and) (NP (NP (VBN activated)) (, ,) (CC but) (NP (RB not) (VBG resting)) (, ,) (NP (NNS lymphocytes)))) (VP (VBD expressed) (NP (DT the) (NP (NN VDR))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN concentration)) (PP (IN of) (NP (DT the) (NP (NN VDR) (NN mRNA))))) (VP (VBD was) (NP (NP (NP (NP (QP (CD 10-LRB--8-RRB-) (TO to) (CD 10-LRB--7-RRB-)) (NN g/g)) (PP (IN of) (NP (JJ total) (NN RNA)))) (PP (PP (IN in) (NP (JJ cell-sorted) (NNS monocytes))) (CC and) (PP (IN in) (NP (FW in) (FW vitro) (VBN activated) (NNS lymphocytes))))) (, ,) (CC but) (NP (NP (QP (RB only) (CD 10-LRB--12-RRB-)) (NN g/g)) (PP (IN of) (NP (JJ total) (NN mRNA))) (PP (IN in) (NP (VBG resting) (NP (NNS lymphocytes)))))) (, ,) (S (VP (VBG establishing) (SBAR (IN that) (S (NP (NP (DT the) (NP (NN VDR) (NN mRNA))) (VP (VBN determined) (PP (IN by) (NP (NP (PRP$ our) (NN method)) (PP (IN in) (NP (NNS PBMCs))))))) (VP (VBZ is) (ADJP (JJ due) (PP (TO to) (NP (NP (JJ constitutive) (NN expression)) (PP (IN in) (NP (NNS monocytes)))))))))))) (. .))))
(S1 (S (S (PP (VBG Following) (NP (NP (DT an) (JJ initial) (NN genotype) (NN screening)) (PP (IN of) (NP (CD 85) (JJ normal) (NNS volunteers))) (PP (IN by) (NP (NP (NN polymerase) (NN chain) (NN reaction)) (CC or) (NP (NP (NN restriction) (NN fragment) (NN length) (NN polymorphism)) (NN analysis)))))) (, ,) (NP (NP (NP (CD 14) (NNS individuals)) (PP (IN with) (NP (DT the) (NN Bb) (NN genotype)))) (, ,) (NP (CD 12) (PP (IN with) (NP (DT the) (NN bb) (NN genotype)))) (, ,) (CC and) (NP (CD 12) (PP (IN with) (NP (DT the) (NN BB) (NN genotype))))) (VP (VBD were) (VP (VBN selected))) (. .))))
(S1 (S (S (S (NP (NP (NP (DT The) (NN concentration)) (PP (IN of) (NP (DT the) (NP (NN VDR) (NN mRNA))))) (, ,) (VP (VBN corrected) (PP (IN for) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NNS monocytes)))))) (, ,)) (VP (VBD was) (ADJP (JJ similar) (PP (IN among) (NP (DT the) (CD three) (NN genotype) (NNS groups)))) (, ,) (SBAR (IN as) (SINV (VBD were) (NP (NP (DT the) (JJ other) (NNS variables)) (VP (VBN examined))))))) (: :) (NP (NP (NN serum) (NN calcitriol)) (, ,) (NP (NN serum) (NN osteocalcin)) (, ,) (CC and) (NP (NP (NN vertebral)) (CC and) (NP (NN hip) (NN bone)) (NP (NN density)))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (NP (NP (NN VDR)) (NN polymorphism)) (VP (VBZ does) (RB not) (VP (VB affect) (NP (NP (DT the) (NN abundance)) (PP (IN of) (NP (DT the) (NP (NN VDR) (NN mRNA)))))))))) (. .))))
(S1 (S (S (S (NP (NP (NN HLA-DMA)) (CC and) (NP (NN HLA-DMB)) (NP (NN gene) (NN expression))) (VP (VBZ functions) (PP (IN through) (NP (DT the) (VBN conserved) (NP (NN S-X-Y) (NN region))))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (NP (NN MHC) (NN class) (CD II) (JJ homologous) (NNS proteins))) (NP (NP (NN HLA-DMA)) (CC and) (NP (NN HLA-DMB)))) (VP (VBP function) (PP (IN in) (NP (NP (DT the) (NN loading)) (PP (IN of) (NP (NNS peptides))) (PP (IN onto) (NP (NN class) (CD II) (NNS molecules)))))) (. .)))))
(S1 (S (S (PP (IN Like) (NP (DT the) (NP (NN class) (CD II) (NNS genes)))) (, ,) (NP (DT the) (NP (NN HLA-DM) (NNS genes))) (VP (VBP contain) (NP (NP (NP (JJ upstream) (JJ regulatory) (NNS sequences)) (ADJP (JJ similar) (PP (TO to) (NP (DT the) (NP (NN S-X-Y) (JJ regulatory) (NN region)))))) (CONJP (RB as) (RB well) (IN as)) (NP (ADJP (JJ additional) (JJ putative) (JJ regulatory)) (NNS sites)))) (. .))))
(S1 (S (S (S (VP (TO To) (VP (VB determine) (SBAR (IN whether) (S (NP (DT the) (NP (NN DM) (NNS genes))) (VP (VBP are) (VP (VBN regulated) (PP (IN in) (NP (NP (DT a) (JJ similar) (NN manner)) (PP (IN as) (NP (NN class) (CD II) (NNS genes)))))))))))) (, ,) (S (NP (NP (DT a) (NN series)) (PP (IN of) (NP (NP (ADJP (FW in) (FW vivo))) (CC and) (NP (ADJP (FW in) (FW vitro))) (NP (NNS analyses))))) (VP (VBD was) (VP (VBN performed)))) (. .))))
(S1 (S (S (NP (NN Deletion) (NN analysis)) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (NN expression)) (PP (IN from) (NP (DT the) (NP (NN DM) (NNS promoters))))) (VP (VBZ is) (ADJP (JJ dependent) (PP (IN on) (NP (DT the) (VBN conserved) (NP (NN S-X-Y) (NN region))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NP (NN class) (JJ II-specific) (NN transcription) (NNS factors))) (NP (NP (NN RFX)) (CC and) (NP (NN CIITA)))) (VP (VBP are) (ADVP (RB also)) (VP (VBN required) (PP (IN for) (NP (NN expression)))) (, ,) (SBAR (IN as) (S (NP (NP (NN cell) (NNS lines)) (ADJP (JJ deficient) (PP (IN in) (NP (DT these) (NNS factors))))) (VP (VBD failed) (S (VP (TO to) (VP (VB allow) (NP (NN transcription)) (PP (IN from) (NP (DT the) (NP (NN DM) (NNS promoters))))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (ADJP (FW in) (FW vivo)) (NN footprint) (NN analysis)) (VP (VBD showed) (S (NP (DT the) (JJ putative) (NP (NN X)) (CC and) (NP (NN Y)) (NP (NNS boxes))) (VP (TO to) (VP (VB be) (VP (VBN occupied) (PP (IN by) (NP (NP (NN transcription) (NNS factors)) (PP (PP (IN in) (NP (JJ wild-type) (NN B) (NNS cells))) (, ,) (CC but) (PP (RB not) (IN in) (NP (JJ RFX-deficient) (NN B) (NNS cells))))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NNS astrocytes))) (, ,) (NP (NP (NN IFN-gamma)) (NN treatment)) (VP (VBD induced) (NP (NP (VBN increased) (NN occupancy)) (PP (IN of) (NP (DT these) (NNS sites))))) (. .))))
(S1 (S (S (NP (NP (NN None)) (PP (IN of) (NP (DT the) (ADJP (JJ other) (JJ putative) (JJ regulatory)) (NNS sites)))) (VP (VBD was) (VP (VBN occupied) (ADVP (FW in) (FW vivo))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (PRP they)) (VP (MD may) (RB not) (VP (VB be) (ADJP (JJ functional))))))))) (. .))))
(S1 (S (S (ADVP (RB Finally)) (, ,) (NP (NN gel) (NN shift) (NN analysis)) (VP (VBD showed) (NP (NP (JJ synergistic) (JJ complex) (NN formation)) (PP (IN between) (NP (NP (NNS proteins)) (SBAR (WHNP (WDT that)) (S (VP (VBP bind) (PP (TO to) (NP (NP (DT the) (JJ putative) (NP (NN X) (NNS boxes))) (PP (IN of) (NP (DT the) (NN DM) (NNS genes))))))))))) (, ,) (SBAR (IN as) (SINV (VBZ is) (VP (VBN found) (PP (IN for) (NP (DT the) (NP (NN DRA) (NN gene)))))))) (. .))))
(S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (DT the) (NP (NN DM) (NNS genes))) (VP (VBP share) (NP (NP (DT a) (JJ common) (NN mechanism)) (PP (IN of) (NP (NN regulation)))) (PP (IN with) (NP (DT the) (NP (NN class) (CD II) (NNS genes))))) (. .))))
(S1 (S (NP (NP (NP (DT An) (NP (JJ enhancer-blocking) (NN element))) (PP (IN between) (NP (NP (NN alpha)) (CC and) (NP (NN delta)) (NP (NN gene) (NNS segments)))) (PP (IN within) (NP (DT the) (NP (JJ human) (NN T) (NN cell) (NN receptor) (NN alpha/delta) (NN locus)))) (. .)))))
(S1 (S (S (S (NP (NP (NP (NN T) (NN cell) (NN receptor) (-LRB- -LRB-) (NN TCR) (-RRB- -RRB-) (NN alpha))) (CC and) (NP (NN delta)) (NP (NN gene) (NNS segments))) (VP (VP (VBP are) (VP (VBN organized) (PP (IN within) (NP (DT a) (JJ single) (JJ genetic) (NN locus))))) (CC but) (VP (VBP are) (ADVP (RB differentially)) (VP (VBN regulated) (PP (IN during) (NP (NN T) (NN cell) (NN development)))))) (. .)))))
(S1 (S (S (NP (NP (DT An) (NP (JJ enhancer-blocking) (NN element))) (PRN (-LRB- -LRB-) (NP (NP (NN BEAD-1)) (, ,) (PP (IN for) (S (VP (VBG blocking) (NP (NN element) (NN alpha/delta) (CD 1)))))) (-RRB- -RRB-))) (VP (VBD was) (ADJP (JJ localized) (PP (TO to) (NP (NP (NP (DT a) (NP (JJ 2.0-kb) (NN region))) (ADVP (ADVP (RB 3') (PP (IN of) (NP (NN TCR) (NN delta) (NN gene) (NNS segments)))) (CC and) (ADVP (RB 5') (PP (IN of) (NP (NN TCR) (NN alpha) (NN joining) (NN gene) (NNS segments)))))) (PP (IN within) (NP (DT this) (NN locus))))))) (. .))))
(S1 (S (S (NP (NN BEAD-1)) (VP (VBD blocked) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NP (DT the) (NP (NN TCR) (NN delta) (NN enhancer))) (PRN (-LRB- -LRB-) (NP (NN Edelta)) (-RRB- -RRB-)))) (S (VP (TO to) (VP (VB activate) (NP (DT a) (NN promoter)))))) (SBAR (WHADVP (WRB when)) (S (ADJP (JJ located) (PP (IN between) (NP (NP (DT the) (CD two)) (PP (IN in) (NP (DT a) (NP (JJ chromatin-integrated) (NN construct)))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP propose) (SBAR (SBAR (IN that) (S (NP (NN BEAD-1)) (VP (VBZ functions) (PP (IN as) (NP (NP (DT a) (NN boundary)) (SBAR (WHNP (WDT that)) (S (VP (VBZ separates) (NP (DT the) (NP (NN TCR) (NN alpha/delta) (NN locus))) (PP (IN into) (NP (NP (JJ distinct) (NP (JJ regulatory) (NNS domains))) (VP (VBN controlled) (PP (IN by) (NP (NP (NN Edelta)) (CC and) (NP (DT the) (NP (NN TCR) (NN alpha) (NN enhancer)))))))))))))))) (, ,) (CC and) (SBAR (IN that) (S (NP (PRP it)) (VP (VBZ prevents) (NP (NN Edelta)) (PP (IN from) (S (VP (VBG opening) (NP (NP (DT the) (NP (NN chromatin))) (PP (IN of) (NP (DT the) (NP (NN TCR) (NN alpha)) (NN joining) (NN gene) (NNS segments)))) (PP (IN for) (NP (NN VDJ) (NN recombination)))))) (PP (IN at) (NP (NP (DT an) (JJ early) (NN stage)) (PP (IN of) (NP (NN T) (NN cell) (NN development)))))))))) (. .))))
(S1 (S (NP (NP (NP (NP (NN Plasma) (NP (NN sialyltransferase)) (NNS levels)) (PP (IN in) (NP (JJ psychiatric) (NNS disorders)))) (PP (IN as) (NP (NP (DT a) (JJ possible) (NN indicator)) (PP (IN of) (NP (JJ HPA) (NN axis) (NN function))))) (. .)))))
(S1 (S (S (S (NP (NP (NP (DT A) (NN dysfunction)) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (DT the) (ADJP (ADJP (JJ hypothalamic-pituitary-adrenal)) (PRN (-LRB- -LRB-) (ADJP (JJ HPA)) (-RRB- -RRB-))) (NN axis)))))) (, ,) (VP (ADVP (RB possibly)) (VBN attributed) (PP (TO to) (NP (NP (DT a) (NN change)) (PP (IN in) (NP (NP (NP (NN glucocorticoid) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN GR)) (-RRB- -RRB-))) (NN functionality)))))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NN depression)))))) (. .)))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN measured) (NP (CC both) (NP (NP (NN lymphocyte) (NN GR)) (NN receptor) (NN binding) (NNS parameters)) (CC and) (NP (NN plasma) (NP (NN sialyltransferase)) (NN activity))) (, ,) (PP (IN as) (NP (NP (DT a) (JJ biochemical) (NN marker)) (PP (IN of) (NP (NP (NN GR)) (NN function))))) (, ,) (PP (PP (IN in) (NP (NP (CD two) (NNS groups)) (PP (IN of) (NP (NP (NNS patients)) (VP (VBG suffering) (PP (IN from) (NP (NP (NN depression)) (CC or) (NP (NN schizophrenia))))))))) (CC and) (PP (IN in) (NP (NP (DT a) (NN group)) (PP (IN of) (NP (NP (NN age-)) (CC and) (NP (ADJP (JJ sex-matched))) (NP (NNS controls))))))))) (. .))))
(S1 (S (S (SBAR (IN While) (S (NP (EX there)) (VP (VBD was) (NP (NP (DT a) (JJ significant) (NN increase)) (PP (IN in) (NP (NN plasma) (NN cortisol) (NNS levels)))) (PP (IN in) (NP (DT the) (JJ depressed) (NN group)))))) (, ,) (S (NP (EX there)) (VP (VBD were) (NP (NP (DT no) (NNS changes)) (PP (IN in) (NP (NP (DT the) (NN lymphocyte) (NP (NN GR)) (NN binding) (NNS parameters)) (PRN (-LRB- -LRB-) (NP (NP (NN K) (-LRB- -LRB-) (NN m) (-RRB- -RRB-)) (CC and) (NP (NN Bmax))) (-RRB- -RRB-))))))) (. .))))
(S1 (S (S (S (NP (EX There)) (VP (VBD was) (, ,) (ADVP (RB however)) (, ,) (NP (NP (DT a) (JJ significant) (NN decrease)) (PP (IN in) (NP (DT the) (NP (NN plasma) (NN sialyltransferase) (: :)) (NN cortisol) (NN ratio)))) (PP (IN in) (NP (DT the) (JJ depressed) (NN group))) (S (VP (VBG suggesting) (NP (NP (DT an) (NN inability)) (PP (IN of) (NP (DT the) (VBN raised) (NN cortisol) (NNS levels))) (S (VP (TO to) (VP (VB induce) (NP (NN enzyme) (NN expression)))))))))) (CC and) (S (NP (DT this) (NN ratio)) (VP (MD may) (VP (VB provide) (NP (NP (DT a) (ADJP (ADJP (JJ useful)) (ADJP (JJ biochemical))) (NN marker)) (PP (IN of) (NP (NN cortisol) (NN receptor) (NN function))))))) (. .))))
(S1 (S (S (SBAR (IN Although) (S (NP (EX there)) (VP (VBD was) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN plasma) (NN activity)) (PP (IN of) (NP (DT the) (NP (NN alpha) (CD 2,6) (NN sialyltransferase) (NN isozyme))))))) (PP (IN in) (NP (DT the) (JJ schizophrenic) (NN group)))))) (, ,) (S (NP (DT no) (JJ other) (NNS changes)) (VP (VBD were) (VP (VBN determined)))) (. .))))
(S1 (S (S (ADVP (RB Therefore)) (, ,) (SBAR (IN while) (S (NP (DT the) (JJ total) (NP (NN plasma) (NN sialyltransferase)) (: :) (NN cortisol) (NN ratio)) (VP (VBZ reflects) (NP (JJ HPA) (NN axis) (NN function))))) (, ,) (S (NP (NP (NNS alterations)) (PP (IN in) (NP (JJ specific) (NN isozyme) (NN activity)))) (VP (MD may) (ADVP (RB also)) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (JJ other) (NN CNS) (NN disease) (NNS states))))))) (. .))))
(S1 (S (NP (NP (NP (NP (NN Involvement)) (PP (IN of) (NP (NP (DT the) (NP (JJ N-terminal) (NN region))) (PP (IN of) (NP (DT the) (NP (JJ human) (NN mineralocorticoid) (NN receptor) (JJ hormone-binding) (NN domain)))))) (PP (IN in) (NP (NP (NN agonist)) (CC and) (NP (NN antagonist)) (NP (NN binding))))) (SBAR (IN as) (S (VP (VBN revealed) (PP (IN by) (NP (DT a) (NP (JJ new) (JJ monoclonal) (NN antibody))))))) (. .)))))
(S1 (S (S (S (S (VP (TO To) (VP (VB gain) (NP (NP (DT a) (JJR better) (NN understanding)) (PP (IN of) (NP (NP (DT the) (NN mechanism)) (PP (IN of) (S (VP (VBG binding) (PP (TO to) (NP (DT the) (NP (NP (JJ human) (NN mineralocorticoid) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN hMR)) (-RRB- -RRB-)))))))))))))) (, ,) (S (NP (PRP we)) (VP (VBD developed) (NP (NP (DT a) (JJ new) (NP (NP (JJ monoclonal) (NN antibody)) (PRN (-LRB- -LRB-) (NP (NN mAb)) (-RRB- -RRB-)))) (VP (VBN raised) (PP (IN against) (NP (DT the) (NP (NP (JJ hormone-binding) (NN domain)) (PRN (-LRB- -LRB-) (NP (NN HBD)) (-RRB- -RRB-))))))))) (. .)))))
(S1 (S (S (PP (IN For) (NP (DT this) (NN purpose))) (, ,) (NP (NNS mice)) (VP (VBD were) (VP (VBN immunized) (PP (IN with) (NP (NP (DT a) (NP (NN fusion) (NN protein))) (VP (VBG including) (NP (NP (DT the) (NN sequence) (NP (NN Thr729-Lys984))) (PP (IN of) (NP (NN hMR))))))))) (. .))))
(S1 (S (S (PP (IN After) (NP (NN ELISA) (NN screening))) (, ,) (NP (NN mAb) (NN 18C7)) (VP (VBD was) (VP (VBN selected) (PP (IN for) (NP (NP (PRP$ its) (NN specificity)) (PP (IN towards) (NP (DT the) (NP (NN HBD)))))))) (. .))))
(S1 (S (S (NP (DT This) (NN antibody)) (VP (VBD recognized) (NP (NP (CC both) (DT the) (NP (VBN denatured)) (CC and) (NP (JJ native) (NN MR) (NNS forms))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT the) (NP (JJ hetero-oligomeric) (NN MR) (NN form))) (CC and) (NP (DT the) (NP (JJ transformed) (NN MR) (NN state)))))) (. .))))
(S1 (S (S (PP (IN By) (S (VP (VBG using) (NP (JJ several) (NP (NN HBD) (NNS subfragments)))))) (, ,) (NP (DT the) (NP (NN mAb) (NN 18C7) (NN epitope))) (VP (VBD was) (ADJP (JJ located) (PP (IN in) (NP (NP (DT the) (NP (JJ N-terminal) (NN region))) (PP (IN of) (NP (DT the) (NP (NN HBD)))))) (PP (IN from) (NP (NN Thr729) (TO to) (NN Leu765))))) (. .))))
(S1 (S (S (NP (PRP We)) (ADVP (RB then)) (VP (VBD studied) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (DT the) (NN antibody))) (PP (IN on) (NP (NP (NP (NN aldosterone)) (CC and) (NP (NN progesterone)) (NP (NN binding))) (PP (TO to) (NP (DT the) (NP (NN hMR)))))))) (. .))))
(S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NN 18C7)) (VP (VBD was) (VP (VBN incubated) (PP (IN with) (NP (JJ liganded) (NN MR))))))) (, ,) (S (NP (PRP it)) (VP (VBD was) (ADJP (JJ able) (S (VP (TO to) (ADVP (RB partly)) (VP (VB displace) (PRN (-LRB- -LRB-) (NP (CD 20) (NN %)) (-RRB- -RRB-)) (NP (DT the) (NN hormone)) (PP (IN from) (NP (PRP$ its) (VBG binding) (NN site))))))))) (. .))))
(S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NN 18C7)) (VP (VBD was) (VP (VBN incubated) (PP (IN with) (NP (NN MR))) (PP (IN before) (NP (NP (NN aldosterone)) (CC or) (NP (NN progesterone)))))))) (, ,) (S (NP (DT the) (NN antibody)) (VP (VBD inhibited) (NP (NP (QP (CD 75-80)) (NN %)) (PP (IN of) (NP (DT the) (NN binding)))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NN 18C7))) (PP (IN on) (NP (DT the) (NN binding)))) (VP (VBD was) (ADJP (JJ similar) (PP (IN with) (NP (DT both) (NNS hormones))))) (. .))))
(S1 (S (S (S (NP (DT A) (NN sucrose) (JJ gradient) (NN analysis)) (VP (VBD indicated) (NP (NP (DT the) (JJ simultaneous) (NN presence)) (PP (IN of) (NP (NP (CD two) (NNS kinds)) (PP (IN of) (NP (NN receptor) (NNS complexes)))))))) (: :) (NP (NP (DT the) (NP (JJ steroid-MR) (NN complex))) (CC and) (NP (DT the) (NP (JJ antibody-MR) (NN complex)))) (. .))))
(S1 (S (S (SBAR (IN After) (S (NP (NP (PRP$ its) (VBN associated) (NNS proteins)) (, ,) (ADVP (RB especially)) (NP (DT the) (NP (JJ heat-shock) (NN protein) (NN hsp90))) (, ,)) (VP (VBD had) (VP (VBN been) (ADJP (JJ cross-linked) (PP (IN with) (NP (DT the) (NP (NN hMR)))) (PP (IN by) (NP (NN dimethylpimelimidate)))))))) (, ,) (S (NP (NN 18C7)) (VP (VBD was) (ADVP (RB still)) (ADJP (JJ able) (S (VP (TO to) (VP (VB react) (PP (IN with) (NP (DT the) (NN receptor))))))))) (. .))))
(S1 (S (S (NP (PRP$ Our) (NNS results)) (VP (VBD indicated) (SBAR (IN that) (S (NP (NP (DT the) (NP (NN epitope))) (VP (VBN recognized) (PP (IN by) (NP (NN 18C7))))) (VP (VBD was) (ADVP (RB directly)) (VP (VBN implicated) (PP (IN in) (NP (NN hormone) (NN binding)))))))) (. .))))
(S1 (S (S (NP (NP (NP (DT The) (NN lack)) (PP (IN of) (NP (NP (NN steroid) (NN binding)) (PP (IN of) (NP (NP (NP (NN HBD)) (NNS mutants)) (PP (IN with) (NP (NP (DT the) (NP (JJ Thr729-Leu765) (NN sequence))) (VP (VBN deleted))))))))) (PRN (-LRB- -LSB-) (NP (NP (NP (NNP Jalaguier)) (, ,) (NP (NNP Mesnier)) (, ,) (NP (NNP Leger)) (CC and) (NP (NNP Auzou))) (PRN (-LRB- -LRB-) (NP (CD 1996)) (-RRB- -RRB-)) (NP (NNP J.Steroid) (NNP Biochem.Mol.Biol.57)) (, ,) (NP (CD 43-50))) (-RRB- -RSB-))) (VP (VBZ supports) (NP (DT this) (NN hypothesis))) (. .))))
(S1 (S (S (PP (IN Because) (IN of) (NP (NP (DT the) (JJ similar) (NNS behaviours)) (PP (IN of) (NP (NP (NN aldosterone)) (CC and) (NP (NN progesterone)))))) (, ,) (NP (PRP we)) (VP (VBP conclude) (SBAR (IN that) (S (NP (NP (DT the) (NP (JJ N-terminal) (JJ Thr729-Leu765) (NN region))) (PP (IN of) (NP (DT the) (NP (NN HBD))))) (VP (VBZ is) (ADVP (RB similarly)) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (DT both) (NNS hormones)))))))))) (. .))))
(S1 (S (S (S (NP (NP (NN Triggering)) (PP (IN of) (NP (NN HLA-DR) (NNS antigens)))) (ADVP (RB differentially)) (VP (VBZ modulates) (NP (NP (NP (NN tumor) (NN necrosis) (NN factor) (NN alpha)) (NN release)) (PP (IN by) (NP (NN B) (NNS cells))) (PP (IN at) (NP (NP (JJ distinct) (NN stage)) (PP (IN of) (NP (NN maturation))))))) (. .)))))
(S1 (S (S (S (S (NP (NP (NN Triggering)) (PP (IN of) (NP (NN HLA) (NN class) (CD II) (NNS antigens))) (PP (IN by) (NP (DT the) (NP (JJ anti-HLA-DR) (JJ monoclonal) (NN antibody) (-LRB- -LRB-) (NN mAb) (-RRB- -RRB-) (NN L243))))) (ADVP (ADVP (ADVP (RB significantly)) (PRN (-LRB- -LRB-) (NP (NP (NN P)) (ADJP (JJR &lt;) (NP (CD 0.05)))) (-RRB- -RRB-))) (CC and) (ADVP (RB differentially))) (VP (VBD enhanced) (NP (NP (DT the) (NN release)) (PP (IN of) (NP (NP (NN tumor) (NN necrosis) (NN factor) (NN alpha)) (PRN (-LRB- -LRB-) (NP (NN TNF-alpha)) (-RRB- -RRB-)))) (PP (PP (IN by) (NP (NP (NP (DT the) (NP (JJ non-Hodgkin) (POS 's) (NN lymphoma) (NNS cells))) (NP (NP (NN Ri-I)) (, ,) (NP (NN Ci-I)) (, ,) (CC and) (NP (NN Sc-I)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (PP (IN at) (NP (NP (DT a) (JJ distinct) (NN stage)) (PP (IN of) (NP (NN B-cell) (NN differentiation)))))))))) (, ,) (CC and) (PP (IN by) (NP (DT the) (ADJP (RBR more) (JJ mature)) (NP (NN Burkitt) (NN lymphoma) (NN cell) (NN Raji)))))))) (: ;) (S (PP (IN in) (NP (NN contrast))) (, ,) (NP (PRP it)) (VP (VBD did) (RB not) (VP (VB induce) (NP (NP (NP (NN TNF-alpha)) (NN release)) (PP (IN by) (NP (NP (DT the) (NP (JJ pre-B) (NN leukemia) (NNS cells))) (NP (NP (NN Nalm-6)) (CC and) (NP (NN BV173))))))))) (. .)))))
(S1 (S (S (S (NP (NP (NN TNF-alpha)) (NN release)) (VP (VP (VBD peaked) (PP (IN at) (NP (CD 24) (NN h)))) (CC and) (VP (VBD decreased) (ADVP (RB thereafter))))) (, ,) (CC and) (S (NP (PRP it)) (VP (VBD was) (UCP (ADJP (NN dose) (JJ dependent)) (CC and) (VP (VBN preceded) (PP (IN by) (NP (NP (DT an) (NN increase)) (PP (IN of) (NP (NN TNF-alpha) (NN mRNA))) (ADJP (JJ detectable) (PP (IN after) (NP (NP (CD 3) (NN h)) (PP (IN of) (NP (NP (NN stimulation)) (PP (IN with) (NP (NN mAb) (NN L243)))))))))))))) (. .))))
(S1 (S (S (S (NP (VBN Secreted) (NP (NN TNF-alpha))) (VP (VBD mediated) (NP (NP (NP (DT the) (NN enhancement)) (PP (IN of) (NP (NP (JJ nuclear) (NN factor) (NN kappa) (NN B)) (PRN (-LRB- -LRB-) (NP (NN NF-kappa) (NN B)) (-RRB- -RRB-))))) (CC and) (NP (NP (NP (NN activator) (NN protein-1)) (PRN (-LRB- -LRB-) (NP (NN AP-1)) (-RRB- -RRB-))) (NN binding) (NN activity))))) (: ;) (S (PP (IN in) (NP (NN fact))) (, ,) (NP (NP (DT the) (NN triggering)) (PP (IN of) (NP (NN HLA-DR) (NNS antigens))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ antihuman) (JJ TNF-alpha-neutralizing) (NNS antibodies)))))) (VP (VBD did) (RB not) (VP (VB upregulate) (NP (NP (NN NF-kappa) (NN B)) (CC and) (NP (NN AP-1)))))) (. .))))
(S1 (S (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (VBN released) (NP (NN TNF-alpha))) (VP (VBD was) (RB not) (ADJP (JJ responsible) (PP (IN for) (NP (NP (DT the) (JJ homotypic) (NN aggregation)) (PP (IN of) (NP (NP (NP (NP (NN Ri-I))) (, ,) (NP (NP (NN Ci-I))) (, ,) (NP (NP (NN Sc-I))) (, ,) (CC and) (NP (NN Raji) (NNS cells))) (VP (VBN induced) (PP (IN by) (NP (NN mAb) (NN L243))))))))))) (, ,) (CC and) (S (NP (PRP it)) (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (DT the) (NN proliferation)) (PP (IN of) (NP (NP (NN B) (NNS cells)) (VP (VBN investigated)))))))) (. .))))
(S1 (S (S (ADVP (RB Altogether)) (, ,) (NP (PRP$ our) (NNS data)) (VP (VBP demonstrate) (SBAR (IN that) (S (: :) (S (LST (-LRB- -LRB-) (LS a) (-RRB- -RRB-)) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN B) (NNS cells))) (S (VP (TO to) (VP (VB release) (NP (NN TNF-alpha)) (PP (IN after) (NP (NP (NN triggering)) (PP (IN of) (NP (NN HLA-DR) (NNS antigens))))))))) (VP (VBZ depends) (PP (IN on) (NP (NP (PRP$ their) (NN stage)) (PP (IN of) (NP (NN differentiation))))))) (: ;) (S (LST (-LRB- -LRB-) (LS b) (-RRB- -RRB-)) (NP (NP (NNS levels)) (PP (IN of) (NP (VBN released) (NP (NN TNF-alpha))))) (VP (VP (VBP seem) (S (VP (TO to) (VP (VB correlate) (PP (IN with) (NP (NP (DT the) (NN stage)) (PP (IN of) (NP (NN B-cell) (NN maturation))))))))) (CC but) (VP (VBP do) (RB not) (VP (VB correlate) (PP (IN with) (NP (NP (DT the) (NNS amounts)) (PP (IN of) (NP (NN cell) (NN surface) (NN HLA-DR) (NNS antigens))))))))) (: ;) (S (LST (-LRB- -LRB-) (LS c) (-RRB- -RRB-)) (NP (VBN secreted) (NP (NN TNF-alpha))) (VP (VBZ regulates) (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NP (NN expression)) (PP (IN of) (NP (NP (NN NF-kappa) (NN B)) (CC and) (NP (NN AP-1))))))) (PP (IN by) (NP (DT an) (JJ autocrine) (NN loop))))) (: ;) (CC and) (S (LST (-LRB- -LRB-) (LS d) (-RRB- -RRB-)) (NP (NP (JJ intracellular) (NNS signals)) (VP (VBG mediating) (NP (NP (NP (NN TNF-alpha)) (NN release)) (PP (IN by) (NP (NN B) (NNS cells)))))) (VP (VBP are) (ADJP (JJ distinct) (PP (IN from) (NP (NP (DT those)) (VP (VBG regulating) (NP (JJ homotypic) (NP (NN aggregation)) (CC and) (NP (NN proliferation)))))))))))) (. .))))
(S1 (S (S (S (NP (NP (JJ Immediate) (JJ early)) (CC and) (NP (JJ early) (JJ lytic) (NN cycle) (NNS proteins))) (VP (VBP are) (NP (NP (JJ frequent) (NNS targets)) (PP (IN of) (NP (DT the) (ADJP (ADJP (JJ Epstein-Barr) (JJ virus-induced)) (ADJP (JJ cytotoxic))) (NN T) (NN cell) (NN response))))) (. .)))))
(S1 (S (S (S (NP (NP (NP (JJ Epstein-Barr) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN EBV)) (-RRB- -RRB-))) (, ,) (NP (DT a) (JJ human) (NN gamma-herpesvirus)) (, ,)) (VP (MD can) (VP (VB establish) (NP (CC both) (NP (ADJP (ADJP (JJ nonproductive)) (PRN (-LRB- -LRB-) (ADJP (JJ latent)) (-RRB- -RRB-)))) (CC and) (NP (ADJP (ADJP (JJ productive)) (PRN (-LRB- -LRB-) (ADJP (JJ lytic)) (-RRB- -RRB-)))) (NP (NNS infections))))) (. .)))))
(S1 (S (S (S (SBAR (IN Although) (S (NP (NP (DT the) (JJ CD8+) (NP (NP (JJ cytotoxic) (NN T) (NN lymphocyte)) (PRN (-LRB- -LRB-) (NP (NN CTL)) (-RRB- -RRB-))) (NN response)) (PP (TO to) (NP (RB latently) (JJ infected) (NNS cells)))) (VP (VBZ is) (ADVP (RB well)) (VP (VBN characterized))))) (, ,) (S (NP (RB very) (JJ little)) (VP (VBZ is) (VP (VBN known))) (PP (IN about) (NP (NP (NN T) (NN cell) (NNS controls)) (PP (IN over) (NP (JJ lytic) (NN infection))))))) (: ;) (S (NP (NP (DT this) (NN imbalance)) (PP (IN in) (NP (PRP$ our) (NN understanding)))) (VP (VBZ belies) (NP (NP (DT the) (NN importance)) (PP (IN of) (NP (JJ virus-replicative) (NNS lesions))) (PP (IN in) (NP (NP (JJ several) (NNS aspects)) (PP (IN of) (NP (NN EBV) (NN disease) (NN pathogenesis)))))))) (. .))))
(S1 (S (S (S (NP (DT The) (JJ present) (NN work)) (VP (VBZ shows) (SBAR (IN that) (S (NP (NP (DT the) (JJ primary) (JJ CD8+) (NN CTL) (NN response)) (PP (TO to) (NP (NN EBV))) (PP (IN in) (NP (JJ infectious) (NN mononucleosis) (NNS patients)))) (VP (VBZ contains) (NP (NP (ADJP (ADJP (JJ multiple)) (ADJP (JJ lytic)) (ADJP (JJ antigen-specific))) (NNS reactivities)) (PP (IN at) (NP (NP (NNS levels)) (ADJP (ADVP (IN at) (JJS least)) (ADJP (RB as) (JJ high)) (PP (IN as) (NP (NP (DT those)) (VP (VBN seen) (PP (IN against) (NP (JJ latent) (NNS antigens))))))))))))))) (: ;) (S (NP (JJ similar) (NNS reactivities)) (VP (VBP are) (ADVP (RB also)) (ADJP (JJ detectable) (PP (IN in) (NP (NN CTL) (NN memory)))))) (. .))))
(S1 (S (S (NP (JJ Clonal) (NN analysis)) (VP (VBD revealed) (NP (NP (JJ individual) (NNS responses)) (PP (PP (TO to) (NP (NP (DT the) (CD two) (NP (JJ immediate) (JJ early) (NNS proteins))) (NP (NP (NN BZLF1)) (CC and) (NP (NN BRLF1))))) (, ,) (CC and) (PP (TO to) (NP (NP (CD three)) (PRN (-LRB- -LRB-) (NP (NP (NN BMLF1)) (, ,) (NP (NN BMRF1)) (, ,) (CC and) (NP (NN BALF2))) (-RRB- -RRB-)))) (PP (IN of) (NP (NP (DT the) (CD six) (NP (JJ early) (NNS proteins))) (VP (VBN tested))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (JJ several) (NNS cases))) (, ,) (NP (NP (NP (DT the) (NN peptide) (NN epitope)) (CC and) (NP (JJ HLA-restricting) (NN determinant))) (VP (VBN recognized) (PP (IN by) (NP (DT these) (NP (NNS CTLs)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN defined))) (, ,) (S (NP (CD one) (JJ unusual) (NN feature)) (VP (VBG being) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NNS responses)) (ADJP (JJ restricted) (PP (IN through) (NP (NN HLA-C) (NNS alleles)))))))))) (. .))))
(S1 (S (S (NP (DT The) (NN work)) (ADVP (RB strongly)) (VP (VBZ suggests) (SBAR (SBAR (IN that) (S (NP (JJ EBV-replicative) (NNS lesions)) (VP (VBP are) (ADJP (JJ subject) (PP (TO to) (NP (JJ direct) (NN CTL) (NN control))) (ADVP (FW in) (FW vivo)))))) (CC and) (SBAR (IN that) (S (NP (NP (JJ immediate) (JJ early)) (CC and) (NP (JJ early)) (NP (NNS proteins))) (VP (VBP are) (ADVP (RB frequently)) (NP (DT the) (JJ immunodominant) (NNS targets))))))) (. .))))
(S1 (S (S (NP (DT This)) (VP (VBZ contrasts) (PP (IN with) (NP (NP (NNS findings)) (PP (IN in) (NP (NP (NP (NP (NN alpha-)) (CC and) (NP (NN beta-herpesvirus)) (NP (NNS systems))) (PRN (-LRB- -LRB-) (NP (NP (NN herpes) (NN simplex)) (, ,) (NP (NN cytomegalovirus))) (-RRB- -RRB-))) (SBAR (WHADVP (WRB where)) (S (NP (NP (JJ viral) (NN interference)) (PP (IN with) (NP (DT the) (JJ antigen-processing) (NN pathway))) (PP (IN during) (NP (JJ lytic) (NN infection)))) (VP (VBZ renders) (S (NP (NP (JJ immediate) (JJ early)) (CC and) (NP (JJ early)) (NP (NNS proteins))) (ADJP (ADVP (RB much) (RBR less)) (JJ immunogenic))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ unique) (NN capacity)) (PP (IN of) (NP (NN gamma-herpesvirus))) (S (VP (TO to) (VP (VB amplify) (NP (DT the) (JJ viral) (NN load)) (ADVP (FW in) (FW vivo)) (PP (IN through) (NP (DT a) (ADJP (ADJP (JJ latent)) (ADJP (JJ growth-transforming))) (NN infection))))))) (VP (MD may) (VP (VB have) (VP (VBN rendered) (S (NP (DT these) (NNS agents)) (ADJP (RBR less) (JJ dependent) (PP (IN upon) (NP (JJ viral) (NN replication))))) (PP (IN as) (NP (NP (DT a) (NN means)) (PP (IN of) (S (ADVP (RB successfully)) (VP (VBG colonizing) (NP (PRP$ their) (NNS hosts)))))))))) (. .))))
(S1 (S (S (S (NP (NP (DT A) (JJ new) (NP (NN mouse) (NN gene))) (, ,) (NP (NN SRG3)) (, ,) (ADJP (JJ related) (PP (TO to) (NP (NP (DT the) (NP (NN SWI3))) (PP (IN of) (NP (FW Saccharomyces) (FW cerevisiae)))))) (, ,)) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (NN apoptosis)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS glucocorticoids)) (PP (IN in) (NP (DT a) (NP (NN thymoma) (NN cell) (NN line))))))))))) (. .)))))
(S1 (S (S (S (NP (PRP We)) (VP (VBD isolated) (NP (NP (DT a) (JJ new) (NP (NN mouse) (NN gene))) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADVP (RB highly)) (VP (VBN expressed) (PP (IN in) (NP (NP (NNS thymocytes)) (, ,) (NP (NN testis)) (, ,) (CC and) (NP (NN brain)))))))))) (. .)))))
(S1 (S (S (NP (NP (DT This) (NN gene)) (, ,) (NP (NN SRG3)) (, ,)) (VP (VBD showed) (NP (NP (DT a) (JJ significant) (NN sequence) (NN homology)) (PP (TO to) (NP (NP (NP (NN SWI3)) (, ,) (NP (DT a) (NP (NN yeast) (JJ transcriptional) (NN activator)))) (, ,) (CC and) (NP (PRP$ its) (NP (JJ human) (NN homolog) (NN BAF155))))))) (. .))))
(S1 (S (S (NP (NN SRG3)) (VP (VP (VBZ encodes) (NP (CD 1,100) (NN amino) (NNS acids))) (CC and) (VP (VBZ has) (NP (NP (ADJP (QP (CD 33-47)) (NN %)) (NN identity)) (PP (IN with) (NP (NN SWI3) (NN protein))) (PP (IN over) (NP (CD three) (NNS regions)))))) (. .))))
(S1 (S (S (NP (DT The) (NP (NN SRG3) (NN protein))) (VP (VBZ contains) (NP (NP (DT an) (NP (JJ acidic) (NN NH2) (NN terminus))) (, ,) (NP (DT a) (NP (JJ myb-like) (NN DNA) (NN binding) (NN domain))) (, ,) (NP (DT a) (NP (JJ leucine-zipper) (NN motif))) (, ,) (CC and) (NP (NP (DT a) (NP (NN proline-) (CC and) (JJ glutamine-rich) (NN region))) (PP (IN at) (NP (PRP$ its) (NP (NN COOH) (NN terminus))))))) (. .))))
(S1 (S (S (NP (NP (NN Rabbit) (NN antiserum)) (VP (VBN raised) (PP (IN against) (NP (NP (DT a) (JJ COOH-terminal) (NN polypeptide)) (PP (IN of) (NP (DT the) (NP (NN SRG3)))))))) (VP (VBD recognized) (NP (NP (DT a) (NN protein)) (PP (IN with) (NP (NP (DT an) (JJ apparent) (JJ molecular) (NN mass)) (PP (IN of) (NP (CD 155) (NN kD))))))) (. .))))
(S1 (S (S (NP (DT The) (NN serum)) (ADVP (RB also)) (VP (VBD detected) (NP (NP (DT a) (NP (JJ 170-kD) (NN protein))) (SBAR (WHNP (WDT that)) (S (VP (VBZ seems) (S (VP (TO to) (VP (VB be) (NP (NP (DT a) (NN mouse) (NN homologue)) (PP (IN of) (NP (JJ human) (NN BAF170)))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Immunoprecipitation)) (PP (IN of) (NP (NN cell) (NN extract))) (PP (IN with) (NP (NP (DT the) (NN antiserum)) (PP (IN against) (NP (DT the) (NP (NN mouse) (NN SRG3))))))) (ADVP (RB also)) (VP (VBD brought) (PRT (RP down)) (NP (NP (DT a) (NP (JJ 195-kD) (NN protein))) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VB be) (VP (VBN recognized) (PP (IN by) (NP (NP (DT an) (NN antiserum)) (VP (VBN raised) (PP (IN against) (NP (JJ human) (NN SWI2) (NN protein))))))))))))) (. .))))
(S1 (S (S (NP (DT The) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (DT the) (NP (NN SRG3) (NN protein))) (VP (VBZ associates) (PP (IN with) (NP (DT a) (NP (NN mouse) (NN SWI2)))))))) (. .))))
(S1 (S (S (NP (DT The) (NP (NN SRG3) (NN protein))) (VP (VBZ is) (VP (VBN expressed) (ADVP (ADVP (QP (RB about) (CD three) (NNS times)) (JJR higher)) (PP (IN in) (NP (NNS thymocytes))) (PP (IN than) (PP (IN in) (NP (JJ peripheral) (NNS lymphocytes))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN expression)) (PP (IN of) (NP (NP (JJ anti-sense) (NN RNA)) (PP (TO to) (NP (NN SRG3) (NN mRNA))))) (PP (IN in) (NP (NP (DT a) (NP (NN thymoma) (NN cell) (NN line))) (, ,) (NP (NN S49.1)))) (, ,)) (VP (VP (VBD reduced) (NP (NP (DT the) (NN expression) (NN level)) (PP (IN of) (NP (DT the) (NP (NN SRG3) (NN protein)))))) (, ,) (CC and) (VP (VBD decreased) (NP (NP (DT the) (JJ apoptotic) (NN cell) (NN death)) (VP (VBN induced) (PP (IN by) (NP (NNS glucocorticoids))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (DT the) (NP (NN SRG3) (NN protein))) (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (JJ glucocorticoid-induced) (NN apoptosis)) (PP (IN in) (NP (DT the) (NP (NN thymoma) (NN cell) (NN line))))))))))) (. .))))
(S1 (S (S (NP (DT This)) (VP (VBZ implicates) (SBAR (IN that) (S (NP (DT the) (NP (NN SRG3))) (VP (MD may) (VP (VB play) (NP (DT an) (ADJP (ADJP (JJ important)) (ADJP (JJ regulatory))) (NN role)) (PP (IN during) (NP (NP (NN T) (NN cell) (NN development)) (PP (IN in) (NP (NN thymus)))))))))) (. .))))
(S1 (S (S (S (NP (NN Cytomegalovirus) (JJ immediate) (JJ early) (NNS genes)) (VP (VBP upregulate) (NP (NP (NN interleukin-6)) (NN gene) (NN expression))) (. .)))))
(S1 (S (NP (NP (NN BACKGROUND) (: :)) (S (NP (NP (DT The) (NP (NP (JJ immediate) (JJ early) (NNS genes)) (PRN (-LRB- -LRB-) (NP (NN IE)) (-RRB- -RRB-)))) (PP (IN of) (NP (JJ human) (NP (NP (NN cytomegalovirus)) (PRN (-LRB- -LRB-) (NP (NN CMV)) (-RRB- -RRB-)))))) (VP (VP (MD can) (VP (VB be) (VP (VBN expressed) (PP (IN in) (NP (JJ monocytic) (NNS cells)))))) (CC and) (VP (VBP are) (VP (VBN known) (S (VP (TO to) (VP (VB regulate) (NP (NP (ADJP (JJ viral))) (CC and) (NP (ADJP (JJ cellular))) (NP (NNS genes))))))))) (. .)))))
(S1 (S (S (NP (NP (NN Interleukin-6)) (PRN (-LRB- -LRB-) (NP (NN IL-6)) (-RRB- -RRB-))) (VP (VBZ plays) (NP (DT a) (JJ central) (NN role)) (PP (IN in) (NP (JJ numerous) (NP (ADJP (JJ inflammatory))) (CC and) (NP (ADJP (JJ immune))) (NP (NNS processes))))) (. .))))
(S1 (S (S (NP (NP (NN Interleukin-6)) (NNS levels)) (VP (VBP are) (VP (VBN increased) (PP (IN in) (NP (NP (NN lung) (NN transplant) (NNS patients)) (VP (ADVP (RB clinically)) (VBN diagnosed) (PP (IN with) (NP (NN CMV) (NN pneumonitis)))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN regulation)) (PP (IN of) (NP (NN IL-6)))) (VP (VBZ is) (ADJP (JJ dependent) (PP (IN on) (NP (NP (JJ various) (NNS stimuli)) (SBAR (WHNP (WDT that)) (S (VP (VBP include) (NP (NP (NP (NN lipopolysaccharide)) (PRN (-LRB- -LRB-) (NP (NN LPS)) (-RRB- -RRB-))) (, ,) (NP (NNS viruses)) (, ,) (CC and) (NP (JJ other) (NP (NNS cytokines))))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS studies)) (VP (VBD examined) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN CMV) (NN IE) (NN gene) (NNS products))) (S (VP (TO to) (VP (VB modulate) (NP (NP (NN IL-6)) (NN production))))))) (. .))))
(S1 (S (NP (NP (NNS METHODS) (: :)) (S (NP (NP (NN THP-1) (NNS cells)) (, ,) (NP (DT a) (NP (JJ monocytic) (NN cell) (NN line))) (, ,)) (VP (VBD were) (VP (VBN transfected) (PP (IN with) (NP (DT the) (NP (NN CMV) (NN IE) (NNS genes))))))) (. .))))
(S1 (S (S (NP (NP (NP (NN Interleukin-6)) (NN protein)) (CC and) (NP (NN IL-6) (NN mRNA))) (VP (VBD were) (VP (VBN measured) (PP (IN in) (NP (NP (JJ control)) (CC and) (NP (NN CMV) (JJ immediate) (JJ early) (VBN transfected) (NNS cells)))))) (. .))))
(S1 (S (S (NP (NP (NN Cotransfection)) (PP (IN of) (NP (NP (NN CMV) (NN IE) (NNS genes)) (CC and) (NP (NP (NP (NN IL-6)) (NP (NP (NN chloramphenicol) (NN acetyl) (NN transferase)) (PRN (-LRB- -LRB-) (NP (NN CAT)) (-RRB- -RRB-)))) (CC or) (NP (NN IL-6) (NN luciferase)) (NP (NNS constructs)))))) (VP (VBD were) (VP (VBN used)) (S (VP (TO to) (VP (VB study) (NP (NN IL-6) (NN promoter) (NN activity)))))) (. .))))
(S1 (S (NP (NP (NNS RESULTS) (: :)) (S (NP (NP (NP (NN Interleukin-6) (NN protein))) (CC and) (NP (NN mRNA) (NN production))) (VP (VBD were) (ADVP (RB significantly)) (VP (VBN increased) (PP (IN in) (NP (NP (NNS cells)) (VP (VP (VBN transfected) (PP (IN with) (NP (DT the) (NP (NN CMV) (NN IE) (NNS genes))))) (CC and) (VP (VBN stimulated) (PP (IN with) (NP (NN LPS))))))) (PP (VBN compared) (PP (TO to) (NP (JJ LPS-stimulated) (JJ control) (NNS cells))))))) (. .))))
(S1 (S (S (NP (NN Cytomegalovirus) (NN IE) (NN gene) (NNS products)) (ADVP (RB significantly)) (VP (VBD enhanced) (NP (NP (NN LPS) (NN stimulation)) (PP (IN of) (NP (NP (NN IL-6) (NN promoter)) (NN activity)))) (PP (IN in) (NP (CC both) (NP (NP (NN IL-6)) (NN CAT)) (CC and) (NP (NN IL-6) (NN luciferase)) (NP (NNS assays))))) (. .))))
(S1 (S (S (NP (NP (DT A) (NN deletion) (NN construct)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBZ contains) (NP (DT a) (NP (NN NF-kappa) (NN B) (NN site)))) (CC but) (VP (VBZ is) (VP (VBG missing) (NP (DT the) (JJ multiple) (NN response) (NN region)))))))) (VP (VBD demonstrated) (NP (NP (DT a) (JJ continued) (NN increase)) (PP (IN in) (NP (NP (NP (NN IL-6)) (NP (NN luciferase)) (NN activity)) (PP (IN in) (NP (JJ LPS-stimulated) (NN CMV) (JJ transfected) (NNS cells))))))) (. .))))
(S1 (S (NP (NP (NN CONCLUSION) (: :)) (S (NP (NN Cytomegalovirus) (JJ immediate) (JJ early) (NN gene) (NNS products)) (ADVP (RB significantly)) (VP (VBD enhanced) (NP (NP (NN expression)) (PP (IN of) (NP (NN IL-6))) (PP (IN in) (NP (JJ LPS-stimulated) (NNS cells)))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN increase)) (PP (IN in) (NP (NP (NN IL-6)) (NP (NN luciferase)) (NN activity)))) (VP (VBZ occurs) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NP (DT the) (JJ multiple) (NN response) (NN region)) (, ,) (NP (NP (DT the) (NN area)) (PP (IN of) (NP (DT the) (NP (NN IL-6) (NN promoter)))) (ADJP (JJ responsive) (PP (TO to) (NP (NP (NN IL-1)) (, ,) (NP (NN TNF) (NN alpha)) (, ,) (NP (JJ cyclic) (NN amp)) (, ,) (CC and) (NP (NN phorbol) (NN 12-myristate) (NN 13-acetate))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN ability)) (PP (IN of) (NP (NN CMV) (NN IE) (NN gene) (NNS products))) (S (VP (TO to) (VP (VB enhance) (NP (NP (NN IL-6)) (NN production)))))) (VP (MD may) (VP (VB play) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (ADJP (JJ immune) (JJ inflammatory)) (NNS states)) (VP (VBN associated) (PP (IN with) (NP (NN CMV) (NN infection)))))))) (. .))))
(S1 (S (S (S (NP (JJ Cellular) (NN redox) (NN status)) (VP (VBZ influences) (NP (NP (CC both) (NP (ADJP (JJ cytotoxic))) (CC and) (NP (NN NF-kappa) (NN B)) (NP (NN activation))) (PP (IN in) (NP (JJ natural) (NN killer) (NNS cells))))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (NN role)) (PP (IN of) (NP (JJ cellular) (NN redox) (NN status))) (PP (IN in) (NP (NP (CC both) (NP (JJ cytotoxic) (NN activity)) (CC and) (NP (NP (NN NF-kappa) (NN B)) (NN activation))) (PP (IN in) (NP (JJ natural) (NN killer) (-LRB- -LRB-) (NN NK) (-RRB- -RRB-) (NNS cells)))))) (VP (VBD was) (VP (VBN investigated))) (. .)))))
(S1 (S (S (NP (DT The) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (NN stimulation)) (PP (IN of) (NP (NP (NN NK) (NNS cells)) (, ,) (UCP (CC either) (VP (ADVP (RB freshly)) (VBN isolated) (PP (IN from) (NP (NP (JJ peripheral) (NN blood) (NNS lymphocytes)) (PRN (-LRB- -LRB-) (NP (NNS PBL)) (-RRB- -RRB-))))) (CC or) (NP (JJ long-term) (VBN cultured) (NN NK) (NNS clones))))) (, ,) (PP (IN with) (NP (JJ specific) (NN cell) (NNS targets)))) (VP (VBZ results) (PP (IN in) (NP (NP (DT an) (VBN increased) (NN binding) (NN activity)) (PP (IN of) (NP (NP (NP (NN NF-kappa) (NN B))) (CC and) (NP (NP (NN AP-1))) (NP (NN transcription) (NNS factors)))) (VP (VBN measured) (PP (IN by) (NP (NN gel) (NN retardation)))))))))) (. .))))
(S1 (S (S (S (NP (NP (NN Pretreatment)) (PP (IN of) (NP (NN NK) (NNS cells))) (PP (IN with) (NP (NP (DT the) (JJ antioxidant)) (NP (NP (NN pyrrolidine) (NN dithiocarbarmate)) (PRN (-LRB- -LRB-) (NP (NN PDTC)) (-RRB- -RRB-)))))) (VP (VBZ leads) (PP (TO to) (NP (NP (DT the) (NN inhibition)) (PP (IN of) (NP (NP (NN NF-kappa) (NN B)) (NN activation))))))) (CC but) (S (NP (NP (DT the) (NP (NN AP-1)) (NN binding)) (PP (TO to) (NP (NN DNA)))) (VP (VBD was) (VP (VBN superinduced)))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN inhibition)) (PP (IN of) (NP (NN NF-kappa) (NN B))) (PP (IN by) (NP (NN PDTC)))) (VP (VBD paralleled) (PP (IN with) (NP (NP (DT an) (NN inhibition)) (PP (IN of) (NP (NP (JJ spontaneous) (NN cytotoxicity)) (VP (VBN mediated) (PP (IN by) (NP (NN NK) (NNS cells))))))))) (. .))))
(S1 (S (S (ADVP (RB Moreover)) (, ,) (NP (NP (NP (DT the) (NNS inhibitors)) (PP (IN of) (NP (NN serine) (NNS proteases)))) (, ,) (NP (NP (NN N-alpha-tosyl-L-lysine) (NN chloromethyl) (NN ketone)) (CC and) (NP (NN N-alpha-tosyl-L-phenylalanine) (NN chloromethyl) (NN ketone))) (, ,)) (ADVP (RB also)) (VP (VBD blocked) (NP (NP (DT the) (JJ cytolytic) (NN activity)) (PP (IN of) (NP (NN NK) (NNS cells)))) (PP (IN against) (NP (NP (DT the) (JJ sensitive) (NN target)) (NP (NN K562))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NN NK) (NN activity)) (VP (VBD was) (RB not) (VP (VBN affected) (PP (IN by) (NP (NP (NN pretreatment)) (PP (IN of) (NP (DT the) (NN effector) (NNS cells))) (PP (IN with) (NP (NP (NP (DT the) (NP (NN proteasome)) (NN inhibitor)) (NP (NN N-acetyl-leu-leu-norleucinal))) (SBAR (WHNP (WDT which)) (S (ADVP (RB selectively)) (VP (VBZ inhibits) (NP (NP (NN NF-kappa) (NN B)) (NN activation))))))))))) (. .))))
(S1 (S (S (ADVP (RB Altogether)) (, ,) (NP (DT these) (NNS results)) (VP (VBP support) (NP (DT the) (NN hypothesis) (SBAR (SBAR (IN that) (S (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN NK) (NNS cells)))) (VP (VBD involved) (NP (NP (ADJP (JJ transcriptional))) (CC and) (NP (ADJP (JJ post-transcriptional))) (NP (NNS events)))))) (, ,) (CC and) (SBAR (IN that) (S (NP (JJ reactive) (NNS intermediates)) (VP (MD may) (VP (VB play) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (DT the) (JJ molecular) (NNS processes)) (ADJP (JJ related) (PP (IN with) (NP (NP (DT the) (NN generation)) (PP (IN of) (NP (DT a) (JJ cytotoxic) (NN response))) (PP (IN by) (NP (NN NK) (NNS cells))))))))))))))) (. .))))
(S1 (S (NP (NP (NP (JJ Abnormal) (NP (NN T) (NN lymphocyte)) (NN development)) (VP (VBN induced) (PP (IN by) (NP (NP (VBN targeted) (NN overexpression)) (PP (IN of) (NP (NN IkappaB) (NN alpha)))))) (. .)))))
(S1 (S (S (S (NP (NP (DT A) (NN role)) (PP (IN in) (NP (JJ thymic) (NN maturation))) (PP (IN for) (NP (NP (NNS factors)) (PP (IN of) (NP (DT the) (NP (NN NF-kappaB) (NN family))))))) (VP (VBZ has) (ADVP (RB long)) (VP (VBN been) (VP (VP (VBN suspected)) (, ,) (CC but) (VP (ADVP (RB not) (RB yet)) (VBN proven))))) (. .)))))
(S1 (S (S (NP (NP (JJ Transgenic) (NNS mice)) (PP (IN with) (NP (NP (DT a) (JJ lymphocyte-specific) (NN defect)) (PP (IN in) (NP (NP (NN NF-kappaB)) (NN activation)))))) (VP (VBD were) (VP (VBN produced) (PP (IN by) (NP (NP (VBN targeted) (NN expression)) (PP (IN of) (NP (JJ human) (NP (NN IkappaB) (NN alpha)))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ thymic) (NN cellularity)) (PP (IN of) (NP (DT these) (NNS mice)))) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN decreased))) (. .))))
(S1 (S (S (S (NP (NP (DT The) (NN proportion)) (PP (IN of) (NP (NP (JJ mature) (, ,) (NP (JJ TCRhigh) (NNS thymocytes))) (PP (IN of) (NP (DT the) (NP (NN alphabeta) (NN lineage))))))) (VP (VBD was) (VP (VBN reduced)))) (, ,) (CC and) (S (NP (DT the) (VBG remaining) (NP (JJ TCRhigh) (NN population))) (VP (VBD contained) (NP (NP (DT an) (ADJP (RB unusually) (JJ high)) (NN proportion)) (PP (IN of) (NP (JJ double-positive) (NNS cells)))))) (. .))))
(S1 (S (S (NP (NP (DT This) (NN defect)) (PP (IN in) (NP (NN maturation)))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (NN transgene) (JJ dose-dependent) (NN reduction)) (PP (IN in) (NP (JJ peripheral) (NN T) (NNS lymphocytes))))) (, ,) (PP (IN with) (S (NP (DT the) (NP (NN CD8) (NN lineage))) (VP (VBG being) (ADVP (RBR more) (RB severely)) (VP (VBN affected)))))) (. .))))
(S1 (S (S (NP (DT These) (NNS data)) (VP (VBP provide) (NP (NP (JJ direct) (NN evidence)) (PP (IN for) (NP (NP (DT the) (NN involvement)) (PP (IN of) (NP (NN NF-kappaB/Rel) (NN family) (NNS proteins))) (PP (IN in) (NP (NP (JJ late) (NNS stages)) (PP (IN of) (NP (NP (NN T) (NN lymphocyte)) (NN development)))))))) (, ,) (ADVP (JJ coincident) (PP (IN with) (NP (NP (ADJP (JJ positive))) (CC and) (NP (ADJP (JJ negative))) (NP (NN selection)))))) (. .))))
(S1 (S (NP (NP (NP (JJ Sequential) (NN development)) (PP (IN of) (NP (NP (NP (ADJP (JJ structural))) (CC and) (NP (ADJP (JJ functional))) (NP (NNS alterations))) (PP (IN in) (NP (NP (NN T) (NNS cells)) (PP (IN from) (NP (NN tumor-bearing) (NNS mice))))))) (. .)))))
(S1 (S (S (S (NP (DT The) (NN TCR) (NP (NN alpha) (NN beta)) (CC or) (NP (NN -gamma) (NN delta)) (NP (NNS chains))) (VP (VBP bind) (NP (DT the) (NN peptide) (NN ligand)) (, ,) (SBAR (IN whereas) (S (NP (DT the) (VBN associated) (NP (NP (NN CD3) (NN delta) (NN epsilon) (NN gamma))) (CC and) (NP (NN TCR) (NN zeta) (NNS subunits))) (VP (VBP couple) (NP (DT the) (NP (NN TCR))) (PP (TO to) (NP (JJ intracellular) (NN signal) (NN transduction) (NNS components))))))) (. .)))))
(S1 (S (S (ADVP (RB Recently)) (, ,) (NP (JJ several) (NNS groups)) (VP (VBP have) (VP (VBN described) (NP (NP (JJ marked) (NNS alterations)) (PP (IN in) (NP (NP (NN signal) (NN transduction) (NNS elements)) (PP (PP (IN in) (NP (NP (NN T) (NNS cells)) (PP (IN from) (NP (NN cancer) (NNS patients))))) (CC or) (PP (IN in) (NP (NP (NNS mice)) (VP (VBG bearing) (NP (NN tumor)) (PP (IN for) (NP (NP (DT a) (JJ few) (NNS weeks)) (PRN (-LRB- -LRB-) (ADJP (JJR &gt;) (NP (CD 26) (NNS days))) (-RRB- -RRB-))))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN sequence)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (DT these) (NNS alterations)) (VP (VBP develop))))) (VP (VBZ is) (ADJP (JJ unknown))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB explore) (NP (NP (DT the) (NNS kinetics)) (PP (IN of) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (NNS alterations)) (PP (IN in) (NP (NP (NP (NN signal) (NN transduction) (NNS molecules)) (PRN (-LRB- -LRB-) (NP (NP (NN TCR) (NN zeta) (NN chain)) (, ,) (NP (NN NF) (NN kappaB) (NN family) (NNS proteins)) (, ,) (CC and) (NP (NN tyrosine) (NN kinase) (NN p56) (-LRB- -LRB-) (NN lck) (-RRB- -RRB-))) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NNS mice)) (VP (VBG bearing) (NP (NN MC38) (NN colon) (NN adenocarcinoma)))))))))))))))) (. .))))
(S1 (S (S (NP (DT The) (NNS results)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (NP (NNS alterations)) (PP (IN in) (NP (NN NF) (NN kappaB) (NN family) (NNS proteins)))) (, ,) (ADVP (RB specifically)) (NP (NP (DT the) (NN failure)) (PP (IN of) (NP (NP (NP (NN p65)) (NN translocation)) (PP (TO to) (NP (DT the) (NN nucleus)))))) (, ,)) (VP (VBP occur) (ADVP (ADVP (ADVP (RBR earlier)) (CC and) (ADVP (RBR more) (RB frequently))) (SBAR (IN than) (S (NP (NP (DT the) (NN decrease)) (PP (IN in) (NP (NN zeta-chain))))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS defects)) (VP (VBP are) (VP (VBN paralleled) (PP (IN by) (NP (DT an) (JJ impaired) (NN ability) (S (VP (TO to) (VP (VB produce) (NP (NP (NN Th1) (NNS cytokines)) (PRN (-LRB- -LRB-) (NP (NP (NN IL-2)) (CC and) (NP (NN IFN-gamma))) (-RRB- -RRB-)))))))))) (. .))))
(S1 (S (S (NP (DT These) (JJ initial) (NNS changes)) (VP (VBP are) (VP (VBN followed) (PP (IN by) (NP (NP (NP (DT the) (JJ eventual) (NN loss)) (PP (IN of) (NP (NP (NN TCR) (NN zeta) (NN chain)) (CC and) (NP (NN p56) (-LRB- -LRB-) (NN lck) (-RRB- -RRB-))))) (CC and) (NP (NP (DT a) (JJ marked) (NN decrease)) (PP (IN in) (NP (JJ cytotoxic) (NN function)))))))) (. .))))
(S1 (S (S (NP (NP (DT An) (VBN increased) (NN rate)) (PP (IN of) (NP (JJ lysosomal) (NN degradation)))) (VP (VBZ is) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (NNS mechanisms)) (ADJP (JJ responsible) (PP (IN for) (NP (NP (DT the) (NN loss)) (PP (IN of) (NP (NN zeta-chain)))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (NN interleukin-10) (NN receptor)) (NN expression)) (PP (IN on) (NP (NN B-cell) (JJ chronic) (JJ lymphocytic) (NN leukemia) (NNS cells))))) (. .)))))
(S1 (S (S (S (NP (NN B-cell) (JJ chronic) (JJ lymphocytic) (NN leukemia) (-LRB- -LRB-) (NN B-CLL) (-RRB- -RRB-) (NNS cells)) (VP (VBP accumulate) (ADVP (FW in) (FW vivo)) (PP (IN in) (NP (NP (DT the) (NN G0/G1) (NN phase)) (PP (IN of) (NP (DT the) (NN cell) (NN cycle))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (PRP$ their) (JJ malignant) (NN expansion)) (VP (VBZ is) (ADJP (JJ due) (, ,) (PP (ADVP (IN at) (JJS least)) (IN in) (NP (NN part))) (, ,) (PP (TO to) (NP (NP (DT a) (NN delay)) (PP (IN in) (NP (NN cell) (NN death)))))))))))) (. .)))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (NP (ADJP (JJ cellular))) (CC or) (NP (JJ molecular) (NNS factors))) (ADJP (JJ responsible) (PP (IN for) (NP (NP (DT a) (NN delay)) (PP (IN in) (NP (NN B-CLL) (NN cell) (NN death))))))) (VP (VBP are) (ADJP (JJ unknown))) (. .))))
(S1 (S (S (S (NP (NN B-CLL) (NNS cells)) (VP (VBP do) (VP (VB express) (NP (NP (NNS receptors)) (PP (IN for) (NP (NP (NP (NN interferon-alpha)) (PRN (-LRB- -LRB-) (NP (NN IFN-alpha)) (-RRB- -RRB-))) (CC and) (NP (NN IFN-gamma)))))))) (, ,) (CC and) (S (NP (NP (NN activation)) (PP (IN of) (NP (DT both)))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB promote) (NP (NP (NN B-CLL) (NN survival)) (ADJP (FW in) (FW vitro))) (PP (IN by) (S (VP (VBG preventing) (NP (NN apoptosis)))))))))))) (. .))))
(S1 (S (S (S (NP (DT The) (NP (NN interleukin-10) (-LRB- -LRB-) (NN IL-10) (-RRB- -RRB-) (NN receptor))) (VP (VBZ is) (NP (NP (DT another) (NN member)) (PP (IN of) (NP (DT the) (NP (NN IFN) (NN receptor) (NN family))))))) (, ,) (CC but) (S (NP (NP (PRP$ its) (NN ligand)) (, ,) (NP (NN IL-10)) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB induce) (NP (NN apoptosis)) (PP (IN in) (NP (NN B-CLL) (NNS cells)))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT the) (JJ current) (NN study))) (, ,) (NP (PRP we)) (VP (VP (VBD undertook) (NP (NP (DT a) (JJ biochemical) (NN analysis)) (PP (IN of) (NP (NP (NP (NN IL-10) (NN receptor)) (NN expression)) (PP (IN on) (NP (ADJP (RB freshly) (VBN isolated)) (NP (NN B-CLL) (NNS cells)))))))) (CC and) (VP (VBD characterized) (NP (NP (DT the) (JJ functional) (NN responsiveness)) (PP (IN of) (NP (NP (NP (NN IL-10)) (NN binding)) (PP (TO to) (NP (PRP$ its) (NP (RB constitutively) (VBN expressed) (NN receptor))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP show) (SBAR (IN that) (S (NP (NN B-CLL) (NNS cells)) (VP (VP (VBP bind) (NP (NN IL-10)) (PP (IN with) (NP (JJ significant) (NN specificity)))) (CC and) (VP (VBP express) (PP (IN between) (NP (NP (QP (CD 47) (CC and) (CD 127)) (NP (NN IL-10) (NN receptor)) (NNS sites)) (PP (IN per) (NP (NN cell))))) (, ,) (PP (IN with) (NP (DT a) (NN dissociation) (NN constant)) (PP (IN in) (NP (NP (DT the) (NN range)) (PP (IN of) (NP (QP (CD 168) (TO to) (CD 426) (CC x) (CD 10-LRB--12-RRB-)) (NN mol/L))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Ligand) (NP (NN binding)) (CC and) (NP (NN activation))) (PP (IN of) (NP (NP (DT the) (NP (NN IL-10) (NN receptor))) (VP (VBN expressed) (PP (IN on) (NP (NN B-CLL) (NNS cells))))))) (VP (VBZ results) (PP (IN in) (NP (NP (DT the) (NN phosphorylation)) (PP (IN of) (NP (NP (NP (NN signal) (NN transducer) (CC and) (NN activator) (IN of) (NN transcription) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN STAT1)) (-RRB- -RRB-))) (CC and) (NP (NP (NN STAT3))) (NP (NNS proteins))))))) (. .))))
(S1 (S (S (NP (NP (DT This) (NN pattern)) (PP (IN of) (NP (NP (NN STAT) (NN protein)) (NN phosphorylation)))) (VP (VBZ is) (ADJP (ADJP (JJ identical) (PP (TO to) (NP (NP (NP (NN IL-10) (NN receptor)) (NN activation)) (PP (IN on) (NP (JJ normal) (NNS cells)))))) (CC and) (ADJP (JJ similar) (PP (TO to) (NP (NP (NP (NP (NN IFN-alpha)) (PRN (-LRB- -LRB-) (NP (NP (NN STAT1)) (CC and) (NP (NN STAT3))) (-RRB- -RRB-))) (CC and) (NP (NP (NN IFN-gamma)) (PRN (-LRB- -LRB-) (NP (NN STAT1)) (-RRB- -RRB-))) (NP (NN receptor) (NN activation))) (PP (IN in) (NP (NN CLL)))))))) (. .))))
(S1 (S (S (ADVP (RB Further)) (, ,) (PP (IN in) (NP (NP (JJ consecutive) (NNS samples)) (PP (IN of) (NP (NP (JJ fresh) (NN blood)) (VP (VBN obtained) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (NN B-CLL) (NNS cells)))))))))) (, ,) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NN IL-10)))) (VP (VP (VBD inhibited) (NP (NP (NN B-CLL)) (NN proliferation))) (, ,) (VP (VBD enhanced) (NP (NP (NN B-CLL)) (NN differentiation))) (, ,) (CC but) (VP (VBD did) (RB not) (VP (VB induce) (NP (NN apoptosis))))) (. .))))
(S1 (S (S (ADVP (RB Indeed)) (, ,) (NP (NP (NN IL-10)) (, ,)) (PP (IN like) (NP (NN IFN-gamma))) (, ,) (VP (VBD was) (ADJP (JJ able) (S (VP (TO to) (ADVP (RB significantly)) (VP (VB reduce) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NP (NN B-CLL) (NN cell) (NN death)) (VP (VBN caused) (PP (IN by) (NP (JJ hydrocortisone-induced) (NN apoptosis)))))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (NP (NP (NNS cytokines)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP signal) (PP (IN through) (NP (NP (DT the) (NP (NN interferon) (NN family))) (PP (IN of) (NP (NNS receptors)))))))) (, ,)) (VP (VBP have) (NP (ADJP (JJ comparable) (JJ functional)) (NNS effects)) (PP (IN on) (NP (NN B-CLL) (NNS cells))))))) (. .))))
(S1 (S (NP (NP (NP (DT An) (JJ isotype-specific) (NN activator)) (PP (IN of) (NP (JJ major) (NN histocompatibility) (NN complex) (-LRB- -LRB-) (NN MHC) (-RRB- -RRB-) (NN class) (CD II) (NNS genes))) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADJP (JJ independent) (PP (IN of) (NP (NN class) (CD II) (NN transactivator))))))) (. .)))))
(S1 (S (S (S (NP (NP (NNS Patients)) (PP (IN with) (NP (NP (CD one) (NN type)) (PP (IN of) (NP (NP (JJ major) (NN histocompatibility) (NN complex) (NN class) (CD II)) (JJ combined) (NN immunodeficiency)))))) (VP (VBP have) (NP (NNS mutations)) (PP (IN in) (NP (NP (DT a) (NN gene)) (VP (VBN termed) (S (NP (NP (NP (NN class) (CD II) (NN transactivator)) (PRN (-LRB- -LRB-) (NP (NN CIITA)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB coordinately)) (VP (VBZ controls) (NP (NP (DT the) (NN transcription)) (PP (IN of) (NP (NP (DT the) (CD three) (JJ major) (NP (JJ human) (NN class) (CD II) (NNS genes))) (, ,) (NP (NP (NN HLA-DR)) (, ,) (NP (NN -DQ)) (, ,) (CC and) (NP (NN -DP))))))))))))))) (. .)))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (ADJP (RB experimentally) (VBN derived)) (NP (JJ B-lymphoblastoid) (NN cell) (NN line))) (, ,) (NP (NN clone) (CD 13)) (, ,)) (VP (VBZ expresses) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NN HLADQ)))) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NP (NN HLA-DR)) (CC and) (NP (NN HLA-DP)))))) (, ,) (PP (IN despite) (NP (NP (PRP$ its) (NN mapping)) (PP (IN by) (NP (NN complementation) (NN analysis))) (PP (TO to) (NP (DT this) (NN group)))))) (. .))))
(S1 (S (S (NP (NP (PRP It))) (VP (VBD was) (ADJP (JJ possible)) (SBAR (IN that) (S (NP (NP (CD one)) (PP (IN of) (NP (DT the) (NP (NN clone) (CD 13) (NN CIITA) (NNS alleles))))) (VP (VBP bore) (NP (NP (DT a) (NN mutation)) (SBAR (WHNP (WDT that)) (S (VP (VBD allowed) (NP (NP (NP (NN HLA-DQ))) (, ,) (CC but) (NP (RB not) (NP (NN HLA-DR)) (CC or) (NP (NN -DP)) (NP (NN transcription)))))))))))) (. .))))
(S1 (S (S (ADVP (RB Alternatively)) (, ,) (NP (NP (DT another) (NN factor)) (, ,) (ADJP (JJ distinct) (PP (IN from) (NP (NN CIITA)))) (, ,)) (VP (MD might) (VP (VB control) (NP (NP (NN HLA-DQ)) (NN expression)))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP report) (ADVP (RB here)) (SBAR (IN that) (S (NP (NP (JJ ectopic) (NN expression)) (PP (IN of) (NP (NP (NN CIITA) (NNS cDNAs)) (VP (VBN derived) (PP (IN by) (NP (NP (JJ reverse) (NN transcriptase) (NN polymerase) (NN chain) (NN reaction)) (PP (IN from) (NP (NN clone) (CD 13))))))))) (VP (VBP do) (RB not) (VP (VB restore) (NP (NP (NN expression)) (PP (IN of) (NP (NN HLA-DQ)))) (PP (IN in) (NP (NP (DT another) (NP (JJ CIITA-deficient) (NN cell) (NN line))) (, ,) (NP (NN RJ2.2.5))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (DT no) (NP (NN CIITA)) (NN protein)) (VP (VBZ is) (ADJP (JJ detectable) (PP (IN in) (NP (NP (NN clone) (CD 13)) (JJ nuclear) (NNS extracts))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (JJ somatic) (NN cell) (NN fusion)) (PP (IN between) (NP (NP (NN clone) (CD 13)) (CC and) (NP (NN RJ2.2.5))))) (VP (VBD restored) (NP (NP (NN expression)) (PP (IN of) (NP (NP (DT the) (NP (NN HLA-DQ)) (NN haplotype)) (VP (VBN encoded) (PP (IN by) (NP (DT the) (NP (NN RJ2.2.5) (NN DQB) (NN gene))))))))) (. .))))
(S1 (S (S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (S (NP (DT these) (NNS data)) (VP (VBP demonstrate) (NP (NP (DT the) (NN existence)) (PP (IN of) (NP (NP (DT an) (NP (NN HLA-DQ) (JJ isotype-specific) (JJ trans-acting) (NN factor))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ functions) (ADVP (RB independently) (PP (IN of) (NP (NN CIITA)))))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Uncoupling)) (PP (IN of) (NP (NN cell) (NN cycle) (NN arrest))) (PP (IN from) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (JJ monocytic) (NN differentiation) (NNS markers))) (PP (IN in) (NP (NN HL60) (NN cell) (NNS variants))))) (. .)))))
(S1 (S (S (S (NP (NN Differentiation)) (ADVP (RB generally)) (VP (VBZ leads) (PP (TO to) (NP (NN cell) (NN cycle) (NN arrest)))) (. .)))))
(S1 (S (S (NP (JJ Human) (NN leukemia) (NN HL60) (NNS cells)) (VP (VP (VBP respond) (PP (TO to) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (NN 1,25-dihydroxyvitamin) (NN D3)) (PRN (-LRB- -LRB-) (NP (NN 1,25D3)) (-RRB- -RRB-)))))) (PP (IN by) (S (VP (VBG expressing) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NP (NNS markers)) (PP (IN of) (NP (DT the) (NN monocyte/macrophage) (NN phenotype)))))))))) (CC and) (VP (VBP become) (VP (VBN arrested) (PP (ADVP (RB predominantly)) (IN in) (NP (NP (DT the) (NN G1) (NN phase)) (PP (IN of) (NP (DT the) (NN cell) (NN cycle)))))))) (. .))))
(S1 (S (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB recently)) (VP (VBN reported) (NP (NP (DT a) (NN series) (-LRB- -LRB-) (NN A) (-RRB- -RRB-)) (PP (IN of) (NP (NP (JJ 1,25D3-resistant) (NNS variants)) (PP (IN of) (NP (NN HL60) (NNS cells))) (SBAR (WHNP (WDT which)) (S (VP (VP (VBP proliferate) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN 1,25D3)))))) (CC and) (VP (VBP do) (RB not) (VP (VB express) (NP (NN differentiation) (NNS markers))))))))))))) (PRN (-LRB- -LRB-) (NP (NP (NNP Exp.) (NNP Cell) (NNP Res.)) (NP (CD 224) (, ,) (CD 312)) (, ,) (NP (CD 1996))) (-RRB- -RRB-)) (. .))))
(S1 (S (S (NP (PRP We)) (ADVP (RB now)) (VP (VBP describe) (NP (NP (DT another) (NN series) (-LRB- -LRB-) (NN B) (-RRB- -RRB-)) (PP (IN of) (NP (JJ such) (NNS variants))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP differ) (PP (IN from) (NP (NP (NN A) (NN series) (NNS cells)) (VP (VBN grown) (PP (IN in) (NP (NP (JJ similar) (NNS concentrations)) (PP (IN of) (NP (NN 1,25D3)))))))) (PP (IN in) (SBAR (IN that) (S (S (NP (PRP they)) (VP (VBP express) (NP (NP (DT the) (NP (NN CD14) (NN antigen))) (CC and) (NP (JJ nonspecific) (NP (NN esterase)))) (, ,) (ADVP (JJ characteristic) (PP (IN of) (NP (DT the) (NN monocyte)))) (, ,) (SBAR (IN while) (S (VP (VBG continuing) (S (VP (TO to) (NP (NN proliferate))))))))) (CC and) (S (NP (PRP they)) (VP (VBP develop) (NP (NP (NP (JJ hypotetraploid) (NN DNA)) (PRN (-LRB- -LRB-) (NP (NN 4C)) (-RRB- -RRB-))) (NN content)) (PP (IN at) (NP (NP (NP (JJR higher) (NNS concentrations)) (PP (IN of) (NP (JJ ambient) (NN 1,25D3)))) (PP (IN than) (NP (DT the) (NN A) (NN series) (NNS cells))))))))))))))) (. .))))
(S1 (S (S (NP (NP (NNS Cells)) (PP (IN in) (NP (DT the) (NN B) (NN series))) (PP (IN with) (NP (NP (NN 4C) (NN DNA) (NN content)) (PRN (-LRB- -LRB-) (NP (NP (NN 100B)) (CC and) (NP (NN 200B))) (-RRB- -RRB-))))) (ADVP (RB also)) (VP (VBD differed) (PP (IN from) (NP (DT the) (NP (NN A) (NN series) (NN 4C) (NNS cells)))) (PP (IN by) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NP (NN DNA) (NN binding)) (PP (IN by) (NP (DT the) (JJ full-length) (NP (NN Sp1)) (NP (NN transcription) (NN factor))))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NN B) (NN series) (NNS cells)) (VP (VP (VBD resembled) (NP (DT the) (NN A) (NN series) (NNS cells)) (PP (IN in) (S (VP (VBG exhibiting) (NP (NP (JJR faster) (NN growth) (NNS rates)) (SBAR (IN than) (S (NP (DT the) (JJ parental) (NP (NN HL60) (NNS cells)))))))))) (CC and) (VP (VBD showed) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NP (NN vitamin) (NN D) (NN receptor)) (CC and) (NP (NN retinoid) (NN receptor) (NN X) (NNS proteins))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (JJ initial) (NNS steps)) (PP (IN in) (NP (DT the) (NN 1,25D3) (NN signaling) (NN pathway)))) (VP (VP (VBP are) (ADJP (JJ intact) (PP (IN in) (NP (NN B) (NNS series) (JJ resistant) (NNS cells))))) (CC and) (VP (VBP lead) (PP (TO to) (NP (NP (DT the) (NN appearance)) (PP (IN of) (NP (NP (JJ early) (NNS markers)) (PP (IN of) (NP (JJ monocytic) (NN differentiation)))))))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (NN progression)) (PP (TO to) (NP (NP (JJ subsequent) (NNS events)) (SBAR (WHNP (WDT which)) (S (VP (VBP comprise) (NP (NP (JJ terminal) (NN differentiation)) (CC and) (NP (NN cell) (NN cycle) (NN arrest))))))))) (VP (VBZ is) (VP (VBN halted) (PP (IN during) (NP (NP (DT the) (NN adaptation)) (PP (TO to) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN 1,25D3))) (PP (IN in) (NP (DT these) (NNS cells))))))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN availability)) (PP (IN of) (NP (DT these) (JJ variant) (NNS cells)))) (VP (MD should) (VP (VB provide) (NP (NP (DT a) (NN system)) (PP (IN for) (S (VP (VBG studying) (NP (NP (DT the) (NN link)) (PP (IN between) (NP (NP (NN differentiation)) (CC and) (NP (NN cell) (NN cycle) (NN arrest))))))))))) (. .))))
